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ABSTRACT 
Oxygen is vital to the survival of many living things, and evolution has provided the human body 
with a complex cardiovascular system to ensure that all of the cells in the body are provided with 
adequate oxygen. Achieving adequate oxygen delivery remains of critical importance to the 
clinical management of many human diseases and has been the impetus for the development of 
many medical procedures and technologies. Despite much advancement in the understanding 
about oxygen delivery in the body, the current inability to attain life-sustaining levels of tissue 
oxygenation remains the major limitation for the emerging fields of cell, tissue, and organ 
replacement. There is a large body of research focused on developing methods to improve 
vascularization and oxygen supply for transplanted cells, tissues and organs, and this substantial 
challenge will require an interdisciplinary approach utilizing both engineering principles and a 
broad understanding of the physical science. The islet transplantation process can be divided into 
three critical steps: tissue procurement and preservation; isolation, culture and shipment; and graft 
transplantation and monitoring. To begin, whole organ oxygen consumption rate (WOOCR) 
measurements are presented for the assessment of organ viability, followed by the description of 
new techniques for improving the efficacy of pancreas cooling during procurement, and the use 
of hypothermic machine perfusion (HMP) to improve pancreas preservation. These methods can 
be used to qualify biological tissue products and to evaluate and improve organ procurement and 
preservation. Next, HMP combined with silicon-rubber-membrane (SRM) culture systems are 
presented as techniques to improve the quality of tissues isolated from juvenile porcine pancreata, 
and advanced nutrient supplementation with suspension culture systems are shown to improve β-
cell expansion. Finally, 19F-MRS oximetry techniques are presented for non-invasive oxygen 
monitoring of tissue-engineered grafts (TEGs), and these techniques are further applied to 
develop, implement, and validate a novel method for oxygen delivery to an implanted tissue-
engineered islet grafts. 
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 INTRODUCTION Chapter 1
 
Background 
Diabetes is a devastating disease, resulting in substantial humanitarian and economic suffering 
around the world. The international diabetes federation1 reports that nearly 1 out of every 12 
people (8.3%) in the world have diabetes and nearly half of those people remain undiagnosed. 
This disease afflicts more than 387 million people in the world today, and this number is expected 
to increase to over 500 million people during the next 20 years. The global economic impact is 
estimated to be 612 billion dollars, and accounts for more than 10% of all health care expenses in 
the world. The rate of diabetes in the United States is even worse with the CDC2 reporting 9.3% 
of the U.S. population has diabetes. This amounts to nearly 30 million people with approximately 
1.7 million new cases each year. These numbers do not account for the estimated 86 million 
Americans with “pre-diabetes” who are at high risk for developing diabetes during their lifetime. 
The economic burden in the United States alone is estimated to be more than 245 billion dollars 
per year. In the United States, diabetes is primarily managed by insulin injection, oral medication 
and lifestyle changes (eg. dietary management). Despite the extensive developments for 
improving treatment of this disease in the past decade, complications related to diabetes are still 
the 7th leading cause of death in the United States. Diabetes is still the primary cause of kidney 
failure, non-traumatic lower-limb amputations, and blindness in adults. Adults with diabetes in 
the U.S. are 1.7 times more likely to die from cardiovascular disease than adults without diabetes. 
This disease is clearly a systemic disease that affects every major organ system in the human 
body, and there is a growing need to improve treatment, optimize management, and to ultimately 
find a cure for diabetes. 
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A brief explanation of the disease itself is important for understanding the motivations of the 
work presented herein. The common disease called “diabetes” is medically termed “diabetes 
mellitus,” and is classified as a defect in carbohydrate metabolism that results in the inability of 
the body to regulate the concentration of glucose in the blood. The term diabetes mellitus 
originates from the Greek and Latin language and the translation is roughly “sweet urination” and 
describes frequent urination, and excessive sugar in the urine, which are defining symptoms of 
the disease. The medical explanations of these symptoms are beyond the scope of this work, but 
some basic terminology is needed to understand the challenges of diabetes treatment, and the 
subject matter discussed herein. People diagnosed with diabetes are classified into two primary 
“types” based on the pathophysiology and onset. Type 1 diabetes (T1D) is defined by the 
complete or near-complete autoimmune destruction of the insulin secreting “islet of Langerhans” 
or simply “islets” within the pancreas, and results in relatively rapid onset of hyperglycemia (or 
high-blood glucose levels) and the associated symptoms. Type 2 diabetes (T2D) is a bit more 
difficult to define, but is primarily characterized by a relatively gradual development of glucose 
intolerance that results from various other medical deficiencies (eg. insulin resistance). 
Regardless of the clinical pathophysiology, the resulting symptoms are similar, and are 
fundamentally caused by insufficient blood glucose regulation due to insufficient endocrine 
function of the pancreas. The hallmark condition resulting in disease progress is insufficient 
production of insulin. Insulin is a metabolic hormone produced by β-cells within a complex 
cluster of cells called the “islets of Langerhans,” which reside in the pancreas. When islets are 
destroyed by the immune system (eg. T1D) or can no longer meet the metabolic demand (eg. 
T2D), then blood glucose levels cannot be effectively regulated. The result is generally increased 
blood glucose concentrations (termed “hyperglycemia”) that are implicated in the majority of the 
complications related to diabetes.  
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As mentioned above, the primary medical treatments for diabetes are either oral or injected 
insulin therapy. This treatment became available following the discovery of insulin by Drs. 
Frederick Banting, and Charles Best in 19213–5, and has successfully prevented the acute 
complications of hyperglycaemia that eventually leads to death. Many advances in the last 
century have allowed patients to live with diabetes; however as the current statistics demonstrate, 
diabetes still causes significant morbidity and mortality around the world. For people diagnosed 
with T1D, insulin therapy is a requirement, and most patients are burdened with the responsibility 
of measuring blood glucose and administering insulin injections 5 or more times each day. Even 
with diligent monitoring and care, patients become susceptible to hypoglycemic events, and the 
numerous chronic complications associated with hyperglycemia discussed above. For people 
undergoing intensive insulin administration (primarily T1D), the primary adverse event is severe 
hypoglycemia (low blood sugars)2,6,7, which can result in coma and death if not immediately 
treated. Despite recent advances in insulin administration technology like insulin pumps and 
continuous glucose sensing, insulin therapies cannot mimic the physiologic feedback-controlled 
regulation of blood glucose provided by native islets. 
Pancreas transplantation was first pioneered by Drs. William Kelly, and Richard Lillehei in the 
1960s, and the following developments indicated that pancreas transplantation could successfully 
normalize blood glucose levels. These observations initiated numerous investigations for 
treatments categorized as β-cell replacement. One such method developed was a less invasive 
technique for islet transplantation8,9, which entails isolation of islets from a surgically procured 
pancreas, and then transplantation of only the islets into a patient. Discussions of these procedures 
are included in the following chapters, but the promise of this basic technique is the basis for the 
work described herein. Briefly, a pancreas is procured from a donor, and then the islets, which 
make up only 2% of the entire pancreas, are subsequently isolated from the rest of the pancreatic 
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tissue (exocrine). Then islets are administered to a patient in such a way that they can function 
and alleviate the hypoglycemic condition. The pancreas can be procured from the patient himself 
or herself, which is termed autogeneic islet transplantation, or from another organ donor, which is 
termed allogeneic transplantation. Autogeneic islet transplantation is primarily performed for 
patients suffering from another disease called “pancreatitis.” In this case, the pancreas must be 
surgically removed to alleviate the symptoms of pancreatitis, and the islets are “salvaged” from 
the pancreas to be re-administered and hopefully preventing the subsequent development of 
diabetes. Allogeneic islet transplantation is currently being investigated for the treatment of 
severe T1D for patients with severe hypoglycemic unawareness. Methods and research 
developments for allogeneic islet transplantation are also discussed in the subsequent chapters of 
this thesis, but limitations in available donor organs will prevent the large-scale application of this 
promising therapy to the millions of people living with this disease. Because of this limitation, 
investigators have turned to alternative islet sources including xenogeneic sources (eg. islet from 
pigs), or stem-cell derived islets. Regardless of the source of β-cells used for therapy, many 
technical and medical advancements are required to extend access of this treatment to all of the 
patients that could benefit from β-cell replacement in general. 
This thesis describes the development and application of technologies for the purpose of 
improving the outcomes and expanding access to β-cell replacement therapies (specifically islet 
transplantation). 
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Overview and Thesis Organization 
In order to advance the development of islet transplantation for the treatment of diabetes the 
following chapters describe academic research studies to develop novel technologies and 
application of these technologies for improving islet transplantation. The chapters herein present 
original research studies previously described in publications included in whole or in part (with 
permission), or from unpublished studies that are in preparation for publication. The full 
reference to included publications and publications in press are included at the beginning of each 
chapter, and the associated co-authors are credited in the reference, and the acknowledgements 
section. Furthermore, additional related studies and co-authored manuscripts are included in the 
Appendices A-E. 
The included studies are organized into three main categories, which coincide with critical stages 
of the islet transplantation process: 
1. Development of assessment technologies and techniques for improving organ 
procurement and preservation 
2. Development of assessment technologies and techniques for improving islet 
isolation, culture and shipment 
3. Development of assessment technologies and techniques for improving tissue-
engineered islet grafts post-transplant 
Each chapter or appendix is also identified as relating to: assessment and monitoring 
technologies, or improvement technologies, and the thesis organization scheme is outlined in 
Figure 1.1 and Figure 1.2 included below. 
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Figure 1.1: Thesis Organization Flow Chart. 
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  Figure 1.2: Thesis Organization Diagram. 
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The first section contains 3 chapters describing techniques for monitoring and improving 
organs during procurement and preservation. 
Chapter 2 includes a published manuscript that describes the development of a novel technique 
for evaluating organ quality following procurement and during preservation. A method for 
measuring whole organ oxygen consumption rate (WOOCR) is described and examined for 
quantitatively determining the viability of porcine kidneys and pancreata. This technique could be 
used for evaluating organs prior to solid organ transplantation or prior to processing for islet 
isolation, and could increase the use of organs from “marginal” donors by confirming viability 
prior to utilization. More recently, other investigators have described and applied this technique10, 
and filed a patent that describes this technique as a means of organ quality testing prior to 
transplantation11. However, others have found that oxygenation during HMP does not provide a 
benefit over HMP in regards to transplant outcomes12. 
Chapter 3 describes the development of techniques and methods for improving organ 
procurement. The included studies investigate the anatomical variability of porcine pancreata, and 
examine various pancreas procurement techniques for improving porcine pancreas quality prior to 
islet isolation. This study emphasizes the unique considerations for porcine pancreas procurement 
and the importance of pancreas cooling techniques used during procurement in a donation after 
cardiac death model. 
Chapter 4 describes studies investigating hypothermic liquid perfusion (HMP) to improve 
pancreas preservation prior to islet isolation. The presented studies include comparison of static 
cold preservation methods with HMP in a porcine pancreas model. This technique is shown to 
directly improve the quality of islets isolated from preserved pancreata compared to static 
preservation methods. This technique was adapted from kidney preservation methods and 
continues to be investigated for improving organ preservation12–14. 
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The second section contains 2 chapters that present technologies for improving the isolation 
and culture of different β-cell sources. 
Error! Reference source not found. describes methods investigated for improving the process of 
islet isolation and the subsequent culture of isolated islets prior to transplantation. This chapter 
includes discussion of techniques to optimize enzyme distribution in pancreata prior to isolation, 
minimize liberated islet destruction during purification, promote islet survival during culture and 
shipment, and improve outcomes of juvenile porcine islet isolation. 
Chapter 6 describes a tangential study for improving the expansion and culture of an alternative 
β-cell source. These studies investigate the application of stirred suspension bioreactors and 
nutrient regulation for improving the expansion of β-cells in vitro. These techniques could 
support the development of alternative sources of β-cells for islet transplantation. 
The final section contains 2 chapters that describe techniques for monitoring and improving 
tissue engineered islet grafts post-transplant. 
Chapter 7 describes the application of 19F magnetic resonance spectroscopy (19F-MRS) to non-
invasively measure oxygen partial pressures (pO2) in vitro and in vivo biological systems. These 
techniques are developed and validated for determining the oxygenation status of implantable 
tissue-engineered grafts (TEGs). Procedures, equipment and rigorous calibration studies are 
described for the application of this technique for non-invasively measuring pO2 in vivo. This 
technique is a valuable research tool for optimizing the oxygenation characteristics of implanted 
TEGs, and could translated into a reliable clinical tool for monitoring functional therapeutic 
TEGs. 
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Chapter 8 describes the application of 19F-MRS techniques for monitoring the oxygenation of 
implanted tissue engineered grafts (TEGs) and a method for delivery of supplemental oxygen 
(DSO) to improve TEG oxygenation in vivo. 
 
The appendices included herein present additional related studies for monitoring and 
improving islet transplantation, and supplemental figures that were not included in the 
published articles. 
Appendices A-E include copies of published and unpublished co-authored manuscripts which 
relate to the work presented in the main chapters of the thesis. 
Appendix F includes additional supportive figures that were not included in published drafts of 
manuscripts presented in the body of the thesis. 
Appendix G includes copyright permission and license documents for reproduced figures and 
text within the body of the thesis. 
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Continuous, Real-time Viability Assessment of Kidneys and 
Pancreas Based on Oxygen Consumption 
Summary 
Current ex vivo quality assessment of donor organs is limited to vascular resistance measurements 
and histological analysis. New techniques for the assessment of organ quality prior to 
transplantation may further improve clinical outcomes while expanding the depleted deceased 
donor pool. We propose the measurement of whole organ oxygen consumption rate (WOOCR) as 
a method to assess the quality of kidneys in real-time prior to transplantation. Five (n = 5) porcine 
kidneys were procured from non-heart-beating donors. The renal artery (RA) and renal vein (RV) 
were cannulated and the kidney was connected to a custom-made hypothermic machine perfusion 
(HMP) system equipped with an in-line oxygenator and fiber optic oxygen sensors. Kidneys were 
perfused at 8°C and the perfusion parameters and partial oxygen pressures (pO2) were measured 
to calculate WOOCR. Without an oxygenator in-line, the pO2 of the perfusion solution at the 
arterial inlet and venous outlet diminished to near 0 within minutes. However, once adequate 
oxygenation was provided a significant pO2 difference was observed and used to calculate the 
WOOCR. The WOOCR was consistently measured from healthy kidneys and results suggest that 
it can be used to differentiate between healthy and purposely damaged organs. Custom-made 
HMP systems equipped with an oxygenator and in-line oxygen sensors can be applied for 
WOOCR measurements. We suggest that WOOCR is a promising approach for the real-time 
quality assessment of kidneys, pancreas and potentially other organs during preservation prior to 
transplantation. 
Furthermore, one human pancreas and 4 porcine pancreata were procured and cannulated in a 
similar fashion. WOOCR measurements in pancreata show large variability in viability upon 
arrival to the lab, suggesting large variabilities in organ quality due to procurement or 
preservation techniques.  
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Introduction 
Renal transplantation is the definitive therapy for patients with end-stage renal disease, offering 
increased longevity and improved quality of life15. At present, one of the main challenges in the 
field of transplantation is that demand for donor organs far exceeds the available supply. To 
address this disparity, the field has promoted programs for living donation, the utilization of 
organs from expanded criteria donors, and donation after cardiac death (DCD)15. As an increasing 
number of marginal organs are used, organ quality assessment prior to transplantation has 
emerged as an important and urgent issue. 
Current ex vivo quality assessment tools for donor kidneys are limited to histological analysis16 
and measurement of vascular resistance during perfusion17. The development of new, real-time, 
quantitative techniques for the assessment of organ quality ex vivo may potentially expand the 
already depleted donor kidney pool. We present a technique for the continuous, non-invasive 
measurement of whole organ oxygen consumption rate (WOOCR) as a method to assess the 
quality of organs during preservation and prior to transplantation. In addition to excluding organs 
that are unsuitable for transplantation, this method could allow for identification of healthy organs 
that would have otherwise been rejected as unsuitable. 
The role of oxygen during organ preservation remains equivocal and even controversial.  On one 
hand, there are concerns that the low levels of molecular oxygen dissolved in organ preservation 
solutions generate free radicals during prolonged storage, leading to the progressive tissue injury 
during the reperfusion phase18. On the other hand, studies have suggested that preservation-
induced hypoxia causes depletion of high energy phosphate (i.e., ATP) and impairment of 
mitochondrial function that can be reversed by raising the pO2 of the perfused medium
19. Clearly, 
optimum HMP preservation will require a balance between these opposing effects. Under normal 
physiological conditions most viable tissues consume oxygen
20
. Consequently, determining 
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WOOCR could be useful for quantifying organ viability even when measurements are conducted 
during cold preservation (4-8 °C). Calculation of OCR has been applied before in the study of the 
heart21, the liver19 and the kidney22–24. It has also been shown that OCR is a reliable and useful 
measure of pancreatic islet quality and can be used to predict islet transplant outcome25–27.  
We present WOOCR as a method for use with a modified hypothermic machine perfusion (HMP) 
system. HMP has been shown to be an effective method of organ preservation and is becoming a 
standard of clinical practice for kidney preservation among organ procurement organizations 
(OPOs)28. Current clinical prototypes of HMP do not include oxygen sensors or an adequate 
oxygenation system to meet the oxygen demand of a viable kidney, even at cold temperatures. 
We propose two simple modifications to currently-available clinical perfusion devices, including 
(1) an in-line oxygenator with oxygen supply and (2) in-line fiber optic oxygen sensors, which are 
added to the HMP system without disturbing the organ. This setup provides the kidney with 
oxygenated perfusate and allows for real-time measurement of WOOCR.  
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Materials and Methods 
Porcine Kidney Procurement 
Five porcine kidneys (n=7) were procured from non-heart-beating donors (NHBDs). Five minutes 
prior to sacrifice, animals received an intravenous injection of 50,000-100,000 U of heparin. 
Euthanasia was performed with a lethal injection of pentobarbital sodium. After sacrifice, the pig 
was eviscerated and the posterior wall of the aorta was incised longitudinally to expose the origin 
of the renal artery (RA) within the aortic lumen. RAs were individually cannulated and each 
kidney was flushed with 1 L of cold lactated Ringer’s solution (LRS) and carefully dissected 
away from the viscera. Warm ischemia time was minimized to less than 10 minutes during the 
procurement. Each kidney was weighed after procurement and before HMP. 
Hypothermic Machine Perfusion and WOOCR Setup 
Arterial and venous ends of each organ were cannulated and connected to the HMP system. In 
our custom-built HMP system, two fiber optic oxygen sensors (Instech Labs, Plymouth Meeting, 
PA) were placed in-line upstream of the RA and two were placed downstream of the renal vein 
(RV) for the measurement of arterial and venous pO2, respectively. These sensors were 
specifically designed in collaboration with Instech Labs for these studies to provide accurate and 
reliable measurements of oxygen in a biological perfusion setting. Drawings of the sensors are 
included in Appendix A for reference. To provide maximum oxygenation without causing 
vascular damage, the flow rate was controlled between 100-200 mL/min and the temperature was 
maintained at 8°C for the duration of the perfusion. The WOOCR of a kidney was calculated 
using a mass balance equation where Q is the flow rate of perfusion (mL/min), pO2 is the partial 
pressure of oxygen (mm Hg), α is the solubility of oxygen at a given temperature (mol/mL·mm 
Hg) and m is the mass of the kidney (grams). 
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𝑂𝐶𝑅 =
𝑄 × (𝑝𝑂2𝐴𝑟𝑡𝑒𝑟𝑖𝑎𝑙 − 𝑝𝑂2𝐴𝑟𝑡𝑒𝑟𝑖𝑎𝑙) × 𝛼
𝑚
 
2.1 
During perfusion of six (n = 6) kidneys, an oxygenator was incorporated into the setup to provide 
a steady supply of oxygenated preservation solution to the organ. Figure 2.1 demonstrates the 
basic setup of the HMP system with in-line fiber optic oxygen sensors and the oxygenator. An 
oxygenator must be incorporated in order to provide a steady supply of the oxygenated 
preservation solution. This modification is integral for two reasons. First, if we assume that 
kidney is the only component extracting oxygen from the perfusion system, OCR of the kidney is 
similar to OCR of pancreatic islets (approximately 200 nmol/min per mg DNA25), and the oxygen 
delivery is not limited by the perfusion flow, than one litter of the preservation solution would be 
depleted of oxygen within minutes.  Second, the delivery of constant concentration of oxygen will 
ensure an accurate measurement of OCR in steady state. Kidneys procured with or without WIT 
were preserved by HMP for up to 24 hours to generate a series of increasing organ damage, and 
WOOCR was measured for each condition. 
Formalin Treatment of the Porcine Kidney 
After a single porcine kidney was harvested and flushed with 1 L of cold LRS, the initial 
measurement was performed to establish WOOCR prior to a formalin treatment. Next, the kidney 
was flushed with 120 mL of 10% buffered formalin through the RA, followed by a flush with 120 
mL of LRS to remove any remaining formalin. The new set of WOOCR data was collected 30 
minutes after the formalin treatment. 
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Figure 2.1: WOOCR perfusion system schematic. Diagram illustrating the perfusion circuit containing 
the in-line oxygenator and oxygen sensors. 
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Results 
Kidneys 
As expected, without an oxygenator the measured pO2 of the perfusate for both the RA and the 
RV approached zero within minutes while perfusing at 100 mL/min at 8°C. After incorporating 
an in-line oxygenator, the inlet (RA) pO2 was maintained at approximately 150 mm Hg (in 
equilibrium with room air), but the outlet (RV) pO2 still remained near zero. When the arterial 
pO2 was elevated to more than 300 mm Hg (using an oxygen supply), the outlet pO2 increased 
and a significant pO2 drop that was not limited by the oxygen supply was measured between the 
RA and RV for every kidney (Figure 2.1A). The average WOOCR for presumably healthy 
kidneys on HMP with an in-line oxygenator was 158 ± 62 nmol/min/g (n = 4, range = 92-229 
nmol/min/g). These results (and our theoretical calculations) verify the requirement of an in-line 
oxygenator to provide an inlet pO2 greater than 300 mm Hg for the adequate oxygenation of the 
entire organ and for the accurate measurement of WOOCR for the average porcine kidney. The 
viability of a kidney was observed to decrease markedly during 4 hours of HMP (Figure 2.2B), 
and a dramatic drop in the WOOCR of the kidney was observed after the formalin insult (17 
nmol/min/g), when compared to the WOOCR of the same organ prior to formalin treatment (187 
nmol/min/g, see Figure 2.2C). 
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Figure 2.2: WOOCR results from porcine kidney. Graph illustrating real-time measurements of pO2 at 
the inlet (renal artery) and outlet (renal vein) of a machined perfused porcine kidney (A), and their time-
dependent profiles over 3 hours of cold preservation; Note the need for active oxygenation of the perfusate 
medium at the inlet, as reflected by a pO2 near zero until it was started. WOOCR (normalized per gram) 
can be calculated for the same kidney from the pO2 measurements (B). WOOCR is negatively affected by 
lengthening ischemic time (B) or exposure to a caustic agent (C), in which WOOCR measurements were 
obtained for a freshly procured porcine kidney (healthy) and after that same kidney was infused with 10% 
buffered formalin solution). Figure is adapted from published manuscript30 to include supplementary parts 
A & B.
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Discussion 
Current clinical HMP systems are not equipped with oxygenators. Rapid depletion of oxygen 
from the reservoir containing non-oxygenated preservation solution subjects the organ to hypoxic 
conditions. A theoretical calculation demonstrates that one liter of LRS equilibrated with air 
would be depleted of its oxygen content in about 5 minutes by an average “healthy” adult porcine 
kidney undergoing HMP. The experimental results confirm that arterial and venous pO2 values of 
the recycled perfusate (i.e., non-oxygenated) decreased to near zero after a few minutes of 
perfusion at 8ºC. The results of this limited study clearly support the need for improved oxygen 
delivery in HMP systems durring kidney preservation.  
One solution is to use an in-line oxygenator which can supply a pO2 of at least 300 mm Hg. Using 
a perfusion solution with a higher oxygen solubility could also improve oxygenation of tissue 
using a lower pO2.  With adequate oxygenation, a significant pO2 drop that was not limited by the 
oxygen supply (i.e., RV pO2 was significantly higher than zero) was observed between the RA 
and RV of every organ, and an average WOOCR value of presumably healthy kidneys on HMP 
was measured at 158 nmol/min/g. This value was similar to the OCR of healthy pancreatic tissue 
at 8°C (200 nmol/min/g)25.   
Our results also indicate a significant variability in WOOCR among freshly procured kidneys 
(range 92-229 nmol/min/g) that were harvested using our standardized technique. We hypothesize 
that the variability in WOOCR among these organ can be correlated with the individual organ 
quality and may identify damaged organs ex vivo that otherwise would be undetected. 
The difference between the WOOCR in presumably healthy and damaged organs was supported 
by comparing the WOOCR of a formalin-treated (damaged) kidney (17 nmol/min/g) to the 
WOOCR of the same organ before treatment (187 nmol/min/g) or the average WOOCR of all 4 
untreated organs (158 nmol/min/g). Detection of any WOOCR in the formalin-treated kidney 
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suggests the incomplete damage of the organ and reflects the OCR of the remaining viable tissue. 
The WOOCR of the kidney would be expected to approach zero if the amount of fixate and the 
duration of the fixation were increased.  
Conclusion 
Based on these data, we conclude that a real-time, non-invasive method for the measurement of 
WOOCR in conjunction with oxygenated HMP may be used to assess organ quality ex vivo. 
These measurements are feasible utilizing a modified clinical prototype of HMP system, and a 
protocol was developed describing how to implement WOOCR with the LifePort Kidney 
Transporter clinical HMP system. The role of oxygenation in organ preservation remains 
controversial18,19,29. The optimum HMP preservation will need to balance the potential damage 
that can occur with the generation of free radicals with the necessity to provide sufficient oxygen 
to sustain healthy tissues. Our future research will be directed towards further validation of the 
WOOCR method by correlating measurements to histological data, molecular profiles, and graft 
function following allogeneic transplantation in a large animal model. 
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Supplementary Data: Kidney and Pancreas WOOCR 
Introduction 
These expanded studies were not included in the published manuscript30 because they were 
completed following publication but these studies follow the same protocols and procedures as 
described in the publication with minor modifications described below. After preliminary success 
with measuring WOOCR of porcine kidneys, the method was also expanded to include a small 
series of kidneys with varying warm and cold ischemia times to verify the sensitivity of the assay 
to individual organ viability.  
Furthermore, these methods were adapted for a small proof of concept study to develop the 
WOOCR technique for use with pancreata. WOOCR was measured from a single human 
pancreas and small number of porcine pancreatic lobes (N=4) using adapted methods described 
below. 
Human and Porcine Pancreases Procurement 
A donor human pancreas was procured for research (n=1). In preparation, the spleen was 
removed and all of the arteries supplying the duodenum were ligated to prevent leakage. The 
splenic artery (SA) and the superior mesenteric artery (SMA) were cannulated and coupled using 
a Y splitter for connection to a peristaltic perfusion pump. One oxygen sensor was placed in-line 
upstream of the arteries to measure the (‘arterial’) oxygen partial pressure (pO2) of the perfusion 
solution and a second sensor was attached to the splenic vein (SV) which was also cannulated to 
measure the effluent (or ‘venous’) pO2. The temperature was maintained at 8°C and the organ 
was perfused. The arterial and venous pO2, the gross whole organ mass and the measured flow 
rate were used to calculate the OCR per gram tissue. Porcine pancreata with preserved 
vasculature were procured from a non-heart beating donor (n=4). The celiac trunk, SMA, and 
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portal vein were all cannulated and all leaks were ligated. The sensor placement, perfusion system 
and OCR calculation were the same as the human pancreas. 
Kidney and Pancreas Supplementary Results and Discussion 
Measurements from kidneys with increasing levels of procurement and preservation damage due 
to varying degrees of warm and cold ischemia are presented in Figure 2.3, and a decreasing trend 
in WOOCR was observed with increasing damage to the organ. 
WOOCR measurements from a pancreas preserved by HMP for up to 20 hours are shown in 
Figure 2.4 to decrease continuously during the preservation period. The average OCR value for 
all 5 organs measured at the time of arrival is 53 +/- 74 nmol/min/g, and individual measurements 
are shown in Figure 2.5.  These findings illuminate a large variability in organ quality prior to 
long term cold storage, and demonstrate the sensitivity of the technique.  More studies are 
required to develop baseline values for determination of donor organ viability. 
These supplementary results support the original findings presented in the original manuscript30 
and confirm that WOOCR could be a valuable tool for evaluating the metabolic integrity and 
viability of kidneys and possibly pancreas for solid organ or islet transplantation. 
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Figure 2.3: Damage from WIT and CIT is detected by WOOCR. WOOCR measurements from a fresh 
kidney, and measurements from kidneys that were exposed to a series of warm and cold ischemia during 
procurement and preservation. The fifth measurement shown is from a kidney damaged by formalin 
fixation. A clear decrease in WOOCR is seen with increasing levels of organ damage. Figure is not 
included in original manuscript30 but is included here to provide additional evidence.
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Figure 2.4: WOOCR of porcine pancreas. WOOCR measurements over time for a porcine pancreas, 
showing the WOOCR decreasing as the organ is perfused with LRS. Results from pancreas were not 
included in original manuscript30, but are included here as supplementary data.
  27 
  
Figure 2.5: WOOCR measures pancreas viability. Porcine pancreas (black) and human pancreas (white) 
WOOCR values measured immediately upon arrival at the lab. Results from pancreas were not included in 
original manuscript30, but are included here as supplementary data.
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Temperature Profiles of Different Cooling Methods in Porcine 
Pancreas Procurement  
Summary 
Furthermore, the second study examines the effect of 4 different cooling Methods on core porcine 
pancreas temperature (n=24) and histopathology (n=16). All Methods involved surface cooling 
with crushed ice and chilled irrigation. Method A, which is the standard for porcine pancreas 
procurement, used only surface cooling. Method B involved an intravascular flush with cold 
solution through the pancreas arterial system. Method C involved an intraductal infusion with 
cold solution through the major pancreatic duct, and Method D combined all 3 cooling Methods. 
Temperature studies demonstrated that surface cooling alone (Method A) gradually decreased 
core pancreas temperature to < 10 ºC after 30 minutes. Using an intravascular flush (Method B) 
improved cooling during the entire duration of procurement, but incorporating an intraductal 
infusion (Method C) rapidly reduced core temperature 15-20 ºC within the first 2 minutes of 
cooling. Combining all methods (Method D) was the most effective at rapidly reducing 
temperature and providing sustained cooling throughout the duration of procurement, although 
the recorded WIT was not different between Methods (p=0.36). Histological scores were different 
between the cooling Methods (p=0.02) and the worst with Method A. There were differences in 
histological scores between Methods A and C (p=0.02) and Methods A and D (p=0.02), but not 
between Methods C and D (p=0.95), which may highlight the importance of early cooling using 
an intraductal infusion. We found that surface cooling alone could not rapidly cool large (porcine 
or human) pancreata. Additional cooling with an intravascular flush and intraductal infusion 
results in improved core porcine pancreas temperature profiles during procurement and 
histopathology scores. These data may also have implications on human pancreas procurement 
since use of an intraductal infusion is not common practice.  
  30 
Introduction 
Widespread clinical application of islet transplantation is currently limited by the shortage of 
human organ donors32. Porcine islet xenotransplantation33–35 provides an opportunity to obviate 
the inadequate supply of human organs by isolating islets from a practically-unlimited supply of 
porcine donors. Just as with human islet isolation, the outcome of porcine islet isolation is 
dependent on the quality of the donor pancreas36, which is in large part affected by the 
procurement and cooling methodologies used. This is especially true in porcine islet 
transplantation since the preservation periods are typically short and limit the negative impact that 
cold ischemia time may have on islet quality.  
Donor porcine pancreata are frequently procured following cardiac death to save on the additional 
cost, complexity, and logistical challenges associated with performing a heart beating 
procurement with an adult porcine donor. However, donation after cardiac death (DCD) is 
accompanied by warm ischemia time (WIT), which is known to be detrimental to the quality of a 
donor pancreas37. The current procurement method involves dissecting the pancreas out as 
quickly as possible, while the core pancreas temperature is reduced by diffusion-based surface 
cooling with crushed ice and cold irrigation. The WIT is traditionally defined and recorded as the 
time from cardiac death until cooling is initiated. In a large organ, like a porcine or human-sized 
pancreas, diffusion-based cooling is not effective at rapidly reducing the core temperature below 
8 ºC and thus the WIT is underestimated. In this study, we evaluate 4 different methods of donor 
porcine pancreas cooling performed during the procurement: surface cooling alone (Method A), 
an intravascular arterial flush (Method B), an intraductal infusion (Method C), and combining an 
intravascular flush with an intraductal infusion (Method D). The primary outcome of this study 
was to establish temperature profiles for the core of the donor porcine pancreas for each of the 
cooling methods and to determine which cooling method most rapidly cools a large organ. 
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Secondary outcomes include correlating the cooling method that was employed with core 
pancreas tissue quality as assessed by histology. The main objective of this study was to optimize 
the DCD porcine pancreas cooling protocol used during procurement, which may also have 
implications on cooling protocols used during human pancreas procurements. .  
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Materials and Methods 
Porcine Pancreas Procurement 
In this study, pancreata (n=94) were harvested following en bloc viscerectomy from DCD 
Landrace pigs. Subgroups of donor pancreata were designated for direct core pancreas 
temperature monitoring during procurement (n=24) and histological evaluation (n=16). All other 
donors (n=56) presented in this study were included to report statistics on the surgical 
procurement (e.g., mean WIT) but were used as part of other studies. All work involving animals 
was approved by the Institutional Animal Care and Use Committee at the University of 
Minnesota. 
The porcine pancreas procurement methods used in this study are described in the previous 
section of this chapter, and have been described previously38. An illustrative timeline for the 
surgical procurement is included in Figure 3.1. Briefly, donors were given intravenous heparin 
(100,000 U bolus) 5 minutes prior to euthanasia, which was done via an overdose with sodium 
pentobarbital (Fatal Plus; Vortech Pharmaceuticals, Dearborn, MI) followed by exsanguination. 
Heparinization of the donor prior to euthanasia was found to be critical for effective removal of 
blood, and inadequate heparainization resulted in extensive thrombus formation in the vasculature 
that could not be flushed out. Examples of a pancreata from an inadequately heparinized donor, 
and a properly heparinized donor are included for reference in Figure 3.2. En bloc viscerectomy 
was performed and the abdominal viscera were transferred to a surgical dissection table. Care was 
taken to preserve the vasculature for all organ procurements regardless of cooling method used. 
Different cooling methods were used for each pancreas during the remainder of the procurement. 
All cooling methods involved standard surface cooling with crushed ice and irrigation with 
chilled (refrigerated) lactated Ringers solution (LRS). Unless designated for surface cooling alone 
(Method A), organs were randomized to undergo enhanced cooling with additional methods 
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described below. Some of the organs underwent direct core pancreas temperature measurements 
throughout the procurement. Following organ cooling and dissection, each pancreas was massed 
and processed as indicated. If pancreas was designated for histological assessment (n=16), 
following procurement, the entire pancreas was flushed through the vasculature with 10% 
buffered formalin solution and biopsies from the core of the pancreas were taken for evaluation. 
If the pancreas was designated for islet isolation (n=18), the pancreas was placed on CPS and 
transported to the isolation facility. 
Porcine Pancreas Cooling 
All donor pancreata were surface-cooled with crushed ice and chilled LRS. Pancreata were then 
randomized to undergo cooling using 1 of 4 cooling Methods: 
Method A 
This Method only involved surface cooling with crushed ice and irrigation with chilled LRS 
(n=8), with no additional cooling technique used. This was considered the standard cooling 
methodology used during DCD porcine pancreas procurement. Two or more liters of crushed ice 
and ≥2 liters of chilled LRS were applied to the surface of the donor pancreas throughout the 
duration of the procurement. Isotonic ice was used for organs designated for histology or islet 
isolation.  Active cooling began as soon as the pancreas was located within the viscera (typically 
within 2 minutes of evisceration), and was completed at the time of total pancreatectomy.  
Method B 
This Method involved additional arterial intravascular flushing which was conducted  as quickly 
as possible (typically between 1-3 minutes) following viscerectomy via cannulation of the aorta 
(Method B1, n=11) or individual cannulation of both the celiac trunk (CT) and superior 
mesenteric artery (SMA) (Method B2, n=10). For Method B1, the supraceliac aorta was flushed 
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anterogradely after the infrarenal aorta was clamped. For Method B2, all major branches from the 
CT that did not supply the pancreas and the intestinal branches from the SMA were ligated prior 
to flushing. Method B1 was initially used during this study, which then evolved to Method B2. 
The methodology was changed because it was observed that substantial amounts of flush solution 
were lost through the numerous lumbar arteries, and needing to ligate these branches prolonged 
the procedure. It was determined that individually cannulating the CT and SMA did not increase 
WIT, so Method B2 replaced Method B1. Regardless of which vessels were cannulated, 3-5L of 
heparinized (1,000 U/L) CPS (modified Cold Storage/Purification Stock Solution from 
Mediatech, Inc., Manassas, Va) or LRS were flushed at a rate of approximately 0.5L/min until 
flush effluent appeared clear of blood. CPS was used instead of LRS for pancreata designated for 
histology or islet isolation. 
Method C 
This Method involved intraductal infusion of CPS (n=6). Following the viscerectomy, the head of 
the pancreas was quickly (typically 2-3 minutes) separated from the bowel, and the main 
pancreatic duct was identified and directly cannulated with an angiocatheter (18-20 gauge 
depending on size). After the catheter was placed, 60 mL of CPS was infused at a rate of 1 
mL/sec. 
Method D 
This Method combined an arterial intravascular flush (Method B) and an intraductal infusion 
(Method C) (n=59). Some of the pancreata were flushed via the aorta (n=4), but most via the CT 
and SMA (n=55). Immediately following transfer of the viscera to the surgical table, the vessels 
were cannulated and the flush was started. Next, the main pancreatic duct was located, 
cannulated, and infused as described above in Method C. Typically, 2 or more surgeons worked 
concurrently to expedite the cannulation and ligation procedures, and all cooling methods were 
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initiated within 4 minutes of viscerectomy. The total flush and infusion volumes of CPS or LRS, 
and flow rates were the same as used in Methods B and C.  
Temperature Measurements 
As mentioned previously, some of the pancreata were designated for direct core pancreas 
temperature monitoring (n=24), and involved organs cooled by Method A (n=4), Method B 
(n=13), Method C (n=4) and Method D (n=3). Individual 33-gauge needle temperature probes 
were placed into the core of the distal splenic lobe, the proximal splenic lobe, the duodenal lobe 
and the connecting lobe38 as soon as the viscera were transferred to the surgical table and the 
pancreas was identified. Figure 3.3 shows the placement of the probes in the pancreas. 
Temperature measurements were recorded in real-time (every 30 seconds) and throughout the 
duration of the procurement. Care was taken to ensure that the probes remained within the core of 
the pancreas as the organ was dissected. The mass of each pancreas was recorded following 
procurement and the mass of the ductal infusion solution was subtracted for relevant pancreata. 
The temperature measurements were used to observe different trends in core temperature profiles 
between groups and to calculate the amount of energy removed from the donor pancreas during 
cooling. These energy values were calculated for each pancreas by multiplying the temperature 
change during a 10-minute period by the pancreas mass and an estimate of the specific heat of 
pancreas tissue. The specific heat for pancreas tissue was approximated assuming the pancreas 
has a density and thermal conductivity equal to that of water at the average observed temperature 
during the procurement. The average energy removed was also converted to a corresponding 
expected temperature drop (ΔT) for a representative and standardized 350-gram pancreas during 
the first 10 minutes of cooling. 
Histology 
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As mentioned previously, some of the pancreata were designated to undergo histological 
evaluation (n=16), and included organs cooled by Method A (n=4), Method C (n=4), and Method 
D (n=8). Histology was not done for any organ cooled by Method B due to budgetary constraints 
and also because significant differences in the histological scores between organs cooled by 
Methods C and D could be attributable to the use of an intravascular flush (which indirectly 
reflects the impact of Method B). Approximately 240 mL of chilled 10% buffered formalin 
solution was infused intravascularly following the surgical procurement, and multiple core 
biopsies were then taken and placed into formalin. The biopsies were then processed by 
embedding in paraffin, sectioning and staining with hematoxylin and eosin (HE). Histological 
evaluation was done in blinded fashion by an experienced histopathologist. Samples were 
systematically scored for the degree of necrosis and autolysis observed in each histological 
section; scoring was graded as follows: 0=none, 1≤10%, 2=11-25%, 3=26-50%, 4=50-75%, 
5≥76%. Necrosis and/or autolysis was defined by the presence of nuclear pyknosis or 
karyorrhexis, cytoplasmic hypereosinophilia, loss of intercellular junctions, loss of tissue 
integrity, cellular lysis, dystrophic mineralization, and disintegration of tissue structures 
sometimes with associated extravasation of blood. 
Statistical Analysis 
All data were reported as mean values and standard errors. Overall differences between groups 
were compared using a one-way analysis of variance (ANOVA, if normally-distributed) or the 
Kruskal-Wallis test (if not normally-distributed). Mean values between all groups were compared 
using Tukey’s multiple comparison post-test (if normally-distributed) or the Mann-Whitney test 
(if not normally-distributed). Statistical significance corresponded to p-values <0.05 using a 95% 
confidence interval. All statistical analyses were performed using Graphpad Prism Version 5.03 
(Graphpad Software, Inc., La Jolla, CA). 
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Figure 3.1: Surgical Timeline. Illustration depicting the relevant surgical times recorded during the 
porcine pancreas procurement. Time interval 4 marks the duration of time between cardiac arrest and the 
initiation of a cooling technique and is effectively the warm ischemia time (WIT). Time interval 6 
represents the total pancreas preservation time. 
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Figure 3.2: Effects of heparinization. Pictures of porcine pancreata illustrating the effects of (A) vascular 
blood clotting in a pancreas from a donor was not properly heparinized before euthanasia, and (B) minimal 
vascular clotting in the pancreas is observed when the donor is properly heparinized. 
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Figure 3.3: Temperature probe placement. Picture of needle temperature probes placed into a porcine 
pancreas during procurement. Probes were placed into the core of each lobe (duodenal, splenic and 
connecting) to monitor the temperature changes during procurements with different cooling methods. 
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Results 
Donors had a mean age of 22 ± 2 months (n=67) and a mean weight of 505 ± 10 pounds (n=87), 
in those donors for which data was available. Mean time required to perform the en bloc 
viscerectomy was 6.0 ± 0.3 minutes. Mean time to complete the arterial intravascular flush was 
31 ± 1 minutes. There were overall differences in the mean donor weight between Methods (p = 
0.008) and total procurement time (p < 0.001), but no differences in the other metrics (Table 3.1). 
When comparing individual Methods, there were differences in the total procurement times 
between Method B1 and every other Method (p < 0.05). This difference is likely explained by the 
increased time needed to ligate numerous lumbar arteries for organs procured using an arterial 
flush through the aorta (Method B1). This difference was not observed with Method B2 or D 
because these organs were primarily procured using direct intra-arterial flush via the CT and 
SMA. All other Methods took a statistically similar total procurement time (p > 0.05). There were 
no differences in the recorded WIT between groups (p= 0.36), and no difference when comparing 
Methods A and D (p = 0.50), which represented the most different cooling methodologies. 
The core temperature profiles were recorded for pancreata procured with each cooling Method 
and representative profiles are illustrated in Figure 3.4. The representative illustration was 
generated based on the actual data obtained from the recorded temperature profiles. Illustrative 
profiles were used to present this data because they accurately reflect the nature of the cooling 
observed with respect to the Method used. This interpretation of the data allows for direct visual 
comparison between cooling methods without the confounding differences that the organ 
variability introduces to the individual organ temperature measurements.  Method A gradually 
decreased the core temperature over a 30 minute period. Method B decreased the organ 
temperature more rapidly than Method A. Method C decreased the core temperature of the 
pancreas rapidly (15-20 ºC during the first few minutes of cooling), but the rate of cooling 
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immediately slowed after completion of the intraductal infusion. Method D provided the most 
optimal cooling, including both rapid cooling in the first few minutes of the procurement and 
sustained cooling throughout the procurement. 
When temperature data was used to calculate the average thermal energy removed during a 10 
minute period and then standardized to a 350-gram pancreas, Method A removed an average of 
10 ± 1.5 kilojoules (KJ) of energy, which corresponded to a ΔT of 10°C. Method B removed an 
average of 18 ± 2.8 KJ of energy, corresponding to a ΔT of 22°C. Method C removed an average 
of 16.8 ± 3.9 KJ of energy, corresponding to a ΔT of 20°C. Method D removed an average of 34 
± 4.8 KJ of energy, corresponding to ΔT of 37°C, and was the Method which provided the most 
rapid cooling (Figure 3.6). These calculations enabled more accurate comparisons between 
cooling Methods in the setting of confounding variables such as different starting core pancreas 
temperatures and organ masses. 
Biopsies obtained from pancreata cooled with Method A exhibited moderate necrosis/autolysis, 
while biopsies from pancreata cooled with Method C exhibited mild necrosis/autolysis.  Biopsies 
obtained from pancreata cooled with Method D exhibited the least (or minimal) necrosis/autolysis 
(Figure 3.7). Histological scores were overall different between the cooling Methods used 
(p=0.04). When compared individually, there were differences in the histological scores between 
Methods A and C (p=0.03) and Methods A and D (p=0.03), but not between Methods C and D 
(p=0.91) (Figure 3.9). 
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Figure 3.4: Procurement cooling method profiles. Illustration depicts the different core pancreas 
temperature profiles for each cooling Method: surface cooling alone (Method A, the current practice), 
intravascular (arterial) flush (Method B), intraductal infusion (Method C), and combined intravascular flush 
with intraductal infusion (Method D). Note the rapid cooling following an intraductal infusion of cold 
preservation solution (CPS), and the improved sustained cooling with an intravascular flush with CPS. 
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Figure 3.5: Combined Method D temperature profile. Representative core temperature measurements 
from the distal splenic lobe of a porcine pancreas cooled with Method D, which combines surface cooling 
with an arterial flush and a ductal injection. 
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Figure 3.6: Cooling method comparison. Calculated average amount of energy removed and estimated 
core temperature drop (ΔT) during the first 10 minutes of cold ischemia time in a standardized 350-gram 
pancreas procured using surface cooling only (Method A, n=4), surface cooling and an intravascular flush 
(Method B, n=13), surface cooling and an intraductal infusion (Method C, n=4) and combined method with 
surface cooling, an intravascular flush, and an intraductal infusion (Method D, n=3).  
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Figure 3.7: Differences in histology sections. Histology of biopsies taken from pancreata cooled by 
Methods A, C and D. Pancreatic tissue cooled using Method A exhibited moderate features of autolysis and 
many of the islet cells have partially condensed nuclear chromatin. Pancreatic tissue cooled using Method 
C showed mild autolysis, nuclear condensation or lysis and some islet cells exhibit cytoplasmic 
hypereosinophilia. Exocrine cells may present some pyknotic nuclei and cytoplasmic condensation. 
Pancreatic tissue cooled using Method D exhibited minimal autolysis. Very few of the islet cells appear 
exhibited cytoplasmic hypereosinophilia and nuclear pyknosis, and cell morphological details are more 
easily distinguishable with exocrine granules being well-preserved.  
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Figure 3.8: Histology and insulin staining images. Images of histological sections with hematolylin and 
eosin stain (Left) and insulin stain (Right) of biopsies taken from a porcine pancreas. Images are from a 
pancreas cooled by Method A resulting in poorly-preserved regions of tissue (TOP) , and images from a 
pancreas cooled with Method D resulting in well-preserved tissue structures (BOTTOM).  
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Figure 3.9: Semi-quantitative histology comparison. Plot of necrosis/autolysis scores from biopsies of 
pancreata cooled using Methods A, C and D. The scores were significantly worse in pancreata cooled only 
with surface cooling (Method A) as compared to pancreata cooled by intraductal infusion (Method C) or the 
combined approach (Method D). Lines and error bars represent the mean ± standard errors. 
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Table 3.1: Surgical procurement data 
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Discussion 
Porcine islet xenotransplantation may offer an attractive alternative to human islet 
allotransplantation if an efficacious immunosuppressant protocol is developed35 or if the 
xenoislets can be immunoisolated39. This would enable access to a practically-unlimited donor 
pancreas supply. Since the isolation procedure itself is expensive and time-consuming, optimizing 
isolation outcomes is imperative. Consequently, optimization of improved porcine pancreas 
procurement protocols is needed. There may be a substantial difference in the core organ 
temperature during procurement depending on the cooling method utilized, but also depending on 
the individual organ size (mass), shape, and condition. There were differences in the average 
pancreas mass in each group (Table 3.1), but these differences were not different between groups 
(p=0.36), and are most likely explained by differences in donor mass or age. To effectively 
compare and interpret the efficacy of cooling methods, the heat removed during the first 10 
minutes of cooling was calculated from the temperature data obtained for each individual organ. 
This calculation can account for the differences in the initial amount of thermal energy in each 
pancreas due to the observed variability in starting core pancreas temperature and organ mass. In 
this study, we found that additional cooling via the combination of an intravascular flush and an 
intraductal infusion of CPS reduced the core pancreas temperature much more rapidly than 
surface cooling alone. Surface cooling alone is incapable of quickly cooling a large organ (like a 
human or porcine pancreas). With surface cooling, heat transfer is very inefficient and highly 
variable, especially for larger organs since it relies on thermal diffusion from the surface of the 
organ. In many cases, it took as long as 30 minutes for a large pancreas to reach a core 
temperature of <15°C. In these cases, the actual WIT is significantly underestimated. The 
deleterious effect of increased WIT on organ function following transplantation has been 
previously recognized40. Prolonged WIT has also been shown to be a critical factor affecting 
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successful islet isolation41. Tanioka et al. reported that periods of WIT >30 minutes result in 
significant reduction in islet yields and viability42.  
Although variations in porcine pancreas anatomy and size can affect temperature profiles 
measured during and after procurement, we have demonstrated that intraductal infusion provided 
the most consistent and dramatic cooling during the first few minutes of the procedure and can be 
done quickly. Intraductal infusion was able to consistently cool the pancreas by >10°C during the 
first 2 minutes of cooling. As shown in Figure 1, a dramatic drop in core pancreas temperature 
was observed with both Method C and Method D. However, once the 60 mL of CPS was infused 
into the pancreatic duct, the rate of cooling was no better than with surface cooling alone. In 
contrast, the intravascular flush provided a sustained cooling of the pancreas throughout the 
duration of the procurement. When Method C was combined with intravascular flushing (Method 
D), core pancreas temperature could be reduced from 37°C to 15°C in 10 minutes. This dramatic 
improvement in cooling rate results from the substantial increase in the surface area available for 
heat transfer, which occurs with flushing CPS into the vasculature and instilling it into the ductal 
system. Method D leveraged both the immediate cooling of intraductal infusion and the sustained 
cooling of the intravascular flush without increasing the time of procurement when compared 
with Method A (p=0.31). Detailed studies focused on the effects of pancreas size and shape on 
cooling method heat transfer would considerably improve our understanding of these methods, 
and could potentially suggest further optimized methods for improved organ cooling. 
Other factors during procurement and beyond WIT may affect the success of subsequent islet 
isolation. Increased pancreatic edema has been shown to correlate with decreased islet yields for 
human islet isolation43. However, there is some conflicting evidence in the literature which 
suggests that some edema may improve islet recovery44. This may explain why the use of 
hypothermic machine perfusion (via the CT and SMA) has been associated with greater porcine 
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islet yields as compared to static cold storage45. We were concerned that flushing and instilling 
fluid into the pancreas may cause edema, which would be problematic. In our study, no obvious 
gross pancreatic edema was observed.  
In addition to improved cooling, the intravascular flush, either via the supraceliac aorta or directly 
through the CT and SMA, appeared to completely clear the intravascular space of residual blood 
(see histology from pancreas cooled by Method D in Figure 3.7). When combined with adequate 
heparinization, the finding of intrapancreatic blood or clotting is unlikely. This is of particular 
importance for islet isolation, because the presence of intravascular thrombi within the pancreas 
has been shown to diminish islet yield46. The number of recovered islets following enzymatic 
digestion correlates inversely with the blood content in the porcine pancreas47.  
Our results indicate that there is a correlation between the rate of core pancreas cooling and 
histological outcomes. Histological scores of the islet tissue sections were compared, and as 
expected, Method A, C, and D resulted in moderate, mild and minimal autolysis observed, 
respectively. The necrosis/autolysis score and necrosis/autolysis score per pancreas also inversely 
correlated with the rate of cooling, and there were differences between Methods A and C (p=0.02) 
and Methods A and D (p=0.02). Histological studies were not conducted for Method B, because of 
budgetary constraints and because differences between Method C and D could be in part 
attributable to the use of an intravascular flush with Method D. Interestingly,  there were no 
differences in the necrosis and autolysis score when comparing samples cooled by Methods C and 
D (p=0.95). This may suggest that the addition of a selective intravascular flush, though able to 
clear blood and facilitate sustained cooling of the organ, may provide less benefit as indicated by 
histology. This study compared the histological necrosis/autolysis score between Methods as an 
early indicator of tissue damage. Tissue biopsies were collected and fixed immediately following 
completion of the procurement and represent a snap-shot of the tissue quality up to the time of 
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tissue fixation. Although beyond the scope of this study, there may be further divergence in tissue 
quality following transplantation and reperfusion. However, the observation that combined 
cooling involving an intraductal infusion may have implications for human pancreas 
procurement, where an intraductal infusion is not standard practice but may be beneficial48,49. 
Porcine DCD donors were used to compare cooling methods in this study, but the temperature 
profiles and energy calculation results can offer insights into cooling methods used for human 
DCD and donation after brain death (DBD) procurements. DCD organs are being utilized in 
higher numbers due to an increasing demand for donor organs and improved organ preservation. 
Enhanced organ cooling may enable even more higher-quality DCD organs to be used for islet 
isolation. Analysis of the temperature data suggests that it could be advantageous to include an 
intraductal infusion during human pancreas procurements. For solid pancreas transplant the 
benefits of the improved cooling would have to be weighed against the potential increased risk of 
contamination associated with cannulation of the pancreatic duct. For human islet isolation, 
ductal cannulation is already necessary for the infusion of enzyme, therefore, the added risk of 
bacterial contamination may be minimal. In these studies, the risk of contamination is reduced 
during the cannulation of the duct by avoiding an enterotomy.  
Improved cooling results in better porcine islet yields and quality, and these results (from a subset 
of pancreata studied herein) have been published previously39. It was reported that when 
pancreata were cooled with both intravascular flush and intraductal infusion, purified islet yields, 
and the number of islet equivalents per gram pancreas increased by >150% compared to surface 
cooling alone. The fractional viability (measured by the oxygen consumption rate normalized to 
DNA content) of islets after 7 days in culture was also significantly improved for pancreata 
procured using combined cooling. The rapid, early cooling resulting from using an intraductal 
infusion may have an effect on islet isolation outcomes
48–51
. Noguchi et al. found that islet yields 
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were improved, islet apoptosis was reduced and ATP levels in the pancreatic tissue were higher in 
human pancreata procured with an intraductal infusion prior to cold storage51. Similarly, 
Matsumoto et al. reported that islet yields and quality were higher in those human pancreata 
undergoing an intraductal infusion48. In contrary, Nakanishi et al. showed no improvement in rat 
islet yield and quality49, which highlights that the greatest benefit of an intraductal infusion may 
be with larger (human or porcine) pancreata. Cold ischemia time (CIT) is a factor that impacts 
islet yield after isolation43. In the present study, CITs recorded for pancreata selected for islet 
isolation38 were found to be comparable with CITs recorded for all pancreata cooled by Methods 
A, C or D of this study (data not shown).  
Conclusion 
In conclusion, using a combined cooling method (Method D) can consistently cool the core of the 
pancreas, in sharp contrast to standard surface cooling alone (Method A) which is ineffective at 
rapidly reducing the core temperature in DCD porcine pancreata and resulted in poorer 
histological outcomes. In our study, intraductal infusion improved initial organ cooling, but is 
limited by the volume of CPS that can be used and does not contribute to sustained organ cooling. 
Alternatively, an intravascular flush can be performed continuously and should be done as it 
provides sustained cooling during the entire duration of the procurement.Combined surface, 
intravascular and intraductal cooling, appears to be the optimized and most consistent cooling 
Method. These data also may have implications on human pancreas procurement since intraductal 
infusion of CPS is not common practice, and should be studied further. 
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Hypothermic Perfusion Preservation of Pancreas for islet grafts: 
validation using a split Lobe Porcine Model  
Summary 
HPP is being investigated for extended pancreas preservation in light of the beneficial effects 
reported for other organs. The present pilot study aimed to establish the potency of porcine islets 
isolated from pancreata after 24-hour of HPP at 4-8°C. The study design included a split-lobe 
pancreas model that permitted paired comparisons of islets isolated from 24-hour HPP splenic 
lobes with non-perfused, fresh control duodenal/connecting lobes stored at 4°C for <3h. Prior to 
transplantation, islet viability was assessed in vitro using the ratio of oxygen consumption rate to 
DNA (OCR/DNA) assay and correlated with subsequent in vivo function by transplantation in 
diabetic immunodeficient mice. The OCR/DNA (mean ±SD) measured after 7 days culture and 
immediately prior to transplantation for islets from the 24-hour HPP group was 269± 19 
nmol/min/mg DNA, which was higher but not statistically different to the mean of 236 ± 43 for 
the counterpart control group. All four nude mice transplanted with islets from the 24-hour HPP 
group showed diabetes reversal, compared with 5 of 6 transplants from the control group. In 
conclusion, islets isolated from adult porcine pancreata after 24-hour HPP exhibited high viability 
as measured by OCR/DNA and were able to consistently reverse diabetes in a nude mouse 
bioassay. 
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Introduction 
The field of islet transplantation for the treatment of Type I diabetes is currently in the phase of 
clinical trials at several centers around the world52,53. The growing recognition that islet 
transplantation is becoming a viable proposition for clinical therapy has led to an increasing 
demand for high quality islets for both research and clinical procedures. Moreover, the potential 
for xenotransplantation to relieve the demand on an inadequate supply of human pancreases will 
also depend upon the efficiency of techniques for isolation of islets from alternative sources, of 
which the pig is highly favored for a number of compelling reasons54. Islets are highly vulnerable 
to irreversible damage after prolonged ischemia, in part because they do not possess the 
enzymatic machinery necessary (LDHα) for ATP generation under anaerobic conditions55–61 and 
cold ischemia of the cadaveric pancreas is detrimental to islet yield62–67. In vitro studies have 
shown a significant reduction in insulin release in response to a glucose challenge even after short 
periods of conventional static cold storage in UW solution63. These observations have been seen 
in clinical practice as there have been no reports of successful single-donor islet transplants with 
prolonged cold storage beyond 10 hours, which is still regarded as the safe limit of cold 
ischemia64. Furthermore, Ryan et al have provided evidence of the detrimental impact of cold 
ischemia on post-transplant islet function68.  
In light of the recent resurgence of clinical interest in hypothermic perfusion preservation (HPP) 
of organs, notably for marginal and expanded criteria organs28 we have recently applied the state-
of-the-art technology to pancreas perfusion as a prelude to islet isolation44,69. It was recently 
reported that, by comparison with conventional static cold storage, hypothermic machine 
perfusion preservation allows safe storage of juvenile pig pancreases for 24 hours with excellent 
in vitro structure and function of islets isolated from the perfused pancreata. The present study 
reports the outcome of a pilot study to validate these in vitro findings using expanded quality 
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assessment including oxygen consumption rate (OCR) analysis25–27 and in vivo transplantation in 
immunodeficient “nude” mice. 
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Materials and Methods 
Experimental Design 
This study was designed to validate, in an adult pig model, the recent findings of Taylor et al44,69 
concerning the functional integrity of islets prepared from the pancreata of juvenile pigs after 24-
hour HPP. To this end, the study assessed the outcome of 10 nude mouse transplants using islets 
derived from 3 adult pig pancreas perfusions compared with 3 paired fresh islet isolations. This 
was achieved using our previously established split-lobe porcine pancreas model as described 
below38.  
Procurement 
Pancreata were procured from adult (1-2 years old) Landrace pigs using a deceased after cardiac 
death DCD donor model involving total viscerectomy followed by en bloc pancreatectomy.  All 
animal care and handling complied with policies and approval of the Institutional Animal Care 
and Use Committee (IACUC) of the University of Minnesota. Following procurement, the 
pancreas was divided into two segments for use in paired isolation outcomes. The first segment 
consisted of the connecting and duodenal lobes38, which were processed for islet isolation with 
the least cold ischemia time (CIT) possible (< 3 hours). The second segment consisted of the 
splenic lobe procured with the entire vascular network which was then prepared for HPP 
according to the technique of Taylor and Baicu44,69. The splenic lobe was selected for perfusion, 
as this lobe in contrast to the connecting and duodenal lobes has the vasculature available for 
perfusion. In our experience with porcine islet isolation, the yields and quality of islets are similar 
for the connecting, duodenal and splenic lobes, so that a different outcome based on differences 
in lobes is not expected.  
Perfusion 
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Both the splenic artery and the celiac trunk attached to the splenic lobe were cannulated using a 
SealRing™ cannula (10mm x 35mm. Organ Recovery Systems, Itasca, IL) and connected to a 
LifePort® Kidney Transporter pulsatile perfusion machine (Organ Recovery Systems, Itasca, IL) 
as described previously44,69. All arterial vessel leaks were identified and ligated. The lobe was 
then perfused for 24 hours with a systolic pressure of 10mmHg, while the pancreas was immersed 
in cold perfusion solution (KPS-1, Organ Recovery Systems) controlled between 4-8°C.  
Islet Isolation, Purification and Culture 
Islets were isolated from both segments of each pancreas using identical conventional techniques 
involving collagenase digestion in a modified Ricordi chamber (BioRep Technologies, Miami, 
FL) as previously described33,44. In brief, the pancreas segment was chopped into pieces and 
digested at 35-37 °C using Liberase MTF enzyme (Roche, Indianapolis, IN) at a concentration of  
150-167 µg/ml. Islets were purified after isolation using established standard continuous Ficoll 
gradient separation with a COBE 2991 (Gambro BCT, Lakewood, CO). After purification, islets 
were cultured between 4 and 12 hours and then assessed using OCR and DNA quantitation25–27.  
Subsequently, islets were cultured in ME199 media at 37°C, for 7-8 days. After the culture 
period, islets were again assessed using OCR and DNA quantitation as well as gross morphology 
using dithizone staining. Aliquots were taken for mouse transplants at this time. 
Islet OCR/DNA 
Islet viability was assessed by measuring the OCR/DNA of the purified islets using a sealed 
chamber fiber optic oxygen sensing system (Instech Labs, Newton, MA) as described 
elsewhere25–27. For this analysis, 5,000 islet equivalents (IE) were allocated immediately after 
purification and again after 7 days of culture. Islets were suspended in a non-supplemented, 
nutrient rich ME199 and sealed in stainless steel chambers. The oxygen partial pressure inside the 
chamber was recorded and the consumption rate was calculated based on the rate of oxygen 
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depletion from the chamber. The DNA quantity in each chamber was determined using the 
Quant-iT Picogreen dsDNA kit (Molecular Probes, Eugene, OR). 
Islet morphology 
Islet samples stained with dithizone for counting were also scored for morphology on a 10-point 
scale. The total score was calculated by summing 5 categories, each evaluated on a 2-point scale: 
1) shape (3D), with more points awarded to more spherical islets; 2) border (2D), with more 
points awarded to well-rounded islets; 3) integrity, with more points awarded to more 
solid/compact islets; 4) presence of single cells, with more points awarded to preparations with 
less single cells; 5) diameter, with more points awarded for larger diameter islets. 
Nude Mouse Bio-Assay 
Diabetes was induced in nude mice using a 240 mg/kg dose of streptozotocin injected 
intravenously, following recommendations of the Clinical Islet Transplant (CIT) consortium 
regarding procedures for the mouse bioassay in testing human islet cell preparations (150-240 
mg/kg)70. The mice were confirmed diabetic after blood glucose levels were maintained above 
500 mg/dL for 2 days. Islets were then transplanted beneath the kidney capsule and distributed 
along the surface of one side of the kidney. Diabetes is considered to be reversed when blood 
glucose measurements were less than 200 mg/dL on two or more consecutive days. After about 4 
weeks the grafts were explanted by nephrectomy to ensure that blood glucose levels in animals 
that had diabetes reversal returned to diabetic levels. Two mice were transplanted with 2000 IE 
after seven days in culture for each pancreas lobe with the exception of the last splenic lobe due 
to a sub-critical mass of islets surviving at 7 days to justify transplantation. A total of 10 mice 
were transplanted, 4 with islets from 24-hour HPP lobes and 6 with islets from controls. 
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Results and Discussion 
Islet yields (<1000IEQ/g) were typically lower than our experience previously for the adult pig 
model. This is attributed, in part, to the decision to switch to the new Liberase MTF enzyme 
preparation, to conform to current clinical practice and the phasing out of the Liberase PI product 
used in prior studies. Moreover, this pilot study was undertaken before the optimal concentration 
of Liberase MTF was determined for this model on the basis that the study design included 
internal controls for each pancreas by virtue of the split-lobe model. The mean (±SEM) yields 
from the control and the 24-hour HPP were not statistically significantly different (see Table 4.1; 
p = 0.4) in the small population of tests in this pilot study. Furthermore, as shown in Table 4.1, 
the purity and yields of islets were more than adequate to satisfy the principal objective of this 
pilot validation study by allowing measurement of viability based on OCR/DNA and in vivo islet 
function based on transplantation outcome in mice and a paired comparison of these parameters 
between experimental perfused lobes and non-perfused controls. 
With respect to viability assessed by the OCR/DNA assay, Table 4.1 shows that the OCR/DNA 
value of islets at day 7 was comparable between the groups and that the pre-transplantation 
OCR/DNA values all exceeded the acceptable threshold of 175 nm/min/mg DNA currently used 
as a release criterion for transplantation of porcine islets in non-human primates71 (Papas et al 
unpublished observations). Figure 4.1 further shows the averaged OCR/DNA data for the two 
groups immediately after isolation and after 7 days of culture. In both cases, there was no 
statistically significant difference between the 24-hour HPP islets and the controls. Moreover, 
Figure 4.1 shows that the freshly isolated islets from both groups demonstrated mean OCR/DNA 
ratios >100 nm/min/mg DNA but failed to meet the pre-determined “release criteria” derived in 
earlier studies for correlating the OCR/DNA index with transplantation outcome. In sharp 
contrast, islets from both groups exceeded this threshold after 7-days culture. This is actually 
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reflecting the clearance of dead tissue (DNA) originally present post-isolation and reflected in 
less than 100% IE recovery. Culture clears dead islet tissue (that did not survive the isolation 
process) while viable tissue is maintained therefore viability (OCR/DNA) increases. Most 
importantly, the recovery and viability of islets from the 24-hour HPP pancreata, which was not 
significantly different to controls, was further corroborated by the transplantation outcome as 
shown in Figure 4.2. Here the individual and mean data for the nude mice transplants shows that 
all 4 mice receiving islets of the HPP group reversed diabetes: the efficacy of the islets was 
proven by the return to the diabetic state after graftectomy. Mice receiving islets from the control 
group showed diabetes reversal in 5 out of 6 cases.  
Islets are highly sensitive to ischemia such that various modes of pancreas preservation are 
currently under investigation. It is generally assumed that using conventional preservation media, 
pancreata do not survive periods of 24-hour cold ischemia with insufficient yields in islet 
manufacturing. The present results give a strong indication that 24-hour HPP provides sufficient 
protection for adult porcine pancreata so that islets in sufficient quantity and of high quality can 
be prepared. 24 hours HPP of adult porcine pancreas yielded high quality islets with a robust in 
vitro viability (based on OCR/DNA) that was equal to non-perfused fresh controls and exceeded 
the established threshold set as a release criterion for transplantation in non-human primates. The 
in vivo functional quality of the islets derived from 24-hour HPP pancreas was sufficient to 
reverse diabetes consistently in a nude mouse bioassay. Hypothermic perfusion preservation 
(HPP) is now favored as the method of choice for clinical kidney preservation when applied to 
marginal or expanded criteria organs that have suffered a warm ischemic insult28,72. HPP is also 
under investigation for pancreas preservation and this study set out to validate recent findings that 
24-hour HPP is tolerated in a porcine model44,69.  
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Figure 4.1: Morphology and function of transplanted islets. Upper panels show brightfield micrographs 
of dithizone-stained islet aliquots immediately prior to transplantation: Panel A shows representative islets 
from the control group which was assigned a mean morphology score of 7.2±0.6 (n=3); Panel B shows 
islets from the HPP group with a mean morphology score of 7.5±0.5 (n=3). Lower panels show individual 
blood glucose levels for mice transplanted on Day 7 for each condition.  The number of animals in which 
diabetes was reversed is indicated. In animals that reversed diabetes after islet transplantation, the effect of 
the transplant was proven by graftectomy 4 weeks after transplantation followed by an increase in blood 
glucose confirming the diabetic state. 
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Figure 4.2: Average OCR/DNA. OCR/DNA of isolated porcine islets by condition for Day 0/1, and Day 
7. Error bars represent the standard error of the mean. 
  65 
  
Table 4.1: Islet Isolation and Quality Control (QC) Data 
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Plasticity and Aggregation of Juvenile Porcine Islets in Modified 
Culture for Xenotransplantation: Preliminary Observations  
Summary 
Diabetes is a major health problem worldwide and there is substantial interest in developing 
xenogeneic islet transplantation as a potential treatment. The potential to relieve the demand on 
an inadequate supply of human pancreata is dependent upon the efficiency of techniques for 
isolating and culturing islets from the source pancreata. Porcine islets are favored for 
xenotransplantation, but mature pigs (>2 years) present logistic and economic challenges and 
young pigs (3-6 months) have not yet proven to be an adequate source.  In this study, islets were 
isolated from 20 juvenile porcine pancreata (~3 months; 25 kg Yorkshire pigs) immediately 
following procurement, or after 24 hours of hypothermic machine perfusion preservation.  The 
resulting islet preparations were characterized using a battery of tests during culture in silicone 
rubber membrane flasks. Islet biology assessment included oxygen consumption, insulin 
secretion, histopathology and in vivo function. Islet yields were highest from HMP preserved 
pancreata (2242±449 IEQ/g). All preparations comprised a high proportion (>90%) of small islets 
(<100 μm), and purity was on average 63±6%. Morphologically, islets appeared as clusters on 
day-0, loosely disaggregated structures at day-1, and transitioned to aggregated structures 
comprising both exocrine and endocrine cells by day-6. Histopathology confirmed both insulin 
and glucagon staining in cultures and grafts excised after transplantation in mice. Nuclear staining 
(Ki67) confirmed mitotic activity consistent with the observed plasticity of these structures. 
Metabolic integrity was demonstrated by oxygen consumption rates = 175±16 nmol/min/mg 
DNA and physiological function was intact by glucose stimulation after 6-8 days in culture. In 
vivo function was confirmed with blood glucose control achieved in nearly 50% (8/17) 
transplants. Preparation and culture of juvenile porcine islets as a source for islet transplantation 
requires specialized conditions. These immature islets undergo plasticity in culture and form fully 
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functional multi-cellular structures. Further development of this method for culturing immature 
porcine islets is expected to generate small pancreatic tissue-derived organoids termed 
“pancreatites” as a therapeutic product from juvenile pigs for xenotransplantation and diabetes 
research.  
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Introduction 
A recent report on worldwide markets and emerging technologies for tissue engineering and 
regenerative medicine emphasizes the alarming statistics concerning the rapidly growing 
worldwide problem of Diabetes as an estimated 366 million cases that will be diagnosed in the 
next 20 years 73. Type 1 diabetes accounts for 5-10% of all diagnosed cases but 27% of Type 2 
diabetes also require insulin. Therefore, about a third of all diabetics could potentially benefit 
from a cell-based therapy that restores insulin production, particularly one that is minimally 
invasive such as isolated islet infusion into a heterotopic site (especially if this can be 
accomplished without the need for systemic immunosuppression). This situation clearly 
demonstrates a major clinical/commercial impact for new technologies that provide desperately 
needed improved methods of pancreas preservation to produce better yields of high quality islets. 
Ever since the first experimental attempts to ameliorate Type 1 diabetes by transplantation of 
allograft donor islets the field has been challenged by the need for improved methods of 
retrieving and/or obtaining islets from donor pancreata.  There is a considerable worldwide effort 
to further develop the concept for treating Type 1 diabetes by transplanting islets, but clinical 
application of the techniques developed in animal models is fraught with many challenges.  The 
source of the islets remains a primary concern, and isolation from donor pancreata demands 
resolution of questions concerning the source, supply, and condition of the donor organs.  
Reliance upon an adequate supply of human organs for this purpose is considered limited, such 
that alternative sources are actively being sought 74,75. 
Various mammals are considered potential candidates for xenogeneic islet transplantation.  Of 
these, pigs are considered the donor species of choice for xenogeneic islet transplantation for a 
number of compelling reasons.  Pigs share many physiological similarities to humans and porcine 
insulin has demonstrated clinical efficacy for many years.  Pigs are raised as a food source and 
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provide an ethical source of donor islets by being housed in a controlled environment to ensure 
safety for porcine islet xenotransplantation 33,76.  However, experiences in many laboratories over 
the past decades show that isolation of porcine islets appears to be more difficult 54,77–80 compared 
with the isolation of human 81, bovine 82, or rodent islets 83. For example, porcine islets are less 
compact and tend to fragment during the isolation procedure and during prolonged periods of in 
vitro culture 84,85. Moreover, the age, and even the strain, of the donor pig has been documented 
by several groups to markedly influence the islet isolation process, with young, so-called market 
size pigs (≤6 months old) proving to be particularly difficult as a source of transplantable islets 
80,85–88. Islets from adult pigs (>2 years old) offered higher yields, and retained better morphology 
during the isolation process and culture, in association with higher functional properties after 
transplantation 87.  Despite the challenge encountered by many groups attempting to isolate islets 
from young pigs, donor pigs of market weight (<50 kg ≤6 months old) are preferred to retired 
breeders (>200 kg ≥2 years old) due to their abundance and relative cost efficiency with lower 
animal and husbandry costs. They are much easier to handle than >200 kg adults and more 
suitable to meet regulatory guidelines for donor tissue for xenotransplantation 80,85–87,89,90.  If the 
supply of islet cells could be augmented by culturing and improving the therapeutic capacity of 
donated islets from more readily available sources (such as young pigs), these new sources would 
provide sufficient material to become a new treatment for insulin-dependent diabetes, assuming 
immunological issues (rejection) are eventually addressed. 
Preservation of the pancreas prior to islet isolation is also a critical step in the procedure and we 
have recently described a technique for 24h hypothermic machine perfusion (HMP) of pancreata 
that facilitates islet isolation from young pigs 44,45,69. The research described here combines this 
technology with a culture method involving silicone-rubber membrane (SRM), gas-permeable 
flasks 91 (<http://www.wilsonwolf.com/>), in an attempt to develop a system for culture and 
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shipping of these fragile juvenile porcine islets for research and possible future 
xenotransplantation. In so doing, the immature porcine islets were observed to undergo plasticity 
during 7 days in culture resulting in larger aggregate structures comprising both endocrine and 
exocrine cells. For convenience, we refer to these aggregates as “pancreatites” to reflect their 
apparent structure as small pancreatic tissue-derived organoids, not previously described to our 
knowledge. 
  
  73 
Materials and Methods  
Ethics Statement: 
For the respective work at each institution, the Medical University of South Carolina (Department 
of Comparative Medicine) Institutional Animal Care and Use Committee (pigs) or the University 
of Minnesota Institutional Animal Care and Use Committee (mice) approved all studies with 
animals as described in this manuscript. Every effort was made to minimize suffering, and all 
studies complied with the USDA Animal Welfare Act Regulations, the Public Health Service 
Policy on Humane Care and Use of Laboratory Animals, and the recommendations in the Guide 
for the Care and Use of Laboratory Animals (NIH).  
Islet Isolation and Culture: 
Islets were isolated by conventional collagenase (Roche MTF) digestion of juvenile porcine 
pancreata (2-3 month old, 25-30 kg Yorkshire pigs) either between 2-3 hours after procurement 
(Fresh), or after 24 hours of hypothermic machine perfusion (HMP) using the methods we have 
previously reported 44,45,69 . Briefly, pancreata preserved by HMP were perfused using the 
Lifeport Kidney Transporter and KPS1 perfusion solution both from Organ Recovery Systems 
(Itasca, IL). The liberated islet tissue was purified by Optiprep density-gradient separation 
(Sigma-Aldrich, St Loius, MO), and cultured for up to 7 days at 37 °C. The isolation and culture 
protocols were identical for both Fresh and HMP pancreata. ME199 medium (Mediatech, 
Herndon, VA) was used for the duration of the culture period, and modified based on our 
experience with the addition of an anti-oxidant, 50 mM Trolox (Roche, Basel, Switzerland), a 
broad spectrum anti-apoptotic agent, Quinoline-Val-Asp-DifluoroPhenoxymethylketone (Q-VD-
OPH,10 µM from MP Biomedical, Santa Ana, California) and 10% porcine serum (Gibco, Life 
Technologies, Carlsbad, CA) 92. The isolation product was then characterized using a battery of 
tests at various time points during culture in SRM flasks (Wilson Wolf, New Brighton, MN). Islet 
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morphology was assessed daily by phase contrast microscopy (Olympus IX70 inverted 
microscope) in the presence of dithizone stain, and the dynamic cell morphology was recorded in 
digital micrographs. Viability, functional status, and islet biology were assessed using established 
islet quality assays at various time points during the culture period, including measurements of 
oxygen consumption rate normalized to DNA (OCR/DNA), static insulin secretion (Glucose-
stimulated insulin secretion: GSIS), immunohistochemistry, and confocal microscopy. Extended 
quality assessment entailed shipment of pancreatite structures overnight by standard courier to the 
laboratories of our collaborators at the University of Minnesota (UMN, Minneapolis, MN) and 
Yale University (New Haven, CT). For these shipments, we used the shipping version of the 
Wilson-Wolf silicone membrane flasks 91, using a temperature controlled shipping system 93. 
Perifusion insulin release measurements were done at Yale as previously reported 94, and post 
shipment evaluation and diabetic nude mice transplantation was done at the UMN. The extended 
assessments at Yale, and UMN did not compare Fresh vs HMP pancreatitis due to limited data 
sets. All data is reported as the mean and the standard error of the mean, with statistical 
comparisons between two groups using a two-tailed unpaired t-test, and comparison between 
multiple groups using one-way repeated measures ANOVA and Tukey’s multiple comparison 
post-test. 
Islet Assessments: 
Islet quantification: Following islet isolation and purification, the total number of islets was 
determined using standard published techniques 85,95. A volume of 50µl of the purified prep was 
added to 2 ml of dithizone stain inside a 35x10 mm tissue dish with grid. Thus, islet tissue 
clusters were stained in contrast to exocrine tissue and then counted and converted to islet 
equivalents (IE) according to standard convention 85,95. Counting the pancreatites using the 
conventional method was challenging given the co-localized nature of stained and unstained 
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tissues in each sample. To ameliorate observer bias, all counts were performed in duplicate by 
two independent observers, and reported values are averages of both counts.  The purity of the 
islet preparation was also assessed by comparing dithizone-stained tissue to unstained exocrine 
tissue. 
OCR/DNA: The OCR/DNA assay is a measure of isolated islet functional viability, and is used 
as a predictor of islet function in-vivo 25–27,96. Oxygen consumption rate measurements of the 
islets were done on the same day as isolation, after 7 days in culture, and after shipment to the 
University of Minnesota (Day 8). Designated islet samples (~5,000 IEQ/sample), were collected, 
washed, and suspended in Dulbecco’s modified Eagle’s medium (Mediatech, Herndon, VA) 
containing 4.5 g/L L-glutamine and supplemented with 100 U/ml penicillin, 100 µg/ml 
streptomycin, 10 mM HEPES without serum. Each islet suspension was divided into three or 
more 200 µL titanium chambers.  The chambers were sealed and maintained at 37°C.  The time-
dependent oxygen partial pressures (pO2) within the chambers were recorded over time using a 
fluorescent-based fiber optic oxygen sensor (Micro Oxygen Uptake System, FO=SYSZ-P250; 
Instech Laboratories, Plymouth Meeting, PA).  The OCR was then calculated as previously 
described 26. The cell suspensions were then carefully removed from the chambers and processed 
for DNA quantification as described below.  
DNA Quantification: Islet samples analyzed by the OCR assays were subsequently sampled for 
quantification of DNA content.  To measure DNA content, islet samples were diluted in an 
aqueous cell lysis solution of 1M ammonium hydroxide (Fisher Scientific, Pittsburgh, PA)  and 
3.4 mM Triton X-100 (Sigma-Aldrich, St Loius, MO),  and sonicated to ensure adequate cell 
lysis. DNA content was determined using the Quant-iT PicoGreen dsDNA kit (Molecular Probes, 
Eugene, OR) as per manufacturer’s instructions.  Fluorescence readings were taken on a 
SpectraMax M5 microplate reader (Molecular Devices, Sunnyvale, CA) 
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Islet Insulin Content and Stimulated Secretion Assay: Islet insulin release upon exposure to 
low and high glucose concentrations was determined following an initial recovery of 1 hour at 37 
°C in low, 2 mM, glucose (in RPMI-1640, Gibco, Life Technologies, Carlsbad, CA) solution. 
Consecutive 30 minute islet incubation periods (37 °C water bath shaker) in 2.5 mM, 16.7 mM 
and then 2.5 mM glucose solution, respectively, were performed, each followed by careful 
supernatant removal and freezing (0.5 mL), and islet resuspension in the next glucose 
concentration solution. A total of 12 x 1.5 mL conical tubes, each containing 25 IEQ in 1 mL 
glucose solution were employed. Gravity driven sedimentation of islets was used prior to 
supernatant removal. The insulin content of frozen supernatants and samples was determined 
using Insulin Porcine EIA kits (Alpco Diagnostics, Windham, NH) and normalized to islet 
equivalents.  
Histology, Immunohistochemistry, and Confocal Microscopy: Islet samples containing 1,000-
2,000 IEQ were collected from cultures 7-8 days following isolation. The samples were 
immediately fixed in 10% buffered formalin (Fisher Scientific, Pittsburgh, PA) for at least 24 
hours and then transferred to a 70% ethanol solution.  Fixed samples were embedded in paraffin 
and sectioned at 4 µm, and stained with hematoxylin and eosin.  For insulin, glucagon, and Ki67 
immunohistochemical staining, sections were cut at 4 µm, de-paraffinized, and rehydrated, 
followed by incubation with 3% hydrogen peroxide to quench endogenous peroxidase activity. 
Following appropriate antigen retrieval, sections were incubated with the primary antibody 
(guinea pig anti-swine insulin, 1:300 dilution, cat.#A0564, Dako, Carpinteria, CA; rabbit anti-
human glucagon, cat.#NB120-1846 Novus Biologicals, Littleton, CO; mouse anti-human Ki67 
monoclonal antibody clone MiB-1, 1:50 dilution, cat. #M7240, Dako.  Antigen detection was 
done with anti-rabbit polymer, EnVision, Dako, and color visualization was done using DAB, 
Dako. The same protocols were used for examining explanted graft tissues. Double 
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immunofluorescence staining for insulin/cytokeratins was done on formalin fixed, paraffin-
embedded sections cut at 4 µm.  For insulin labeling, sections were first deparaffinized, 
rehydrated, and incubated with guinea pig anti-swine insulin (Dako) for 60 minutes.  Next 
sections were incubated in the dark with FITC-conjugated, goat anti-guinea pig immunoglobulin 
(NOVUS, cat # NB7397) for 60 minutes.  Sections were next incubated with antibodies to wide 
spectrum cytokeratin (Rabbit anti-cytokeratin, cat.#Z0622, Dako) followed by incubation in the 
dark with Streptavidin-AlexaFluor-594 (Invitrogen, cat # 21207) for 60 minutes.  Finally, nuclear 
staining was done using TOPRO-3 (Molecular Probes, Eugene, OR).  Labeled sections were 
examined with a Biorad laser confocal microscope. 
Nude Mouse Bioassay: Islets from six different preparations were shipped to the University of 
Minnesota for implantation into diabetic nude mice (n=17). Mice (Crl:NU-Foxn1nu mice from 
Charles River Laboratories, Wilmington, MA) were rendered diabetic by a 240 mg/kg 
intraperitoneal injection of streptozotocin (Zanosar) 71.  After diabetes establishment 
(hyperglycemia) was confirmed, and based upon our previous experience using this model a dose 
of 2,000 IEQ of islets were transplanted into the renal subcapsular space of each mouse, and 
blood glucose and body weights were observed for between 30-60 days.  The standard 30 day 
follow-up period was extended for a sub-group (n=8) of these implants because it was suspected 
that these under-developed pancreatite structures may continue to mature in-vivo and may offer 
delayed graft function. In some animals, the observation period was extended if the glucose levels 
were observed to decrease following transplant but had not yet reached the critical conclusive 
levels. Mice were considered to be diabetic when three consecutive blood glucose measurements 
of >300 mg/dL where observed, and a graft was considered functional upon a return to stable 
glycemic control when three consecutive blood glucose measurements were <200 mg/dL during 
the observation period. Mice with functioning grafts were nephrectomized following the 
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observation period to ensure that blood glucose measurements returned to diabetic levels, after 
which the mice were euthanized 26,71,97. 
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Results 
Yields and purities for both fresh and HMP islets are reported in Table 5.1, along with culture 
recoveries and insulin data. The average purified islet yield per gram of digested tissue was 
notably higher for islets isolated from HMP organs when compared to islets isolated from fresh 
controls with a 57% improvement observed for these studies, but due to the limited number of 
isolations studied and large variability this difference was not statistically significant (p=0.285). 
Following culture for one week, pancreatites from both conditions demonstrated to be fully 
functional in terms of insulin secretion in response to glucose challenge (Table 5.1). When 
compared using a two tailed unpaired t-test; average yield, average purity, culture duration, 
culture recovery, insulin stimulation index and insulin content were not different between groups 
(p>0.05). These observations were consistent with our recently published findings describing islet 
isolation from juvenile porcine pancreas after 24-hr hypothermic machine perfusion preservation 
44,45,69. Islets isolated from HMP and Fresh pancreata exhibited similar behavior in culture and 
yielded comparable functional outcomes (OCR/DNA, immunohistochemistry, nude mouse 
transplants); therefore, the results reported on these aspects represent the observations of islets 
from both groups. 
As illustrated in Figure 5.1A, islet preparations from both Fresh and HMP pancreata comprised a 
high proportion (>90%) of small islets (<100 µm) immediately following isolation. The dithizone 
stained islets appeared as “grape-like” clusters on Day 0. Figure 5.1 also shows the plasticity 
observed during subsequent post-isolation culture of the immature islets. The term “plasticity” is 
used according to the definition of the ability of a biological system to be altered into different 
shapes and/or behavior according to varying environmental conditions. Each panel in Figure 5.1 
(A-E) shows the typical appearance of the β-cells (stained red with dithizone) and exocrine 
(unstained grey-brown) at various time points during 1 week of culture post-isolation, and after 
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shipment (Figure 5.1G). The gross morphology of the islets was observed to change during the 
first 24-48 hours in culture. (Compare the looser more fragmented nature of the Day 1 cultured 
islets in Figure 5.1B, with the “grape-like” clusters of islets on day 0 immediately post-isolation 
in Figure 5.1A. 
During the initial 48 hours of culture, the islets appeared to disaggregate to form strings of cells 
and then they associated with residual non-dithizone stained tissue (Figure 5.1B-C). The most 
significant observation is the transition of the tissue from this loosely disaggregated appearance at 
24 hours (Day 1) to more condensed aggregated structures comprising both exocrine and 
endocrine cells by Days 4-7 (Figure 5.1D-E).  
The pancreatite structures shipped to Yale University maintained their structural integrity, and 
demonstrated dynamic insulin secretory responses to a standard panel of secretogogues as 
described in a previous publication 94. Moreover, pancreatite samples shipped to University of 
Minnesota (n=5) retained their morphology and their metabolic capability as demonstrated by the 
oxygen consumption measurements, which were not significantly different to the pre-shipment 
values (Figure 5.2). The OCR/DNA (mmol/min/mgDNA) was measured to be = 134±19 at Day 
0; 159±25 on Day 7 (pre-shipment) and 175±16 on Day 8 (post-shipment), and analysis by one 
way ANOVA (p=0.3391) with Tukey’s multiple comparisons post-test concluded that no 
significant differences were observed between time-points.  
Upon arrival in Minnesota, immunohistochemistry of the tissue showed cells with insulin or 
glucagon immunoreactivity among cells in the cultured aggregates (Figure 5.3A&B 
respectively). Nuclear staining for Ki67-MiB confirmed mitotic activity within the cell aggregates 
during culture (Figure 5.3C), and within the graft post-transplant (Figure 5.4B inset).  These 
observations suggest that the formation of pancreatites was not simply due to aggregation but also 
due to growth by cell division, and possibly maturation in culture and in vivo.  Confocal 
  81 
microscopy of double immunofluorescently stained pancreatites showed strong, non-overlapping 
staining for insulin and wide spectrum cytokeratins indicating the presence of both beta cells and 
ductal epithelial cells within the tissue (Figure 5.4D). 
The pancreatites maintained metabolic integrity, demonstrated by oxygen consumption rates 
(175±16 nmol/min/mgDNA) ,and physiological function, confirmed by both static and previously 
published dynamic glucose stimulation 94. Furthermore, in vivo function was examined by 
transplantation under the kidney capsule in nude mice. Figure 5.4A shows the average blood 
glucose measurements for the 8 animals that achieved glycemic control (blood glucose levels 
≤200 mg/dL for 3 consecutive days), as well as the average blood glucose measurements of the 9 
animals that did not (shown separately for clarity). Glycemic control was achieved in 8/17 mice 
(47%) on average 25 days post transplantation (for these mice) with 7 animals achieving control 
10 or more days following transplant (Figure 5.4B). Post-explant glucose measurements were 
excluded from this figure due to variable explant timing, but all animals returned to 
hyperglycemic state (≥3 consecutive BG measurements ≥300 mg/dL) following graft explant. 
The average mass of all animals was observed to decrease by 0.3  grams from the time of 
transplant until nephrectomy or euthanasia which is not statistically significant (p=0.3722 for 
paired student t-test comparing starting mass and final mass), and no animal was observed to lose 
more than 10% of starting body mass. Histopathology of explanted grafts confirmed persistent 
islet tissue within the graft and sections showed strong insulin and glucagon staining (Figure 
5.5). Furthermore, continued mitotic activity was observed within the graft as indicated by Ki67-
MiB staining, and a representative image is shown as an inset in Figure 5.4B.  
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Table 5.1: Isolation and Culture Results 
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Figure 5.1: Pancreatite plasticity micrographs. Micrographs demonstrating the plasticity of pancreatite 
structures during 7 days of culture, and after shipment. Phase contrast micrographs of dithizone-stained 
(red) islet cultures at critical times in culture (A-E) and after shipment (F). Exocrine tissue remains un-
stained (light grey/yellow). Day 0 purified islets (A) show the familiar irregular shape of “grape-like” islet 
clusters. During the first 24 hours in culture (B), the islets appear to disaggregate into strings of loosely 
clustered islets associated with the residual exocrine tissue. Between 2 and 4 days of culture (C&D), this 
process continues and the clusters become larger and more condensed aggregate structures comprising both 
exocrine and endocrine cells. By 7 days, the larger re-aggregated structures, which we termed 
“pancreatites,” were clearly more dense and compact. The final panel (F) shows that the pancreatites 
remained morphologically intact following ambient shipment to Minnesota in Wilson-Wolf flasks.  Scale 
bars represent 100 µm. 
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Figure 5.2: Juvenile porcine islet viability. OCR/DNA was 134±19 at Day 0; 159±25 on Day 7 (pre-
shipment) and 175±16 nmol/min/mgDNA on Day 8 (post shipment) The viability of the pancreatites 
improved in culture, and was on average 18±14% higher but not significantly different post-shipment 
compared to pre-shipment. 
  85 
 
  
Figure 5.3: Juvenile porcine islet immunohistochemistry. Immunohistochemistry staining of 7-day 
cultured pancreatite tissue shows staining for islet markers and proliferation markers. Upon arrival at 
Minnesota, pancreatites showed strong staining of both insulin (A) and glucagon (B) from the islets. Ki67-
MiB nuclear staining (C) shows mitotic activity in these structures providing evidence of cell proliferation. 
Confocal microscopy of double immunofluorescently stained pancreatites (D) showed staining for insulin 
and wide spectrum cytokeratins indicating the presence of both beta cells and ductal epithelial cells within 
the tissue.  
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Figure 5.4: Nude mouse diabetes reversal. Mean blood glucose measurements (A) and diabetes reversal 
rate plot (B) from diabetic nude mice. Data from mice that received a renal sub-capsular transplant of 
pancreatites shipped to Minnesota for assessment. Blood glucose data shown is grouped by outcome; 8 of 
17 animals achieved glycemic control after an average of 25 days. Blood glucose measurements following 
explant are not shown for clarity due to differing points of euthanasia, although all animals revered to 
hyperglycemia following explanation of the graft. Achievement of glycemic control was defined as three 
consecutive blood glucose measurements ≤ 300 mg/dL following transplant. The delayed control of blood 
glucose levels is suspected to reflect possible generation of a critical mass of insulin-secreting cells by 
neogenesis as evidenced by the positive Ki67-MiB immunostaining in the explanted grafts [inset]. 
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  Figure 5.5 Insulin (A) and glucagon (B) staining in explanted pancreatite grafts. Sections from 
explanted grafts show strong staining for both insulin (A) and glucagon (B), which confirms the 
preservation of endocrine cell phenotypes within these pancreatites in vivo. Future studies with co-localized 
staining to investigate the mitotic activity observed in these grafts will further illuminate the behavior and 
plasticity of these pancreatites in vivo. 
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Discussion 
Clinical trials are underway at several centers around the world to assess the efficacy of 
implantation of functional pancreatic islet cells as a potentially curative treatment for Type 1 
diabetes 52,53. Nevertheless, the limited availability of donor human pancreata means that clinical 
islet transplantation may not reach its full potential without reliance upon alternative sources of 
islets. Porcine islets are favored for xenotransplantation for a variety of reasons 54 but mature pigs 
(>2 years old) present logistic and economic challenges and young pigs (3-6 months) have not yet 
proved to be an adequate source. As discussed by several investigators, experiences in many 
laboratories over several decades show that isolation of porcine islets appears more difficult than 
other mammals including human, and the economically-favored juvenile pig has proved even 
more problematic due to poor yields and extreme fragility of the immature islets 87,98–100. Despite 
some reports for the successful isolation of islets from young market pigs (4-6 months old) the 
studies did not involve culturing the islets 100, which remains a significant challenge. For 
example, Rijkelijkhuizen et al report 80% attrition of adult porcine islets after 1 day culture 99. 
More recently, Lakey’s group has reported successful post-isolation culturing of partially digested 
pancreatic fragments from infant pigs (<4 weeks old) 101. This model produces small numbers of 
islets compared with conventional models using older pigs, but the study demonstrates a robust 
capacity for continued in vitro development in culture thus supporting the basic premise of our 
study.  
Preservation of the pancreas prior to islet isolation is also a critical step in the procedure and we 
have recently described a technique for 24hour hypothermic machine perfusion (HMP) of 
pancreas that facilitates islet isolation from young pigs 44,45,69. The research described here 
combines this technology with an effective culture method involving silicone-membrane, gas-
permeable flasks, in an attempt to develop a system for culture and shipping of juvenile porcine 
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islets for research and possible future xenotransplantation. This contrasts sharply with 
conventional culture of porcine islets from pigs of any age, especially juvenile, which have 
proved to be too fragile and labile in culture to be of practical utility 84,86,87,99.  
Special Conditions for Culture of Juvenile Porcine Islets: 
An important achievement of the studies reported here is the successful isolation and culture of 
juvenile porcine islets, which are notoriously difficult to establish and maintain in culture 86,87,99. 
Until the introduction of the use of gas permeable culture flasks 91 (Wilson Wolf Manufacturing, 
MN) our experience was the same as many in the field in that islets from young market-size pigs 
are very difficult to maintain in culture. Conventional culture in regular flasks led to the demise 
of the islets within 12-24 hours of culture. Even the purest preparations resulted in disappearance 
of islets within the first 24 hours as reported previously by other investigators 84,86,99.  
Although considerable attention has been given to the formulation of media for islet culture as 
reviewed by Clayton 102 and London and Murdoch et al. 103, very little attention was given to the 
role of oxygen transport until the introduction of gas permeable substrates in the form of silicone 
rubber membrane flasks 91. Islet density and aggregation have been shown to negatively impact 
islet survival in culture such that a marked improvement was demonstrated by increasing external 
pO2 and culturing on a SRM 
91. This new technology was therefore introduced in this study to 
complement changes to the culture medium and islet isolation after hypothermic machine 
perfusion 44,69,104.  
The ME199 medium was specially modified for porcine islet culture through the addition of 
various supplements and porcine serum 92. Using this scheme, it was observed that the juvenile 
islets did not behave the same as conventional cultures of adult pig islets, or even human islets. 
As described above the immature porcine islets underwent plasticity during 7 days in culture 
resulting in larger, re-aggregated structures. This contrasts markedly with the typical behavior of 
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islets from adult species, which maintain their islet individuality and post-isolation structure 
throughout conventional tissue culture. In cultures of adult islets, the contaminating exocrine 
tissue tends to disintegrate and disappear by autolysis leaving an even purer preparation of 
individual islets 98. In contrast, the tissue from juvenile pigs appeared to re-aggregate into larger 
new structures comprising endocrine and exocrine cells in coexistence, hence the term 
“pancreatite”. Confocal double-staining (Figure 5.3D) clearly demonstrated the heterogeneous 
aggregated tissue character, and confirmed the presence of both beta cells and ductal epithelial 
cells in the structures after 7 days in culture.  
For convenience, we refer to these aggregates as “pancreatites” to reflect their apparent structure 
as small pancreatic tissue-derived organoids, not previously described to our knowledge. These 
preliminary observations have been achieved by combining previously reported developments for 
modified preservation solutions and juvenile porcine islet isolation after HMP, with the use of 
SRM flasks. This phenomenological discovery of pancreatite formation using the combined 
technologies has been generated without specific knowledge of the relative contributions of each 
of the component systems. Hence, this new phenomenon provides the basis for further research to 
employ this combination of technologies for the synergistic development of “pancreatites” as a 
potentially new solution for generating a therapeutic product from juvenile pigs for 
xenotransplantation and diabetes research.  
In vitro functional assessment: 
The pancreatite cultures were monitored daily for one week to observe these changes in 
morphology, and were assessed at critical points for quality by OCR/DNA, Insulin secretion, 
histopathology, and immunohistochemistry. The islet tissue function was also tested in vivo by 
nude mouse bioassay. The OCR/DNA results showed high tissue viability following culture 
(159±25 nmol/min/mgDNA), and this viability was maintained following shipment to the 
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University of Minnesota (175±16 nmol/min/mgDNA). These observations are consistent with 
reports in literature using similar shipping methods 105. The OCR/DNA assay in conjunction with 
the total transplanted OCR dose has been shown to be an accurate predictor of diabetes reversal in 
nude mice transplanted with human islets. The viability level of the pancreatite structures was 
comparable with high-viability human islets reported in literature 26, and sufficiently higher than 
the reported minimum OCR/DNA boundary (150 nm/min/mgDNA) required to reverse diabetes 
in mice with rat islets 96. This comparison can only be considered as a reference because as 
discussed above, these preparations exhibit notable morphological and functional differences 
between adult pig islets, and are also different from observations with human, or rat islets. These 
differences, along with the limited reports in literature warranted a brief examination of these 
structures in vivo, and suggest a need for further studies examining the viability and function of 
these pancreatites. 
In vivo functional assessment: 
Further examination of the pancreatite functionality was assessed with a limited number of nude 
mouse transplants (n=17). The average blood glucose of all the animals shown in Figure 5.4A 
(separated into reversed and not reversed groups) demonstrates a gradual decrease in average 
fasting blood glucose levels with reversal glycemic control achieved on average 25 days post 
transplantation. Despite strong staining for insulin and glucagon in culture, (Figure 5.3A-B 
respectively) delayed function was observed in 7 of the 8 animals that reversed diabetes. These 
animals gained glycemic control 10 or more days following transplant as shown in Figure 5.4B. 
This is likely due to an inadequate functional beta cell mass immediately following transplant 
with possible islet neogenesis contributing to the primary graft function after 10 or more days in 
vivo. These results are consistent with the findings of Korbutt et al. describing the delayed graft 
function of neonatal porcine islet cell (NIC) aggregate transplants in nude mice 
106
. Neonatal pigs 
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represent a much earlier stage of development (1-3 days old) compared to juvenile pigs used in 
our studies (1-3 months old). His studies found a dose-dependent return to normoglycemia in 
nude mice transplanted with NIC aggregates, and reported 100% achieved normoglycemia after 8 
weeks for grafts with 2,000 aggregates 106. However, only 30% of these animals achieved 
normoglycemia after 4 weeks, suggesting that pancreatite grafts may offer expedited graft 
function compared to NIC grafts. It should also be noted that these in vivo results are highly 
dependent on the initial amount of grafted tissue (eg. islet dose), and more rigorous methods for 
quantification of pancreatite tissue (eg. DNA) or total beta cell mass would allow for a better 
understanding of the dose-dependent nature of glycemic control.  Future studies to parallel these 
findings, which extend the transplant follow-up period of mice with pancreatite grafts, would 
provide a valuable comparison of these two similar cell-sources. Furthermore, pancreatites 
exhibited notable staining for Ki67-MiB in culture (Figure 5.3C) and in explanted grafts (Figure 
5.4B Inset), indicating an elevated level of mitotic activity. Separate sections from explanted 
grafts were also stained for insulin and glucagon (Figure 5.5) to confirm the presence of 
endocrine islet tissue in the explanted graft. Strong staining for both hormones indicated that the 
endocrine phenotypes of these pancreatite cells were maintained in vivo.  This finding supports 
the hypothesis of in vivo islet neogenesis, but quantitative morphometric analysis and co-
localization with insulin staining would be required to confirm this mechanism. 
Observed pancreatite potential for regeneration: 
Over the past decade, significant advances have been made in developmental biology of the 
pancreas and other endoderm-derived organs. Studies on islet morphogenesis show that the 
majority of islet cells are formed in late gestation by the process of neogenesis from precursor 
cells. The changes observed in the early periods of our juvenile porcine islet culture system 
closely resembles the budding of islet cells from the ducts and re-organization to form clusters, 
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during the process of islet morphogenesis seen both in vitro and in vivo 107–109. Bonner-Weir et al. 
among others have reviewed the plasticity of adult pancreatic cells and the ultimate feasibility of 
in vivo neogenesis 74,75,107. In vitro differentiation of stem/progenitor cells into β-cells is being 
pursued as an important approach to generate a reliable and replenishable source of β-cells. 
Pancreatic ductal cell lines and primary ductal cells have been successfully differentiated into 
insulin-expressing cells by in vitro approaches, including treatment with growth factors (e.g. 
EGF, Gastrin, exendin), expression of pancreatic transcription factors, and aggregation 107. The 
aggregation and plasticity of the pancreatic cell cultures derived in our preliminary studies using 
juvenile porcine pancreas is consistent with this approach and is remarkably complementary to 
the parallel studies of Bonner-Weir et al. For example, her group has shown that discarded 
digested pancreatic tissue from human islet isolations can be successfully processed to expand 
and differentiate the ductal cells over a period of 3-4 weeks in vitro to cultivate human islet buds 
consisting of cytokeratin-19 positive duct cells and hormone positive islet cells 110. On the basis 
of these findings it may be important to extend the culture period of the juvenile porcine islets to 
28 days to parallel Bonner-Weir’s studies using human tissue. Since it is now believed that in 
vitro neogenesis may recapitulate development of the embryonic pancreas, the system we propose 
to develop using immature porcine pancreatic tissue will not only be an important, readily 
available and economically viable source of therapeutic material, but will also generate a new 
model to identify potential markers of neogenesis and to determine the molecular mechanisms 
underlying the process. 
Pancreatite size: 
The notable growth or size change of these structures is demonstrated by our observations in 
Figure 1. In our 2010 study of HMP of juvenile pig pancreas we included an analysis of the size 
distribution of the islets in the purified preps showing that >90% of the young pig islets fall 
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within the range 50-100 µm and very rarely were any islets found with diameters greater than 200 
µm 44. In contrast the micrographs here (Figure 5.1) shows that most of the pancreatite structures 
are much bigger (>100 µm) and often substantially larger as illustrated by the large (387 µm) 
structure in Figure 5.1E. It is likely that the changing size, morphology, and cellular composition 
of the pancreatite structures gave rise to some error in the estimate of “islet equivalents” for the 
purpose of tissue quantification. The reported data is based upon the usual convention of counting 
individual islets that are primarily composed of dithizone stained endocrine cells only, while 
these pancreatites were composed of both exocrine and endocrine cells. This complication 
undoubtedly led to an overestimate of the islet mass transplanted in the nude mouse assay and 
may in part be responsible for the delayed graft function observed in some recipients as noted 
above. This is also consistent with the observations in several other studies involving the 
transplantation of adult pig islets in which the numbers of IEQ transplanted show considerable 
variation and range 10-fold from 1000 IEQ/mouse to 10,000 IEQ/mouse. Moreover, the time-to-
normoglycemia showed considerable variance often taking > 50 days 99. Hence achieving 
glycemic control in 47% (8 of 17 transplanted mice) in this study is comparable with reports in 
the literature for adult pig islets as discussed by Rijkelijkhuizen 99. Further extended studies will 
necessitate a titration of the pancreatite dose in the transplanted mice to resolve this issue of the 
critical Beta-cell mass within the pancreatites necessary for achieving glycemic control. 
Advantages of the juvenile pancreas model 
A variety of strategies are currently being investigated to deliver regulatory factors to pancreatic 
cells, in vitro, aimed at increasing β-cell mass for transplantation. Trans-differentiation of α-cells 
into β-cells is another approach that has merit for in vivo regeneration and neogenesis 107. The 
processes of neogenesis of β-cells in vitro are currently inefficient for adult human cells and do 
not generate sufficient β-cell mass to normalize hyperglycemia 107. In contrast, we demonstrate 
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here preliminary data showing that the pancreatite cell clusters derived from juvenile porcine 
pancreas are able to reverse diabetes in a diabetic nude mouse model (Figure 5.4). The 
association of multiple cell types in the formation of the pancreatite cell clusters is another 
important characteristic with potential therapeutic benefit since there is mounting evidence for 
improved transplantation outcome using impure islet preparations containing non-endocrine cells, 
notably ductal epithelial cells 111. In the broad context of processing tissue to generate a readily 
available cost-effective product for therapeutic treatment of diabetes, the novel “pancreatite” 
structures derived from juvenile pigs is potentially an innovative solution to the inevitable 
deficiency of supply of human tissue. 
The delayed return to glycemic control, which took on average 25 days, may be an indication of 
the generation of a critical mass of insulin-secreting cells by cell division as evidenced by the 
positive Ki67-MiB staining in the explanted grafts (Figure 5.4B inset). There is insufficient 
evidence in this preliminary study however, which did not include a rigorous correlation of 
insulin immunostaining co-localized with the evident Ki67 staining, to fully support this 
hypothesis. Nevertheless, the phenomenological appearance of strong insulin, glucagon and Ki67 
staining in the explants supports the notion of on-going islet development and maturation in the 
graft and provides encouragement for further more in depth studies to test this hypothesis.  
Conclusion 
The pancreatites (pancreatic cell aggregates) derived from the preservation, isolation, and culture 
of juvenile porcine pancreas tissue using the described techniques could provide an unlimited 
source of β-cells to integrate into a reproducible, economic and safe system for therapeutic and 
research applications. Moreover, the model we propose here meets the stringent economic 
demands that have emerged in the healthcare marketplace, and could be a cost-efficient 
alternative to standard management of diabetes 112. We conclude from these preliminary 
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observations that immature islets isolated from juvenile porcine pancreas form cellular aggregates 
comprising both exocrine and endocrine cells in modified tissue culture. This phenomenon has 
not previously been reported to our knowledge presumably because of the notorious difficulty of 
maintaining juvenile pig islets in conventional tissue culture. 
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Nutrient regulation by continuous feeding removes limitations on 
cell yield in the large-scale expansion of mammalian cell spheroids 
Summary 
Cellular therapies are emerging as a standard approach for the treatment of several diseases. 
However, realizing the promise of cellular therapies across the full range of treatable disorders 
will require large-scale, controlled, reproducible culture methods. Bioreactor systems offer the 
scale-up and monitoring needed, but standard stirred bioreactor cultures do not allow for the real-
time regulation of key nutrients in the medium. In this study, β-TC6 insulinoma cells were 
aggregated and cultured for 3 weeks as a model of manufacturing a mammalian cell product.  
Cell expansion rates and medium nutrient levels were compared in static, stirred suspension 
bioreactors (SSB), and continuously fed (CF) SSB.  While SSB cultures facilitated increased 
culture volumes, no increase in cell yields were observed, partly due to limitations in key 
nutrients, which were consumed by the cultures between feedings, such as glucose.  Even when 
glucose levels were increased to prevent depletion between feedings, dramatic fluctuations in 
glucose levels were observed.  Continuous feeding eliminated fluctuations and improved cell 
expansion when compared with both static and SSB culture methods. Further improvements in 
growth rates were observed after adjusting the feed rate based on calculated nutrient depletion, 
which maintained physiological glucose levels for the duration of the expansion. Adjusting the 
feed rate in a continuous medium replacement system can maintain the consistent nutrient levels 
required for the large-scale application of many cell products.  Continuously fed bioreactor 
systems combined with nutrient regulation can be used to improve the yield and reproducibility of 
mammalian cells for biological products and cellular therapies and will facilitate the translation of 
cell culture from the research lab to clinical applications. 
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Introduction 
Cell replacement therapies in humans require the production of large-scale culture of viable, 
functioning cells. Reproducibility of cell product, and optimal cell yield and function all depend 
on the presence of appropriate levels of key nutrients, and sub-toxic levels of cell waste products 
113,114. For research purposes, mammalian cells are typically cultured in static culture and 
propagated by passaging at regular intervals, with supplemental medium changes as needed. This 
method is limited by the requirement for frequent manipulations, which results in variability of 
culture conditions and increased risk of contamination115–118. Further, these culture methods are 
time intensive and require trained technicians to maintain large-scale cultures. Stirred suspension 
bioreactors (SSB) can be used as an alternative to static cell culture for microorganism cultures to 
increase culture volume and density, and decrease handling119. This approach has been applied to 
mammalian cells, including pluripotent stem cells120–129. However, SSB cultures still require 
interventions for medium changes, exhibit fluctuations in nutrient and waste product levels, and 
provide limited information about culture status. A perfusion system can be used to address these 
challenges by continuous infusion and removal of medium, but parameters such as calculating 
feed rate based on real-time cell requirements must be established130–133. 
In this study, SSB culture was used to expand an insulinoma cell line with many beta cell features 
intact, β-TC6 cells134–138, to increase culture scale and improve cell expansion rates without 
compromising viability. These cells, like most mammalian cells, are dependent on a key nutrient, 
glucose, for energy production139. In addition, beta cells are sensitive to chronic high levels of 
glucose103. For this study, β-TC6 cells were allowed to form spheroids in culture approximating 
islet cluster sizes in vivo, and then allocated to either static or SSB culture conditions. While 
stirred bioreactors allowed the increase of culture volume by more than 10-fold, a continuous 
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feeding perfusion bioreactor system127–130,140 was required to both maintain stable culture 
conditions, and maintain cell growth. 
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Materials and Methods 
Cell Line and Maintenance 
The β-TC6 cells were provided by the ATCC (Manassas, VA). In preparation for the study, they 
were cultured, passaged, and cryopreserved according to provider instructions in Dulbecco’s 
Modified Eagles Medium (DMEM, Invitrogen, Carlsbad, CA), with 4 mM L-glutamine, 4.5 g/L 
glucose and 1 mM sodium pyruvate (all from Invitrogen). Cells were passaged at a ratio of 1:3 
every 3-4 days. 
β-TC6 Spheroid Formation 
This technique is described in literature127–130,140–143, and was slightly modified to accommodate 
spheroid formation of β-TC6 cells. For all conditions, β-TC6 cells were first cultured and 
expanded in adherent cultures described above, until enough cells were obtained to reach the 
required (total n=12) numbers for 250 ml stirred bioreactors (Corning, Corning, NY). The cells 
were collected by gentle trypsinization (0.25% (w/v) Trypsin- 0.53 mM EDTA, Invitrogen) at 
room temperature aided by mechanical agitation for 2-3 minutes, and seeded into bioreactors at a 
density of 1.32x106 ± 5.7% cells/mL in 200ml culture medium. Cells were then cultured in the 
bioreactors without feeding for 3 days at 37°C, with 5% CO2, 100% relative humidity, and stir 
rate of 70 rpm to allow spheroids to form. No significant proliferation was observed during the 
three day spheroid formation period. After spheroid formation, each bioreactor was allocated to a 
specific culture condition. 
Experimental Culture Conditions 
After spheroid formation, spheroids were divided among three culture methods: static culture, 
stirred suspension bioreactor (SSB) culture, and continuously fed SSB culture. Cultures were 
compared at three different glucose concentrations (1.0 g/L, 2.75 g/L, and 4.5 g/L) to represent 
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the range between physiological glucose (approximately 0.7 g/L) and standard β-TC6 culture 
medium (4.5g/L). Static Culture: Spheroids from the initial bioreactor cultures were transferred 
to 10cm diameter cell culture dishes (Nunc, Rochester, NY) containing 10 ml of culture medium. 
Parallel cultures were established for each glucose concentration; 100% medium exchange was 
done every 3 days by collecting the spheroids in 50 ml conical tubes (Falcon, San Jose, CA). The 
spheroids were gently pelleted using a refrigerated centrifuge at 4°C and 52.1xG. Culture medium 
was aspirated and pellets were re-suspended in fresh medium and placed back into culture.  
Stirred Suspension Bioreactor Culture (SSB): Stirred bioreactors remained in bioreactor 
conditions identical to spheroid formation cultures for the duration of the 21-day culture. Medium 
was replenished by performing a 100% medium exchange every three days.  For media changes, 
cultures were removed from the bioreactor and processed as for static cultures above. Fresh 
medium was then added to re-establish the 200ml culture volume. Continuously Fed SSB 
Culture: Stirred bioreactors identical to the SSB condition were adapted with a lid designed for 
this study to provide connection to a continuous feed. The feeding system, described in detail 
below, was designed to maintain stable culture conditions by continuously adding fresh medium 
at a regulated rate, and removing waste medium at the same rate. Initially, continuously fed SSB 
cultures had the same medium replacement rate as the SSB and static cultures with 100% of the 
medium replaced every three days. Fresh medium was constantly added at an average rate of 
0.046 ml/min (200ml/3 days) and removed at the same average rate to maintain a consistent 
culture volume.  Later experiments utilized a variable feed rate to maintain nutrient levels based 
on the rate of cell usage. 
Continuous Feeding System 
The continuous feeding system design was based on systems described in literature127–130,144–146. 
Briefly, the system consists of five primary components: a media reservoir, peristaltic pump, 
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stirred bioreactor, waste reservoir, and custom designed tubing/sampling set. The medium 
reservoir consisted of a 1L glass bottle (Corning), the waste reservoir was a 2L glass bottle 
(Corning), and the stirred bioreactor was a 250 ml volume glass reactor (Corning). A Masterflex 
digital peristaltic pump with an 8 channel pump head (Cole Parmer, Vernon Hills, IL) was used to 
control medium exchange. Reservoir and bioreactor lids were manufactured from hard plastic 
(Delran, Dupont, Wilmington, DE) with stainless steel pipe pass-through ports providing 
ventilation through sterile filters, and allowing for medium transfer between reservoirs and 
bioreactor. The bioreactor lid contained additional pass-through ports for optional instrumentation 
and monitoring probes (eg. oxygen monitor). The bioreactor lid also contained a novel outflow 
tube (OT) fabricated from porous glass aeration tubes that had an average pore size range of 40 
µm to 60 µm, and a pore density of 40%. The OT pore size was chosen to remove only medium 
and cell debris, leaving cell aggregates in culture. 
Custom autoclavable perfusion tubing sets were assembled from polyvinylidene fluoride (PVDF) 
tubing connectors and PharMed BPT Tubing (PharMedCorp, Westlake, OH). The tubing set 
consisted of three parts: a feed line, a waste line, and a sample line. The feed line was assembled 
using L/S 14 tubing for the primary lengths with a disposable L/S 13 section spliced in the middle 
as a replaceable “pump section.” This line connected to the fresh medium reservoir stored inside a 
refrigerator to reduce soluble factor degradation, passed through the pump head, and terminated 
at the feed port of the stirred bioreactor inside a NuAire (Princeton, MN) cell culture incubator. 
The second line for bioreactor waste removal was similar to the feed line but consisted of L/S 16 
tubing for its primary lengths, and L/S 14 tubing for the replaceable “pump section.” The tubing 
diameters used for the waste line were larger to allow removal of medium from the bioreactor at 
the same rate as fed conditions to avoid significant culture volume changes, and to avoid the 
possibility of media overflows. The same tubing diameters could not be used to accomplish this 
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task because any small variability in the tubing quality could result in a removal rate that was 
slower than the feed rate. Effectively, the waste line was pumping at a higher speed than the feed 
line because of the larger diameter tubing, and the volume in the reactor was controlled by setting 
the OT to the appropriate level. 
The system functions by continuously pumping medium into the bioreactor, resulting in a rise in 
the level of medium in the bioreactor until reaching the height of the OT. The medium is removed 
through the OT, leaving the cell spheroids in culture, until the medium level falls below the 
bottom of the OT. This method of volume control with continuous feeding is used in many large-
scale culture applications used to generate cell products144,145. The system is designed to be simple 
without the need for specialized sensors and automation systems to control pump speeds. The 
medium level in the bioreactors fluctuates slightly because the surface tension of the media 
allows the outflow tube to remove medium briefly from the bioreactor after the average medium 
level is below the bottom of the tube. This small variability in culture volume does not exceed 6% 
of the total culture volume, and did not appear to adversely affect the spheroids during culture. To 
avoid vapor lock or pressure build up inside the sealed vessels, sterile vents were added to allow 
sterile air exchange. This was also important for allowing gas exchange between the incubator 
(5% CO2) environment and the bioreactor, which is necessary to maintain the correct pH. 
The final component of the tubing set was a sample collection assembly.  Briefly, it consisted of 
three short (~6 cm) L/S 14 tubing lengths connected together with a T-type PVDF connector, and 
two small hose clamps on two of the tubing lengths. One of the clamped lengths contained a 
sterile gas filter for gas venting, and the other was used for connection to a sterile sampling 
syringe. The third end was connected to a stainless steel sample connector attached on the lid of 
the bioreactor.  This entire assembly was autoclavable and connected to the bioreactor for the 
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duration of the experiment. The assembly was used to collect a sterile sample from the bioreactor 
as needed without disturbing the continuous feed process.   
Spheroid Settling Rate Measurements 
In order to ensure cell clusters were not being removed by the continuous feeding system, the 
settling rate of β-TC6 spheroids were measured by observing their descent in a large diameter 
plastic pipette. β-TC6 cells were cultured in SSB bioreactors to form spheroids as described 
above. After 3 days of culture, 30 ml samples of the spheroid suspension were gently pipetted to 
distribute evenly in suspension and placed in a large diameter 25 ml pipette, and the time for all 
of the spheroids to settle 5 cm was recorded. This was repeated three times for each of the three 
separate samples, and the data was averaged and used to determine the linear settling rate of the 
cells. 
Cell Counts, Viability, and Glucose Concentration Measurements  
Samples were collected from each bioreactor every three days before a medium change. For static 
and SSB culture methods all cells were collected as described above, and samples were taken 
from the cell suspension for cell counts and medium glucose measurements. Samples were 
collected using a wide orifice pipette to carefully suspend the spheroids and remove a 
representative sample, which consisted of no more than 2% of the total culture. Continuously fed 
SSB cultures were sampled using a specialized sampling port. For all culture methods, cells were 
dissociated by incubation for 2 minutes in trypsin-EDTA (0.25% (w/v) Trypsin- 0.53 mM EDTA, 
Invitrogen), and counted in triplicate using a standard hemocytometer with trypan blue staining 
147. Cell viability was calculated by recording live (unstained) cells, and dead (stained) cells 
independently (viability % = live cells / total cells). Cell growth rates are reported as a fold 
expansion percentage, calculated by dividing the live cell count after 21 days of culture to the 
original cell count at the beginning of the culture (Day 0). Glucose levels were measured in 
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triplicate using a blood glucose meter (One Touch Ultra, Johnson & Johnson, New Brunswick, 
New Jersey), and single use test-strips (one touch ultra-strips). Both the fresh medium and waste 
medium were tested for glucose concentration, and measurements lower than 20 mg/dL 
(detectable threshold of the meter), although undetectable, were plotted as 20mg/dL. 
Statistics 
All data are reported as the mean +/- the standard error of the mean for at least three discrete 
measurements. Cell counts and glucose measurements were done in triplicate, and the two tailed 
un-paired student-t test was used to compare conditions.  A p value < 0.05 was considered 
significantly different. 
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Results 
β-TC6 cell expansion in static and SSB cultures 
In order to determine whether clusters of β-TC6 cells could be scaled up simply by increasing 
culture volume in a stirred suspension bioreactor.  Static and SSB cultures were compared 
directly for cell yield and growth rate over a 3 week culture period.  Although the SSB culture 
offers benefits when compared with static culture, Figure 6.1 demonstrates that there was no 
improvement in cellular expansion when compared to static cultures. The batch fed method had 
the same fold expansion over 21 days, and offered no significant improvement in growth rate 
compared with the static culture method.  
Nutrient fluctuations in static and SSB cultures 
As glucose is a key nutrient in cell culture, and glucose concentrations above normal are toxic to 
β cells over time in vivo [38], high and low levels of glucose were investigated as a limiting 
reagent for growth rate in static and SSB cultures with regular (3 day) medium changes.  Static 
and SSB cultures were compared using standard medium with high glucose (4.5 g/L) as well as 
intermediate (2.75 g/L), and low (physiological) glucose (1.0 g/L) medium. Measurements were 
taken every 3 days, and it was found that static cultures experienced significant fluctuations in 
glucose levels (Figure 6.2a), which may limit cellular expansion and could diminish cellular 
viability and function. However, similar fluctuations were observed in the SSB cultures (Figure 
6.2b), which may explain the similarities in cell expansion rates demonstrated in Figure 1 for 
static and SSB cultures.  These results were consistent with the observation that no differences 
were observed in cell yields between static and SSB cultures (Figure 6.2c). 
To determine whether the high levels of glucose observed when using standard medium or the 
fluctuations themselves were responsible for the limited cell expansion, cultures with different 
glucose concentrations were compared over the three week period. Culture medium with lower 
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glucose concentrations could not maintain physiological glucose levels, and resulted in 
undetectable levels after 15 days of culture. Glucose measurements from β-TC6 spheroids using 
high (4.5 g/L) glucose medium resulted in super-physiological glucose levels for the duration of 
the 21 day culture period. Medium with intermediate (2.75 g/L), and low (1.0 g/L) glucose 
concentrations fluctuated between super-physiological and sub-physiological glucose 
concentrations, and resulted in levels below the detection threshold after 15 and 21 days of 
culture for SSB and static culture methods respectively. Despite maintaining glucose levels closer 
to the physiological range [39] in both culture methods by feeding with reduced glucose medium, 
Figure 6.2c illustrates that cell expansion was not improved, and was actually slightly reduced 
when compared to the standard (high glucose) cultures, although only the intermediate glucose 
SSB culture was significant (p=0.027).  The cell expansion was statistically similar between the 
static and SSB cultures at each glucose level.  Thus, fluctuations in glucose levels are likely 
contributing to the limitation of cell expansion. 
Development of the continuous feeding (CF) culture system 
To eliminate glucose fluctuations, a continuous feeding stirred suspension bioreactor system, 
shown in Figure 6.3, was assembled, that continuously replenished medium in the culture system 
with no manual manipulation during the culture period131,132. The perfusion circuit regulated the 
addition of refrigerated medium to the bioreactor while removing medium through the outflow 
tube at the same rate. The total culture volume was maintained by adjusting the depth of the 
outflow tube inside the bioreactor. The outflow tube illustrated in Figure 6.3b, allowed the 
removal of waste medium from the bioreactor without removing the cell spheroids using a fritted 
glass filter tube with small pores (40-60um) that prevent the spheroids from being removed. The 
pore density was high (>40%) and the surface area was large, so that the linear flow velocity 
through each pore does not exceed the measured settling velocity of the spheroids. The linear 
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flow velocity (VP) through a pore was calculated using Equation 6.1 below by dividing the 
maximum volumetric flow rate through the outflow tube (Q) divided by the total pore area 
calculated by multiplying the pore surface density (ρT) by the bottom surface area of the outflow 
tube (AT). 
 
𝑉𝑝 =
𝑄
𝜌𝑇 × 𝐴𝑇
 
6.1 
The average settling velocity for the spheroids measured after three days of SSB spheroid 
formation was observed to be 2.53 ± 0.26 cm/min, which is more than ten times the calculated 
average linear medium velocity through a single pore (0.17 cm/min). This difference ensured that 
spheroids near the outflow tube were not pulled into the pores of the tube because they settled 
(due to gravity) much faster than the flow rate pulled them in. This design also ensured that the 
outflow tube would not become obstructed with spheroids. 
Continuous feeding increased cell expansion 
Eliminating the nutrient fluctuations allowed greater cell expansion. The continuously fed culture 
was fed at a constant rate equivalent to the other culture methods, replacing 100% of the medium 
every three days. All cultures were fed with the same high glucose (~500 mg/dL) medium. 
Figure 6.4a shows that continuous feeding at a constant rate eliminated the glucose fluctuations 
observed when using static or SSB culture methods, but resulted in a super-physiological 
concentration of glucose in the culture medium for the duration of the culture period. Eliminating 
these nutrient fluctuations resulted in the general improvement in cell expansion observed in 
Figure 6.4b. Spheroid size was compared on day 6 and day 21 for all conditions. The 
average sizes on day 6 were 0.20±0.01 mm, 0.17 ±0.01 mm, 0.18 ±0.01 mm for static, SSB, 
and CF-SSB respectively. The average sizes after 21 days of culture were 0.14 ±0.02 
mm, 0.12±0.01mm, and 0.28 ±0.04 mm for the same conditions. Average spheroid sizes were 
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not significantly different between culture methods for all conditions after 6 days of culture 
(p > 0.08), while the spheroids in the CF condition were significantly larger than either static or 
SSB cultures (p < 0.02) after 21 days of culture. The larger size of the spheroids in the CF culture 
group is consistent with our cell count data, suggesting a higher growth rate for cells in the CF 
group. The average viability for all days and all culture conditions was 96.23 ±0.85%, and no 
differences were observed when comparing culture conditions or culture time points. This 
suggests that increased cell yields are primarily the result of increased growth rate, rather than 
reduced cell death following reduction of glucose fluctuations.   
Continuous feeding could not maintain Physiological glucose levels 
Although the continuous feeding system eliminated the glucose fluctuations and improved the 
cell expansion, physiological levels could not be maintained using the recommended culture 
medium. In order to reduce the average glucose concentration in the culture, media with low or 
intermediate glucose levels were used. The continuous feeding system replaced medium in the 
culture at a rate of 100% medium change every three days. Figure 6.5 shows that using feed 
medium with decreased glucose concentration cannot maintain physiological levels for the 
duration of the 21 day culture period. Further, the glucose levels for the CF culture using the 
ATCC recommended high glucose culture medium stayed super-physiological for the entire 21 
day expansion period, while the intermediate and low glucose medium cultures dropped to sub-
physiological glucose levels by the 15th day of culture, and this may explain the slightly reduced 
expansion for these conditions. 
Adjusting feed rate can maintain physiological glucose levels in SSB culture 
Continuously fed cultures with a constant feed rate were not able to maintain a physiological 
glucose level during the 21 day culture period. In order to maintain a more constant culture 
environment, an algorithm was developed to adjust the feed rate by incorporating data obtained 
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from regular culture samples. The algorithm incorporated the predicted growth rate based on 
current cell counts, the predicted medium replacement rate based on historical glucose 
consumption measurements, and the adjusted feed rate based on current medium glucose 
measurements. Adjusting the feed rate based on this algorithm in a continuously fed SSB culture 
improved the cell expansion by 25% (Figure 6.6a) compared to the constant feeding method and 
the glucose level in the medium was maintained near physiological levels for the duration of the 
21 day culture (Figure 6.6b). 
Predicted linear growth rate 
Equation 6.2 represents a linear approximation that was used to predict growth in culture. 
Previous spheroid culture data was fit, and a linear approximation most closely resembled the 
growth profile of the β-TC6 spheroids. This equation was used to predict the cell number every 
three days of culture. The equation calculates the predicted cell count (N2) by adding the cell 
count on the day of sampling (N1) to the linear growth rate approximated by fitting previous 
growth data (RG=1.26 x 10
8 cells/day), which is multiplied by the culture period (t2-t1).  
 𝑁2 = 𝑁1 + 𝑅𝐺 × (𝑡2 − 𝑡1) 6.2 
Predicted medium replacement rate 
To predict the feed rate that was needed to replace the glucose consumed during culture, 
Equation 6.3 incorporated the predicted cell growth to calculate the glucose consumption during 
the culture period. The feed rate (RF) was calculated by assuming that it should equal the 
estimated glucose consumption of the entire culture and dividing by the glucose concentration in 
the feed medium (CF). This equation used the cellular glucose consumption rate (R1=1.25 x 10
-10 
mg/cell/min), which was calculated by averaging the consumption rate empirically measured in 
previous SSB cultures over a 21 day culture period. The cellular consumption rate was multiplied 
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by a weighted average of the cell number counted in a sample (N1) and the predicted cell number 
(N2) from Equation 6.2 to approximate the glucose consumption during the culture periods. The 
weighted average weights N1 two times over the predicted cell number in the average to increase 
the influence of the experimentally obtained data specific to each culture.  This consumption rate 
was then divided by the glucose concentration (CF) in the feed medium (4.5 g/dL for these 
experiments) to obtain the predicted medium replacement rate needed to maintain a constant 
glucose concentration in culture. 
 
𝑅𝐹 =
𝑅1 ×
2𝑁1 + 𝑁2
3
𝐶𝐹
 
6.3 
Adjusted feed rate based on glucose levels 
In order to incorporate actual glucose levels observed during culture, Equation 6.4 was added to 
provide a feedback control system. This adjusted the predicted culture medium replacement rate 
to account for the measured glucose levels in the culture medium on each sample day. The 
glucose adjusted feed rate (GAFR) is the rate that medium was actually replaced in the culture. 
This equation incorporated a unit-less engineering feedback control constant (X) ranging from 0-
1 (value of 0.5 used for these experiments). It could be adjusted to change the amplitude of the 
feedback control with a smaller “X” causing less control, and larger “X” cause more control. C1 
was the glucose concentration measured in the culture medium on the sample day, and CD was the 
desired medium glucose concentration (100 mg/dL). The difference between C1 and CD was 
divided by CD to obtain a ratio describing the deviation from the desired glucose concentration, 
which was then multiplied by the control constant. The final value was subtracted from 1 to 
obtain the adjustment factor used to adjust the predicted medium replacement rate found in 
Equation 6.3 (RF). This adjustment decreased the feed rate when the glucose levels were higher 
than the desired concentration, and increased the feed rate when glucose levels were lower than 
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the desired concentration. The effects of the feedback control are shown in Figure 6.6, where the 
calculated feed rate was plotted on the right hand axis. A large spike in the feed rate as calculated 
by the growth rate prediction part of the equation was observed on the 9th day of culture, that was 
“corrected” downward by the feedback control on the 12th day when the glucose levels in the 
medium were measured to be increasing above the desired concentration. 
 
𝐺𝐴𝐹𝑅 = [1 − 𝑋 (
𝐶1 − 𝐶𝐷
𝐶𝐷
)] 𝑅𝐹 
6.4 
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Figure 6.1: Culture in SSB. Fold expansion of β-TC6 spheroids after twenty one days compared stirred 
suspension bioreactor to static culture using standard high glucose medium. 
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Figure 6.2: Glucose measurements in SSB cultures. Glucose measurements from β-TC6 cell spheroids 
cultured in (A) Static cultures, and (B) stirred suspension bioreactors using high (4.5g/L), intermediate 
(2.75g/L), and low (1.0g/L) glucose medium, as depicted by their position on the Y axis. The physiological 
glucose range is indicated by the grey bar.  Error bars for glucose measurements are too small to be visible 
on the scale shown (Standard Error ≤ 4% for all measurements). (C) No difference was seen comparing 
static to SSB cultures with any of the glucose levels.  Comparison of expansion of β-TC6 spheroid cultures 
indicated that changing the glucose in the medium to achieve levels closer to the physiological range did 
not significantly improve cell expansion. (* indicates a p value of 0.027 compared with the same culture 
method using high glucose medium.) SSB: stirred suspension bioreactor. 
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Figure 6.3: Perfusion SSB  diagram. (A) Schematic diagram of continuous feeding perfusion circuit with 
fresh medium, perfusion pump, outflow tube, and waste medium. Solid blue lines are medium connections, 
dashed green lines are fiber optic connections, and dotted black lines are electronic connections.  (B) 
Exploded illustration of outflow tube showing small pores, which do not allow spheroids to pass through, 
but allow the removal of waste medium. The continuous feeding system was designed to help improve 
consistency of nutrient and supplement concentrations making β-TC6 cell culture parameters more stable 
and controlled. 
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Figure 6.4: Continuous feeding glucose and cell expansion. (A) Glucose measurements for β-TC6 
spheroid culture medium using static, SSB, and CF-SSB culture methods and feeding with standard high 
glucose medium. The physiological glucose range is indicated by the grey bar. Error bars for glucose 
measurements are too small to be visible on the scale shown (Standard Error ≤ 4% for all measurements). 
(B) Fold Expansion of β-TC6 spheroids over 21 days of culture comparing static, SSB, and CF culture 
methods. SSB: stirred suspension bioreactor. CF: Continuously fed stirred suspension bioreactor. 
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Figure 6.5: Glucose measurements with continuous feeding. Culture medium glucose measurements 
from continuous fed cultures with high, intermediate, or low glucose medium during 21 days of expansion. 
The physiological glucose range is indicated by the grey bar. 
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Figure 6.6: Adjusted feed rates improve SSB cultures. (A) Cell counts comparing constant feed rate to 
adjusted feed rate from the same cultures (* represents a p value < 0.05 indicating a significant difference 
in culture expansion). (B) Average culture medium glucose levels from 21 day constant feeding, and 
adjusted feeding bioreactor cultures. The physiological glucose range is indicated by the grey bar. Error 
bars for glucose measurements are too small to be visible on the scale shown (Standard Error ≤ 4% for all 
measurements). 
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Discussion 
Cell therapies are the subject of intense research activity, and are becoming a realistic treatment 
option for many human diseases148–151. Many cell therapies will require the large-scale culture and 
monitoring of mammalian cells, as well as defined and validated culture conditions. Large-scale 
bioreactors provide an established approach from bio-pharmaceutical applications and culture of 
microorganisms that can be applied to the culture of mammalian cells with specific modifications 
to address this challenge.  Mammalian cell culture techniques use static culture in disposable 
dishes for most research applications. Simply scaling up from static cultures to SSB methods still 
requires medium changes at regular intervals that result in dramatic changes in the cell culture 
environment. Cells are dosed with high concentrations of nutrients and growth factors at these 
batch-style medium changes to ensure survival between changes. During the culture intervals, 
cells experience steadily decreasing nutrient levels and increasing waste products. To address 
these issues in this study, glucose measurements were made to estimate degrading and consumed 
nutrients in the medium that spike immediately following medium change, and drop significantly 
over time, resulting in a constantly changing environment for the cells over the culture period. 
This study demonstrated that glucose levels fluctuated dramatically in the static and SSB culture 
of β-TC6 beta cell line, with 100% medium changes every 3 days. During cell expansion, when 
the cell density was greatest, glucose concentrations dropped as much as 275 mg/dL over three 
days. Although the glucose concentration never dropped to a physiological level during the 21 
day culture period when culturing with DMEM high glucose medium (450 mg/dL) that is 
standard for the β-TC6 cell line, these fluctuations limited cell yield. The SSB medium glucose 
levels dropped at a similar rate with static cultures, and were nearly identical after 21 days of 
culture in static and SSB conditions. 
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Most cells experience environments in vivo that are more stable than cell culture conditions, with 
regulated levels of nutrients, and the constant processing and removal of cellular waste products. 
In this case, fluctuations in nutrient levels were sufficient to limit cell expansion.  One strategy to 
improve the continuity of culture conditions is to increase the frequency of medium changes, 
decreasing nutrient level fluctuations and buildup of waste. Despite the improvements this 
approach would bring to nutrient and waste levels, for large-scale and long-term mammalian cell 
cultures, the time and cost associated with frequent batch-style medium changes make this 
approach impractical. The data presented in this study suggest that use of a stirred suspension 
bioreactor with growth adjusted continuous medium replacement can both maintain controlled 
culture conditions and improve culture outcomes without significant impact on cell viability. The 
increase in cell number and spheroid size, along with the consistent viability levels among culture 
groups suggest that CF culture conditions support increased growth rates in these cultures. 
Spheroids in static cultures were slightly larger than those in a SSB cultures, likely due to 
observed agglomerations under static conditions. 
The adjusted feed algorithm used for these studies incorporated the linear growth rate of the cells 
in a spheroid, assumed a constant and average glucose consumption rate for all of the cells in 
culture, and included a feedback control system to account for the variability of individual 
cultures. A linear growth rate was used based on observed data from suspended β-TC6 cell 
spheroid cultures, but exponential growth, or more complex growth profiles could be used for 
various cell types. Glucose consumption and feeding can be generalized to a number of key 
nutrients in the medium. The glucose consumption used for these calculations were assumed to be 
constant and the same rate for each cell in the culture, but more complex glucose consumption 
relationships could be used in the same algorithm for cultures that contain more than one cell type 
or cell types that change during the culture period, such as differentiating stem cells. These 
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techniques could also be used in conjunction with other advanced culture technologies including 
encapsulation, or micro-carrier surface cultures for adherent cells to improve cell growth rates. 
Any empirically determined glucose consumption profile specific to a cell type could be used to 
determine the needed medium replacement rate. In this study, the average glucose consumption 
rates observed in all conditions were similar to the rates observed in surface attached cultures 
suggesting that spheroid formation itself did not affect the glucose consumption of individual 
cells. The feedback adjustment system for this algorithm is a simple control that incorporates the 
scaled difference between the observed glucose levels and the desired glucose levels in the 
culture medium. More complex adjustment systems could be implemented to provide tighter 
culture control. The effects of this simple control system were apparent after nine days of culture 
(Figure 6.6a), when the predicted growth rate and glucose consumption rates were not able to 
maintain physiological levels on their own. The feedback control parameter was able to account 
for the increasing glucose concentrations in the culture, and adjust the predicted glucose 
replacement rate, decreasing it to account for the real-time observed glucose concentrations 
despite the increasing cell numbers. Furthermore, more complex cellular models tied to feedback 
control systems152,153 could be used to help regulate other culture parameters such as pH, 
dissolved oxygen concentration, and temperature. The adjusted feed system could be incorporated 
into a fully automated culture system125,133 and the feed rate could be adjusted based on more 
frequent sampling measurements which would further improve the control of nutrient levels in 
the medium. The automated system could control any culture parameters making mammalian cell 
cultures more consistent and production more reproducible. 
Federal regulatory bodies have decided that mammalian cellular products for implantation or 
other cell therapy will be held to a similar standard as other transplant therapies. The industry is 
focused on developing and providing completely defined culture media154–156 and working to meet 
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these guidelines. Cell culture and manufacturing parameters will need to be controlled, monitored 
and recorded to ensure the efficacy and reproducibility of cellular products. As new products 
translate from the research lab into the clinic, the challenges of scale-up and production will be a 
significant barrier to implementation. As cell therapies are emerging as a treatment option for 
many human diseases, it is essential that culture parameters for cellular products are clearly 
defined, controlled, and monitored during the manufacturing process. Continuous medium 
replacement can reduce or eliminate fluctuations in critical nutrients observed in both static and 
stirred suspension bioreactor cultures. Incorporating an adjusted feed rate algorithm can further 
improve the control of culture conditions and can maintain near physiological nutrient levels for 
an extended culture period.  
Conclusion 
The continuous feed system maintains glucose levels in the physiological range, when adjusted 
for cell growth and glucose consumption rate. Maintenance of glucose levels and removal of 
waste products continually supported cell expansion while maintaining viability. These systems 
could be adapted for expansion and differentiation of other cell types, including pluripotent stem 
cells, in addition to their utility for therapeutic mammalian cell spheroid culture.  
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Development and validation of noninvasive magnetic resonance 
relaxometry for the in vivo assessment of tissue-engineered graft 
oxygenation. 
Summary 
This chapter describes a 19F magnetic resonance spectroscopy (19F-MRS) method for non-
invasive evaluation of oxygen levels (pO2) within implanted TEGs. Our early studies and 
literature have identified perfluoro-15-crown-5-ether (PFCE) as the optimal choice for in vivo 
oximetry, and we developed robust oxygen and temperature calibration data sets using this 
compound. 19F-MRS methods were validated in vitro with a temperature and oxygen regulating 
bioreactor, and in vivo by implanting into a dorsal subcutaneous pocket of Lewis rats (Charles 
River, Wilmington, MA). Fiber optic fluorescence-quenching sensors (Ocean Optics, Dunedin, 
FL) were used to simultaneously measure oxygen levels in vitro and in vivo,  and 19F-MRS data 
were collected for all animals using a 16.4 T horizontal-bore magnet (Agilent Technologies, 
Santa Clara, CA). The pO2 within TEGs were determined using the fluorine spin-lattice relaxation 
rate, R1 (=1/T1), and the established calibration between R1 and pO2. PFCE within the TEG was 
detected with sufficient signal to noise (SNR), and oxygen was measured non-invasively both in 
vitro and in vivo.  Fiber optic (FO) oxygen sensor measurements in vivo reporting single point 
oxygen pressures were on average 11 mmHg higher than 19F-MRS measurements (p<0.05), 
which represent an average pressure within the scaffold. 19F-MRS could be a valuable tool for the 
non-invasive assessment of oxygenation within an implanted macro-encapsulated TEG. The 
average pO2, provided by the MRS method, is a more robust measurement of the overall graft 
oxygen status when compared to FO single point measurements. Further studies investigating 
local oxygen delivery systems and relating pO2 measurements with changes in TEG status or 
condition are described in Chapter 8. 
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Introduction 
Tissue engineering is an emerging field, and implantable tissue-engineered grafts (TEGs) have 
the potential to treat numerous debilitating diseases. Pancreatic islet transplantation (ITx) is a 
potential cure for type 1 diabetes, but favorable long-term outcomes are inconsistent, and the liver 
may not be the optimal site. Macro-encapsulation of islets within a TEG could offer many 
advantages, however oxygenation is a critical limitation for the development of large-scale and 
high-cell density implanted TEGs57,157. Islets are especially sensitive to prolonged exposure to 
hypoxia, which has been shown to decrease graft viability and function59. Oxygen limitations are 
a critically important consideration for the development of large-scale implantable TEGs, and a 
tool for non-invasive monitoring of the oxygen partial pressure (pO2) could be used to improve 
graft development and potentially monitor graft viability post-implant.  
Eppendorf needle probes, utilizing polarographic techniques, remain the gold standard for in vivo 
oxygen measurements. These needle probes, however, remain invasive, MR-unsafe, and only 
measure the oxygen at a single point necessitating multiple measurements to map the average 
oxygenation of a given volume. Luminescence-based fiber optical (FO) sensors are an MR-
compatible oxygen-measurement technique providing equivalent results when compared with 
Eppendorf probes while remaining invasive and limited to single-point measurements. 
Magnetic Resonance Spectroscopy (MRS) is a useful tool for observing real-time biological 
changes in a non-invasive way. The nuclear spin relaxation mechanisms of some biocompatible 
fluorine compounds (perfluorocarbons, PFCs) are sensitive to dissolved oxygen concentrations, 
and fluorine-19 nuclear magnetic resonance spectroscopy (19F-MRS) can be used to quantify the 
oxygenation status of a TEG. Highly substituted fluorine molecules have demonstrated to be 
useful for the measurement of oxygen concentration in vitro and in vivo 158–173, but have had 
limited clinical applications due to high levels of uncertainty and difficulty with molecule 
  128 
delivery to target tissues174. 19F itself has many qualities that make it an ideal nuclear target for 
oxygen measurements in vivo. Specifically 19F has a relatively large magnetic moment, and this 
provides and relatively high sensitivity (similar to 1H). Furthermore, there is very little 
background 19F signal in the body, due to its relative scarcity in biological systems, and this 
allows for detection of relatively small amounts fluorine without background interference. 
The observed spin-lattice relaxation rate constant (R1) of the 
19F nuclei is established to have a 
linear relationship to the local oxygen concentration158,159,175–177. Relaxation in the context of MRS 
describes the physical phenomena of the change in magnetization that occurs following nuclear 
spin excitation in the presence of a magnetic field. Two basic relaxation mechanisms are 
observed in magnetic resonance (MR); they are defined as the transverse (spin-spin) relaxation 
time and the longitudinal (spin-lattice) relaxation time. The transverse relaxation time is defined 
by a decay constant (T1) and it describes the exponential return of exited magnetization to the 
lowest energy state (thermal equilibrium). This is sometimes called “spin-lattice” relaxation 
because the decay occurs as the individual spins loose energy to the surrounding “lattice.” This 
mechanism is strongly influenced by the temperature and local oxygen concentration (due to its 
quadrupolar nature), which results in an associated change in the relaxation rate constant 
(R1=1/T1). The details of this physical process are described by Parhami and Fung
158 among 
others175,176. The trasverse relaxation time is defined by a second time constant (T2) and it 
describes exponential decay of MR signal caused by the loss of spin coherence or “de-phasing” 
following spin excitation. This complex relaxation mechanism is also influenced by numerous 
physical and chemical interactions, and in our hands has been less reliable for these purposes, 
nevertheless, this mechanism should be explored further in future work. 
Perfluorocarbons (PFCs) are used for biological oxygen measurements using 19F-MRS, and 
perfluoro-15-crown-5-ether (PFCE) is the preferred choice due to reasonable biocompatibility, 
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high oxygen solubility, and optimal signal intensity161,168,170,172,178–181. Researchers have developed 
in vitro, and in vivo MRS methods for the determination of oxygen concentrations within 
microcapsules loaded with cells 161,168–170, and our lab has used similar methods for determination 
of TEG viability in vitro 182. This study expands these methods for non-invasive measurement of 
oxygen concentrations within a bio-artificial pancreas (TEG) constructs implanted in rats. 
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Materials and Methods 
Comparison of PFC Compounds 
Various PFC materials were tested for oxygen and temperature sensitivity using neat compounds. 
An extensive literature review supported these findings159–162,168,183–185, and PFCE was chosen for 
the following studies due to the high oxygen sensitivity and large number of equivalent 19F 
(N=20). The large number of equivalent 19F atoms resulted in much higher relative signal 
intensities for a single resonance when using the same amount of PFC chemical. Perfluorodecalin 
(PFD) was also used for development of an implantable temperature probe that was used for 
some preliminary in vitro studies due to the abundant availability and established 
biocompatibility. 
TEG Construction 
TEG construction is described in detail in Chapter 8. Briefly, Model TEGs were prepared by 
loading encapsulation devices with an oxygen sensitive matrix. Fluorine-loaded fibrin gels were 
prepared with 75 μl of porcine plasma (Sigma Aldrich, St. Louise, MO, USA) that was emulsified 
with 75 μl of perfluoro-15-crown-5-ether (Exfluor Research Corporation, Round Rock, TX, 
USA). The mixture was emulsified by manual agitation, injected into a 40 μl TheraCyte device 
(TheraCyte, Inc. Laguna Hills, CA) using a 250 µl precision syringe (Hamilton), and then cross-
linked with 5% v/v bovine thrombin solution. The thrombin solution was made by diluting 
concentrated topical thrombin solution (GenTrac Inc., Middleton, WI) in PBS++. The cell access 
port was trimmed short, and sealed with adhesive (Dermabond, Ethicon Inc., Somerville, NJ, 
USA).  These grafts were used for calibration as well as in vitro and in vivo validation studies. 
19F-MRS Acquisition 
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19F-MRS spectra were acquired with a 16.4 Tesla MR system (Agilent Technologies, Santa Clara, 
CA, USA) using a custom-built single-loop surface coil tuned to 656.8 MHz. Pictures of 
equipment developed and designed for use in these studies are included in Appendix A. An 
inversion-recovery pulse sequence was used to measure the spin-lattice relaxation rate, R1. 
Adiabatic half-passage (at60ph0) and adiabatic inversion pulses (invpat10) were used to ensure a 
uniform flip angle. At the beginning of each study, the coil was tuned and the samples were 
placed into the bore of the magnet. PFC resonance was confirmed to ensure hardware 
functionality, and the iso-center was located by performing a 1D profile and adjusting the sample 
position to center the maximum signal intensity within the bore. First and second order shims 
were manually adjusted to achieve maximal signal intensity and to minimize the spectral line-
width for the desired resonance. Representative spectra from two PFCs studied (PFCE, and PFD) 
are presented in Figure 7.1. For each scan, the magnetization recovery was interrogated after 10 
different inversion-recovery delays (0.05, 0.1, 0.15, 0.25, 0.5, 0.75, 1, 2, 4, and 5 seconds), each 
spectral array was integrated (integralWater3), and integrations were fit to Equation 6.4 using 3-
parameter non-linear regression with GraphPad Prism software (v5, Graphpad Software Inc., La 
Jolla, CA, USA). 
 𝑀𝑧(𝑡) = 𝑀𝑧,𝑒𝑞(1 − 2 ∙ 𝑒
−𝑡/𝑇1) + 𝐶 7.1 
Representative integration data and fit-curve are shown in Figure 7.2 (spectral lines are included 
for illustrative purposes). Equation 6.4 is the solution to the time (t) dependent Bloch equation 
for the longitudinal magnetization, Mz(t), during an inversion-recovery pulse sequence when 
TR>>T1 and TE<<T2. To achieve the most robust measurement of T1, three parameters are fit 
with regression: Mz,eq (the equilibrium magnetization), T1 (the spin-lattice relaxation time 
constant), and  C (a fitting constant). Mz = A ∙ (1-2e-R1∙t) + B. Each condition was measured in 
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replicate (n=6) with a TR of at least 5 x T1 seconds (6 seconds was used for most studies using 
PFCE). 
Calibration and Temperature Compensation 
A small pilot study was done using a PFD loaded temperature probe. Pictures of the probe used 
are included in Appendix A for reference. PFD (~2 ml) were sealed in a 1.5 mm diameter glass 
NMR tube to ensure that oxygen cannot diffuse into or out of the sealed tube. A method for 
temperature compensation was initially investigated using the developed PFD temperature probe 
to compensate for any temperature changes encountered during the course of the study. A 
temperature calibration curve using the PFD probe was generated. The PFD probe was tested to 
ensure that it was not sensitive to oxygen by a same bubbling technique described in the 
calibration section below, and confirming that PFD-R1 did not change. The R1 of the PFD probe 
was measured by 19F-MRS under 4 temperature conditions confirmed by MRI compatible 
thermocouple. The results were fit to Equation 7.2 assuming a linear relationship between R1 and 
temperature (T), and the line is shown in Figure 7.3. 
 𝑅1 = 𝐴 ∙ 𝑇 + 𝐵 7.2 
The same technique was used to determine the temperature sensitivity of neat PFCE using 6 
different temperatures confirmed by MRI compatible thermocouple, and the curve is presented in 
Figure 7.4A. Due to the relatively small change in the oxygen sensitivity with changing 
temperature (see Figure 7.5), the room-air (pO2 ≈ 150 mmHg) condition was used for the PFCE 
temperature curve. The PFD temperature probe was used for a brief series of experiments where 
the probe was included during oxygen calibration of PFCE loaded TEG. The R1 of PFD in the 
temperature probe was used with the calibration line presented in Figure 7.3 to determine the 
temperature of the sample. The calculated temperature was then used along with the PFCE 
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temperature calibration fit (Figure 7.4A) to determine the difference in the calculated PFCE R1 
and the R1 at 37 °C in room-air. This difference was then subtracted from the measured sample 
PFCE-R1, and then fit on the oxygen sensitivity curve for PFCE at 37 °C presented in Figure 
7.4B to calculate the temperature-adjusted pO2 of the sample. Temperature control and 
measurement using an MRS compatible thermocouple during in vitro and in vivo studies were 
greatly improved during the development of these methods. The multi-parametric calibration fit 
equation described below was used along with thermocouple temperature measurements instead 
of the PFD MRS temperature probe for all future studies. This approach was found to be equally 
reproducible, more practical, more time efficient. These factors expedited the collection of 19F-
MRS data for in vivo applications, which was an important consideration when transitioning to 
studies in living animals. 
19F-MRS Calibration with TEGs 
TEGs were prepared as described above and placed into a 50 ml conical tube filled with 
phosphate buffered saline with calcium and magnesium (PBS++). The vial was placed in the 
center of a custom-built surface coil and inserted into a 16.4 T MR system (Varian Inc., Palo 
Alto, CA). The sample was then bubbled with a gas of known oxygen concentration for 30 
minutes while the temperature was held constant with a circulating water bath, and forced-air 
heater. A fiber optic oxygen probe (Ocean Optics, Dunedin, FL) was inserted into the TEG for 
comparisons to the 19F-MRS measured pO2. R1 was then measured with an inversion-recovery 
sequence utilizing adiabatic pulses. Measurements were made for five different pO2s (0, 38, 76, 
114, and 160 mmHg) at three different temperatures (21, 37, and 45 degrees C). The R1 was 
assumed to be a function of the pO2, temperature (T) shown in Equation 7.3 and four calibration 
constants (A, B, C, and D). R1 measurements were fit to the multi-parametric calibration equation 
using a Levenberg–Marquardt algorithm (OriginLab, Northampton, MA). Equation 7.4 is the 
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same equation solved for pO2 to illustrate the linear relationship with R1 with a given constant 
temperature. The oxygen curves for each temperature investigated are presented in Figure 7.5A. 
 𝑅1 = 𝐴 ∙ 𝑝𝑂2 + 𝐵 ∙ 𝑇 + 𝐶(𝑝𝑂2 ∙ 𝑇) + 𝐷 7.3 
 
𝑝𝑂2 = 𝑅1 ∙
−1
𝐴 + (𝐶 ∙ 𝑇)
+
𝐵 ∙ 𝑇 + 𝐷
𝐴 + (𝐶 ∙ 𝑇)
 
7.4 
Validation of 19F-MRS pO2 Measurements in vitro 
As described in the calibration section above, FO oxygen probes were used in conjunction with 
19F-MRS to compare the two techniques. The FO oxygen probe was inserted into the central 
compartment of the TEG and measurements were obtained simultaneously in the same samples 
using both methods. A correlation plot comparing both methods is shown in Figure 7.5B. 
Furthermore, in vitro studies were performed using a perfusion bioreactor system with controlled 
temperatures and oxygen to confirm that 19F-MRS methods could be used to monitor the kinetic 
changes in oxygen when exogenous oxygen is delivered to the TEG itself. 
Perfusion Bioreactor  
In vitro studies were conducted using a perfusion bioreactor system, which continuously perfused 
with porcine islet culture medium (ME199 based, Mediatech Inc.) around a TEG modified for 
delivery of supplemental oxygen (DSO). TEGs devices with DSO were used for these in vitro 
19F-MRS oxygen measurement studies without porcine islets, and placed inside a perfusion 
bioreactor chamber. Detailed analysis and discussion of the DSO system and in vivo studies using 
these devices is described in Chapter 8. The bioreactor perfusion circuit illustrated in Figure 7.6 
was composed of a perfusion-chamber to contain the TEG, a peristaltic pump to circulate culture 
medium, a gas exchanger to control dissolved oxygen levels in the perfusion medium, and a heat-
exchanging system to control the ambient temperature in the chamber. The perfusion chamber 
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design, illustrated in Figure 7.7 and Figure 7.8, was instrumented with FO oxygen and 
temperature probes to confirm the pO2 and temperature of the perfusion medium. The bioreactor 
containing a TEG was placed inside a 16.4 T MRS system (Agilent Technologies, Santa Clara, 
CA, USA) to obtain baseline oxygen measurements prior to beginning perfusion. An illustration 
of the experimental set-up is also included in Figure 7.9, which includes a picture of the 
perfusion chamber and the 16.4 T scanner (note that islets were not used for these studies, but are 
included in the figure for illustrative purposes). The perfusion medium was de-oxygenated (pO2 = 
30±5 mmHg) to simulate the low external oxygen levels observed in vivo, and the reactor was 
maintained at 37±2 °C by heating the perfusion medium with a water-bath and heat exchanger. 
The conditions within the bioreactor are also described in Figure 7.8 and Figure 7.9. Following 
acquisition of the baseline oxygen measurements, the perfusion medium was circulated at 30 
ml/min while the pO2 and temperature of the perfusion medium was continuously monitored 
using MR compatible oxygen and temperature probes. Non-invasive measurements of the pO2 
inside the TEG were obtained every 1-5 minutes with 19F-MRS for the duration of the study. 
After a steady-state pO2 was observed in the TEG, suggesting acclimation to the surrounding 
perfusion medium, DSO was initiated. DSO was achieved by delivering oxygen-supplemented 
gas to the internal compartment of the TEG within the bioreactor at a flow rate of 2 ml/min with 
two different target oxygen pressures. The first phase delivered gas with a pO2 = 380 mmHg, 
which was continued until a steady state pO2 in the TEG was observed. Then the pO2 of the 
delivered gas was increased to 760 mmHg in the second phase until a second steady state pO2 
was observed inside the TEG. Finally, DSO was stopped and oxygen measurements were 
continued until the pO2 inside the TEG decayed down to the external pO2 of the perfusion 
medium (~30 mmHg). These studies were repeated 5 times to confirm the reproducibility and 
reliability of the DSO system. 
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Animal Research 
All animal research presented herein was approved and overseen by the University of Minnesota 
Institute for Animal Care and Use Committee (IACUC), the University of California IACUC, or 
the University of Arizona IACUC. This study was designed to minimize the pain and suffering of 
animals used for the study, and the three R’s were observed. These techniques were developed, 
refined and tested in vitro and in deceased animals to minimize the number of animals used to 
obtain quantitative and significant results. The body weight, and general well-being of each 
animal was monitored for the duration of the studies described, and no adverse events were noted. 
Validation of 19F-MRS pO2 Measurements in vivo 
A small group of in vivo validation studies were used in the context of measuring oxygen of 
implanted TEG in rats. Details of the implant preparation, surgical procedures, and global study 
design are described in Chapter 8. The 19F-MRS pO2 measurements of a subset of TEGs with 
porcine islets (n=3) and control TEGs (n=3) were validated with an FO oxygen probe in vivo. 
These devices were equipped with an additional access port (Figure 7.10). These rats were 
followed for up to 29 days; on the day of scanning rats were anesthetized and a catheter was 
transcutaneously inserted into the access port. A previously calibrated FO oxygen probe was then 
threaded through the catheter into the TEG and the rat was inserted into the MR system. FO pO2 
was measured simultaneously with the MR pO2 measurement technique. Furthermore, additional 
rats (N=3) were equipped with DSO systems and implanted with TEGs modified for DSO. 19F-
MRS methods were used to monitor the improvement of TEG oxygenation in vivo by measuring 
the pO2 in implants after 24 hours of DSO. DSO was then stopped for > 24 hours and 
measurements were repeated, and compared to implants without DSO.  
In vivo oximetry in Rats 
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A series of rats (N=9) were implanted with a PFCE loaded TEG. On the day of implantation, rats 
were anesthetized with inhalation isoflurane using a respirator and vaporizer. Details of the 
device loading and surgical procedure are described in Chapter 8. Briefly, TEGs were prepared 
by loading them with a PFCE fibrin matrix, and were subcutaneously implanted on the dorsal side 
of Lewis rats. Animals were divided into three groups with three animals in each group. Each 
group was assigned a critical terminal time-point (1, 7, 15 days post-implantation) when 19F-MRS 
was used to measure the internal pO2 of the implanted TEG prior to euthanasia. On the day of 
measurement, rats were anesthetized with inhalation isoflurane. The rats were immobilized onto a 
holder with the device centered over the custom-built surface coil. The rat holder and coil were 
designed for use with rats in the 16.4 T MRS system, and pictures of these equipment are 
included for reference in Appendix A. The holder was inserted into a 16.4 T MRS system and 
scanned while anesthesia depth was continuously monitored and adjusted as needed. Rat body 
temperature was maintained at 37 +/- 0.2 °C as measured with a rectal thermocouple and 
regulated with a forced air heater. Six R1 measurements were made with an inversion-recovery 
sequence utilizing adiabatic pulses. The R1 of each measurement was converted to a pO2 using 
the previously determined multi-parametric calibration. In vivo pO2 was measured 1, 4 and 15 
days post-implantation. 
Implants with DSO 
A small group of animals (N=3) were fitted with harness and tether apparatus for two weeks to 
allow for acclimation prior to implantation with a TEG modified for DSO. The TEGs were 
modified to include cannulas for trans-cutaneous oxygen delivery and by including an internal 
compartment to allow for continuous DSO in vivo. Briefly, the 40 µl TheraCyte device 
previously described 186–191 was modified by adding two additional internal membranes to create a 
three chamber device with an internal oxygen compartment, and two distinct cell compartments 
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on either side of the central oxygen compartment. Furthermore, three additional access ports were 
added to the device to access each compartment. Two access ports on the longitudinal ends 
provide access to the central compartment to allow for oxygen gas infusion and effusion. Two 
more ports are situated on the transverse sides of the device with one port providing access to a 
cell compartment on top and the second port providing access to the cell compartment on the 
bottom. TEGs for DSO were prepared by loading the cell-compartments of the modified devices 
with a PFCE-plasma gel emulsion (no islets) as described above. 
The TEGs were then implanted in the subcutaneous space as described above leaving oxygen 
compartment access cannulas protruding through the incision for attachment to dual-channel 
harness and tether apparatus (Instech Laboratories, Plymouth Meeting, PA, USA). The harness 
and tether apparatus contains a swivel, and counter-balance system to allow for animal movement 
around the cage, and normal feeding, drinking, and grooming behaviors. The tether system was 
connected through the cage top to an oxygen generating system previous described (Giner Inc., 
Auburndale, MA, USA) and a specialized manifold to regulate and monitor the delivery of 
oxygen gas to the implanted devices. Pure humidified oxygen gas (760 mmHg) was continuously 
delivered through the harness and tether apparatus to the modified TEG for the duration of the 
study with limited disconnection to monitor animal weights and well-being. Extended sections of 
tubing were used to continue DSO during MRS procedures. 
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Figure 7.1: PFCE and PFD spectra. Example spectra from pefluro-15-crown-5-ether (PFCE) and 
perfluorodecalin (PFD) collected at 16.4 T. PFCE has 20 equivalent 19F atoms generating a single 
resonance, while PFD has 5 distinct resonances with added J-coupled splitting. The peak used for oxygen 
measurements has two equivalent 19F atoms as is illustrated in the figure (red arrow). 
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Figure 7.2: Inversion recovery illustration. Example inversion recovery results from pefluro-15-crown-
5-ether (PFCE). The plotted points (N=10) represent the relative integral area of each time-delayed point 
collected during the inversion recovery sequence. Spectral lines are included for illustrative purposes (red), 
and the equation for the fitting curve (dotted black) is included for reference. 
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Figure 7.3: PFD Temperature probe calibration. Temperature calibration of perfluorodecalin (PFD) 
loaded temperature probe. This probe was developed to non-invasively measure the temperature of the 
probe using 19F-MRS. The measured R1 of the PFD within a sealed glass tube was used with this 
calibration line to determine the local temperature of the probe for a small set of preliminary studies. A 
linear relationship between R1 and temperature was confirmed. 
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Figure 7.4: Temperature compensation with PFD probe. Preliminary temperature and oxygen 
calibration lines for pefluro-15-crown-5-ether (PFCE). A) The temperature measured using the 
perflurodecalin probe was used to establish the change in R1 that was due to the change in temperature 
when compared to the 37 °C R1. B) The oxygen calibration line of PFCE at 37 °C. The measured R1 of the 
sample was then adjusted based on the R1 difference determined with the temperature calibration. This 
method was successfully used to compensate for sample temperature variability and successfully 
determined the pO2 of the sample.  
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Figure 7.5: Calibration and validation of 19F-MRS. In vitro oxygen calibration and validation of 
perfluoro-15-crown-5-ether using 19F-MRS relaxation rate (R1) and fiber optic oxygen sensors. (A) 
Calibration of  R1 results shown for PFCE-fibrin loaded TheraCyte devices at various oxygen levels at 
three temperatures (21 °C, 37 °C and 45 °C) measured in 16.4 T MRS system. These values were used to 
generate the multi-parametric non-linear calibration coefficients used for all of the studies described. (B) 
Correlation plot of 19F-MRS in vitro oxygen measurements against fiber optic (FO) fluorescent lifetime 
oxygen measurements showing a highly correlated relationship between the MRS measurements and FO 
measurements. These results validate the success or a robust and reliable calibration that accounts for 
temperature variability observed during a measurement. 
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Figure 7.6: Schematic diagram of perfusion bioreactor.
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Figure 7.7: Perfusion bioreactor chamber viewed from the side. A) diagram showing the end view of 
the chamber, and emphasizing the individual components and the positioning of the tissue engineered graft. 
The heat exchanger was built into the lid to provide direct temperature regulation of the internal 
compartment of the chamber. The MRS surface coil was positioned directly beneath the bioreactor to 
obtain maximum sensitivity. B) Side view of the chamber. 
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Figure 7.8: Perfusion bioreactor chamber viewed from the top. The illustration highlights the individual 
components of the chamber as the external conditions controlled by the oxygenation and temperature 
regulation components of the bioreactor system. The temperature was regulated to 37 ± 2 °C using the heat-
exchanger and measured with the included temperature probe. The oxygen concentration within the 
chamber (outside of the tissue engineered graft) was controlled by contuously circulating deoxygenated 
medium (30 mmHg) through the chamber. The oxygen concentration within the chamber was monitored 
using an MR compatible oxygen probe to confirm the stability of the hypoxic environment. 
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Figure 7.9: Bioreactor MRS Illustration. Diagram, illustration, and picture of the bioreactor chamber 
inside the 16.4 T MRS system. The chamber was connected to the bioreactor using long sections of tubing 
and then positioned over the surface coil and inserted in the scanner. Temperature and oxygen levels in the 
chamber were controlled and monitored for in vitro validation studies while 19F-MRS was used to measure 
the internal pO2 within the tissue engineered graft. Oxygen was delivered at 380 mmHg, and 760 mmHg to 
the internal compartment of the TEG to observe the kinetic changes of the pO2 within the TEG under these 
conditions. 
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Figure 7.10: Validation of 19F-MRS in vivo. Illustration of TheraCyte Implant with access port (Red) in 
the subcutaneous pocket on the dorsal side of a Lewis rat. For fiber optic measurements the 250 um thin-
fiber oxygen probe (green) was inserted through the skin and the access port into the central portion of the 
cell compartment of the TheraCyte implant. The 19F-MRS coil (blue) was placed on the back-side of the 
anesthetized rat to detect the 19F-MRS signal for the PFCE within. 
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Results 
The SNR of PFCE loaded TEGs was sufficient to measure the T1 relaxation time, and example 
spectra, and inversion recovery fit are presented in Figure 7.1 and Figure 7.2.  PFCE and PFD R1 
were found to be directly proportional to pO2 with the slope and intercept dependent on 
temperature (Figure 7.5A). A linear relationship between R1 and temperature was also found for 
both PFCE and PFD. A PFD temperature probe confirmed that temperature has a profound effect 
on the measurement of pO2 with 
19F-MRS. The independent MR temperature probe can be used 
to measure large temperature differences successfully (Figure 7.3), and these results can be used 
to compensate for the changing temperature without requiring independent calibration data sets 
for every temperature measured (Figure 7.4). Compensation for temperature with 19F-MRS 
oxygen measurements dramatically improves measurement accuracy, but a separate 19F-MRS 
temperature probe was not necessary when MR compatible thermocouples could be used to 
measure temperature accurately, and temperature was adequately controlled in the MRS system.  
A multiparametric calibration equation containing R1, pO2, and temperature was successfully 
extrapolated (Equation 7.4), and used for all future in vitro and in vivo oxygen measurements. 
With adequate temperature control and measurement, 19F-MRS oxygen measurements correlated 
well (p<0.0001) with FO oxygen measurements in vitro (Figure 7.5B). These data validate 19F-
MRS as a robust and reliable measurement technique in vitro. 
Non-invasive oxygen measurements from TEGs in a bioreactor show significantly increased 
internal pO2 for implants with DSO. A group of 5 TEG devices were prepared for in vitro oxygen 
measurements with DSO by placing TEGs inside a temperature regulated perfusion bioreactor 
(Figure 7.6, Figure 7.7, Figure 7.8). A continuous series of 19F-MRS oxygen measurements 
acquired from TEGs inside a bioreactor are presented in Figure 7.11. The results demonstrate 
that optimal DSO was achieved with delivery of either 380 or 760 mmHg enriched oxygen gas, 
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and implants equilibrated to a steady-state internal pO2 in ≤20 minutes regardless of the pO2 of 
the delivered gas. The external pO2 of each TEG was controlled to simulate the hypoxic pO2 
levels previously observed in vivo. The hypoxic external environment was verified by continuous 
fiber-optic probe measurements (34±6 mmHg), and confirmed with 19F-MRS measurements 
when the internal pO2 of each TEG acclimated to the external pO2 within an hour after beginning 
perfusion. The average internal pO2 of all TEGs reached 64±4% of the delivered pO2 regardless 
of the DSO concentration. TEG implants achieved average steady-state internal pO2 
measurements of 207±22 mmHg and 469±40 mmHg for DSO with pO2=380 mmHg and 760 
mmHg respectively. After steady-state measurements, DSO was stopped to record the internal 
pO2 decay as the TEG returned to ambient external oxygen. Oxygen measurements were fit with 
a mono-exponential decay function yielding an average characteristic time-constant (τ) of 15±1 
minutes. 
In vivo validation using simultaneous FO oxygen probe and 19F-MRS methods for measuring pO2 
showed that FO probes consistently measured significantly higher oxygen levels than 19F-MRS 
methods when compared using a two-tailed paired student t-test, and the results are presented in 
Figure 7.12. The pO2 measured with FO oxygen probes were on average 11 mmHg higher than 
19F-MRS measurements, but all measurements indicated similar hypoxic oxygen conditions in 
vivo. The variability of FO probe measurements was greater than 19F-MRS measurements, and the 
standard deviations were 15 and 13 mmHg respectively for these techniques. 
Delivery of supplemental oxygen (DSO) was successfully achieved and sustained for at least 24 
hours in a subset (N=3) of animals for preliminary examination. These animals received DSO to 
the internal compartment of a modified control TEG (no islets) for 24 or more hours, and then 
internal TEG pO2 was determined using MRS methods. The average internal pO2, presented in 
Figure 7.13, was observed to be significantly higher (p<0.0001) for animals that received DSO in 
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vivo when compared to the TEGs which did not receive DSO, achieving 532±35 mmHg one day 
following implantation. After DSO was stopped, the average pO2 returned to low-levels (pO2 = 
26±21 mmHg) that were not significantly different from the values observed without DSO 
(p=0.56). 
19F-MRS was used to measure the internal pO2 of implanted TEGs after 1, 8, and 15 days 
following implantation, and the results are presented in Figure 7.14. Oxygen levels started high 
one day following implantation, and then decreased to hypoxic levels for the following 
measurements. The pO2 one day following implantation was elevated with an average of 69 ± 22 
mmHg and decreased to 16 ± 3 and 0 ± 10 mmHg after 8 and 15 days post implantation 
respectively. This study was expanded to include more time-points and higher numbers of 
animals, and those results are presented and discussed in Chapter 8. The implications of the data 
presented here suggest that 19F-MRS can successfully be used to track the pO2 changes within 
implanted TEGs over time. 
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Figure 7.11: Oxygen measurements in bioreactor. Time series of oxygen levels measured in a typical 
bioreactor using 19F-MRS. Oxygen levels were allowed  to equilibrate with the surrounding medium, and 
then delivery of supplemental oxygen (DSO) was initiated at 300 mmHg and then increased to 760 mmHg 
and then followed by stopping DSO. The pO2 decay after stopping DSO was also quantified and the decay 
constant was measured to be an average of 15±1 minutes. 
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Figure 7.12: Fiber optic (vs) 
19
F-MRS oxygen measurements. Comparison of 19F-MRS and fiber optic 
(FO) oxygen measurements in vivo. Average oxygen partial pressure measured in subcutaneous implants 
over 30 days using FO oxygen sensors and 19F-MRS method. Oxygen levels measured with both methods 
were less than venous blood oxygen concentration (40 mmHg), but there was a significant difference 
between methods with the FO probes measuring an average of 11 mmHg higher than the 19F-MRS method 
(* indicates significant difference P<0.05). 
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Figure 7.13: Validation of 
19
F-MRS methods in vivo with DSO. Delivery of supplemental oxygen (DSO) 
increases 19F-MRS measured oxygen partial pressures in bioartificial pancreas devices tested in vivo. 
Average 19F-MRS oxygen partial pressures measured in devices subcutaneously implanted in rats with, and 
without DSO. Oxygen was delivered at 760 mmHg continuously following implantation, and then assessed 
by 19F-MRS. For a subset of animals (N=3), oxygen delivery was stopped for at least 24 hours, and then re-
assessed showing a return to ambient oxygen partial pressures seen without oxygen delivery. (* indicates a 
significant difference, p<0.05, when compared to the control, No DSO, condition).
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Figure 7.14: Preliminary oxygen measurements in vivo. Series of 19F-MRS oxygen measurements of 
TEG in vivo at 1, 8, and 15 days post implantation. Oxygen levels within implanted TEGs start at elevated 
levels (69±22 mmHg), but decrease to hypoxic levels (< 20 mmHg) measured after 8 and 15 days 
following implantation.
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Discussion 
To develop a better understanding of the oxygen available to subcutaneous implanted TEGs, we 
developed a method for non-invasive oxygen measurements within TEGs in vivo using 19F-MRS. 
Traditional oxygen sensors for oxygen measurement in vivo use Clark electrodes 57,174,192, or fiber 
optic fluorescence quenching probes. Traditional polarographic, “Clark type,” electrodes suffer 
from inaccuracy due to the consumptive nature during operation, and both conventional methods 
are mechanically invasive. The traditional “needle” type probes require mechanical disturbance of 
the sampled tissue, and may actually introduce oxygen to the system during the measurement 
procedure. These traditional sensors also provide a single point measurement at the tip of the 
probe itself, and thus multiple mechanically disruptive measurements are required to obtain an 
average pO2 measurement with high levels of confidence. There are some reports using a 
photoacoustic lifetime imaging methods 193,194 for oxygen measurement, but these methods are 
only applicable for very superficial measurements in tissues. 19F-MRS methods overcome many 
of these limitations, and offer a sensitive, accurate, and non-invasive method for oxygen 
measurements in vivo.  
Our lab has investigated 19F-MRS methods for functional graft assessment in vitro 182, and others 
have explored similar methods for measuring oxygen levels in vivo using raw perfluorocarbons 
(PFC) 172, PFC lipid emulsions 163,179,195–197, or PFC loaded alginate beads 161,168–170,172,183, but none 
have attempted to measure the average localized oxygen concentration within a macro-
encapsulation device in vivo. Our methods were optimized and adapted for measurements within 
macro-encapsulated TEGs using an ultra-high field 16.4T MRS system for optimal signal 
intensities. We examined a number of PFC compounds and chose to use PFCE due to the 
reported biocompatibility 172,180,181 and large number of equivalent fluorine atoms which provide 
an intense signal at a single resonance (singlet). We also used PFD to test a dedicated 19F-MRS 
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temperature sensor for simultaneous determination of temperature with oxygen. Example spectra 
are presented in Figure 7.1. 
Our experiences with in vitro studies (Figure 7.2-Figure 7.5) and reports in literature 159,174,177,198 
document the sensitivity of 19F-MRS relaxation rates to both oxygen and temperature, yet many 
reports using 19F-MRS for oxygen measurement do not address this multi-parametric physical 
nature. Controlling and even measuring the body temperature of anesthetized animals inside an 
MRS system can be technically challenging, but due to the high sensitivity of 19F-MRS relaxation 
rates to both oxygen and temperature, temperature must be considered to achieve a high-level of 
oxygen measurement accuracy.  
To account for the relaxation effects of both oxygen and temperature, we chose to perform 
detailed and robust multi-parametric oxygen and temperature calibrations using control TEGs 
loaded with a PFCE impregnated plasma gel matrix 199. We fit this oxygen-temperature data set 
using established numerical methods to derive the calibration constants used for these studies 
159,174. Despite these complex calibrations, the oxygen measurements are still susceptible to errors 
in temperature measurement, and 19F-MRS methods for oximetry would greatly benefit from 
improved temperature measurement techniques, especially if the temperature measurements could 
be localized to the area of interest. An MRS method to locally measure temperature in vivo would 
be an ideal complement to 19F-MRS oximetry, and development in this area would greatly 
improve the sensitivity and accuracy of the described methods. A PFD loaded temperature probe 
was developed, and used for temperature compensation for a small number of in vitro 
experiments. This method was able to compensate for large temperature variabilities observed 
during the study, but the two-parameter calibration method used with an MRS compatible 
thermocouple achieved sufficient accuracy. This method was used for all future in vitro and in 
vivo studies due to the relative simplicity, and reliable results observed. Despite these findings, an 
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internal temperature standard could provide significant improvements in measurement accuracy 
when temperature is difficult to control or measure. High accuracy and precision in calibration 
were achieved by measuring R1 using a surface coil, a standard inversion recovery pulse sequence 
with adiabatic pulses, and a two-parameter fit accounting for temperature sensitivity. These 
measurements were correlated with measurements from FO oxygen probes, and a high correlation 
was observed with the correlation coefficient was 0.979. These results suggested that 19F-MRS 
methods could reliably measure the pO2 of in vitro samples with a high level of accuracy. 
The next objective was to validate these methods further by approximating the in vivo 
environment using a bioreactor and novel DSO methods to increase the local oxygen 
concentration inside a modified TEG device. The design of this complex bioreactor system is 
described in Figure 7.6 through Figure 7.9, and Figure 7.11 shows the representative oxygen 
measurements from a series of 5 studies with this bioreactor. 19F-MRS methods were able to 
detect significantly elevated pO2 levels within a TEG device, despite the surrounding hypoxic 
environment. The perfusion bioreactor was used to maintain physiologic temperature and to 
provide a controlled external environment that would simulate the hypoxic environment. The pO2 
and temperature of the perfusion medium inside the bioreactor was continuously monitored using 
MRS compatible temperature and oxygen sensors to ensure controlled conditions were 
maintained throughout the study. 19F-MRS methods were used to measure the average pO2 within 
TEG non-invasively during a series of changing internal and external oxygen conditions. The 
studies began by measuring the starting pO2 within the TEG before any controlled conditions 
were initiated. The observed average pO2 initially began at 123±19 mmHg, which was only 
slightly different from the ambient humidified atmospheric pO2 (152 mmHg). The deviation from 
the atmospheric level is explained primarily by the variability in starting temperature (36.7-42.8 
°C), which was difficult to regulate before perfusion was started. When the perfusion circuit was 
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started, deoxygenated culture medium was continuously circulated to maintain a constant hypoxic 
external condition (average measured pO2 = 34±6 mmHg) for the TEG inside the bioreactor. The 
internal pO2 of the TEG shown in Figure 7.11 was observed to acclimate to the surrounding 
perfusion medium within the first hour following initiation of perfusion, and an average steady 
state pO2 of 38±3 mmHg was observed prior to beginning DSO. DSO was tested at two different 
oxygen concentrations (50% or 380 mmHg, and 100% or 760 mmHg), and the pO2 time-series of 
the delivered gas is presented in Figure 7.11. The initial pO2 tested for DSO was 380 mmHg, and 
the measured internal pO2 of TEGs rose quickly to an average of 207±22 mmHg. The pO2 of 
DSO was then switched to 760 mmHg, and the internal pO2 again quickly rose up to an average 
of 469±40 mmHg. At the completion of the study, DSO was stopped and the pO2 decay to 
equilibrium with the surrounding pO2 was observed. Further analysis and discussions of DSO and 
oxygen kinetics within a TEG with DSO are included in Chapter 8. These results clearly 
demonstrate that 19F-MRS methods can be used to measure changes of internal TEG pO2, and 
could be used to non-invasively study the kinetic effects of interventions (such as DSO) on 
implanted TEG. 
Validation studies were continued with a small series of animals (n=6) that received TEG devices 
that were modified with an addition of an access-port to allow for insertion of a FO oxygen probe. 
This modification allowed for simultaneous pO2 measurement using the FO oxygen probe and 
19F-MRS at various time-points. A paired comparison between FO oxygen measurements and 19F-
MRS measurements indicated a significant difference in the measured in vivo pO2 within 
implanted TEGs. This difference is significant, but both measurement techniques confirm a 
hypoxic oxygen level within the TEG in vivo. It is important to recognize some critical 
differences between the FO oxygen probe measurements and 19F-MRS methods. The FO oxygen 
probe provides a single-point measurement of pO2 within the TEG, while 
19F-MRS provides a 
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volume average measurement of the internal pO2. This difference makes the FO probe method 
susceptible to local variabilities in oxygen levels, and probe placement is critical to results 
measured with these kinds of probes. It is also important to note that the FO probe requires 
invasive intrusion into the TEG itself to obtain a reliable oxygen measurement. The probe has to 
be inserted into the central compartment of the TEG, and this certainly disturbs the condition of 
the tissues/cells within the TEG. The probe itself is also likely introducing some oxygen to the 
TEG during the insertion process as it will be acclimated to atmospheric pO2, and opens access to 
the external environment during the insertion procedure, which will likely contribute to 
measurement error. Measurements with the FO oxygen probe had slightly higher standard 
deviations when compared to 19F-MRS methods. Despite the differences observed with these in 
vivo studies, 19F-MRS can clearly provide reliable and reproducible measurements of internal 
TEG pO2, and may offer significant advantages over traditional invasive oxygen measurement 
techniques. 
As described above and in Chapter 8 for further confirmation of 19F-MRS oxygen measurement 
methods in vivo, the TheraCyte device was modified to provide for a separate central oxygen 
chamber, and additional access ports to allow for continuous delivery of supplemental oxygen 
(DSO) to the TEG in vivo. 19F-MRS measurements suggest a dramatic increase in available 
oxygen in the TEGs with DSO, and the results are reported in Figure 7.13. Discussion of the 
DSO system and the development of a functional bio-artificial pancreas is limited here because 
this topic is not the primary focus of these studies. However, a limited number of preliminary 
proof-of-concept studies were done in 3 animals implanted with these TEGs modified for oxygen 
delivery.  The implants were prepared in a similar way to the standard TEGs, but contained two 
chambers loaded with the PFCE-matrix material on either side of the central oxygen chamber, 
and did not contain any islets or other cells. These TEGs were implanted like others in the 
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subcutaneous space of Lewis rats, and connected by transcutaneous cannulas to the DSO system. 
Oxygen gas (100%) was generated using an electrochemical oxygen generator, and continuously 
delivered to the implanted TEGs through a harness and tether system for 24 hours. After this 
period of acclimation, DSO was continued during the 19F-MRS procedure, and the average 
internal pO2 was measured for each implant. After these initial measurements, DSO was stopped 
for at least 24 hours for these animals, and then 19F-MRS oxygen measurements were repeated. 
The oxygen levels observed during DSO reached an average internal pO2 of 532±34 mmHg, and 
then returned to ambient tissue oxygen levels (26±21 mmHg) when DSO was ceased for at least 
24 hours. The results of these preliminary studies suggest that 19F-MRS oxygen measurements 
can be used to measure the oxygenation of therapeutically relevant macro-encapsulated TEGs in 
vivo. These measurements can be used to optimize these types of interventions, and to determine 
the optimal parameters for DSO. 
Finally to confirm that 19F-MRS methods can reliably monitor changing oxygen conditions 
based on physiological changes in vivo, 9 animals were implanted with TEGs and oxygen levels 
were measured after 1, 8 and 15 days. These limited studies are expanded for discussions of in 
vivo oxygen availability in Chapter 8, but these preliminary studies demonstrated that 19F-MRS 
methods can be used to track changes of oxygenation status that occur due to natural 
physiological changes in graft oxygen environment.  
Conclusion 
In conclusion, a robust two-parameter calibration was successfully developed to account for 
temperature changes that are encountered during oxygen measurement studies, and this method 
improves the reliability of the measured pO2 in vivo.  Rigorous validations of 
19F-MRS method in 
vitro using a bioreactor and in vivo using Lewis rats confirmed reliable measurements of internal 
TEG pO2, and that these methods can detect both natural physiological changes in oxygen 
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environment as well as interventional change in oxygenation by using DSO. Application of these 
techniques are used to study the natural progression of oxygenation within TEG in vivo, and to 
evaluate the success of DSO for increasing internal oxygenation of implanted TEG for up to 29 
days, and these studies are described in Chapter 8. 
  
  163 
 OXYGENATION OF IMPLANTED TEGS Chapter 8
 
 
Sections of this chapter are reproduced in whole, or in part from the following publications with 
permission: 
 
Presented Abstracts: 
Weegman BP, Einstein SA, Steyn LV, Suszynski TM, Firpo MT, Graham ML, Janecek J, Eberly 
LE, Garwood M, Papas KK, “Continuous oxygen delivery improves oxygenation of tissue-
engineered islet grafts in vivo as measured with fluorine-19 magnetic resonance spectroscopy” 
Abstract accepted for a mini-oral presentation at the Joint IPITA-IXA-CTS Congress, November 
2015, Melbourne, AUS 
 
Manuscripts in Preparation: 
 
Weegman BP, Einstein SA, Steyn LV, Avgoustiniatos ES, Suszynski TM, Firpo MT, Graham 
ML, Janecek J, Eberly LE, Papas KK, Garwood M, “Non-invasive monitoring of hypoxia in 
tissue-engineered islet grafts in vivo using fluorine-19 magnetic resonance spectroscopy” 
Intended for submission December 2015 
 
Weegman BP, Steyn LV, Einstein SA, Garwood M, Papas KK, “Delivery of Supplemental 
Oxygen Alleviates Hypoxia and Improves Function of Encapsulated Islet Grafts: Measurements 
with 19F- Magnetic Resonance Spectroscopy” Intended for submission December 2015 
 
License and agreement documentation is included in Appendix G. 
 
Acknowledgements: The authors would like to thank the Schott Foundation, the Minnesota 
Lions Diabetes Foundation, the Juvenile Diabetes Research Foundation (JDRF 5-2013-141), 
Giner Inc., the Schulze Diabetes Institute, and the NIH (P41 EB015894, and S10 RR025031) for 
supporting this research. 
  164 
Overview 
Islet transplantation (ITx) offers a minimally invasive alternative to pancreas transplantation, and 
shows promise as a possible cure for type 1 diabetes, but widespread application of this therapy is 
still inhibited by numerous barriers. Due to persistent challenges and limitations, there has been a 
recent resurgence of interest in developing a bio-artificial pancreas (BAP) construct based on 
augmenting islet transplantation by applying tissue-engineering approaches. Adequate 
oxygenation within tissue engineered grafts (TEGs) is critical, as both hypoxia and anoxia are 
detrimental to islet function and survival. This chapter includes a comprehensive discussion of the 
oxygenation challenges associated with development of a functional TEG, and uses methods 
described in Chapter 7 to examine and improve oxygenation of TEG devices implanted in rats. 
This chapter is broken into two sections based on two manuscripts in preparation. The first 
section describes the use of 19F-MRS methods to monitor the internal pO2 of implanted TEGs for 
up to 29 days. The findings of this study re-enforce the findings of earlier studies and confirm that 
an implanted TEGs will suffer from a severely hypoxic environment in vivo, and that this 
condition is further strained by the presence of islets at high-densities. A model predicts that the 
hypoxic condition observed will severely compromise graft viability and function unless 
oxygenation is improved. The second section investigates a novel method for delivery of 
supplemental oxygen (DSO) to a TEG device, and evaluates the improvement in oxygenation 
using non-invasive 19F-MRS techniques. DSO was found to dramatically-increase the 
oxygenation of TEG devices in vivo for up to 29 days, and a feasibility study in diabetic nude rats 
suggest that DSO could promote long-term survival of high-islet density and functional tissue 
engineered BAP devices. 
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Non-invasive monitoring of tissue-engineered islet grafts in vivo 
Summary 
Tissue engineering is an essential component within the field of regenerative medicine, and 
implantable tissue-engineered grafts (TEGs) have the potential to treat numerous debilitating 
diseases. Oxygen limitations are a critically important consideration for the development of large-
scale implantable TEGs, and a tool for non-invasive monitoring of the oxygen partial pressure 
(pO2) could be used to improve graft development and potentially monitor graft viability post-
implant. TEGs with high cell-densities inevitably fail in vivo due to oxygen limitations, and 
viability and function of islets are predicted to decrease with increasing islet densities. Methods 
for non-invasive oxygen measurement are described in Chapter 7, and this study applies these 
19F-MRS techniques for the non-invasive measurement of pO2 within macro-encapsulated TEGs 
in vivo. We examined the oxygen concentration within TEGs with or without porcine islets for 29 
days following subcutaneous implantation in Lewis rats. 
A model predicting viability and function of TEGs loaded with various islet densities was 
developed, and the predictions were verified by measuring explant viability of TEGs loaded with 
variable islet densities. TEGs were constructed by injecting an emulsion of perfluoro-15-crown-5-
ether  and porcine plasma into a 40-µL TheraCyteTM immunoisolation device (TheraCyte, Inc. 
Laguna Hills, CA), which was then cross-linked using 5% v/v bovine thrombin solution making a 
fluorine loaded fibrin scaffold. Control TEGs (no cells, N=6), or TEGs seeded with porcine islet 
cells (N=6) were implanted into a dorsal subcutaneous pocket of Lewis rats (Charles River, 
Wilmington, MA). 19F-MRS data were collected as described in Chapter 7 at critical time-points 
after 1, 4,8, 15,22 and 29 days following implantation. 
The model and experimental findings demonstrate a strong inverse-correlation between islet 
density and graft function and viability when the graft maintained in a hypoxic in vivo 
  166 
environment. The mean pO2 measured by 
19F-MRS began at 39±9 mmHg for controls and 27±6 
mmHg for porcine islet-loaded TEGs on the first day following implantation, and decreased to 
≤10 mmHg and remained at low levels up to 29 days. These preliminary results indicate that the 
subcutaneously implanted TEGs become hypoxic within 1 week post-implantation, and this 
suggests that supplemental oxygenation may be required to sustain cells and tissues at high 
densities in these implants. Further studies described in the next section explore local oxygen 
delivery systems, and correlate pO2 measurements with changes in TEG viability both pre- and 
post-transplantation. 
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Introduction 
Islet transplantation remains an experimental treatment despite its potential to be a minimally 
invasive cure for type 1 diabetes200,201. Despite recent improvements, only 50% of patients 
achieve insulin independence at five years post-transplant53,200,202–208. Intraportal delivery of islets 
to the sinusoids of the liver may be suboptimal and lead to loss of graft function or graft death. 
Factors leading to graft function and viability losses in the liver include blood-mediated reactions 
resulting in inflammation and thrombus formation209,210, recurrent autoimmunity211, 
immunosuppression cytotoxicity212–214, and poor oxygenation215–220. Additionally, cells 
transplanted into the liver are irretrievable and difficult to monitor221–223. Due to these persistent 
challenges and limitations, there has been a recent resurgence of interest in developing a bio-
artificial pancreas construct157,224–226.  
Extrahepatic islet transplantation using tissue-engineered grafts (TEGs) may alleviate many of 
these barriers, but there is a plethora of considerations when designing such a device. One 
approach is to protect from the immune system by imposing a physical immunological barrier 
using a macro-encapsulation device39,186,189,225–228. TEGs that incorporate an immunoisolating or 
encapsulation device may reduce or eliminate the need for systemic immunosuppression post islet 
transplantation, but increase the challenges associated with oxygen and nutrient diffusion within 
such a device129,132,157,190,229.  Transplanting cells inside such a TEG also allows the graft to be 
retrievable and more accessible for graft assessment in vivo. Previous efforts to develop a 
bioartificial pancreas have failed to translate clinically39,129,131,132,229,230, but with recent 
developments in stem cell technologies231–235 and the promise of scalable alternative β-cell 
sources79,236–238, there is a renewed interest in developing a bioartificial pancreas157. The 
implantation site for such a device is also a critical question and must ensure proper access to 
nutrients and allow for kinetically sufficient secretory responses188. Many extrahepatic sites have 
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been considered and even investigated239–242, but little is known about the local pO2 at these 
alternative prospective sites. 
Maintaining adequate oxygenation within TEGs is critical, as both hypoxia and anoxia are 
detrimental to islet function and survival59,130,192,243–246. Islets are highly vascularized in vivo245,246, 
and even short-term hypoxia can permanently impair islet function192,243. Colten, Chhabra, and 
Yang have recently provided comprehensive reviews examining many of these subjects in 
detail157,224,242. These reviews summarize recent work that highlights the importance of oxygen for 
such implantable devices, and demonstrates the limitations of these implants and a need for 
improved oxygenation. Oxygenation is especially challenging when using high cell densities, 
which create significant diffusion-reaction limitations within a graft157. Monitoring the 
oxygenation status of TEGs, therefore is crucial, especially in the early post-transplant period 
before potential revascularization. Additionally, this assessment of TEGs may detect 
oxygenation-altering events such as cell proliferation, inflammation, cell death, and fibrous 
capsule formation. Finally, quantitative measurements of oxygenation could allow for the real-
time estimation of cell and tissue viability182. 
Magnetic Resonance Spectroscopy (MRS) is a useful tool for observing real-time biological 
changes in a non-invasive way. Detailed methods and background of this technique are included 
in Chapter 7, and the studies described in this chapter expand and apply these techniques for 
non-invasive measurement of oxygen concentrations within a tissue engineered graft (TEG) 
constructs implanted in rats. Furthermore, a model for describing the harmful effects of hypoxia 
on islet graft viability and function is presented, and validated by explant TEG viability 
measurements ex vivo. 
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Materials and Methods 
Engineering Model of Hypoxia 
A diffusion-reaction oxygen transport model was developed based on the size and shape of the 
dimensions of the devices described in this study using methods previously described227,229,247–250. 
Briefly, Comsol Multiphysics software (Comsol Inc., Stockholm, Sweden) was used to develop a 
finite-element model describing the steady state 1D diffusion-reaction condition within a macro-
encapsulating TEG device (described below). The TEG is modeled as a thin-slab of oxygen 
consuming tissue surrounded by the device membranes. Oxygen diffusion into the device is 
described by the permeability of the membranes and the pO2 differential between the inside and 
outside of the implant251. Transport of oxygen through the consuming tissue is governed by the 
diffusion through the tissue and the oxygen consumption rate (OCR) of the tissue229. The model 
was used to determine the steady state spatial oxygen concentrations within the central tissue of 
TEGs with various islet densities, and these oxygen concentrations were used to estimate the 
fractional viability and function of the tissue within the central compartment of the device. The 
model used an external oxygen pressure of 30 mmHg based on reports of in vivo tissue oxygen 
pressures in literature57,161,168,169,183,251,252, and an OCR of highly viable islets of 300 nmol/min/mg 
DNA96.  Islets were considered anoxic (non-viable) if the steady state pO2 was < 0.1 mmHg
59, 
and islets were considered non-functional if the steady state pO2 was < 10 mmHg
59. 
Animal Research 
All animal research presented herein was approved and overseen by the University of Minnesota 
Institute for Animal Care and Use Committee (IACUC), the University of California IACUC, or 
the University of Arizona IACUC. This study was designed to minimize the pain and suffering of 
animals used for the study, and the three R’s were observed. These techniques were developed, 
refined and tested in vitro and in deceased animals to minimize the number of animals used to 
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obtain quantitative and significant results. The body weight, and general well-being of each 
animal was monitored for the duration of the studies described, and no adverse events were noted. 
Tissue Engineered Graft (TEG) Construction 
TEG constructs were composed of isolated islets of Langerhans suspended in a matrix and 
protected within a clinically established macro-encapsulating immunoisolation device (TheraCyte 
Inc., Laguna Hills, CA, USA) which is well described and studied in literature187–191,253. Briefly, 
the device was completely fabricated using plastic (PTFE) membranes designed for flexibility 
and biocompatibility, and a single PE100 access port to an internal cell compartment. TEGs were 
prepared using human islets for implantation followed by in vitro explant viability assessments, 
and with porcine islets for in vivo oxygen measurements. All procedures for implantation were 
done using sterile technique and sterile materials and reagents. 
Human islets were isolated at the University of California, San Francisco, cultured at 22 °C in 
supplemented CMRL culture medium for up to 14 days, and shipped to the University of Arizona 
in 10 cm2 G-Rex devices (Wilson Wolf Manufacturing, New Brighton, MN, USA). Islets were 
quantified by DNA content25,26,254,255 and allocated in various doses; ranging from 500-8000 islet 
equivalents (IE) per device. Each dose was then allowed to settle at the bottom of a tube (gentle 
pellet), the supernatant was removed, and the islets were re-suspended in 5-20 µl of sterile 1 % 
sodium alginate solution. The islet suspension was then drawn into a 100 µl precision syringe 
(Hamilton, Reno, NV, USA) and injected into the cell compartment of a 4.5 or 20 µl TheraCyte 
device. The TEG was then submerged in a 1.2  mM of calcium chloride solution (PBS++) for 20-
30 minutes to cross-link the alginate, and transported in sterile PBS++ solution to the surgical 
suite for implantation. 
Porcine islets were isolated from porcine donors at the Schulze Diabetes Institute at the 
University of Minnesota. Islets were cultured at 37 °C in 10 cm2 G-Rex devices using 
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supplemented ME199 culture medium for up to 14 days prior to use for this study. For these 
implants, 10,000 IE were quantified by DNA content assay (Quant-iT PicoGreen dsDNA Assay 
Kit, Life Technologies, Carlsbad, CA, USA) and collected into a centrifuge tube on the day of 
implantation. The islets were allowed to settle at the bottom of the tube (gentle pellet) and the 
supernatant was carefully removed. The islets were re-suspended in 75 μl of porcine plasma 
(Sigma Aldrich, St. Louise, MO, USA) and then mixed with 75 μl of perfluoro-15-crown-5-ether 
(Exfluor Research Corporation, Round Rock, TX, USA) by manually agitating the tube. This 
emulsion was drawn into a 250 µl precision syringe (Hamilton), injected into a 40 μl TheraCyte 
device and then cross-linked with 5% v/v bovine thrombin solution. The thrombin solution was 
made by diluting concentrated topical thrombin solution (GenTrac Inc., Middleton, WI) in 
phosphate buffered saline with calcium and magnesium. The cell access port was trimmed short, 
and sealed with adhesive (Dermabond, Ethicon Inc., Somerville, NJ, USA). The implant has a 
functional surface area of 6.5 cm2 (two flat sides) resulting in an effective islet surface density of 
1,500 IE/cm2. Additional TEGs were prepared in the same manner, without islets to act as 
controls and for calibration purposes. 
Experimental Conditions 
A total of 34 TEGs were prepared in a sterile manner for implantation. TEGs (N=19) loaded with 
various doses of human islets were implanted in the subcutaneous space of 7 non-diabetic nude 
rats (Athymic nude mutant, Hsd:RH-Foxn1rnu, Harlan Laboratories, Inc, Indianapolis, IN, USA) 
for ex-plant viability assessment. Each rat received between 2 and 4 implants into the 
subcutaneous space, and after 7 days the implants were removed for explant viability assessment. 
Porcine islet loaded TEGs (N=6), and control TEGs (N=6) were implanted in the subcutaneous 
space of non-diabetic Lewis rats (RT1I, Charles River Laboratories International, Inc., 
Wilmington, MA, USA) for 
19
F-MRS oxygen measurements. For 
19
F-MRS studies, only one 
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implant was used for each animal, and implants were monitored for 29 days, and then explanted 
for histopathology assessments. A small set (N=3) of control TEGs were prepared in the same 
manner and implanted in the peritoneal cavity of three non-diabetic Lewis rats for 19F-MRS 
measurements. 
Surgical Implantation and Ex-plantation of TEGs 
On the day of implantation, rats were anesthetized with inhalation isoflurane using a respirator 
and vaporizer. The surgical sites were shaved with an electric clipper, and the skin was surgically 
prepped with chlorhexidine or equivalent antiseptic. For subcutaneous implants, a 1.5 cm incision 
was made in the skin on the dorsal side, just inferior to the scapulae, and perpendicular to, but 
symmetric across the medial line. Using gentle blunt dissection, a small pocket was created 
adjacent to the vertebral column just large enough to accommodate one or more devices snugly. 
The pocket was rinsed and lubricated with saline, and the device(s) were tucked into the pocket. 
For peritoneal implants, a 1.5 cm incision was made through the skin and abdominal lining to 
expose the peritoneum. The TEG implant was gently tucked in the peritoneal space, and then 
tacked to the abdominal lining using permanent sutures to hold it in place. The abdominal lining 
and the incisions were closed with absorbable suture in a normal fashion using at least two layers 
and taking care to make sure the device components were not directly below the incision. 
Surgical glue was applied over the closed incision as a barrier. NSAIDs (meloxicam 1 mg/kg) 
were administered by subcutaneous injection to minimize pain and inflammation for 3 or more 
days following surgery. Animals were monitored daily during recovery for up to 14 days until the 
incision was fully healed. After completion of the study, animals were euthanized by inhalation of 
100% CO2 for 5 or more minutes until death was confirmed. The TEGs were then surgically 
removed and used for ex-pant OCR evaluation or histopathology analysis. 
Ex-plant Oxygen Consumption Rate (OCR) Measurements 
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Implants containing various doses of human islets were implanted in rats for 7 days and then ex-
planted for oxygen consumption measurements. The OCR of each ex-planted TEG was measured 
using a method similar to methods described in literature for the assessment of free islet viability. 
Briefly, after ex-plant, the TEGs were surgically recovered following euthanasia, and prepared by 
removing any surrounding tissue that had adhered to the outer surface of the device. The implant 
was then placed into a modified OCR chamber25 and filled with air-saturated cell culture medium 
(supplemented DMEM). The chamber was sealed and the pO2 of the medium was monitored until 
an adequate linear slope was observed. The slope was used to calculate the OCR, which was then 
normalized, by the number of IE loaded into each device to calculate the individual graft viability 
(OCR/IE). The viability values were grouped based on the surface density of islets loaded into 
each device, and the relative average OCR/IE is reported as a percentage (%) of the control, low-
density (≤500 IE/cm2) condition. 
19F-MRS Acquisition 
The relaxation rate constant (R1) was measured from implanted TEGs using a 16.4 Tesla, 
horizontal bore, magnetic resonance imaging system (Agilent Technologies, Santa Clara, CA, 
USA). Detailed methods are described in Chapter 7. Briefly, a custom-built single-loop surface 
coil with a 1.5 cm radius was used as a transceiver and tuned to 19F resonance frequency (656.8 
MHz). The coil was positioned on the surface of the skin covering the implanted TEG to obtain 
the highest possible signal intensity. An inversion-recovery pulse sequence with adiabatic pulses 
was used to measure R1. The inversion-recovery curve was fit to the Bloch equation solution for 
the longitudinal magnetization using 3-parameter non-linear regression with Graphpad-Prism 
software (Graphpad Software Inc., La Jolla, CA, USA). Each R1 was measured in replicate (n=6) 
with a repetition time of 6 seconds (Ensuring complete relaxation between repetitions). 
19F-MRS Calibration 
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Detailed methods are described in Chapter 7, but briefly, control TEGs without cells were 
prepared as described above and placed into a 50 ml conical tube (source) filled with phosphate 
buffered saline (with calcium and magnesium). The vial was placed in the center of a custom-
built surface coil and inserted into a 16.4 T MRS system. The sample was then bubbled with a gas 
of known oxygen concentration for 30 minutes while the temperature was held constant. A fiber 
optic oxygen probe (source) was inserted into the TEG to verify the pO2. R1 was then measured 
with an inversion-recovery sequence utilizing adiabatic pulses. Measurements were made for five 
different pO2s (0, 38, 76, 114, and 160 mmHg) at three different temperatures (21, 37, and 45 
degrees C). The R1 was assumed to be a function of the pO2, temperature, and four fitting 
constants (A, B, C, and D). R1 measurements were fit to the multi-parametric calibration equation 
using a Levenberg–Marquardt algorithm (OriginLab, Northampton, MA). 
Measurement of in vivo TEG pO2 
On the day of measurement, rats were anesthetized with inhalation isoflurane. The rats were 
immobilized onto a holder with the device centered over the custom-built surface coil. The holder 
was inserted into a 16.4 T MRS system and scanned while anesthesia depth was continuously 
monitored and adjusted as needed. Rat body temperature was maintained at 37 +/- 0.2 degrees C 
as measured with a rectal thermocouple and regulated with a forced air heater. Six R1 
measurements were made with an inversion-recovery sequence utilizing adiabatic pulses. The R1 
of each measurement was converted to a pO2 using the previously determined multi-parametric 
calibration. In vivo pO2 was measured 1, 4, 8, 15, 22, and 29 days post-implantation. 
Histopathology and Immunohistochemistry 
Ex-planted TEGs were fixed in 10% buffered formalin for ≥ 24 hours, and then transferred to 
70% ethanol solution. The TEGs containing various densities of  human islets explanted from 
nude rats after seven days were carefully embedded in paraffin wax and sectioned into 5 µm 
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sections and then stained for DNA (DAPI, source), insulin (stain, source), and caspase-3 (stain, 
source). Micrographs of immune-stained sections were collected, and composite images were 
colored and assembled (red = insulin, green = caspase 3, blue = DAPI). TEGs containing porcine 
islets were ex-planted from Lewis rats after 29 days, fixed as described, and prepared for 
histology. Three 5 µm sections from different locations of each ex-plant were histologically 
examined to assess the degree of vascularity, the extent of foreign body reaction present, and the 
extent of fibrosis in the adhered tissue surrounding the TEG. The internal contents of the TEG 
were also examined to determine the extent of necrosis and autolysis of tissue within the cell 
compartment. The degree of vascularity in the surrounding tissue of each TEG was scored in a 
blinded manner by an experienced pathologist on a scale from 0-3. Vascularity scores indicate the 
following tissue condition: 3 = well vascularized; 2 = moderate vascularity; 1 = minimal 
vascularity; 0 = avascular. The degree of foreign body reaction (FBR) was scored from 0-6 by 
examining the degree of inflammatory cell infiltrate comprised of multinucleated inflammatory 
giant cells, macrophages, and the lack of lymphocytes and plasma cells. The following scores 
indicated the extent of FBR: 6 = severe; 5 = moderate-severe; 4 = moderate; 3 = mild-moderate; 2 
= mild; 1 = minimal; 0 =  none. The degree of fibrosis was scored using the same scale but 
examined based on the density of fibrosis in the surrounding tissue. 
Serum C-peptide measurements 
Blood samples were collected from the tail vein of anesthetized animals implanted with porcine 
islet containing TEGs for measurement of systemic porcine C-peptide concentrations. After 15 
and 29 days following implantation (at the same MRS assessment time-points during the study), 
200 µl blood samples were drawn from the lateral tail vein of each animal using a 25-gauge 
needle attached to a 1-ml syringe. Blood samples were collected into serum separator tubes (BD 
Microtainer SST, Franklin Lakes, NJ, USA ) containing 2 µl of aprotinin (Sigma Aldrich, St. 
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Louise, MO, USA), and then spun (300 x gravity) in a chilled centrifuge (4°C) for 10 minutes. 
The serum was then removed from the tube and stored at -80°C for storage prior to assay. Serum 
C-peptide (porcine) was measured using a porcine C-peptide ELISA (Mercodia, Uppsala, 
Sweden). 
Statistical Analysis 
Average values are reported as the mean value and the standard error of the mean (SEM). 
Weighted-means and error values are reported for oxygen measurements due to large variabilities 
observed with some of the oxygen measurements. The weighted means are calculated by 
weighting each oxygen measurement by the inverse of the error in the measurement squared. This 
method is considered superior to the arithmetic mean for increasing the confidence in average 
values of these kinds of data. Statistical comparisons were done using Graphpad-Prism software 
or SAS (version 9.2) analysis package. When comparisons between mean values of multiple 
groups are compared, a one-way analysis of variance (ANOVA) is used to determine if any 
statistical differences exist between groups, and a Tukey’s post-test is used to compare individual 
groups. A repeated measures two-way ANOVA is used to compare differences between groups 
with the time-series of oxygen measurements. For nonparametric data (histology scores), the two-
tailed Mann-Whitney rank sum test was used to compare two groups. Differences are considered 
significant if p<0.05. 
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Results 
Engineering Model of Hypoxia 
The diffusion reaction model results are presented in Figure 8.1A, showing a predicted decrease 
in graft viability (% of tissue) at high islet densities (≥4000 IE/cm2) in the thin macro-
encapsulated TEG device with only 57% viability of the graft when the density is 8,000 IE/cm2. 
At this high-density approximately 52,000 IE are loaded in each 40 µl TEG. The model predicts a 
more dramatic drop in graft function with increasing islet densities with 84% of the total 
functional capacity (% functional tissue) for the low-density condition of 500 IE/cm2, and only 
13% predicted function for high-density TEGs with 8,000 IE/cm2. 
Ex-plant Oxygen Consumption Rate (OCR) Measurements 
Viability measurements of ex-planted TEGs suggest a more dramatic effect on viability than the 
engineering model predicts. TEGs with various islet densities were implanted in nude rats for 7 
days, and were then ex-planted and assessed for viability by measuring the total graft OCR. TEGs 
were grouped based on islet density, and the average measured viabilities are expressed as a 
percentage of the average viability of low-density control grafts (<500 IE/cm2) in Figure 8.1B.  
The average viability (measured by OCR) of ex-planted grafts drops to only 25±12% of the low-
density (control, N=7) TEGs when the density is increased to between 500-1,000 IE/cm2 (N=3). 
As the model predicts, the measured viability (viable tissue %) decreases with increasing islet 
density, but exhibits a more pronounced decrease in viability at moderate densities with only 
14±2% average viability for grafts with 1,000-2,000 IE/cm2 (N=7) , and 7±4% average viability 
for grafts with ≥2,000 IE/cm2 (N=2). 
Histology and Immunohistochemistry 
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Explanted TEGs with high-densities (≥2000 IE/cm2) of human islets exhibited elevated caspase-3 
activation based on immunohistochemical staining when compared to low-density (500 IE/cm2) 
TEGs. Representative images shown in Figure 8.2 of low-density (500 IE/cm2, Figure 8.2A) and 
high-density (4,000 IE/cm2, Figure 8.2B) implants show the strong staining for caspase-3 
indicating increased activation of apoptotic pathways.  The caspase stain is also localized to the 
insulin-stained tissue within the graft. TEGs from oxygen measurement studies contained porcine 
islets loaded at a moderate density (1,500 IE/cm2) and were explanted after 30 days in vivo.  
Histological examination (hematoxylin and eosin staining) of the ex-plants indicated no 
significant differences in the vascularity (p=0.72) or the fibrosis (p=0.92) of the adherent tissue 
surrounding the TEGs when comparing implants with and without porcine islets. All of the 
implants had moderate-well vascularization (scores range from 2-3), and exhibited only mild-
moderate levels of fibrosis. Figure 8.3 includes representative images and sections of the 
adherent tissue surrounding explanted TEGs, and similar vascular structures with the presence of 
red bloods cells were clearly identified embedded within the vascularization membrane of all 
TEGs. The degree of foreign body reaction was however significantly higher (p=0.03) for 
implants containing porcine islets. The average histology scores for all conditions are reported in 
Table 8.1. Examination of the internal compartments of the TEGs showed remaining eosinophilic 
material in all ex-plants indicating some remaining fibrin scaffold, however very little cellular 
tissue remained in the devices that originally contained porcine islets. No inflammatory cell 
infiltration was observed within the internal chamber of the TEGs suggesting that the 
immunoisolation chamber remained intact in vivo for up to 29 days. 
Measurement of in vivo TEG pO2 
The average pO2 values within TEGs in vivo were observed to be less than 40 mmHg at all time-
points examined for both conditions. 19F-MRS signal with good signal-to-noise ratio (SNR = 100-
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500) was obtained from the PFCE-matrix within all implanted TEGs investigated. A 
representative example of a fused image from 19F  and 1H-MRI presented in Figure 8.4 clearly 
demonstrates that the 19F signal originates from within the TEG device, and no signal was present 
outside of the graft. A time-series of average internal 19F-MRS pO2 measurements were 
successfully obtained from implanted TEGs containing only the matrix or 10,000 IE of porcine 
islets at 1, 4, 8, 15, 22, and 29 days following implantation. These results are summarized in 
Figure 8.5. The measured pO2 within TEGs containing porcine islets were consistently and 
significantly lower (p=0.0470) than control TEGs which only contained the control matrix. The 
average internal pO2 of control TEGs one day following implantation was 39±9 mmHg and 
decreased to very low levels (≤10 mmHg) for all remaining time-points. In a similar way, TEGs 
containing porcine islets were observed to have an internal pO2 of 27±6 mmHg after one day in 
vivo, which then decreased to very low levels (≤10 mmHg) for all remaining time-points. The pO2 
within TEGs was significantly higher (p<0.0001) on the first day following implantation than any 
of the following days for both conditions. 
Serum C-peptide measurements 
For all animals tested, porcine C-peptide levels in rat serum were below detectible levels (≤0.2 
ng/ml) after 15 and 29 days in vivo.  
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Figure 8.1: High islet densities decreases graft viability and function. Mathematical estimates and 
explant measurements of graft viability loss, and functional impairment for tissue engineered islet grafts. 
(A) Theoretical calculations suggest that TEGs with high islet densities will suffer from hypoxia causing a 
significant decrease in islet viability, and a more pronounced decrease in islet function. Islet viability and 
function decrease with increasing islet densities. (B) Viability measurements of islets in explanted TEGs 
loaded with different densities show an even more dramatic decline in OCR (viability) with increasing islet 
density than predicted by theoretical models. Plotted values are normalized to control TEGs implanted with 
≤ 500 IE/cm2 and bars indicate the mean + standard error of the mean percentage. (* indicates p < 0.05 for 
post-test when compared to low density controls, while all other values are not significantly different from 
each other.)  
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Figure 8.2: High and Low islet density immunohistochemistry images. Ex-planted TEG 
immunohistochemistry staining (representative images) comparing TEGs with (A) low 500 
IE/cm2 and (B) high 4000 IE/cm2 islet densities show DAPI (blue), insulin (red), and increased 
caspase-3 (green) activation with high islet densities. Caspase-3 staining (green) is co-localized 
with insulin staining in TEGs with high islet densities, and this indicates that these beta cells have 
activated apoptotic pathways. TEGs were implanted subcutaneously in nude rats and ex-planted 
after 7 days for assessment. 
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Figure 8.3: Vasculature in surrounding tissue. (A-C) Representative histology sections of tissue 
surrounding the explanted TEG after 29 days in vivo. Clear vascular structures (arrows) are visible in the 
tissue immediately surrounding and adhered to the vascularization membrane of the TEG. Red blood cells 
are also clearly seen inside the vascular tracks that are formed in the newly remodeled tissue. (B-D) 
Representative pictures of explanted TEGs prior to fixation with vascular network clearly incorporated in 
the adherent tissue surrounding the TEGs. 
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Table 8.1: Average Histology Scores 
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Figure 8.4: Overlaid 19F (red) and 1H (greyscale) MRI of subcutaneous TEG. PFCE is distributed 
throughout the TEG in vivo  and strong signal is present within the device, while no signal is 
detected outside of the device suggesting that the PFCE is adequately contained with the TEG. 
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Figure 8.5: Internal pO2 of implanted TEG. Time-course plots of oxygen partial pressures 
measured inside subcutaneous implanted TEGs followed for 30 days using non-invasive 19F 
MRS method. Average pO2 in TEGs containing control scaffolds (N=6) or scaffolds seeded with 
10,000 IE of porcine islets (N=6) were measured at each time point (1, 4, 8, 15, 22, and 29 days 
post implantation). Oxygen levels in implants containing porcine islets were consistently and 
significantly lower than implants without cells (*, p=0.0470), and were significantly higher (†, 
p<0.0001) on the first day following implantation than any of the following days for both 
conditions. 
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Discussion 
Many researchers have previously described the challenges of oxygenation for tissue-engineered 
grafts (TEG), especially if such a graft requires high-cell densities for therapeutic or practical 
reasons157,224,242. In this report, these challenges were first examined by developing a model to 
predict the oxygenation of a macro-encapsulated islet graft, and then the effects on islet viability 
and function were predicted to examine implants with various islet densities. Next, the findings of 
the model were experimentally tested by implanting TEGs with various islet densities in nude rats 
for 7 days, and then measured the viability of the ex-planted devices using oxygen consumption 
rate measurements. Finally, 19F-MRS methods were used to non-invasively measure the internal 
pO2 of implanted TEGs with and without islets. 
Other reports in literature have examined the effects of hypoxia and anoxia on pancreatic islet 
viability and function59,60,130,192,243–246,256, and some have reported results from diffusion-reaction 
models that predict oxygen limitations in macro-encapsulated TEGs227,229,247–250. We developed a 
1D diffusion-reaction model to evaluate the viability and function of a macro-encapsulated islet 
grafts with various islet densities with the results shown in Figure 8.1A. The model demonstrates 
that as the islet density increases, the fractional viability and fractional function of a TEG 
decreases. Islet function is more dramatically affected by islet density because islet function is 
compromised at pO2 ≤ 10 mmHg
59, while viability is not compromised until oxygen levels fall 
below 0.1 mmHg59. These results suggest that thin devices with high-oxygen permeability are 
required to prevent hypoxic damage to encapsulated tissues, and that low islet densities are 
needed to ensure adequate islet function. To accommodate TEGs with such low islet densities 
(≤500 IE/cm2), very large implants would be required to achieve the surface area needed for 
adequate oxygenation, and this large-size would be impractical for implantation in humans. 
Literature suggests that oxygen levels of tissues in vivo are below venous oxygen levels (40 
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mmHg)257,258, and our model assumed an external pO2 of 30 mmHg to be consistent with these 
reports252. With this low-level of surrounding tissue oxygen, high-densities of islets within a 
reasonably sized device will suffer from hypoxia in vivo as well as greatly decreased function 
(Figure 8.1A). 
To examine these findings experimentally, a series of TEGs containing various densities of 
human islets were implanted in nude rats and then explanted 7 days later for viability assessment 
using the OCR assay and evaluation by immunohistochemistry. The results of explant OCR 
measurements reported in Figure 8.1B support the model findings that TEG viability decreases 
with increasing islet density, but the experimental observations indicate a more pronounced drop 
in viability starting at moderate densities and a profound drop in viability at high islet densities. 
These findings suggested that the encapsulated islet grafts were suffering from a more-harsh 
environment than the model assumes. Representative ex-plant immunohistochemistry 
micrographs shown in Figure 8.2 further support the findings of the model, and the experimental 
viability measurements. After 7 days in vivo, TEGs with low islet densities (≤500 IE/cm2) showed 
strong insulin staining of islet tissue inside the cell compartment of the immunoisolation device 
indicating that β-cells can survive in this environment for up to 7 days in vivo. However, TEGs 
with high islet densities (≥4,000 IE/cm2) also showed some insulin staining in surviving islet 
tissue; these implants also exhibited strong staining for caspase-3. The insulin staining with the 
strong co-localized caspase-3 staining suggests increased activation of apoptosis pathways in the 
islet tissue. When combined, the results from the predictive model of hypoxia, the experimental 
measurement of ex-plant viability, and the confirmatory results from immunohistochemical 
examination suggest that TEGs with high islet densities suffer from catastrophic and possibly 
irreversible damage within the sub-cutaneous environment. Furthermore, these results indicate 
that oxygen limitations may in-fact be more severe than our initial model presumed. More 
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detailed examination of literature provided only limited reports of direct oxygen measurements of 
in vivo tissues56,57,161,168–170,183. 
To gain a better understanding of the oxygen available to subcutaneous implanted TEGs, we 
developed a method for non-invasive oxygen measurements within TEGs in vivo using 19F-MRS. 
Traditional oxygen sensors for oxygen measurement in vivo use Clark electrodes57,174,192, or fiber 
optic fluorescence quenching probes. Traditional polarographic, “Clark type,” electrodes suffer 
from inaccuracy due to the consumptive nature during operation, and both conventional methods 
are mechanically invasive. The traditional “needle” type probes require mechanical disturbance of 
the sampled tissue, and may actually introduce oxygen to the system during the measurement 
procedure. These traditional sensors also provide a single point measurement at the tip of the 
probe itself, and thus multiple mechanically disruptive measurements are required to obtain an 
average pO2 measurement with high levels of confidence. There are some reports using a 
photoacoustic lifetime imaging methods193,194 for oxygen measurement, but these methods are 
only applicable for very superficial measurements in tissues. 19F-MRS methods overcome many 
of these limitations, and offer a sensitive, accurate, and non-invasive method for oxygen 
measurements in vivo. 
Our lab has investigated 19F-MRS methods for functional graft assessment in vitro182, and others 
have explored similar methods for measuring oxygen levels in vivo using raw perfluorocarbons 
(PFC)172, PFC lipid emulsions163,179,195–197, or PFC loaded alginate beads161,168–170,172,183, but none 
have attempted to measure the average localized oxygen concentration within a macro-
encapsulation device in vivo. Our methods were optimized and adapted for measurements within 
macro-encapsulated TEGs using an ultra-high field 16.4 T MRS system for optimizing signal-to-
noise ratio. Our experiences with in vitro studies and reports in literature159,174,177,198 document the 
sensitivity of 
19
F-MRS relaxation rates to both oxygen and temperature, yet many reports using 
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19F-MRS for oxygen measurement do not address this multi-parametric physical nature. 
Controlling and even measuring the body temperature of anesthetized animals inside an MRS 
system can be technically challenging, but due to the high sensitivity of these methods, 
temperature must be considered to achieve a high-level of measurement accuracy. To account for 
the relaxation effects of both oxygen and temperature, we chose to perform detailed and robust 
multi-parametric oxygen and temperature calibrations using control TEGs loaded with a PFCE 
impregnated plasma gel matrix199. We fit this oxygen-temperature data set using established 
numerical methods to derive the calibration constants used for these studies159,174. Despite these 
complex calibrations, the oxygen measurements are still susceptible to errors in temperature 
measurement, and 19F-MRS methods for oximetry would greatly benefit from improved 
temperature measurement techniques, especially if the temperature measurements could be 
localized to the area of interest. An MRS method to locally measure temperature in vivo would be 
an ideal complement to 19F-MRS oximetry, and development in this area would greatly improve 
the sensitivity and accuracy of the described methods. We chose to use PFCE due to the reported 
biocompatibility172,180,181, and large number of equivalent fluorine atoms, which provide an 
intense signal at a single resonance (singlet).  Six control TEGs were prepared without any islets 
for subcutaneous implantation in rats to examine the ambient oxygen availability without the 
confounding factor of oxygen consumption. Six more functional TEGs each containing 10,000 
porcine IE (1,500 IE/cm2) were implanted in the subcutaneous space to examine any changes in 
average oxygen levels when functional islet tissue is present in the graft. Furthermore, a small set 
(N=3) of control TEGs without islets were implanted in the peritoneal space to determine if the 
peritoneal space offered a more favorable oxygen environment. 
Oxygen measurements from these implant studies, presented in Figure 8.5, indicate that in vivo 
TEGs are far more hypoxic than predicted by our diffusion-reaction model. Oxygen levels in 
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control TEGs (no islets) started at 39±9 mmHg one day following implantation, but then 
decreased to ≤10 mmHg for all remaining time-points. These very low levels of available oxygen 
in the subcutaneous space dramatically affect the results from the diffusion-reaction model. The 
model assumed an external pO2 of 30 mmHg and the results predicted a modest decrease in 
viability at moderate islet densities and a more profound decrease in graft function. The trend of 
decreasing viability with increasing islet density predicted in the model was supported by the ex-
plant OCR viability measurement; however, the explant measurements predicted a much more 
dramatic drop in viability at moderate densities. The control TEG measurements of available 
oxygen in vivo suggested that the external oxygen availability in the subcutaneous space is much 
lower than assumed in the model with an average available pO2 of 6.8 mmHg after the first day. 
With this low-oxygen availability confirmed, the predictions change, and the model suggest a 
more dramatic drop in islet viability at moderate densities and a profound drop in graft function. 
These adjusted model results are in strong agreement with the ex-plant viability measurements 
(Figure 8.1B), and predict an extremely hypoxic environment within TEGs with moderate and 
high islet densities. The profoundly hypoxic condition within these TEGs result in dramatic 
effects on islet graft viability and function, and better explain the observations from ex-plant 
viability measurements. TEGs implanted in the peritoneum had a similar pO2 trend and a similar 
hypoxic environment as subcutaneous TEGs during the 29-day measurement period. The 
maximum pO2 of peritoneal implanted TEGs was 3±7 mmHg after the first day in vivo. 
Measured average internal pO2 in TEGs containing porcine islets were significantly lower than 
observed in control subcutaneous implanted TEGs (without islets) at all time-points investigated. 
These results are anticipated due to the increased oxygen consumption of the islet tissue within 
the graft causing further decreases in pO2 when compared to the ambient oxygen availability. 
TEGs with porcine islets had a maximum average internal pO2 of 4±5 mmHg after the first day in 
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vivo, and all average pO2 values were lower than values observed in control TEGs. Due to the 
very low oxygen levels (near zero) observed in some implants containing porcine islets, and the 
natural variability in the measurement techniques, the application of the established calibration 
curve occasionally yielded mildly negative pO2 values. These SEM for these measurements 
included zero, and the values were not statistically different from a measurement of zero oxygen 
(p ≥0.05). As previously discussed, the 19F-MRS measurement method is susceptible to 
variability in the absolute temperature of the TEG and the uncertainty in the measurement of the 
temperature using the rectal probe. Therefore, the analysis herein interprets such values to be near 
zero pO2 and “immeasurably-low” such that the oxygen levels are in-fact lower than the error of 
the measurement method.  
These results suggest a critical need for improved oxygenation in macro-encapsulated TEGs to 
support the high-cell densities needed for therapeutic applications. These studies investigate 
applications of TEGs for islet transplantation, but these observations are pertinent to the entire 
field of tissue engineering. Many engineered tissues for the treatment of human disease will 
require development of complex tissues with high cell densities (near native cell densities) to 
provide a therapeutic benefit. Oxygenation is a critical challenge facing the field of tissue 
engineering, and specifically for encapsulation approaches that do not allow complete re-
vascularization of tissues. These challenges are recognized in recent reviews in the field157,224,242, 
and some have had marginal success with approaches for increasing oxygenation of implanted 
TEGs226,227,259–266. To address the oxygen limitations observed in our TEG system, an exogenous 
oxygen delivery system was developed by the Klearchos Papas lab at the University of Arizona. 
As described above in Chapter 7 and in more detail in the next section, the TheraCyte device 
was modified to provide for a separate central oxygen chamber, and additional access ports to 
allow for continuous delivery of supplemental oxygen (DSO) to the TEG in vivo. 
19
F-MRS 
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measurements suggest a dramatic increase in available oxygen in the TEGs with DSO, and the 
results were reported in Figure 7.13. The results of these preliminary studies suggest that a 
continuous DSO system could be used to improve the oxygenation of therapeutically relevant 
macro-encapsulated TEGs, which require high islet densities. 
The oxygen levels of implanted TEGs were monitored for a 29-day period to examine the kinetics 
of oxygen concentrations, and the pO2 on the first day following implantation was observed to be 
significantly higher than all of the future time-points studied. No other significant differences 
between time-points were found; however, a predictable trend in oxygen availability was 
observed for both TEG varieties. For both conditions, the oxygen levels started at the highest 
levels observed on the first day following implantation, and these high levels are likely due to the 
continued presence of oxygen in the TEGs and surrounding surgical fluid at this early time-point. 
A second phase is characterized by a dramatic decrease in pO2 observed on the fourth day 
following implantation with oxygen levels reaching near-zero levels at this time-point. This 
dramatic drop in oxygen is expected due to the early recruitment of highly-metabolic 
inflammatory cells to the site of tissue damage (surgical site). These cells migrate to the surface 
of the TEG, and begin the regenerative process to repair the tissues damaged during the surgery, 
and to respond to the newly implanted device. As the regenerative process continues, the cellular 
tissues grow closer to the TEG, and actually grow into the outer membrane of the TEG causing an 
average decrease in local oxygen availability. The third-phase in the trend occurs from 8-22 days 
following implantation when a moderate and gradual increase of pO2 is observed. This modest 
increase in pO2 can be explained by vascular formation in the adherent tissue surrounding the 
implanted TEG. However, this vascular formation does not significantly improve TEG 
oxygenation, and cannot alleviate the hypoxic condition suffered by the encapsulated islet graft. 
In the final phase, TEG oxygen levels appear to reach a steady-state with minimal change from 
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22-29 days following implantation. These trends in oxygen levels are not statistically significant, 
but they are consistent with the general regenerative process that occurs following a surgical 
insult to tissue and implanted materials. Deviations in this predictable trajectory could be 
indicative of catastrophic or interventional events, and with further development, these 
temporally repeated measurements could provide a functional tool for non-invasive examination 
of TEGs. 
The same TEGs used for oxygen measurements were ex-planted after 29 days, and processes with 
the surrounding adhered tissue to examine the engraftment by histopathology. The surrounding 
tissue was scored in a blinded fashion by an experienced histopathologist to assess the degree of 
vascularity, the extent of foreign body reaction, and formation of fibrosis in the surrounding 
tissue with the results presented in Table 8.1. The results suggest that the surrounding tissue in 
both grafts that contain porcine islets and grafts without islets had developed a moderate level of 
vascular formation with average scores of 2.5 and 2.3 respectively with no significant differences 
observed for this metric. The adherent tissues surrounding implanted TEGs exhibited only mild 
fibrosis with the same average score of 2.3 for both conditions of TEGs. The extent of the foreign 
body reaction was significantly higher for implants that contained porcine islets; however, the 
response was only moderate for these implants with an average score of 3.8. These results are 
consistent with previous reports using similar TEGs157,248,251, and moderate levels of fibrosis and 
foreign body reactions are expected with these materials267–269. The increase in the foreign body 
reaction observed in TEGs that contained porcine islets can also be expected using an 
immunocompetent animal model like the Lewis rats used for these studies. The TheraCyte device 
has been reported to effectively protect allogeneic grafts186,191, but it has not proven to be 
effective for protecting xenogeneic grafts228,269. The presence of xenogeneic islet tissue within the 
TEG is expected to cause an elevated inflammatory response despite the immunoprotective 
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capacity of the device, and this likely explains the increased scores for these TEGs. Histological 
examination of the internal cellular compartments of the explanted TEGs showed remnant 
amounts of eosinophilic material (PFCE-fibrin matrix) in all devices, but only minimal surviving 
islet tissue remained in porcine islet loaded TEGs after 29 days in vivo. These findings are 
consistent with the measured oxygen levels and suggest that the severely hypoxic environment 
may be causing complete loss of the islet graft after 29 days. The results are also likely 
confounded by the xenogeneic response, as the TheraCyte has not been effective for protecting 
xenogeneic grafts 228,269. Systemic porcine C-peptide levels were also measured on day 15, and 29 
for animals that received TEGs with porcine islets, and no detectible levels were observed in any 
of the animals adding further support to the hypothesis of early graft failure and death due to the 
severly hypoxic environment within the TEGs. 
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Conclusions 
Oxygenation is a critical barrier to the success of any highly cellular implantable tissue 
engineered graft (TEG). Hypoxic stress is suspected to be the primary cause of TEG failure for 
encapsulated grafts that do not accommodate direct vascularization or re-vascularization of tissue. 
Our model describing a macro-encapsulated TEG demonstrates that adequate oxygenation is not 
possible in vivo with high islet densities, and that graft viability and function will be severely 
limited without intervention. Oxygen consumption measurements and immunohistochemical 
examination of ex-planted TEG conclude that hypoxic conditions in vivo have harmful effects on 
graft viability and function, and that TEGs with moderate islet densities suffer from dramatic 
losses in viability after 7 days. To examine the oxygenation status of implanted TEGs, 19F-MRS 
methods were successfully developed to measure pO2 non-invasively. The developed 
19F-MRS 
method is robust, accurate, and reproducible; and can be used to track the oxygenation status of 
TEGs for long durations post-implantation (up to 29 days). Oxygen measurements of control 
TEGs in rats showed that the subcutaneous and peritoneal spaces are severely hypoxic 
environments that cannot support the oxygen requirements of a TEG with high islet densities. The 
same measurements in TEGs containing porcine islets further support these conclusions, and 
demonstrate that external graft vascularization in the first 29 days is not sufficient to promote 
graft survival. However, delivery of supplemental oxygen could alleviate the hypoxic condition 
and promote TEG survival in vivo. In conclusion, further development of novel methods for 
improving oxygenation in vivo are needed to support the function of macro-encapsulated TEGs, 
and innovative non-invasive assessment techniques, like 19F-MRS, are critical to the development 
and validation of various oxygenation approaches. 
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Oxygen Delivery Improves Islet Graft Function in vivo 
Summary 
Macro-encapsulation and immunoisolation to create a tissue engineered bio-artificial pancreas 
(BAP) could allow for islets and beta-cells from alternative sources to be implanted in diabetic 
patients to restore glycemic control without the need for immunosuppression. However, 
oxygenation remains a critical limitation for the application of tissue engineered grafts (TEGs) 
that contain therapeutic cell doses at practical cell-densities. This study describes the 
development of a non-invasive method for the measurement of internal oxygen partial pressures 
(pO2) using fluorine-19 magnetic resonance spectroscopy (
19F-MRS) within an implanted TEG, 
with and without the in situ delivery of supplemental oxygen (DSO). TEGs were constructed 
using a TheraCyte immunoisolation device (TheraCyte, Inc. Laguna Hills, CA) modified to allow 
for DSO. TEGs were prepared with or without porcine islets (20,000 islet equivalents) suspended 
within a matrix containing perfluoro-15-crown-5-ether (PFCE) as an oxygen probe for 19F-MRS 
measurements. TEGs with and without DSO were implanted into a dorsal subcutaneous pocket in 
non-diabetic Lewis rats (Charles River, Wilmington, MA). The internal pO2 was monitored 
periodically for 29 days in vivo using the methods described in Chapter 7. A small feasibility 
study implanting TEG devices in diabetic rats with or without DSO was done to examine the 
functional impact of DSO. Blood glucose measurements were done to evaluate graft function. As 
described in the previous section of this chapter, without DSO, the average in vivo pO2 was 
severely hypoxic at all time-points investigated for both conditions. TEGs with DSO in vivo 
achieved pO2 > 300 mmHg the first day after implantation, which remained elevated for up to 29 
days in islet loaded and islet-free TEGs. Functional outcomes (BG levels) suggest that DSO 
supports prolonged high-islet density graft function for up to 30 days. Non-invasive 19F-MRS can 
be used for the accurate measurement of pO2 within an implanted TEG. DSO successfully 
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increased the internal pO2 of implants with and without islets, and supported prolonged graft 
function in diabetic nude rats.  
  198 
Introduction 
Islet transplantation (ITx) offers a minimally invasive alternative to pancreas transplantation, and 
shows promise as a possible cure for type 1 diabetes200,201, but widespread application of this 
therapy is still inhibited by numerous barriers. Despite recent improvements with single-donor 
ITx at some centers, the five-year insulin independence rate is only 50%, and many cases still 
require more than one transplant to achieve insulin independence53,200,202–208. Furthermore, due to 
the insurmountable shortage in available donor pancreata, this therapy is currently limited to 
select patients with severe hypoglycemic unawareness53,207,242. To expand access to this promising 
therapy, many are investigating methods to improve donor pancreas quality20,31,37,44,45,50,69,104,270–
273, optimize isolation processes36,274–277, and optimize the use of immunosuppressive 
drugs200,204,207,208. Despite these improvements, the limited source of allogeneic donor islet tissue 
will never be sufficient to treat the growing population suffering from diabetes. Investigators have 
turned to xenogeneic76,89,90,238,278–280 and stem-cell sources to alleviate this shortage, but these 
sources introduce further challenges related to long-term immune protection and physiological 
islet function. There has been limited success with xenogeneic porcine islet transplantation in 
animal models33,34,281–290, but aggressive immunosuppression protocols are needed to prevent 
rejection, which increases patient risk and has been shown to harm to islet grafts212–214. There 
have also been promising advances toward development of functional stem-cell derived islets231–
235, but concerns remain about the increased risk and safety of these sources. 
Macro-encapsulation approaches to create a tissue engineered bioartificial pancreas (BAP) could 
offer physical immunoprotection and containment of transplanted islet tissue addressing concerns 
for the use of both xenogeneic and stem-cell derived sources. Various encapsulation techniques 
have been investigated, and some success has been achieved with small doses of islets in animal 
models, but scaling these devices to therapeutic sizes for humans is not practical. Tissue 
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engineered grafts (TEGs) which contain high-densities of islet tissue suffer from sever hypoxic 
stress resulting in graft failure and limited function after only a few days in vivo. Extensive 
discussion of previous efforts and detailed explanations of these challenges are described in the 
recent reviews of Colten, Chhabra, and Yang157,224,242. Various approaches for increasing 
oxygenation of macro-encapsulated implants have been investigated, and results suggest that re-
vascularization alone will not support sufficient oxygen transport, and continuous oxygenation 
will be required for these approaches226,227,259–266. To evaluate various oxygenation strategies, and 
to optimize methods for oxygen delivery; a robust method for non-invasive oxygen measurement 
is needed. Our lab182 and others161,163,168–170,172,179,183,195–197 have successfully applied 19F-MRS 
methods for non-invasive measurements of oxygen within implanted TEG devices, and the results 
confirmed a persistent hypoxic environment in vivo. The non-invasive nature of these methods 
can provide accurate and reliable measurements of oxygen partial pressures (pO2) in vivo, without 
disrupting the surrounding tissue or the integrity of the implanted device. 
These studies evaluate the feasibility and functionality of a macro-encapsulated islet graft 
employing a method for delivery of supplemental oxygen (DSO) to alleviate hypoxia in vivo. 
High islet density grafts were implanted in the subcutaneous space of rats and supplemented with 
exogenous oxygen delivery while periodic non-invasive oxygen measurements were obtained by 
19F-MRS.  
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Materials and Methods 
Experimental Approach 
The work presented herein represents the results of collaborative projects done at the University 
of Minnesota (UMN), and the University of Arizona (UA). To examine the effects of continuous 
oxygen delivery on the success of encapsulated islet grafts, these studies test the efficiency and 
function of a TEG being developed at the UA intended for future clinical application. To 
determine the efficacy of oxygen delivery, Fluorine-19 magnetic resonance spectroscopy (19F-
MRS) methods were used to measure the internal oxygen partial pressure (pO2) of TEG devices 
non-invasively in vitro and in vivo. All 19F-MRS oxygen measurement studies were done at the 
UMN. A series of 5 TEG devices modified for DSO were prepared without islets for in vitro 
studies using 19F-MRS measurements to validate successful delivery of oxygen to TEGs within a 
perfusion bioreactor. A second series of TEGs with DSO were implanted in 12 non-diabetic 
Lewis rats (RT1I, Charles River Laboratories International, Inc., Wilmington, MA, USA) with 6 
of the rats receiving implants containing 20,000 porcine islet equivalents (PIEs), and 6 receiving 
control implants containing only an oxygen sensitive hydrogel-matrix. The internal pO2 of 
implanted TEGs were monitored for up to 29 days. Furthermore, a series of 6 rats were implanted 
with control TEGs (no islets) that did not receive oxygen to compare against ambient available 
oxygen levels. For preliminary assessment of graft survival and function in vivo, a small number 
of TEGs with (N=2) and without DSO (N=6) were loaded with 24,000 PIE and implanted in 
diabetic nude rats (athymic nude mutant, Hsd:RH-Foxn1rnu, Harlan Laboratories, Inc, 
Indianapolis, IN, USA). Graft function and survival were evaluated by measuring daily blood 
glucose levels in diabetic animals, and histological examination of all explants. Furthermore, 
blood samples were collected from all animals that received porcine islets porcine C-peptide 
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measurements as secondary measure of graft function in vivo. All studies with diabetic animals 
were conducted at the UA. 
Tissue Engineered Graft (TEG) Device Preparation 
A modified TEG was built by adapting the clinically-established TheraCyte (TheraCyte Inc., 
Laguna Hills, CA, USA) device 186–191 to allow for continuous DSO in vivo. All studies with DSO 
used these modified devices, while studies without DSO used an un-modified 40-µl TheraCyte 
device. Briefly, for TEGs with DSO, the 40-µl device was modified to include a central chamber 
that allowed for direct delivery of oxygen gas to the internal aspect of the device, and additional 
ports were added for access to this central oxygen chamber. The TheraCyte device is originally 
constructed by sandwiching two PTFE immunoisolation membranes to form an internal cellular 
chamber, which is surrounded by two vascularizing membranes that provide structural support 
and improved vascularization of the device surface in vivo. A single access port allowed for 
loading of the internal cell compartment. The modified device was constructed with two 
additional PTFE immunoisolation membranes layered on top of each other, which created two 
distinct cellular chambers on either side of a central oxygen chamber. Additional access ports 
were included with two ports on the longitudinal end to provide access to the central oxygen 
chamber, and two lateral ports to provide individual access to each cell-chamber. One of the DSO 
access ports provided for oxygen gas flow into the central chamber (inlet), while the other port 
allowed gas to flow back-out of the device (outlet). The access port design and cannula 
attachments are included in Appendix A. This approach was intended to accommodate constant 
flow of oxygen-rich gas through the modified device, which provided for continuous 
replenishment of oxygen within the device. 
To prepare TEGs, porcine islets (if included) were suspended in a hydrogel-matrix and injected 
into the cell compartments of each device (the total dose was split between both cell 
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compartments for TEGs with DSO). Porcine islets were isolated at the University of Minnesota, 
and cultured for up to 14 days prior to use for this study. All islet doses were quantified by DNA 
content assay (Quant-iT PicoGreen dsDNA Assay Kit, Life Technologies, Carlsbad, CA, USA). 
For 19F-MRS oxygen measurement studies, the hydrogel-matrix was composed of perfluoro-15-
crown-5-either (PFCE, 19F oxygen probe, Exfluor Research Corporation, Round Rock, TX, USA) 
emulsified in porcine plasma (Sigma Aldrich, St. Louise, MO, USA)  which was cross-linked 
using 5% v/v solution of topical bovine thrombin (GenTrac Inc., Middleton, WI)  following 
injection into the device. For diabetic rodent studies, the matrix was composed of a 5% alginate 
solution, which was cross-linked using a 1.2 mM calcium chloride solution following injection 
into the device. Additional TEGs were prepared using the same methods without islets for 
bioreactor studies, control implants, and for 19F-MRS oxygen calibrations. 
Perfusion Bioreactor  
In vitro studies were conducted using a perfusion bioreactor system, which continuously perfused 
with porcine islet culture medium (ME199 based, Mediatech Inc.) around a TEG modified for 
DSO. These methods are described in detail in Chapter 7 TEG devices with DSO were prepared 
as described for in vitro 19F-MRS oxygen measurement studies without porcine islets, and placed 
inside a perfusion bioreactor chamber. 
Animal Research 
The Institute for Animal Care and Use Committee (IACUC) at the University of Minnesota 
(UMN) and the University of Arizona (UA) reviewed and approved all animal studies described 
herein. Animal welfare was carefully monitored daily during all studies. 
Implantation of TEG devices and DSO in vivo. 
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A total of 26 rats were implanted with subcutaneous TEG devices, and the surgical implantation 
procedure was similar for all animals presented in this study with minor differences for animals 
which did not receive DSO. Two or more weeks prior to surgery, animals designated to receive 
TEGs with DSO were fitted with a vascular access harness and tether apparatus (Instech 
Laboratories, Plymouth Meeting, PA, USA) to allow for sufficient acclimation to restraint. The 
harness and tether apparatus consisted of a flexible-silicon adjustable harness, which provided a 
sterile access port on the back of the animal. A tether assembly attached securely to the access 
port and consisted of plastic cannulas protected by a flexible stainless steel spring that extended 
out the top of the cage to a swivel and counter-balance assembly, which provided for minimal 
restraint of natural feeding, drinking, and grooming behaviors. Animals were monitored daily 
during the acclimation period and for the duration of the study to ensure animal welfare. Body 
weights along with any signs of distress were recorded and complications were documented and 
remedied if necessary throughout the study. All animals successful acclimated to the restraint 
during the two-week period. 
In preparation for surgery, the harness was removed, and anesthesia was induced with 3% 
isoflurane and maintained at 1.5% isoflurane during the procedure using a small animal respirator 
system. Animal temperature was maintained using a warming pad, and monitored using a rectal 
temperature probe. The surgical site, on the dorsal side, was shaved and prepared using 
chlorhexidine antiseptic swabs. A 1.5 cm incision through the skin was made in a transverse 
direction on the dorsal side, inferior the scapulae and symmetric across the medial line. Gentle 
blunt dissection was used to create a small pocket under the skin and adjacent to the vertebral 
column to accommodate the modified TEG device. After rinsing the pocket with sterile saline, the 
TEG device was gently tucked into the space leaving the DSO cannula extending out of the 
incision (for TEGs with DSO). The incision was closed using at least two layers in a normal 
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fashion around the cannula using absorbable sutures, and then sealed by applying a light coat of 
surgical sealant (Dermabond, Ethicon Inc., Somerville, NJ, USA). Care was taken to ensure that 
the implant components did not put pressure on the incision, and to ensure that DSO 
transcutaneous cannulas were not obstructed during closure. A new sterile harness was then re-
fitted, and oxygen gas flow for DSO was confirmed by manual injection through the harness. 
Anesthesia was then stopped and the animal was allowed to recover completely on the surgical 
warming pad prior to returning the animal to the cage and attaching to the tether apparatus. Upon 
returning to the cage, DSO was immediately initiated (when applicable), and oxygen-rich (650 
mmHg) gas was continuously delivered at a target flow rate of 1.5 ml/min for the duration of the 
study. DSO was only stopped for brief periods (1-2 minutes) when animals were disconnected 
from the tether apparatus for daily monitoring and examination. TEGs without DSO (N=12) were 
implanted using the same surgical approach, but non-modified TharaCyte devices were used, 
transcutaneous cannulas were omitted, and animals were not restrained via the harness and tether 
apparatus. 
The DSO system was composed of an electrochemical oxygen generator (EOG, Giner Inc., 
Auburndale, MA, USA) along with a specialized DSO regulating manifold. The EOG system 
generated a constant stream of humidified pure oxygen gas (760 mmHg), which flowed directly 
to the DSO manifold. The manifold was designed using a series of gauges and valves to 
independently monitor and control the pressure and flow of oxygen-rich gas to each TEG. The 
outlet side of the manifold was connected to external connections in the animal cage lids, and 
provided oxygen to the tether apparatus. Extended DSO tubing was used to continue DSO during 
19F-MRS measurement procedures. Gas flow through each TEG was confirmed daily by 
measuring flow through the manifold, and confirming a continuous stream of gas leaving the 
implanted TEG through the outlet cannula.  
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For diabetic animals that achieved blood glucose control, the TEG was surgically removed after 
30 days using the same surgical techniques that were used for implantation. Animals were then 
allowed to recover and were monitored for up to 5 days to observe a return to diabetic state.   
Upon completion of each study, animals were euthanized by inhalation of 100% CO2 for 5 or 
more minutes until death was confirmed. The TEGs were then surgically removed and processed 
for explant histopathology analysis. 
19F-MRS Oxygen Measurements 
Oxygen measurements were obtained using methods previously described by our group and in 
Chapter 7. Briefly, the 19F relaxation rates of control TEG (without cells and without DSO) 
devices were measured in vitro at 6 controlled pO2 levels (0, 38, 76, 114, 160, and 760 mmHg) 
and at three different temperatures (21, 37, and 45 °C) to generate calibration curves using a 16.4 
Tesla MRS system. All 19F R1 measurements were obtained using an inversion recovery sequence 
with adiabatic pulses and a custom-made surface coil tuned to the 
19
F resonance frequency (656.8 
MHz). The calibration data was fit to a multi-parametric calibration equation using regression 
methods to generate the needed calibration constants that relate R1 to pO2 and temperature. The 
calibration constants were then used to determine the bulk average oxygen concentration within 
TEG implants based on 19F-R1 and temperature measurements. For in vivo studies, animals were 
anesthetized by isoflurane inhalation and were immobilized on an MRS bed with the TEG 
centered over the custom-built coil. The animal was inserted in the 16.4 T MRS scanner, and 
body temperature was maintained at 37±0.2 mmHg using a forced-air heater. The average 
internal pO2 of each TEG device was measured by 
19F-MRS after 1, 4, 8, 15, and 29 days 
following implantation. Oxygen measurements from TEGs for in vitro in bioreactors described 
above were measured in the same way. 
Diabetic Rodent Model & Functional Measurements 
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TEGs containing 25,000 ± 1000 PIE with or without DSO were implanted in diabetic nude rats, 
and function was assessed by measuring non-fasting daily blood glucose levels. Diabetes was 
chemically induced in nude rats by intraperitoneal injection of a 60 mg/kg dose of streptozotocin 
(Zanostar) reconstituted in fresh sterile citrate buffer (10 mM, pH 4.5). Following induction, 
blood glucose (BG) measurements were recorded at the same time every day from diabetic 
animals using a blood glucose meter (True track glucose monitoring system, NIPRO Diagnostics, 
Fort Lauderdale, FL, USA). For each animal, the tail was pricked at the tip using a sharp lancet, 
and a small drop of blood was collected on the test-strip of the glucose meter. Induction was 
considered successful after measuring 3 consecutive daily BG levels of >300 mg/dL. After 6-7 
days, TEG devices with or without DSO were implanted in diabetic rats as described above. After 
implantation BG measurements were continued daily to monitor graft function. 
Serum C-peptide 
Samples of blood were collected from the tail vein of animals with TEGs containing porcine 
islets during anesthesia prior to 19F-MRS oxygen measurements. Blood samples were processed 
for porcine C-peptide content by centrifuging (300 x gravity) blood in serum separator tubes 
containing 2 µl aprotinin (Sigma Aldrich, St. Louise, MO, USA) for 10 minutes. The separated 
serum was collected and porcine C-peptide levels were measured by ELISA (Mercodia, Uppsala, 
Sweden). 
Histopathology and Immunohistochemistry 
At the completion of each study, the TEG devices were explanted, and then fixed in a 10% 
buffered formalin solution for ≥24 hours, and then transferred to 70% ethanol for long-term 
storage. Sections from three separate locations in each TEG were embedded in paraffin, and 
stained for histopathology with hematoxylin and eosin, to assess the extent of fibrosis, 
vascularity, and foreign body reaction in the adhered tissue surrounding the TEG. An experienced 
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histopathologist scored each section in a blinded manner for each metric. The degree of 
vascularity was scored on a scale from 0-3; 3 = well vascularized; 2 = moderate vascularity; 1 = 
minimal vascularity; 0 = avascular. The foreign body reaction (FBR) and degree of fibrosis were 
scored in a similar way from 0-6: 6 = severe; 5 = moderate-severe; 4 = moderate; 3 = mild-
moderate; 2 = mild; 1 = minimal; 0 = none. 
Statistical Analysis 
Statistical comparisons were made between all groups with sufficient replicates, and average 
values are reported as the mean value with the standard error of the mean (SEM). Graphpad-
Prism software or SAS version 9.2 analysis package was used for statistical analysis. A one-way 
analysis of variance (ANOVA) is used for comparisons between multiple groups, and a Tukey’s 
post-test is used to compare individual groups. A two-way repeated measures ANOVA was used 
for comparing time-series data (BG, and oxygen measurements). The two-tailed Mann-Whitney 
rank sum test was used to compare groups of non-parametric data (histology scores). Differences 
were considered significant if p<0.05. 
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Results 
Oxygen measurements of TEGs with DSO in vitro 
Non-invasive oxygen measurements from TEGs in a bioreactor show significantly increased 
internal pO2 for implants with DSO. These results are presented in Chapter 7, but included here 
as well for comparing in the context of in vivo oxygen delivery. A continuous series of 19F-MRS 
oxygen measurements acquired from TEGs inside a bioreactor are presented in Figure 8.6, which 
is reproduced from Figure 7.11. The results demonstrate that optimal DSO was achieved with 
delivery of either 380 or 760 mmHg enriched oxygen gas, and implants equilibrated to a steady-
state internal pO2 in ≤20 minutes regardless of the pO2 of the delivered gas. The external pO2 of 
each TEG was controlled to simulate the hypoxic pO2 levels previously observed in vivo. The 
hypoxic external environment was verified by continuous fiber-optic probe measurements (34±6 
mmHg), and confirmed with 19F-MRS measurements when the internal pO2 of each TEG 
acclimated to the external pO2 within an hour after beginning perfusion. The average internal pO2 
of all TEGs reached 64±4% of the delivered pO2 regardless of the DSO concentration. TEG 
implants achieved average steady-state internal pO2 measurements of 207±22 mmHg and 469±40 
mmHg for DSO with pO2=380 mmHg and 760 mmHg respectively. After steady-state 
measurements, DSO was stopped to record the internal pO2 decay as the TEG returned to ambient 
external oxygen. Oxygen measurements were fit with a mono-exponential decay function 
yielding an average characteristic time-constant (τ) of 15±1 minutes. 
Oxygen measurements of TEGs with DSO in vivo. 
DSO was also very successful in vivo and highly elevated internal pO2 levels were measured one 
day after implantation in non-diabetic immunocompetent rats (shown graphically in Figure 7.13 
from Chapter 7). TEGs receiving 760 mmHg DSO without islets achieved an average internal 
pO2 = 556±19 mmHg (N=9) while implants containing 20,000 PIE achieved 370±49 mmHg 
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(N=4). When DSO was stopped for a sub-set (N=3) of implanted TEGs without islets, the internal 
pO2 decreased to an average of 22±2 mmHg which is not significantly different then the oxygen 
concentrations observed in TEGs without DSO. Measurements presented in Figure 8.7 from 
critical time-points during the 29-day study period show that the average internal pO2 inside 
implanted TEGs starts at a high level on the first day following implantation, and then decreases 
until 15 days after implantation when an apparent steady-state is reached. The internal pO2 of 
TEGs with porcine islets (N=6) were significantly lower (p<0.05) than control TEGs without 
islets (N=6) at every time-point investigated with an average overall difference of 186±23 mmHg. 
All TEGs with DSO had a significantly higher average internal pO2 than implants that did not 
receive DSO (p<0.05), and results from implants without DSO are reproduced here from Figure 
8.5 for direct comparison.  
Functional assessment of TEGs with DSO in diabetic rodents. 
A TEG with DSO demonstrated improved graft function when compared to TEGs without DSO. 
Results from BG measurements demonstrated that sustained diabetes reversal was achieved in an 
animal that received a TEG implant with DSO. Figure 8.8 shows that a subcutaneous implanted 
TEG with DSO effectively regulated BG levels in a diabetic rodent; which were significantly 
lower (p<0.05) than animals who received TEGs without DSO. BG levels were quickly 
normalized (≤200 mg/dL) and sustained for 30 days with DSO, while levels remained elevated 
(>300 mg/dL) when TEGs did not receive DSO. 
Serum C-peptide measurements 
Porcine C-peptide was detected in the serum of non-diabetic Lewis rats both 1 and 4 days 
following implantation of TEGs with DSO that contained 20,000 PIE. The average detected 
porcine C-peptide was 0.1±0.4 ng/ml on the first day after implantation, which increased to 
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0.4±0.08 ng/ml on the fourth day; however, there was no detectible porcine C-peptide (≤0.05 
ng/ml) in serum for any following time-points investigated. 
Histology and Immunohistochemistry 
Histology of TEGs explanted from non-diabetic Lewis rats used for 19F-MRS studies, showed 
minor differences in the surrounding adherent tissue of implants with and without DSO. Tissue 
surrounding TEGs with DSO had slightly lower levels of vascularity, and slightly higher levels of 
FBR than TEGs without DSO after 30 days in vivo, and these differences were significant 
(p<0.05). There were no significant differences in fibrosis of the surrounding tissue between 
groups, and there were no significant differences between implants with or without porcine islets.  
With or without DSO, the internal cell-compartments of TEGs containing porcine islets 
implanted in Lewis rats contained only scattered fragments of islet tissue after 30 days in vivo. 
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Figure 8.6: Measuring oxygen in bioreactor with DSO. Reproduction of figure Figure 7.11 Oxygen 
levels in a typical bioreactor with DSO at 300 mmHg and then 760 mmHg followed by observed pO2 decay 
without DSO. 
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Figure 8.7: Internal pO2 of TEGs with DSO. 
19F-MRS oxygen measurements within TEGs implanted for 
29 days with and without DSO. The measurements without DSO (inset) are much lower than arterial (red-
bar) or venous (blue-bar) pO2. 
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Figure 8.8: Blood glucose measurements of rats with TEGs (+/-) DSO. Blood glucose (BG) 
measurements from the rat implanted with a TEG containing 25,000±1000 porcine islet equivalents 
modified for DSO demonstrating diabetes reversal, and graft function for up to 30 days. In contrast, rats 
implanted with control TEGs (no DSO) never achieved diabetes reversal, and remained hyperglycemic for 
the duration of the study. 
  214 
Discussion 
Macro-encapsulation of an islet (or β-cell) graft for immune protection has been extensively 
investigated over the past two decades with limited success 39,186,189,225–228. Macro-encapsulation 
solutions to create a TEG as a possible “bio-artificial pancreas” offer the promise of reducing the 
need for potent and harmful immunosuppressive drugs, and provide a contained vessel to 
investigate the use of alternative β-cell sources such as porcine islets, or stem-cell-derived islets. 
However, the success of TEGs in small animals has not translated to large-animal systems due to 
the large doses of functional tissue needed for effective therapy. When small-animal approaches 
are scaled-up to accommodate the large tissue doses needed for treatment in large-animals, a very 
high islet density is needed to maintain a reasonably sized implant. With these high islet densities, 
oxygen limitations within the TEG create a stressful hypoxic environment that decreases overall 
graft viability, and limits proper islet function59,60,130,192,243–246,256,291. 
Recent efforts focused on improving graft oxygenation have demonstrated promising results by 
frequent injection of oxygen directly into the TEG device226,227,259–266. We are investigating a 
similar approach by developing an implantable system for continuous delivery of supplemental 
oxygen (DSO) to an immunoisolating TEG. The approach presented herein describes a novel 
proof-of-concept method for continuous DSO using an electrochemical oxygen generator to 
deliver oxygen-rich gas to a central compartment of a modified TheraCyte device. For these 
studies, we use non-invasive 19F-MRS methods to examine the changes in the average internal 
pO2 of TEGs receiving DSO in vitro and in vivo, and briefly investigated the therapeutic function 
of high-islet-density TEGs with DSO in diabetic nude rats. 
The first objective was to determine if the novel DSO methods could significantly increase the 
local oxygen concentration inside a modified TEG device in vitro. Figure 8.6 is reproduced from 
Figure 7.11 shows the representative oxygen measurements from a series of 5 studies, and they 
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clearly show that despite the surrounding hypoxic environment, DSO can achieve significantly 
elevated pO2 within a TEG device. A perfusion bioreactor was used to maintain physiologic 
temperature and to provide a controlled external environment that would simulate the hypoxic 
environment observed in earlier in vivo implant studies described in the previous section. The pO2 
and temperature of the perfusion medium inside the bioreactor was continuously monitored using 
MRS compatible temperature and oxygen sensors to ensure controlled conditions were 
maintained throughout the study. 19F-MRS methods previously developed in our lab 182 and 
described in Chapter 7 were used to measure the average pO2 within TEG devices non-
invasively during a series of changing internal and external oxygen conditions. The studies began 
by measuring the starting pO2 within the TEG before any controlled conditions were initiated. 
The observed average pO2 initially began at 123±19 mmHg, which was only slightly different 
from the ambient humidified atmospheric pO2 (152 mmHg). The deviation from the atmospheric 
level is explained primarily by the variability in starting temperature (36.7-42.8 °C), which was 
difficult to regulate before perfusion was started. When the perfusion circuit was started, 
deoxygenated culture medium was continuously circulated to maintain a constant hypoxic 
external condition (average measured pO2 = 34±6 mmHg) for the TEG inside the bioreactor. The 
internal pO2 of the TEG shown in Figure 8.6 was observed to acclimate to the surrounding 
perfusion medium within the first hour following initiation of perfusion, and an average steady 
state pO2 of 38±3 mmHg was observed prior to beginning DSO. 
DSO was tested at two different oxygen concentrations (50% or 380 mmHg, and 100% or 760 
mmHg), and the pO2 time-series of the delivered gas is also presented in Figure 8.6. The initial 
pO2 tested for DSO was 380 mmHg, and the measured internal pO2 of TEGs rose quickly to an 
average of 207±22 mmHg. The pO2 of DSO was then switched to 760 mmHg, and the internal 
pO2 again quickly rose up to an average of 469±40 mmHg. The kinetic and steady state oxygen 
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concentrations measured inside the TEG are governed by the basic equations of diffusion 
dominated mass transport, and the steady-state solution for this simple geometry is a linear pO2 
gradient within each segment of the TEG device. The perfusion bioreactor maintained a constant 
external pO2 and continuous DSO maintained a constant internal pO2, and therefore, the gradient 
within each cell-compartment is predicted to be linear between these two controlled conditions. 
For the purpose of this analysis, the gradients within the membranes themselves are considered 
negligible because the diffusional distances are very small compared to the thickness of the 
loaded cell compartment. Under this assumption, the average pO2 of this linear gradient across 
the thickness of the cell-compartment is simply the average value between the internal and 
external pO2 for this case. The predicted internal pO2 of in vitro TEGs would be 207 and 396 
mmHg for DSO with 50% and 100% oxygen respectively. The 19F-MRS technique measures the 
average “bulk” oxygen concentration of the PFCE-loaded fibrin-matrix that is contained inside 
the cell compartments of the TEG device modified for DSO. The measured results agree strongly 
with the expected values, but the measured oxygen with DSO of 760 mmHg was 76 mmHg 
higher than the expected value. This difference is likely due to the thicker external membrane on 
the outside of the device causing an increased diffusional barrier resulting in higher internal 
oxygen concentrations within the device. This difference is more apparent with steeper oxygen 
gradients during DSO with 760 mmHg. These results confirmed that continuous DSO could 
successfully increase the internal pO2 of TEG devices despite a hypoxic external environment, 
and that the immunoisolation membranes do not present a significant diffusional barrier to 
oxygen delivery from within the device. The internal pO2 can also be controlled and adjusted to 
optimal levels by manipulating the oxygen concentration of the DSO gas. The success of these 
initial in vitro tests encouraged further testing and development of the continuous DSO system in 
vivo. 
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The DSO system was further examined with a series of implant studies to investigate the 
oxygenation of control TEGs without islets, and functional TEGs with high densities of porcine 
islets. The average internal pO2 of TEG devices implanted in non-diabetic Lewis rats was 
measured at critical time-points for a 29 day period to observe the efficiency of oxygenation with 
DSO, and to track any changes during the healing and remodeling processes. Figure 7.13 from 
Chapter 7 from the previous section shows the average internal pO2 of implanted control TEG 
devices the day after implantation with and without DSO. The oxygen measurements of implants 
without DSO from previous studies are included with permission in the figure to provide context 
for the average ambient oxygen concentrations within TEGs without DSO. TEGs with DSO 
achieved significantly elevated pO2 levels compared to implants without DSO after one day in 
vivo, and TEGs with DSO containing porcine islets had significantly lower pO2 levels than 
control implants without porcine islets. The TEGs containing porcine islets were expected to have 
a lower oxygen concentration when compared to controls because the presence of highly-
metabolic islets will consume oxygen in the cell compartment resulting in a lower average 
concentration. DSO was stopped for at least 24 hours for a small group of animals implanted with 
control TEGs (N=3), and the measured internal pO2 levels returned to hypoxic levels that were 
not significantly different than implants without DSO. The observed return to hypoxic pO2 levels 
suggest that continuous DSO may be needed to sustain sufficient oxygenation. 
The internal pO2 levels of implanted TEGs with DSO were measured at various time points for up 
to 29 days. The time-course of oxygen levels for control and porcine islet loaded TEGs with DSO 
are presented in Figure 8.7 along with measurements from control TEGs without DSO 
reproduced with permission from previous section. The internal pO2 for both control and porcine 
islet loaded TEGs began at highly elevated levels one day after implantation, and then gradually 
decreased to an apparent steady-state internal pO2 over the next 29 days. It is clear that 
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continuous DSO can achieve significantly elevated oxygen levels for up to 29 days in vivo for 
both control and porcine islet loaded TEGs. The lowest average oxygen level observed for TEGs 
with DSO was 124±35 mmHg after 29 days in vivo, which is higher than the minimum reported 
value of 60 mmHg needed to maintain islet viability and function without a necrotic core 157. 
TEGs loaded with porcine islets had significantly lower internal pO2 levels than control TEGs, 
and these implants had higher variability in the measured internal oxygenation as well (indicated 
by the larger error-bars for mean values). Porcine islet tissue consumes oxygen within the cell 
compartments of loaded TEGs and results in lower average internal pO2 levels. The islet loading 
procedure and differences between individual islet preparations likely result in the increase 
variability of pO2 levels observed in these implants. Non-invasive oxygen measurements using 
19F-MRS may provide a means for individual graft assessment. In a future clinical setting, these 
measurements could be used to specifically optimize the DSO system for each individual TEG to 
ensure adequate oxygenation despite intrinsic graft variability. 
It is also apparent that the measured pO2 levels in control TEGs after one day in vivo were much 
higher than the expected values predicted and observed during in vitro studies, with 556±18 
mmHg observed compared to the expected 396 mmHg. Control TEGs without islets in vivo were 
expected to have a similar average internal pO2 as the TEGs tested in the bioreactor because the 
steady-state oxygen concentration is still determined by the same diffusion-dominated transport. 
This observed difference on the first day following surgery is likely due to transiently increased 
external pO2 following implantation of the TEG. The external pO2 in the bioreactor was 
controlled at a constant hypoxic level by continuously circulating deoxygenated perfusion 
medium around the implant. By controlling the external pO2 within the bioreactor, the oxygen 
gradient within the TEG was able to quickly reach a steady state with a predictable average pO2. 
The controlled environment within the bioreactor is not reflective of the highly variable and 
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changing environment surrounding the TEG during the healing and remodeling process following 
surgical implantation. Immediately following implantation, the TEG would be surrounded by 
surgical fluid, and the surrounding tissue would be kept at a distance until the fluid is absorbed. 
This condition increases the diffusional distance, so that the pO2 gradient extends from the 
highest level at the inside of the TEG until it reaches the lowest point in the surrounding tissue. 
Extending the gradient across a greater distance would result in a smaller gradient within the 
TEG, and a higher average pO2 within the cell compartment. This increased diffusional distance 
could explain the higher oxygen levels on the first day following implantation of the TEG. As the 
healing process begins at the implant site and the surrounding tissues starts to remodel and grow 
closer to the implant surface. The gradient distances gets shorter, and the gradient gets steeper 
resulting in a lower average pO2 within the cell compartment until the tissue has adhered very 
closely to the surface of the TEG. As the tissue grows closer to the TEG, and vasculature begins 
to form on the surface of the vascularizing membrane, the system approaches an equilibrium 
condition that is similar to the bioreactor case where the external pO2 remains constant. The 
observed changes in pO2 are consistent with the progression and timing of the healing 
process189,267–269,292. 
The average pO2 within the cell compartments of control TEGs with DSO approached an 
apparent steady-state of 288±31 mmHg during the 29 day period studied. Interestingly, this value 
is much lower than the expected value for DSO with 100% oxygen (396 mmHg). The EOG 
system generates 100% oxygen (760 mmHg), but oxygen was lost within the manifold, tubing, 
and tether system so that the pO2 of the gas entering the device was measured at 652±8 mmHg. 
Even if this lower DSO pO2 is taken into account, the expected steady state pO2 would be 342 
mmHg, which is still 54 mmHg higher than the observed value. For all of the previous estimates 
of average internal pO2, the oxygen gradients within the immunoisolation membranes themselves 
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were ignored because the permeability of the membranes is relatively high 188,190,253,293, and the 
membranes are much thinner than the material within the cell compartments. The permeability of 
the immunoisolation membranes within the TEG have been shown to change over-time in vivo 
188,190,293, and this may have significant effects on the transport of oxygen within the device itself. 
It is also observed that the internal pO2 levels of TEGs that contain porcine islets are on average 
186±23 mmHg lower than the levels observed in control TEGs at every time-point studied. A 
significant difference between conditions is expected due to the oxygen consumption of the islets 
within the cell compartments of the devices, but more complex models that consider the diffusion 
and reaction effects are required to estimate the magnitude of this difference. This estimation is 
also made increasingly complex when considering the progression of immunological responses 
and potential proliferation or degeneration of cells within the device. Many others have examined 
such models by employing finite-element techniques and then investigating a series of assumed 
conditions to help determine the functional and practical limits of tissue engineered systems 
157,248–251,294. Complex analyses of these models, and consideration of material and physiological 
kinetics are beyond the scope of the discussion here, but acknowledgement of these complex 
interactions highlight the importance and value of direct oxygen measurements. Direct 
experimental observations of TEG oxygenation by 19F-MRS can provide valuable information for 
refining predictive models, improving TEG design, and optimizing DSO specifications. 
Furthermore, with continued development, these techniques may offer a non-invasive method for 
periodic observation for individual clinically implanted therapeutic TEG devices. 
TEG devices with DSO used for 19F-MRS oxygen studies were explanted at the end of the study 
period (29 days), and processed for histology to examine the adherent tissue surrounding the 
devices. Furthermore, a small set of TEGs were implanted in diabetic nude rats to examine the 
functional effects of DSO on the encapsulated islet grafts. Only minor differences were observed 
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in the tissue surrounding the explanted devices from Lewis rats. The adherent tissue surrounding 
all of TEGs studied were moderately well vascularized after 29 days but TEGs with DSO had 
slightly less vascularization than previously studied TEGs without DSO. Slightly higher levels of 
foreign body reaction were also observed in the tissue surrounding TEGs with DSO, but only 
mild-moderate levels were present in any of the explanted devices. There were no differences 
observed between control TEGs and TEGs that contained porcine islets, and all TEGs exhibited 
only mild-moderate levels of fibrosis. Despite the positive histopathology of the tissue 
surrounding the explanted TEG devices, assessment of the internal cell compartments showed 
that only scattered fragments of islet tissue remained after 29 days in Lewis rats. Previous reports 
concluded that the Theracyte device alone was unable to protect a xenogeneic graft against 
rejection 269, and the histology, and porcine C-peptide results reported herein agree with these 
earlier findings. Increasing the average internal pO2 by incorporating a system for DSO 
successfully alleviated the hypoxic condition within the TEG as confirmed by 19F-MRS 
measurements, but this did not appear to improve the immunoprotective capability of the 
encapsulation system. Measurements of porcine C-peptide in serum samples from these rats 
suggest that grafts were no longer functional after 4 days, and this is typical of the rejection 
observed in previous xenogeneic islet transplant studies 269. Histology also confirmed that very 
few islets remained within the cell compartment despite DSO; however, there were some 
surviving islets. These findings present a notable difference compared to TEGs without DSO 
from previous studies that had no detectible islet tissue remaining after 29 days. 
The 19F-MRS measurements suggest that DSO improves oxygenation within TEG devices in vivo, 
but xenogeneic grafts were not functional for more than 4 days in immunocompetent Lewis rats. 
The results from these studies in non-diabetic Lewis rats prompted preliminary investigations 
with a small set of diabetic nude rats, to eliminate the effects of xenogeneic rejection and test the 
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functional capacity of TEGs with DSO. For these early feasibility studies, 5 diabetic Lewis rats 
were implanted with TEG devices and one were modified for DSO. The TEGs were loaded with 
25,000 ± 1000 porcine IE, and graft function was evaluated by testing BG levels for up to 30 
days. The TEGs were also explanted after 30 days and examined by immunohistochemistry to 
evaluate the contents of the cell compartments. The BG measurements presented in Figure 8.8 
show that a TEG with DSO was able to reverse diabetes and achieve glucose control for up to 30 
days while TEGs without DSO were not. The TEG with DSO was successfully able to regulate 
BG levels for up to 30 days. 19F-MRS measurements showed that the internal compartments of 
implanted TEG devices returned to hypoxic conditions within one day after stopping DSO, and 
prolonged hypoxia (>24 hours) has been shown to inhibit islet graft function, and cause 
irreversible damage to isolated islets 59,60,130,192,243–246,256,291. These findings are consistent with the 
observations in diabetic nude rats that demonstrate prolonged graft survival with DSO, and 
subsequent graft failure when DSO was discontinued. More studies are needed to study the 
functional effects of DSO in allogeneic islet transplant models, but observations from this 
preliminary investigation with diabetic nude animals suggest that continuous DSO may alleviate 
hypoxic stresses and enable long-term survival of encapsulated islet grafts loaded with a 
therapeutic dose of islets.  
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Conclusions 
In summary, continuous DSO can improve oxygenation of macro-encapsulated islet TEGs to 
promote long-term graft survival in vivo, and this approach could be used to create a functional 
and feasible BAP device for the treatment of diabetes. Non-invasive oxygen measurements using 
19F-MRS confirm that continuous DSO can regulate and increase internal oxygen concentrations 
within implanted TEG devices, and this enables immunoisolation of therapeutic doses of islets 
within a practically-sized macro-encapsulation device. Although studies in Lewis rats confirmed 
that this model could not sufficiently prevent xenograft rejection, a feasibility study in diabetic 
nude rats demonstrated that continuous DSO might enable long-term survival of TEG devices 
loaded with therapeutically relevant doses of islets. It is clear that 19F-MRS is a valuable tool for 
the continued development, and potentially for non-invasive monitoring and real-time 
optimization of implanted tissue engineered devices. These promising results suggest that this 
approach for non-invasive monitoring, and continuous DSO to an encapsulation device is a 
critical first step toward the development of a functional BAP for the treatment of diabetes. 
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 CONCLUSIONS AND FUTURE DIRECTIONS Chapter 9
 
Islet transplantation offers real promise as a cure for type 1 diabetes, and further development 
defining alternative β-cell sources, improving islet isolation processing, and overcoming immune 
barriers will expand access to this therapy in the future. The work presented herein describes 
developments for monitoring and improving the quality of organs, tissues and cells. 
Development of assessment technologies and techniques for improving organ procurement 
and preservation. 
The first section includes three chapters describing unique approaches for evaluating the quality 
of organs, improving the organ procurement process, and improving the preservation or organs 
following procurement. First, in Chapter 2, a novel quantitative method using whole organ 
oxygen consumption rate (WOOCR) measurements was presented for organ quality assessment, 
which could provide a reliable method for qualifying organs prior to transplantation, and could be 
applied to expand the availability of marginal organs for solid organ transplantation or islet 
isolation. This technique could also be used as a research tool for evaluating organ preservation 
methods, and guide improvements in this field. This technique was shown to reliably quantify the 
viability of porcine kidneys and pancreata during hypothermic machine perfusion, and minor 
adaptations could extend the application to other organs such as heart, liver, or lungs. This 
technique also holds promise for incorporation with comprehensive clinical organ preservation 
systems (such as clinical HMP devices) for the in-line and real time viability assessment of 
organs for transplantation10,11. In Chapter 3, a study examining techniques for improving organ 
cooling during the procurement procedure is presented. These studies aimed to improve the 
procurement of pancreata from porcine donors as an alternative source of islets for possible 
xenogeneic transplantation. A related study of the anatomic variability of porcine pancreata is 
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included in Appendix A, and in Chapter 3 the anatomic information was used to evaluate 
various techniques to ensure optimal pancreas cooling during procurement from a porcine 
donation after cardiac death model. A combined cooling approach was devised that used surface 
cooling in conjunction with arterial flushing and a ductal infusion to minimize warm ischemia 
time and improve blood clearance. These methods could be used to improve the quality of organs 
procured from porcine or human donors specifically in the case of donation after cardiac death. 
Next in Chapter 4, hypothermic machine perfusion (HMP) was shown to improve organ quality 
and extend preservation time when compared to cold storage techniques. HMP was studied by 
paired comparison against static cold storage in a model for extended preservation time using 
split-lobe porcine pancreata. HMP was shown to improve the viability and quality of isolated 
porcine islets when pancreatic lobes were preserved for 24 hours. A related study included in 
Appendix B describes a novel method for gaseous oxygen perfusion (persufflation, PSF) PSF for 
extending preservation of both human and porcine pancreata. This technique was shown to 
improve pancreatic ATP levels271, as well as improve isolated islet viability, histology, and 
morphology when compared to static cold storage methods270. These advanced preservation 
techniques could be applied to extend preservation time of pancreata procured for islet isolation, 
and may improve the quality of islets isolated from preserved pancreata. The developed PSF 
technique is currently being investigated for this purpose in a clinical setting in our lab. 
Development of assessment technologies and techniques for improving islet isolation, 
culture and shipment 
The second section focuses on technologies for improving islet and cell culture process. The islet 
isolation process has many steps and each step offers an opportunity for improvement. Chapter 5 
describes the use of HMP and advanced silicon rubber membrane (SRM) devices for improving 
the isolation and culture of juvenile porcine islets. Juvenile porcine islets offer many logistical 
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benefits compared to adult porcine islets, but isolation and culture of these fragile islets has 
historically proven challenging. By utilizing advanced organ preservation techniques, HMP, and 
an advanced culture system with SRM have shown to improve isolation outcomes, and islet 
recovery in culture. With further development, this approach could provide a reliable source of 
islets from juvenile porcine donors, and may offer a valuable option for an alternative islet source 
needed for the eventual success of xenotransplantation. Chapter 6 presented advanced culture 
techniques for improving the reliable expansion of pancreatic β-cells. This method uses 
continuous nutrient regulation scheme with stirred suspension bioreactors that can successfully 
regulate glucose levels during the culture of renewable β-cells. These methods were shown to 
significantly improve cell-yield during culture, and could be adapted for the expansion of 
renewable β-cell lines or stem cell derived islets for therapeutic applications. 
Enzyme delivery or pancreas “distension” is the first step of the isolation protocol, and in 
Appendix C, supplementary investigations for improving enzyme distribution by evaluating 
infusion techniques using contrast-enhanced magnetic resonance imaging (MRI) are presented. 
The ductal anatomy of porcine pancreata presented in Appendix A suggested the possibility for 
improving the distension process, and MRI was used to evaluate three different techniques 
enzyme administration in porcine pancreata. MRI imaging of these three techniques confirmed 
that the standard approach for enzyme delivery is incapable of delivering enzyme consistently 
and uniformly to all pancreatic regions given the large variability in porcine ductal anatomy. 
These methods could be used to make further improvements in the distension step of the isolation 
process, and could help identify a more robust method for uniform enzyme delivery in porcine 
pancreata.  
The next steps in the islet isolation protocol are digestion and purification. To supplement this 
work, Appendix E describes a method for combining these steps by using eliminating the density 
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gradient purification step in favor of using a quadrupole magnetic separation (QMS) method for 
continuous purification of digested pancreatic tissue. This method employs the use of iron oxide 
particles295 and a specially developed magnetic separator to continuously-separate isolated islets 
during the collection phase of digestion. This method decreases isolated islet exposure to the 
toxic environment following digestion, and decreases the overall duration of the isolation 
procedure. Porcine islets separated by QMS had significantly improved morphology and viability 
when compared to islets purified using standard techniques. QMS offers the possibility of 
improving the quality of isolated porcine islets, and could be adapted for use during human islet 
isolation to improve islet viability. Improving islet viability may decrease the amount of islets 
needed to reverse diabetes, and could possibly improve the graft success rates for autogeneic and 
single-donor allogeneic islet transplantation. 
Islet isolation is an incredibly complex procedure, and only a limited number of centers have had 
success using this technique. The proposed model for this therapy would utilize a select number 
of islet isolation centers that distribute islets to numerous treatment centers for transplantation. 
This model requires validated methods for islet shipment, and verification of islet quality 
following shipment. Supplemental studies included in Appendix D describe the development of 
improved shipping techniques for maintaining temperature and pressure during islet shipment. 
This method was shown to allow for sufficient temperature and pressure regulation during 
shipments up to 24 hours under harsh environmental conditions. Using these techniques, isolated 
islets could be reliably shipped overnight anywhere within the US without the risk of exposure to 
harmful temperature or pressure fluctuations.  
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Development of assessment technologies and techniques for improving tissue-engineered 
islet grafts post-transplant 
The final section focuses on the development of a technique for non-invasive monitoring of tissue 
engineered islet grafts, and application of that technique to evaluate and improve oxygen delivery 
to implanted grafts. In Chapter 7, 19F magnetic resonance spectroscopy techniques were adapted 
for non-invasive measuring the internal oxygen concentration of implantable tissue engineered 
grafts (TEGs). This non-invasive method for graft assessment was developed for the purpose of 
investigating and optimizing alternate implant sites, as well as defining and optimizing implant 
parameters. The developed protocols were validated against established fiber optic oxygen probes 
in vitro using a temperature and oxygen regulating bioreactor, and in vivo by measuring oxygen 
of implanted TEGs in rats. 19F-MRS offers many benefits compared to traditional probes for 
measuring oxygen in vivo, and could be a valuable research tool for evaluating the oxygenation 
status of various designs of TEGs. This non-invasive approach could also be adapted for 
simultaneous use with other MRI techniques or for use with portable magnetic resonance 
equipment, which could provide a real-time assessment technique for clinical implanted TEGs. 
Chapter 8 is the final chapter that presents original scientific research and describes the 
application of 19F-MRS techniques to determine the oxygen levels of implanted TEGs containing 
porcine islets. These techniques were further used to evaluate a bioartificial pancreas system that 
uses delivery of supplemental oxygen for improving oxygenation in vivo. Oxygen levels were 
confirmed to be severely hypoxic within implanted TEGs, and inclusion of porcine islets proved 
to decrease internal pO2 further. DSO was able to increase the internal pO2 of therapeutic TEGs 
containing a high-density of porcine islets for up to 29 days in vivo. These techniques could be 
used to optimize the design of TEG devices and improve graft survival in vivo. Further 
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developments result in a clinically relevant tool for this a non-invasive monitoring of functional 
implanted TEG devices for the treatment of diabetes. 
In conclusion, the studies presented herein describe the development of novel techniques for 
evaluating and improving the oxygenation of organs, tissues, and cells for improving the 
treatment of diabetes with β-cell replacement therapies. Continued development of these 
described methods could contribute to the advancement of islet transplantation technologies 
including the development of a functional TEG device. Furthermore, these innovations will be 
valuable to improving treatment of diabetes and expanding access to β-cell replacement therapies. 
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Pig Pancreas Anatomy: Procurement, Preservation, and Islet 
Isolation  
Summary 
To investigate the anatomy, pancreata were removed by en bloc viscerectomy from 65 female 
Landrace pigs. The results from anatomical studies showed that 15% of organs exhibited 
inconsistent vascular branching from the celiac trunk. All organs had uniform patterns of 
branching at the superior mesenteric artery. The superior and inferior mesenteric veins (IMV) 
merged to become the portal vein in all but one case in which the IMV drained into the splenic 
vein. 97% of pancreata had three lobes: duodenal (DL), connecting (CL), and splenic (SL); 39% 
demonstrated ductal communication between the CL and the other two lobes; 50% had ductal 
communication only between the CL and DL; and 11% presented other types of ductal 
delineation. Accounting for the variations in vascular and ductal anatomy, as detailed in this 
study, will facilitate development of protocols for preservation, optimal enzyme administration, 
and pancreas distention and digestion, and ultimately lead to substantial improvements in 
isolation outcomes. 
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Introduction  
Islet transplantation (ITx) is a promising treatment option for selected patients with type 1 
diabetes296,297. Increasing evidence demonstrates the ability of human islet allografts to 
consistently restore normoglycemia and insulin independence in immunosuppressed recipients 
without the procedural risks associated with vascularized pancreas transplantation9,53,202,298–301. 
Technical and immunological challenges, however, remain prior to larger scale, cost-effective 
application of ITx. Technical challenges relate to the limited human islet supply from cadavers 
and to the low islet yield and quality associated with donor brain death and long cold-ischemia 
times during organ procurement, storage, and transportation302–305. 
The use of islets isolated from pig pancreata, a source with an unlimited supply238, will have a 
marked impact as it will enable the application of ITx to a larger segment of the population in 
need. The recent achievement of long-term diabetes reversal after porcine islet 
xenotransplantation in non-human primates (NHP) demonstrated the potential of islet 
xenotransplantation in humans33,34.  
In addition to addressing safety concerns, clinical use of porcine islets will also require the 
development and implementation of protocols that maximize the viable islet yield per donor pig 
pancreas54,306. Consistent isolation of large numbers of high-quality islets from porcine donors is 
dependent on advances in organ procurement, organ preservation, and islet isolation, all of which 
will benefit from detailed knowledge of the porcine pancreatic anatomy307–309. Even though 
studies of porcine pancreatic anatomy have been previously published310, the detailed information 
needed for optimizing pancreas preservation and ductal perfusion is unavailable. Since variations 
in porcine anatomy have been reported as limiting in these studies311,312, it is important to 
establish an understanding of the extent and implications of such anatomical variations of the pig 
pancreas in the context of pancreas procurement, pancreas preservation, and islet isolation.  
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The first goal of this investigation was to gain a detailed understanding of the porcine pancreas 
vascular anatomy to facilitate the development and implementation of improved procurement and 
perfusion-based preservation techniques. The second goal was to develop a better understanding 
of the ductal branching structure and gain critical knowledge to facilitate the development of 
improved techniques for ductal enzyme loading for optimal pancreas distention prior to islet 
isolation.  
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Materials and Methods 
A total of 65 female Landrace non-heart beating donor pigs were pancreatectomized in order to 
study the vascular and ductal anatomy of the pancreas. The age of the animals was between 6 and 
24 months. The mean weight was 452 ± 99 lbs, with a range between 248 and 680 lbs. All 
experiments were conducted according to the rules and regulations of the Institutional Animal 
Care and Use Committee of the University of Minnesota. Animals were heparinized, sacrificed 
by sodium pentobarbital overdose, and then, following the cessation of heart rhythm completely 
bled out and eviscerated. All of the internal organs were placed onto a procurement table. The 
pancreas was then removed by en bloc viscerectomy to study the pancreatic lobes and general 
anatomy. The vasculature was studied in situ by dissecting and identifying all the vessels that 
supply the pancreas, allowing for the investigation of perfusion-based preservation techniques. 
The pancreatic vascular supply and ductal drainage systems were studied following organ 
procurement by the infusion of colored 0.9% NaCl saline (Figure A.1).  
Surgical procedure  
1. Once all the internal organs were out of the pig abdominal cavity, the greater omentum 
was incised.  
2. The peritoneum that covers the surface of the viscera was opened and the tail of the 
pancreas (distal splenic lobe (SL)) was dissected from its posterior attachments starting 
laterally adjacent to the spleen. The upper and lower margins of the pancreatic tail were 
freed of their mesenteric attachments. The tail of the pancreas was isolated and the spleen 
was then mobilized.  
3. The distal splenic artery and vein were divided to the left of the pancreas.  
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4. With the splenic artery as a landmark, the celiac trunk (CT) was located and dissected to 
completely expose the upper part of the abdominal aorta.  
5. The tail and distal portions of the body (proximal SL) of the pancreas were mobilized to 
the junction of the splenic vein, superior mesenteric vein (SMV), and portal vein (PV).  
6. The posterior attachments of the pancreas and all tissues between the splenic artery and 
the junction of the splenic vein and PV were divided.  
7. The dissection between the left adrenal gland and the pancreas was later determined to 
provide more rapid access to the CT, the superior mesenteric artery (SMA), and the aorta, 
which was isolated by sectioning of the fibromuscular extensions of the diaphragmatic 
crura and the abdominal lymphatic duct.  
8. Dissection continued along the superior margin of the pancreas. The left gastric artery 
(LGA) was divided at its origin from the splenic artery. The body of the pancreas wraps 
the PV with a large anterior and thin posterior ring, termed the “portal ring”.  
9. After dissecting the hepatoduodenal ligament, the common bile duct (which enters 
proximally into the duodenum on the major duodenal papilla, about 2–5 cm from the 
pylorus) was cut off at its entrance into the duodenum, and the proper hepatic and 
gastroduodenal arteries were ligated.  
10. The body of the pancreas and the connecting lobe (CL) were dissected free from the PV 
by ligating the vascular branches between them.  
11. The head of the pancreas (duodenal lobe (DL)) was then dissected and mobilized to the 
right of the aorta. The head of the pancreas is in a C-shape with respect to the duodenum 
and is attached to the second, third, and fourth parts of the duodenum. The duodenum 
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was pulled up and the pancreas was dissected free from the right portion of the PV and 
the infrahepatic vena cava.  
12. The pancreas was then carefully separated from the pancreaticoduodenal vascular arcade 
so that the pancreatic branches of this vessel could be individually ligated.  
13. The main pancreatic duct opens about 20 cm distally into the second (descending) portion 
of the duodenum. The peritoneum on the right side and behind the lower part of the 
duodenum was subsequently incised and the transverse colonic ligament was sharply 
dissected to expose the SMA and the SMV.  
14. The right part of the CT, the SMA, and the aorta were then isolated.  
15. The inferior pancreatic artery was also ligated, after the dissection of the SMA in the root 
of the aorta, about 2 cm caudal to the CT.  
16. The pancreas was excised by dissection and individual ligation and division of the small 
vessels from the SMA to the pancreas.  
17. The portal ring around the PV was dissected free from the surrounding structures.  
18. The proximal and distal duodenum were ligated and transected.  
19. The inferior and anterior aspect of the gland is attached to the mesocolon, which had to 
be transected to remove the organ completelyin finishing the total pancreatectomy.  
20. The pancreas was ready to be removed after sectioning of the portal ring and after 
transection of the vasculature. 
Pancreatic lobes  
The pancreas is composed of three lobes featuring a nodular surface with irregular margins 
(Figure A.1 and Figure A.2). The “splenic” lobe (corresponding to the tail and body in the 
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human pancreas) is situated posteriorly and is attached to the spleen and the stomach. The 
“duodenal” lobe (corresponding to the head of the pancreas) is located adjacent to the duodenum 
while the “connecting” lobe (corresponding to the uncinate process) is an extension of the 
pancreas which is attached to the anterior aspect of the portal vein. There is a “bridge” of 
pancreatic tissue serving as an anatomical connection between the splenic and connecting lobes.  
Arterial anatomy  
The abdominal aorta is retroperitoneal. The viscera had to be moved aside and the parietal 
peritoneum had to be removed to locate the aorta. The aorta was immediately dissected from the 
rest of the tissue. The CT was the first branch off the abdominal aorta infra-diaphragmatically and 
branched into the splenic artery, the LGA, and the common hepatic artery, as is common in the 
human (Figure A.3a). These arteries were immediately identified and transected distally to the 
pancreas. The splenic artery was the first branch identified, dissected, and tied. The posterior or 
dorsal pancreatic artery (PPA) is a small pancreatic branch originating from the splenic or hepatic 
artery and was next identified along the upper border of the pancreas. In some cases the PPA can 
have its origin more proximal off of the splenic artery, but distal to the celiac trifurcation. In some 
animals, more than one PPA were identified with large variability in size. The other two main 
branches from the CT were then identified. The first was the LGA, which runs parallel to the left 
gastric vein to supply the stomach, and the other was the common hepatic artery which supplies 
the liver with arterial blood. The proper hepatic artery and common bile duct were ligated and 
divided. The gastroduodenal artery arises from the hepatic artery before its bifurcation into the 
right and left hepatic artery. The pyloric region of the gastroduodenal artery exhibits two 
branches that supply the duodenal lobe of the pancreas: (1) the superior pancreaticoduodenal 
artery and (2) the right gastroepiploic (or gastroomental) artery. The superior 
pancreaticoduodenal artery supplies the descending duodenum in addition to the DL. This artery 
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anastomoses with the inferior pancreaticoduodenal artery that originates from the SMA. The 
pancreaticoduodenal vascular arcade runs between the pancreas and the duodenum, and also 
extends branches to both organs.  
Caudal to the CT was the SMA and the renal arteries (found by following the abdominal aorta to 
the level of the kidneys). The SMA and the SMV were isolated at the lower edge of the pancreas 
on the left side of the PV. The SMA gives branches (jejunal arteries, right colic artery, middle 
colic artery, and ileocolic artery) that supply the distal part of the descending duodenum to the 
proximal part of the ascending colon. The CL, the bridge, and the inferior aspect of the SL are 
vascularized by an arterial branch, the inferior pancreatic artery, which emerges from the inferior 
pancreaticoduodenal arterial arcade (Figure A.3b).  
In order to study which lobes are supplied by which main arteries, the aorta was cut open 
longitudinally and then the CT and the SMA were cannulated separately. Then, colored saline 
was infused through them to highlight (by introducing visible contrast) the distribution of the 
arterial blood supply. Once the infusion was completed, the vascular anatomy was mapped by 
recording the regions supplied by the CT and SMA, respectively, and by dissecting to determine 
the borders of these regions. The differently-colored saline infusions were surprisingly visible, 
even to the naked eye. The normal pig pancreatic anatomy along with the major variants are 
presented in Figure A.4a and Figure A.4b respectively.  
Venous blood outflow (drainage)  
The PV collects the blood from stomach, pancreas, intestine, and spleen. The PV, on its way from 
the root of the mesentery to the liver, penetrates the pancreas at an acute angle so that it lies 
caudally on the ventral surface and rostrally on the dorsal surface of the pancreas. The PV has 
two branches which drain into it, the splenic vein and the SMV. The splenic vein drains the body 
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and tail of the pancreas and it is partly surrounded by pancreatic tissue. Veins draining blood 
from the stomach (left gastric vein, left gastroepiploic vein) also come out into the splenic vein.  
The SMV passes through the portal ring receiving the inferior pancreaticoduodenal vein. The 
inferior mesenteric vein (IMV) usually flows into the SMV, which would be considered an 
unusual variation in the human anatomy. Small branches drain the CL into the SMV. The 
gastroduodenal vein empties into the SMV immediately before its junction with the splenic vein. 
The gastroduodenal vein receives small veins from the DL. Peripherally, the gastroduodenal vein 
receives the superior pancreaticoduodenal vein which anastomoses with the inferior 
pancreaticoduodenal vein.  
Pancreatic duct  
Following dissection, the pancreas was removed from the viscera utilizing an en bloc style 
procurement technique and placed onto a cooled dissection tray for trimming. The next step was 
the cannulation of the pancreatic papilla. In some cases, the pancreatic duct was cannulated in situ 
during the dissection of the viscera. Ductal anatomy was investigated by infusing colored saline 
into the main pancreatic duct (Figure A.1) while clamping access to the CL (position 1 in Figure 
A.2) and tracing the color change. Next, the CL was infused with a differently colored saline 
solution while access to the DL was clamped off (position 2 in Figure A.2). The pancreas was 
then further dissected to determine the extent of ductal communication between the lobes. A 
classification scheme for the different types of pancreatic ductal networks was designed by 
observing the ductal anatomy (Figure A.5).  
Statistical Analysis 
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We performed a descriptive analysis of the number of cases reporting median and extreme, 
average, and standard deviation (SD). For statistical analyses, we used the Statistical Package for 
Social Sciences program (SPSS Inc, Chicago, USA).  
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Figure A.1: The Lobes of a porcine pancreas. The divisions between the lobes were determined by 
flushing the arterial system with preservation solution that contained a food-grade dye. Different colors 
were used for different arteries. For this pancreas, the celiac trunk was flushed with red dye, and the 
superior mesenteric artery was flushed with blue dye. 
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Figure A.2: Porcine Pancreas bridge communication. Photograph of an excised pig pancreas exhibiting 
normal anatomy with the duodenal, splenic, and connecting lobes, as well as the bridge. Ductal connections 
were obstructed with a clap to determine if there was ductal communication through the “bridge” portion 
between the splenic lobe and the connecting lobe.  Position 1: Dotted lines indicate the positioning of the 
clamp restricting flow to the connecting lobe. Position 2: Dotted lines indicate the positioning of the clamp 
restricting flow to the duodenal lobe. 
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Figure A.3: Pig pancreas arterial anatomy. (A) Celiac trunk and the main branches (splenic artery, 
hepatic artery, and left gastric artery). (B) Arterial system (superior mesenteric artery with distal branches). 
The branch of SMA to pancreas (inferior pancreaticoduodenal artery) is distributed mainly in the 
connecting lobe. SMA, superior mesenteric artery; IPDA,; MCA, middle colic artery. 
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Figure A.4: Porcine pancreas variational vascular anatomy. Diagram of (A) normal vascular pancreatic 
anatomy and (B) the major variants of vascular pancreatic anatomy.  
(A) GDA: Gastroduodenal artery; HA: Hepatic artery; IMV: Inferior mesenteric vein; IPDA: Inferior 
pancreaticoduodenal artery; LGA: Left gastric artery; PDVA: Pancreaticoduodenal vascular arcade; PPA: 
Posterior pancreatic artery; SA: Splenic artery; SMA: Superior mesenteric artery; SMV: Superior 
mesenteric vein; SPDA: Superior pancreaticoduodenal artery; SV: Splenic vein. (B) (a) Posterior pancreatic 
artery from the hepatic artery; (b) Posterior pancreatic artery from the celiac trunk; (c) Posterior pancreatic 
artery from the proximal splenic artery; (d) Posterior pancreatic artery from the distal splenic artery. GDA: 
Gastroduodenal artery; HA: Hepatic artery; IMV: Inferior mesenteric vein; IPDA: Inferior 
pancreaticoduodenal artery; LGA: Left gastric artery; PDVA: Pancreaticoduodenal vascular arcade; SA: 
Splenic artery; SMA: Superior mesenteric artery; SMV: Superior mesenteric vein; SPDA: Superior 
pancreaticoduodenal artery; SV: Splenic vein. VARIANT 1: “Accessory” splenic artery travelling along 
with the splenic artery; VARIANT 2: LGA from the splenic artery; VARIANT 3: LGA from the common 
hepatic artery; VARIANT 4: LGA from the CT; VARIANT 5: Inferior mesenteric vein draining into the 
splenic vein. 
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Figure A.5: Ductal anatomy classification types. Illustrations of the different ductal variational 
anatomies. Type A drains some of the connecting lobe through the bridge and splenic lobe into the primary 
duct. Type B drains part of the splenic lobe through the bridge and connecting lobe into the primary duct. 
Type C has no drainage through the bridge. Type X describes all other ductal anatomies that do not fit into 
categories A, B or C. 
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Results 
The pig pancreas is a retroperitoneal organ, with comparable anatomical orientation and 
localization to the human. However, there are significant differences between the pig and human 
pancreas with respect to the number and distribution of the pancreatic lobes. In our series, 63 of 
the 65 porcine pancreata examined (97%), exhibited the three lobes (duodenal, splenic, and 
connecting) that we considered the normal representation of the pancreas in the porcine model 
(Figure A.2). One pancreas presented no “bridging tissue” between the SL and the CL, and 
another case exhibited a “ring-shaped” pancreas (the portal vein ran parallel to the duodenum and 
both were covered by the DL). A third pancreas that had the three expected lobes also contained 
an additional piece or elongation of pancreas tissue extending from the SL. After the pig pancreas 
was removed and trimmed each organ was weighed. The mean weight of the whole trimmed 
gland was 347±103 g, with a range from 190 to 698 g. The mean weight of the different lobes 
was: duodenal, 75±9 g (68–85); splenic, 246±50 g (188–308); connecting, 84 ±17 g (71–114) 
(Table A.1).  
The arterial and venous vasculature was studied in 61 animals. It was observed that 51 pigs (84%) 
exhibited normal branching from the CT. We found variations in CT anatomy in 10 cases (Table 
A.2, Figure A.4b). All pigs exhibited traditional branching at the SMA, sending branches to the 
CL of the pancreas (inferior pancreaticoduodenal artery). However, one displayed a branch below 
the SMA that supplied the bowel and another presented additional branches from the SMA 
towards the colon without variation in the pancreatic supply. Another pig had a branch to the 
bowel that came off the SMA before the pancreatic branches. Anatomical findings related to the 
PPA were very diverse and are shown in Table A.3 (Figure A.4b). It was found that the PPA 
most commonly branches from the hepatic artery (54%).  
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After inserting the cannulas into the root of the CT and the SMA, and infusing each one with 
different colors, it became apparent that the CT supplied the entire DL and the majority of the SL. 
The SMA supplied the CL, the bridge, and the inferior aspect of the SL.  
The venous outflow occurred through the PV as a result of the merging of the splenic vein and 
SMV. The splenic vein typically traveled around the superior and posterior aspect of the pancreas 
and drained the body and the tail (SL). The rest of the pancreas was drained by branches coming 
from the SMV and the PV. In the cases we examined, the SMV and IMV merged to become the 
PV in all but one pig; the exception was the IMV draining into the splenic vein, as is the 
traditional case in humans (Figure A.4b). The left gastric vein drained into the splenic vein in all 
studied cases.  
The pancreatic ductal network was traced by differential colored saline infusions in 36 pancreata 
(Table A.4). Fourteen of the 36 pigs (39%) of the pigs exhibited ductal communication between 
the CL and the other two lobes. Eleven pigs (31%) exhibited ductal communication only from the 
SL to the CL with the clamp in position 1 (Figure A.5, type A). In one case (2.8%) the 
communication only existed from the CL to the SL when the clamp was in position 2 (Figure 
A.5, type B). In two cases (5.6%), the colored infusion illustrated that the whole organ could be 
infused through from both communications, with the clamp in either position (Type A + B). 
Eighteen pigs (50%) of the pigs exhibited no ductal communication between the SL and CL, but 
featured communications solely from the DL (Type C). We classified a type X (neither type A, B, 
or C) ductal anatomy in four cases (11.1%). In this category, one pig exhibited no anatomical 
connection between the SL and CL (bridge atresia); another pig exhibited two separate ducts (one 
for the DL and SL, and the other for the CL); and in two pigs, the pancreata exhibited minimal 
ductal communication between the CL and distal SL after the initial infusion and clamping off of 
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the connection between the DL and SL. After clamping off the connection between the DL and 
CL, the infused colored saline flowed into the DL and the proximal SL.  
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Table A.2: Variations of the celiac trunk (CT) anatomy 
Table A.1: Porcine pancreas weights 
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Table A.4: Types of pancreatic ductal structure 
Table A.3: Variations in posterior pancreatic artery (PPA) anatomy 
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Discussion  
There is a lack of literature describing the detailed anatomy of the pig pancreas. Comprehensive 
knowledge of the pig pancreatic anatomy is essential for improvements in pancreas procurement, 
preservation, and islet isolation protocols45,313. It has been reported that the pancreatic anatomy 
may vary from donor to donor314 and several studies80,315 have demonstrated the importance of pig 
strain on islet isolation outcome. Although the use of different breeds was considered, it was 
decided to focus on Landrace pigs, as this breed is considered to be the most suitable donor for 
islet isolation316–318. Recent literature319–321
 
suggests that this breed is desirable for use in 
xenotransplantation since isolations yield large numbers of islets and pancreata contain a high 
islet volume density (3.4%) when compared to other breeds (1–2%). For this reason the 
investigation was focused on understanding the anatomy of the Landrace breed in detail. 
Krickhahn et al100 demonstrated that pancreatic islet size may be an important parameter 
influencing islet yield after isolation and this may be dependent on the strain of the pig.  
The present study provides more detailed information about the distribution of the lobes in the 
pancreas and demonstrates that almost 97% of pancreata exhibited three lobes. One pancreas 
presented no bridge and another case exhibited a “ring” shaped pancreas. It is important to 
recognize these kinds of variations if the porcine pancreas is to be used as a source of islets for 
clinical xenotransplantation. It is critical to understand the functional relationship between 
pancreatic ducts and drained pancreatic tissue for proper infusion of digestive enzymes and the 
subsequent isolation of islets. A lack of anatomical knowledge can result in poor or incomplete 
distension and digestion of the gland. In the 1970s, Calne et al322 had described two lobes 
attached near the duodenum to the body of the pancreas. Other authors323 divided the pig pancreas 
into three parts, but named these parts differently as compared to our study: body of the pancreas 
(corpus pancreatis), right lobe of the pancreas (lobus pancreatis dexter), left lobe of the pancreas 
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(lobus pancreatis sinister). Kumagai et al324 described the pancreas as consisting of the tail, body, 
head, and the bridge lobes. Gänger et al325, described the pig donor operation to obtain 
duodenopancreaticosplenic specimen for experimental transplantation. They located the orifice of 
pancreatic duct in the distal tip of the uncinate process, which corresponds to a duodenal lobe 
according to our nomenclature. Our data provides a reliable system to classify the pancreatic 
lobes and the variants in the anatomy eliminating inconsistency in the naming and distribution of 
the lobes described in the literature; this is an important point with major implications in the field 
of pig islet isolation and xenotransplantation.  
The present study has demonstrated 10 variations related to the CT anatomy and normal 
branching coming from the SMA. The distribution and disposition of the PPA were unpredictable 
(Table A.3). The most common origin of the PPA in the series of Morel et al309
 
was from the 
splenic artery along the upper border of the pancreas. They found that only 2 pigs exhibited a 
major pancreatic artery coming from the hepatic artery, but a small arterial branch from the 
splenic artery was also observed. Shokouh-Amiri MH et al308 had classified the variations in 
arterial blood supply of the porcine pancreas with three types as they related to the major 
pancreatic artery (PPA in our study). Nonetheless, they found a PPA arising from the root of the 
CT. They concluded that segmental pancreatic autotransplantation was technically possible in all 
animals regardless of the type of arterial supply if the anatomy of the vasculature is known 
adequately. In contrast, Traverso and McFarlene311, based on the description of variations in the 
arterial blood supply to the body and tail of the pancreas, concluded that the pig is unsuitable for 
pancreatic autotransplantation studies.  
Some authors326 used the tail of the pancreas for various experiments, to minimize complexities 
associated with variations in the anatomy of the head of the pancreas. To develop a pig model 
either for whole or segmental pancreas transplantation, the arterial anatomy of the pancreas must 
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be precisely mapped out. The blood supply of the pancreas is provided by the celiac and superior 
mesenteric arteries. The DL of the pancreas receives its blood supply from the superior 
pancreaticoduodenal artery, which is in all cases a branch of the gastroduodenal artery. In contrast 
with this finding, Schröder et al327, described the origin of the superior pancreaticoduodenal artery 
from the splenic artery. The SL is supplied by the splenic artery and the inferior 
pancreaticoduodenal artery which branches off from the SMA and also supplies the CL and the 
bridge as well.  
After the abdominal aorta was opened through the anterior wall and cannulas were placed into the 
CT and SMA, the organ was infused with colored saline. It was observed that the color was 
distributed homogenously throughout the whole gland. The finding demonstrated that CT and 
SMA cannulation is a suitable technique to sufficiently perfuse the pancreas and could be used in 
other experiments related to pancreas preservation. In fact, Zhang et al328 used the pig model for 
pancreaticoduodenal transplantation and the donors were perfused via the abdominal aorta 
without clamping the portal venous outflow. Gäbel et al329, used the entire pancreas with intact 
vascular supply to get a graft from a pig donor to transplant in a pig recipient. The organ was 
perfused via the CT only with no mention of the SMA. These authors described early graft failure 
caused by concomitant acute pancreatic necrosis, probably followed by vascular complications. 
To avoid these kinds of complications, it could be very useful to dissect the CT and the SMA 
selectively to ensure good perfusion of the entire pancreas, even if you use it for islet 
transplantation or for a vascularized graft for pancreas transplantation. 
In our study, as well as in others308,309, few variations were found in the venous drainage of the 
pancreas. In only one pig the IMV drained into the splenic vein instead of the SMV.  
The impetus to study the pancreatic ductal system was to better understand the ductal branching 
structure for the purpose of applying the knowledge to the development of enzyme perfusion and 
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pancreatic distention techniques within the context of the pig model. All but one pancreas 
exhibited only one main pancreatic duct. Only in one case we found two separate ducts, one for 
the DL and SL and the other for the CL. There are some discrepancies in the literature. König-
Liebich323 described the dual origin of the pancreas as arising from dorsal and ventral primordial 
buds, stating that some species have two pancreatic ducts, and the pig is one of them. The 
accessory pancreatic duct enters the duodenum at the minor duodenal papilla located distal to the 
major duodenal papilla310. On the other hand, Swindle330 asserted that the pancreas is related to 
the proximal duodenum with a single pancreatic duct entering the duodenal lumen distal to the 
common bile duct. Morel et al309 in a series of 49 Yorkshire pigs, found one pancreatic duct 
emerging from the lower right part of the pancreatic head, draining into the second part of the 
duodenum. Only in one instance of this study was an accessory duct found draining the 
connecting lobe into the third part of the duodenum. Pitkaranta et al331, developed an 
experimental model of chronic pancreatitis in the pig. They observed a papilla obstruction failure 
rate of 30%, suggesting the presence of an accessory duct. However, our data do not support 
these findings.  
Even though the pancreatic ductal system and its variability remain the Achilles’ heel in islet 
isolation, the detailed anatomy described here helps to overcome the difficulties associated with 
complete distention of the gland. Understanding the variable ductal distribution facilitates simple 
adaptation of technical distention protocols to make the process more efficient and effective.  
In conclusion, the vascular anatomy of the pig pancreas makes it suitable for perfusion via the 
suprarenal aorta, as is the case in humans. The knowledge of the variations in the anatomy in the 
vascular supply could help to develop successful new models of whole or segmental pig pancreas 
preservation and transplantation and islet isolation and transplantation45,313. However, the ductal 
anatomy can be highly variable, with branching from the connecting lobe being extremely 
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inconsistent. If cannulation is not carefully performed, one portion of the organ may not be 
properly distended with proteolytic enzymes, resulting in a substantial loss of the islets present in 
this portion. Careful consideration of all these anatomical findings is likely to facilitate less 
variable and more economical pig islet isolation for research studies and therapeutic purposes.  
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Pancreas oxygen persufflation increases ATP levels as shown by 
nuclear magnetic resonance 
Summary 
Islet transplantation is a promising treatment for type 1 diabetes. It is important to maximize 
viable islet yield due to a shortage of suitable human pancreata, high cost and the large dose of 
islets currently required for long-term diabetes reversal. Traditional methods of pancreas 
preservation have been identified as suboptimal with oxygenation thought to be one of the key 
areas for improvement. One method of delivering oxygen throughout the organ, persufflation 
(PSF), is explored here. Human pancreata were obtained by a combined pancreas-liver 
procurement from brain-dead donors. Porcine pancreata were procured by en bloc viscerectomy 
from heparinized non-heart beating donors. Porcine pancreata were divided with lobes either 
preserved by TLM or PSF. Following procurement, organs were transported to a 1.5 T magnet for 
31P-NMR spectroscopy to investigate their bio-energetic status by measuring the ratio of ATP-to-
inorganic phosphate (ATP:Pi) and by assessing PSF homogeneity by MRI. Prior studies have 
shown that TLM can effectively raise ATP:Pi levels in rat pancreata. When a similar study was 
attempted in the larger porcine model, ATP:Pi levels decreased to almost undetectable levels. 
When human or porcine organs were persufflated, ATP:Pi was elevated to levels similar to those 
observed in the rat model. MRI showed that pancreatic tissue was homogeneously filled with gas. 
Methods developed for human and porcine pancreas PSF oxygen delivery throughout the organ. 
This elevates ATP levels during preservation and may improve current islet isolation outcomes 
while enabling the use of marginal donors, expanding the donor pool. 
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Introduction 
Islet transplantation is an emergent treatment alternative for type 1 diabetes9,332. Currently, 
clinical islet allotransplantation is limited by a shortage in suitable donor organs, loss of islets 
throughout the islet manufacturing and engraftment process, as well as by the high cost and the 
large dose of islets required for long-term diabetes reversal. Islets may be predisposed to death 
before or during isolation due to improper handling of the organ during procurement and/or 
suboptimal cold preservation (CP) during transport. Significant research effort has focused on 
investigating the efficacy of the two-layer method (TLM), the present state-of-the-art for pancreas 
preservation333–338. In the late nineties, many centers reported improvements in islet isolation 
outcome using TLM for CP. These improvements were attributed to an increase in tissue ATP 
due to enhanced tissue oxygenation with TLM compared to the previously used CP in University 
of Wisconsin (UW) solution alone3-8. However, recent studies have suggested that TLM is not 
able to oxygenate large portions of human or porcine pancreata during CP20,339. In addition, 
several large retrospective analyses have found no significant improvement in isolation outcomes 
for pancreata stored with TLM when compared to pancreata stored on UW solution alone340–342. 
Therefore, it is of great importance to develop novel methods of preservation, which can better 
oxygenate large organs throughout CP. One such preservation method investigated here is 
persufflation (PSF), or vascular gas perfusion. PSF has been investigated in the heart, liver and 
kidney, but until now not reported for pancreas preservation343–352. This method is investigated in 
more detail in the next section; however, it is equally important to develop methods for evaluating 
the efficacy of preservation methods. Current methods of organ viability assessment are limited to 
examination of donor records, histopathology assessment,16 or visual and manual inspection. 
These methods are not definitive or quantitative, and thus require very large groups to make 
scientific comparisons. In Chapter 2, we presented a method for measuring solid organ viability 
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using whole organ oxygen consumption rate (WOOCR)30, and in this section, we introduce 
another method for solid organ viability measurement. To evaluate the viability of organs and to 
compare preservation methods, we developed equipment and techniques for non-invasive organ 
assessment using 31P magnetic resonance spectroscopy (31P-MRS). 31P-MRS is an established 
technique for monitoring the amount of ATP present relative to inorganic phosphate (Pi) in 
tissues. 31P-MRS has been extensively used to study tumor biology, bioenergetics as well as 
metabolism and the health status of organs, such as the heart, brain, kidney, liver, and recently, 
the pancreas313,353–361. The non-invasive nature of 31P-MRS and its ability to provide information 
in real time make it an effective and powerful tool for monitoring the bio-energetic status of 
pancreata during CP. 
Hypoxia experienced during CP has been shown to cause depletion of ATP in organs, and results 
in impairment of mitochondrial function19. There is evidence that this effect can be reversed by 
raising the pO2 in perfused medium
19.  The hypothesis presented herein is illustrated in Appendix 
F. We predict that ATP levels will not be detectible in large organs preserved by TLM and that 
levels are expected to rise when oxygen is introduced by briefly exposing the organ to PSF. 
Furthermore, we predict organs that are continuously oxygenated by PSF during preservation will 
maintain higher levels of metabolic function resulting in maintenance of ATP levels during 
preservation. ATP levels in all CP organs are expected to decrease during the preservation period 
indicating general loss of organ viability during the preservation period. The large size of porcine 
and human organs will prevent sufficient oxygen diffusion to the center of the organ. The 
majority of the organ will not be adequately oxygenated during TLM preservation339. To assess 
the efficacy of preservation of large organs, we compared the ATP:Pi ratios of organs preserved 
with TLM compared with PSF. We also compare these data with that collected from our previous 
study of murine pancreata313.  
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Materials and Methods 
Procurements 
Rat pancreata were investigated as detailed by Scott WE et al313. All procedures using laboratory 
animals were approved by the University of Minnesota IACUC. Pig pancreata and kidneys were 
procured by en bloc viscerectomy from heparinized non-heart beating Landrace donors as 
detailed by Ferrer J, et al38. Organs were then preserved either with TLM or by PSF. All 
procedures using laboratory animals were approved by the University of Minnesota IACUC. 
Human pancreata were procured by a combined pancreas-liver procurement from brain-dead 
donors. In short, after the adequate exposure was obtained through a cruciate abdominal incision, 
the preliminary dissection was performed with intact donor circulation. Once the donor was fully 
heparinized, the distal aortic cannula was inserted with the infusion of the chilled preservation 
solution after the encircled supraceliac aorta was cross-clamped. It was left up to the liver team to 
decide whether portal venous infusion should be performed through cannulation of the inferior 
mesenteric vein. The venous system was decompressed via venotomy. The organs remained in 
situ until the cold infusion was complete. The pancreas was harvested either en bloc with the liver 
and separated on the back table or the research pancreas was removed once the clinical organs 
were harvested. Research consent was obtained from all donor families before procurement. 
Static Preservation (TLM) 
Lobes preserved by TLM were preserved as previously described362.  In brief, lobes were 
suspended halfway between 1 L of CP solution and perfluorodecalin, which was pre-oxygenated 
for 1 hour prior to preservation by bubbling with 99% oxygen gas. Preservation was performed in 
specially constructed vessels composed of magnetic resonance (MR)-compatible materials. 
Drawings and pictures of this equipment are included in Appendix F. 
Persufflation 
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PSF methods and outcomes are discussed in more detail in the next section, but briefly, all 
persufflated organs were oxygenated by pumping 20 ml/min of 40% humidified gaseous O2 to 
both the superior mesenteric artery and either the splenic artery (human) or celiac trunk (pig) 
utilizing an electrochemical oxygen concentrator (EOG, Giner Inc, Newton, MA). Following 
procurement, organs were transported to an MRI facility and 31P-MRS was performed on a 1.5 T 
magnet to investigate their bio-energetic status by measuring the ratio of ATP to inorganic 
phosphate (ATP:Pi). 
31P-NMR Spectroscopy 
For the pig and human organs, 31P-MRS was done in the 1.5 T magnet by placing a surface coil 
tuned to 25.85 MHz as close to the organ as possible. A diagram and images of the coil are shown 
in Appendix F. Each critical peak in the 31P-MRS spectrum was analyzed with an NMR analysis 
package (ACD 1D-NMR software) to determine the relative integral areas of each peak. The 
areas of the α-, β-, and γ-ATP peaks were compared with the area of the inorganic phosphate (Pi) 
peak to compare the bio-energetic status of the organs. A schematic of how organs were placed 
into the magnet and maintained during preservation is included in Appendix F. The organ was 
cannulated as described, and the cannulas were connected access points on an MRI safe organ 
container. Long sections (approximately 10 meters) of tubing were used to connect the EOG to 
the organ container to achieve PSF inside the MRI system, and during MRS acquisition as 
needed. The organ was maintained at hypothermic temperatures (< 8 °C) by placing the organ 
container inside a specially constructed MRI safe heat exchanger, which was cooled using a 
standard refrigerated circulating water bath. These custom components are described in more 
detail in Appendix F. 
MRI 
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All proton imaging (1H-MRI) was done at 1.5 T in a birdcage coil tuned to 63.85 MHz.  
Assessment of the homogeneity of PSF was done by observing the presence of gas in the 
vasculature by the negative contrast it develops during MRI. 
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Results 
1H-MRI images of PSF organs typically exhibited the presence of negative contrast (indicating 
the presence of gas in the vasculature) in 90% of the tissue. Representative images from a PSF 
pancreas and a pancreas that exhibited significant gas leakage are shown in Figure B.3A and B. 
Also shown in Figure B.3C is a well PSF porcine kidney showing typical vascular branching 
structure and a non-PSF kidney that exhibited no negative contrast. As previously reported, rat 
pancreata exposed to TLM exhibited high levels of ATP:Pi
313 (Figure B.2A). When we 
investigated porcine pancreata preserved with TLM, ATP levels dropped to nearly undetectable 
levels (Figure B.2B). These data were similar to data collected from porcine organs preserved in 
preservation solution alone. This suggests the inability of TLM to adequately supply the majority 
of the pancreas with oxygen in larger organs, such as from pigs or humans. However, when we 
investigated human pancreata undergoing PSF, we observed elevated ATP:Pi levels similar to 
those observed from the rat model preserved by TLM (Figure B.2C). When PSF was abruptly 
stopped and the pancreas was exposed to static preservation alone, ATP:Pi quickly decreased to 
undetectable levels, similar to those observed from porcine organs preserved by TLM. This 
observation confirms that PSF was responsible for the elevated β-ATP:Pi observed during 
preservation, and that 31P-MRS can detect and quantify changes in ATP levels of large organs 
when oxygen is provided by PSF.  
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Figure B.1: Schematic of 31P-MRS studies. Diagram illustrating how the pancreas was placed into the 
magnet during data acquisition. 
.
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Figure B.2:
 
ATP spectra from rat, pig, and human pancreata. 
31P-NMR spectra acquired from a) a rat 
pancreas preserved by the Two-Layer Method (TLM); b) a porcine pancreas preserved by TLM; c) a 
persufflated human pancreas. Peak numbering corresponds to: (1) phosphomonoester, (2) inorganic 
phosphate, (3) phosphodiester, (4) γ-ATP, (5) α-ATP, and (6) β-ATP.
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Figure B.3: MRI of persufflated pancreas. Gradient echo MRI of a) a well persufflated pancreas with gas 
filling the vasculature indicated by dark regions. This is typical of what was observed in general. b) A 
pancreas with poor persufflation which had a large arterial gas leak. c) A well persufflated kidney (left) and 
a non-persufflated kidney (right). The persufflated kidney shows typical vascular branching(dark regions). 
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Discussion 
In this paper we utilized a 31P-MRS method to evaluate the metabolic status of organs undergoing 
CP, and to non-invasively assess the efficacy of different preservation protocols (i.e., TLM, PSF) 
in maintaining ATP levels (a direct reflection of respiration and a measure of organ health and 
viability) in rat, porcine, and human organs. Previous investigation demonstrated that, in the rat 
pancreas model, CP with TLM results in dramatically improved ATP levels313. To study the 
impact of TLM, CP methods were investigated in porcine pancreata and the TLM was compared 
with a novel method of pancreas preservation, PSF, in pig and human models. ATP levels were 
consistently low for all large organs preserved by static methods, such as TLM. However, ATP 
levels of human and porcine pancreata undergoing PSF were consistently higher than those 
observed from organs exposed to static preservation, approaching levels observed from the 
smaller rat pancreata preserved by TLM. This is due to the improved oxygenation the tissue 
experiences during PSF by providing humidified oxygen directly into the bulk of the solid organ 
through the extensive, native and intact vasculature. This delivery method circumvents the 
problem of limited oxygen diffusion into the core of larger organs (such as human or porcine 
pancreata) associated with the static methods of preservation. MRI results support that PSF can 
actively supply most of the pancreas with gaseous oxygen during cold preservation. 
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Supplemental Results and discussion of 
31
P-MRS measurements 
with PSF 
 
Results: 
A series of 31P-MRS measurements were obtained from a small set of (N=4) individual human 
research pancreata during PSF immediately upon arrival to the lab. A representative spectrum 
from a human pancreas oxygenated by PSF with individual peak assignment and analysis is 
shown in Figure B.4. The resulting spectra from each organ were analyzed by identifying each 
critical peak and then fit assuming a lorentzian shape. The individual peak areas were calculated 
and then ATP levels are reported as ratios of ATP:Pi. The results presented in Figure B.5 show 
variability in the initial β-ATP:Pi upon arrival, which appears to correspond to the amount of 
warm ischemia time (WIT) recorded in the donor records. One pancreas which was indicated to 
have no WIT did not fit this trend, and showed lower β-ATP:Pi levels than expected. 
31P-MRS 
measurements for one pancreas were continued for a 24 hour CP period, and the β-ATP:Pi results 
are plotted in Figure B.6. PSF was started as soon as the pancreas arrived at the lab to obtain the 
initial “base-line” ATP levels, and PSF was continued for up to 24 hours. PSF was stopped 
between 8-12 hours to observe any decrease in ATP when oxygenation was stopped. Almost 
immediately following succession of PSF, the ATP levels were observed to drop significantly. 
When PSF was resumed, the β-ATP:Pi then increased to approximately 50% of the initial base-
line measurement. 
The β-ATP levels proved to be more sensitive to oxygenation status than the total ATP (α+β+γ), 
and β-ATP:Pi is reported for these studies with CP organs for this reason. Representative total 
ATP data from the same pancreas is also included in Figure B.6 to illustrate this observation. 
Furthermore, additional human pancreata preserved with PSF were examined using 31P-MRS 
(N=4), and the complete data set is included in Figure B.7. These results show the maintenance 
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of ATP levels in organs with continuous PSF (n=7), and again, a single human pancreas with 
interrupted PSF showing the dramatic drop in ATP when oxygenation is stopped. 
A single porcine kidney was examined in a similar study, and 31P-MRS measurements were 
collected during CP with continuous PSF for up to 80 hours. The results are presented in Figure 
B.8. For this kidney, PSF also stopped for a brief period between 7-9 hours of CP, and the β-
ATP:Pi levels also quickly decreased to near-zero, and recovered to approximately 50% of the 
initial measurement when PSF was resumed. Measured β-ATP:Pi continued to fluctuate and 
generally decreased during the 80 hour CP time, but maintained 27% of initial levels at the end of 
the study. 
Discussion: 
The implications of the early studies in rats were that improved oxygenation provided by the 
TLM allowed for increased aerobic metabolic activity of the organ, which in turn increased the 
generation of available ATP. This is a reasonable assertion because the TLM will increase the 
oxygen available in the preservation solution, and will increase the oxygen partial pressure, and 
available oxygen at the surface of the organ. Oxygen will then diffuse into the organ and restore 
the aerobic metabolism of the tissues allowing for efficient production of ATP by oxidative 
phosphorylation. This outcome may decrease the production of harmful byproducts of anaerobic 
metabolism and allow for improved recovery when the organ is transplanted and exposed to 
physiological temperatures and oxygenation. This is an important finding, and laid the foundation 
for the hypothesis that increased oxygenation results in increased available ATP levels in tissues 
during CP. However, others have hypothesized that the rat model is not appropriate for the study 
of large organ preservation due to the relative size difference with human organs339. TLM 
provides oxygenation through diffusion of oxygen into the organ by exposing only the surface of 
the organ to increased levels of oxygen. This approach will only result in oxygenation of the 
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tissue near the outer surface of the organ, and will leave the internal aspects of the organ in a 
potentially harmful hypoxic state. 
Elevated ATP:Pi levels (when compared to static methods of CP like TLM) were observed in all 
large organs investigated when oxygenated by PSF, and a representative spectrum showing the 
relative integral areas is shown in Figure B.4. There was significant variability in organ viability 
(as indicated by ATP levels) upon arrival to the lab (Figure B.5), and these differences correlate 
with the WIT noted in the donor medical records. For one organ, the reported WIT did not fit 
with the observed trend. When the donor records were re-inspected, it was noted that the donor 
had experienced a 180 minute “hypoxic episode” prior to donation. Although this is not 
technically a period of WIT, this prolonged hypoxic stress may have resulted in damage to this 
sensitive organ. This observation may explain why this individual pancreas did not appear to 
follow the observed trend. 31P-MRS may provide a “comprehensive picture” of the metabolic 
capability of an organ prior to transplantation, as it accounts for a large variety of stress factors 
that an organ experiences during CP. 
Furthermore, these results demonstrate that β-ATP:Pi ratios are a better indicator of oxygenation 
and metabolic status that total ATP:Pi. Figure B.6 clearly shows that most of the kinetic changes 
in total ATP are due to changes in the β-ATP peak. The total ATP:Pi trends with β-ATP:Pi for the 
duration of the study, but the changes appear to be “muted” when compared to β-ATP:Pi. It is 
also observed that the β-ATP peak is more sensitive to oxygenation status, and this peak becomes 
un-detectibly small almost immediately after oxygenation by PSF is stopped, while the total ATP 
levels seems to reach a static depressed level without continuous oxygenation by PSF. This 
finding was unexpected, but may be a residual effect of the generally depressed metabolic state 
that tissues revert to when undergoing CP. The effect of decreased temperature (hypothermia) on 
the general metabolic activity of tissues is reasonably well understood, and this is the primary 
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impetus for employing CP techniques. When examining the process of aerobic metabolism, ATP 
is first de-phosphorylated to adenosine diphosphate (ADP) and an individual Pi. At 1.5 T 
magnetic field, the phosphate peaks of ADP overlap with the α-ATP and γ-ATP peaks of ATP, 
and cannot be separately resolved. With the decreased metabolic activity of tissues during CP, the 
continued process for de-phosphorylation of ADP may be dramatically reduced resulting in a 
direct trade-off of ATP to ADP and Pi. This hypothesis would support the findings presented 
herein, that the β-ATP peak is the first one to disappear as aerobic metabolism progresses with 
the introduction of oxygen. This would also explain the relatively stable α-ATP and γ-ATP peaks 
observed in these studies. 
The total ATP:Pi is also shown to decrease during the preservation period, and may reflect the 
general degeneration of tissues during CP, and could be indicative of irreversible tissue damage. 
These preliminary findings suggest that 31P-MRS could be a successful method for assessment of 
organ quality, and may be able to provide a quantitative measurement of organ viability. It is 
clear that increasing oxygenation of organs by PSF increases the aerobic metabolism of the 
tissues, and the β-ATP:Pi ratio can be used as a sensitive indicator of aerobic metabolic activity 
of organs during CP. These results also confirmed that increased tissue oxygenation using PSF 
increases the β-ATP:Pi and total ATP:Pi, and furthermore appears to slow down the overall 
decline in ATP observed during prolonged periods of CP. 
 
  
  303 
Figure B.4: Integration analysis of 
31
P-MRS spectrum. Representative 13P-MRS spectrum from a human 
pancreas oxygenated by persufflation (PSF) with peak assignment and integration analysis. Dimethyl 
methylphosphonate (DMMP) standard, phosphomonoester, inorganic phosphate (Pi), and α, β, and γ ATP 
peaks are shown with calculated integration areas. These areas were compared to report the β-ATP:Pi 
ratios, and the total ATP:Pi ratios for these studies.
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Figure B.5: β-ATP/Pi levels in human pancreata. β-ATP/Pi observed in 4 individual human research 
pancreata upon arrival at the lab. Decreased levels are observed in organs that experienced increased stress 
levels (warm ischemia time, WIT) as indicated in the patient chart. One organ (white bar) arrived with no 
indicated damage (0* minutes of WIT), but upon further inspection, the chart indicated that a single 180 
minute hypoxic episode occurred prior to procurement. This suggests that the organ was likely damaged 
during this period of hypoxia and partially recovered prior to procurement. The β-ATP/Pi measurements 
were able to resolve this damage that was not indicated by the WIT alone. This method may be able to 
provide a “snap-shot” indication of organ viability that accounts for the numerous factors and stresses that 
organs experience during prolonged cold preservation.
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Figure B.6: Measurements of ATP by 
31
P-MRS in human pancreas with PSF. β-ATP:Pi measurements 
for one persufflated (PSF) human pancreas. PSF was initiated after 3 hours of cold ischemia time (CIT), 
and then stopped after 8 hours CIT. A sharp drop in β-ATP was observed, and after 4 hours of measuring 
little to no β-ATP, PSF was resumed (after 12 hours of CIT) and the levels recovered to about 50% of the 
maximum, and finaly decreased to 25% over the next 12 hours. Total ATP/Pi (α+β+γ) measurements from 
the same human pancreas are also plotted, and demonstrate that the total ATP levels do not reach zero 
when oxygenation is stopped, but the β-ATP peak completely disappears to undetectable levels when 
oxygen is not available.
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Figure B.7: PSF maintains ATP in human pancreata. Charts showing relative β-ATP:Pi levels 
(normalized to 8 hour time-point) for (A) individual pancreata, and (B) averaged conditions. Results 
demonstrate that ATP levels were maintained in human pancreata during 24 hours of cold preservation with 
PSF. Human pancreata were preserved by PSF for 24 hours and examined by 31P-MRS after 8, 16, and 24 
hours. PSF was stopped for one pancreas after 8 hours, and β-ATP:Pi precipitously dropped to undetectable 
levels. A modest recovery in β-ATP:Pi was observed in that organ when PSF was re-initiated (after 12 
hours), but it remained much lower than organs with continuous PSF. 
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Figure B.8: β-ATP/Pi measurements in porcine kidney. β-ATP/Pi measurements from a porcine kidney 
preserved for 80 hours by PSF. As observed with human pancreata, the β-ATP level drops to undetectable 
levels without adequate oxygenation, and this is observed between 7-9 hours when PSF was inadequate. 
The PSF was re-established after 9 hours and the β-ATP levels are again observed to increase but do not 
recover to initial levels. PSF was continued for the remainder of the study, and a gradual decrease in β-
ATP/Pi was observed for the duration of the study. 
 
  308 
 USING MRI TO IMPROVE ENZYME Appendix C
DISTRIBUTION 
 
 
Sections of this chapter are reproduced in whole, or in part from the following publications with 
permission: 
 
Scott III WE, Weegman BP, Balamurugan AN, Ferrer-Fabrega J, Anazawa T, Karatzas T, Jie T, 
Hammer BE, Matsumoto S, Avgoustiniatos ES, Maynard K, Sutherland DER, Hering BJ, Papas 
KK “Magnetic resonance imaging: A tool to monitor and optimize enzyme distribution during 
porcine pancreas distention for islet isolation” Xenotransplantation, July 2014 
 
License and agreement documentation is included in Appendix G. 
 
Acknowledgements: The authors would like to thank the Schott Foundation, the Minnesota 
Lions Diabetes Foundation, the Juvenile Diabetes Research Foundation (JDRF 5-2013-141), 
Giner Inc., the Schulze Diabetes Institute, and the NIH (P41 EB015894, and S10 RR025031) for 
supporting this research. 
We thank William G. Purvis and Jennifer P. Kitzmann for graphical and editorial assistance and 
Samuel A. Stein for technical assistance with MRI imaging. This work was supported by the 
NIH, National Institute of Diabetes and Digestive and Kidney Diseases Grant Numbers 
R01DK068717 and R44 DK070400, as well as The Carol Olson Memorial Diabetes Research 
Fund, The Iacocca Foundation, and The Schott Foundation. 
The authors acknowledge Kurt Albreck of Donovan Specialties (Osseo, Minn), Denice Dudero, 
Laurie Macleod, Dr Kristen Maynard, Heather Nelson, William E. Scott III, and Christine 
Vincent from the Diabetes Institute for Immunology and Transplantation at the UMN. 
The research described here was supported in part by grants from US National Institute of Health 
(R44DK065508-02 - MJT,1 R44 DK076326-0 & 5 R44DK076326-03- MJT, and R44DK069865 
- JW). 
 
  
  309 
Magnetic resonance imaging: A tool to monitor and optimize 
enzyme distribution during porcine pancreas distention for islet 
isolation 
 
Summary 
Porcine islet xenotransplantation is emerging as a potential alternative for allogeneic clinical islet 
transplantation. Optimization of porcine islet isolation in terms of yield and quality is critical for 
the success and cost effectiveness of this approach. Incomplete pancreas distension and 
inhomogeneous enzyme distribution have been identified as key factors for limiting viable islet 
yield per porcine pancreas. The aim of this study was to explore the utility of Magnetic 
Resonance Imaging (MRI) as a tool to investigate the homogeneity of enzyme delivery in porcine 
pancreata. Traditional and novel methods for enzyme delivery aimed at optimizing enzyme 
distribution were examined. Pancreata were procured from Landrace pigs via en bloc 
viscerectomy. The main pancreatic duct was then cannulated with an 18g winged catheter and 
MRI performed at 1.5 T. Images were collected before and after ductal infusion of chilled MRI 
contrast agent (gadolinium) in physiological saline. Regions of the distal aspect of the splenic 
lobe and portions of the connecting lobe and bridge exhibited reduced delivery of solution when 
traditional methods of distension were utilized. Use of alternative methods of delivery (such as 
selective re-cannulation and distension of identified problem regions) resolved these issues and 
MRI was successfully utilized as a guide and assessment tool for improved delivery. Current 
methods of porcine pancreas distension do not consistently deliver enzyme uniformly or 
adequately to all regions of the pancreas. Novel methods of enzyme delivery should be 
investigated and implemented for improved enzyme distribution. MRI serves as a valuable tool to 
visualize and evaluate the efficacy of current and prospective methods of pancreas distension and 
enzyme delivery. 
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Introduction 
Porcine islet xenotransplantation is emerging as an attractive alternative to allogeneic clinical islet 
transplantation as porcine pancreata may be a source of islets capable of meeting the demand 
(potentially millions of patients with type 1 diabetes). The possibility of islet isolation from 
porcine pancreata promises a convenient solution to the limited supply of human pancreata (in the 
thousands per year in the US) by offering the potential for on demand high quantity and quality 
islets. Porcine islets have been shown to reverse diabetes in a number of small animal models and 
to maintain normal glucose levels in diabetic non-human primates for more than 100 
days33,238,281,363, under the coverage of potent immunosuppression. Clinical translation of porcine 
islet xenotransplantation will require “clean pigs” maintained in highly specialized and tightly 
monitored facilities, a costly endeavor89,319,364. This high cost, coupled with current difficulties in 
consistently obtaining high yields of viable islets from even fully mature animals, highlights the 
need for further optimization of the porcine islet isolation procedure. The successful intraductal 
infusion of enzyme solution into the pancreas is known to play an important role in obtaining 
successful islet isolation outcomes and has been highlighted in this study as an area to be targeted 
for improvement365–367. 
In this regard, comprehensive knowledge of the anatomy of the porcine pancreatic ductal system 
is essential for the development of innovative techniques for pancreas preservation and 
improvements in islet isolation procedures. Due to the complexities of the anatomy of the ductal 
system and variations between donors38,69,85,104, complete distension and homogeneous enzyme 
distribution remain a challenge despite substantial experience in the field. Failure to consistently 
obtain high viable islet yields from porcine pancreata with traditional enzyme delivery methods 
may actually be, in part, due to issues associated with incomplete distention and inhomogeneous 
enzyme distribution. 
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Depending on the anatomy and individual variations in the pancreatic ductal system, following 
the division of the pancreas into its three distinct lobes, significant portions of the organ may not 
be reachable by the enzyme. In this study we utilized Magnetic Resonance Imaging (MRI) to: 1) 
investigate the delivery, completeness of distension and homogeneity of enzyme distribution by 
traditionally used methods of enzyme delivery; and 2) compare two novel strategies for enzyme 
delivery into porcine pancreata and compare them with the traditional method.  
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Materials and Methods 
Six female Landrace non-heart beating donor pigs aged between 6 to 24 months with mean 
weight of 452 ± 99 lb (average ± standard deviation, range 248 to 680 lb) were subjected to 
pancreas resection. All animals were operated on according to the rules and regulations of the 
Institutional Animal Care and Use Committee of the University of Minnesota.  
Procurement: 
 Animals were heparinized, euthanized by sodium pentobarbital overdose, and, following the 
cessation of heart rhythm, completely bled out and eviscerated. All intra-abdominal organs were 
procured en bloc onto a procurement table where the pancreas was dissected free of the other 
organs, as previously described38. 
MRI: 
Following procurement, the pancreata were placed on ice and transported to a 1.5 T magnet 
(Magnex Scientific, Abingdon, UK) using an Apollo spectrometer (Tecmag, Houston, TX) for 
MRI. Pancreata were placed into the magnet, as illustrated in Figure C.1. Briefly: after division 
and cannulation, pancreata or separated lobes were placed into the MRI system and baseline 
images were acquired. A circulating water bath chiller and heat exchanger were used to maintain 
cold temperatures throughout the infusion and imaging process. Syringes attached to pre-primed 
lines running into the bore of the magnet were then used to manually infuse each pre-cannulated 
ductal bed with 5 mM gadolinium contrast solution (Magnevist®, Bayer Healthcare, Berlin, 
Germany), and post-infusion images were taken to determine the extent of contrast distribution. 
The dosing of the contrast was selected based on prior experience to maximize the contrast for 
this magnet. Temperatures were maintained from 4-8 °C with a specially designed water jacket 
running to a refrigerated water bath. Imaging was performed using a Gradient Echo Imaging 
sequence with a 90° flip angle, an echo time (TE) of 14 ms and a repetition time (TR) of 20 ms. 
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Images spanned a field of view of 30 cm x 30 cm at a resolution of 256 x 256 from 5 mm slices, 
each image had 4 acquisitions averaged to ensure clarity. 
Pancreas Distention:  
Based on the pancreatic ductal anatomy and the different types of ductal networks described in 
our previous work38, the following 3 methods of ductal infusion were investigated twice for each 
method: Method 1, division of the pancreas into its 3 distinct lobes followed by anterograde 
infusion of the main duct of the splenic lobe, the main duct of the connecting lobe, and the main 
duct of the duodenal lobe (traditional method); Method 2, division of the duodenal lobe from the 
rest of the pancreas leaving the bridge between connecting and splenic lobes intact followed by 
anterograde infusion into the  pancreatic lobes via cannulation of the main duct of the duodenal 
lobe, the main duct of the splenic lobe, and the main duct of the connecting lobe ; Method 3, 
cannulation of the main pancreatic duct at the papilla of an in-tact pancreas, and infusion of the 
total amount of contrast solution. Examples of each of these methods are illustrated in Figure 
C.2. Pancreata were infused with up to a total of 0.6 cc of  Lactated Ringer’s solution, doped with 
5 mM gadolinium contrast agent (Magnevist®, Bayer Healthcare, Berlin, Germany), per gram of 
pancreas. For Method 2, 33% of the combined weight of the splenic and connecting lobes was 
assigned to the connecting lobe and 67% to the splenic lobe for purposes of contrast solution 
allocation.  
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Figure C.1: Ductal MRI experimental setup. Illustration of the experimental setup for ductal infusion in 
a 1.5 T magnet for MRI. (Right Side) After division and cannulation, pancreata or separated lobes were 
placed into the MRI system and baseline images were acquired. A circulating water bath chiller and heat 
exchanger were used to maintain cold temperatures throughout the infusion and imaging process. (Left) 
Syringes attached to pre-primed lines running into the bore of the magnet were then used to manually 
infuse each lobe or section of the pancreas with the gadolinium contrast solution, and post-infusion images 
were taken to determine the extent of contrast distribution. 
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Figure C.2: Ductal MRI cannulation approaches. Pictures depicting the different cannulation and 
infusion methods: (A) Traditional method separating the pancreas into 3 distinct lobes with anterograde 
infusion of the main ducts (Method 1); (B) Separation of the duodenal lobe with anterograde infusion into 
divided pancreas via cannulation of the main ducts with the bridge left intact (Method 2); and (C) 
Cannulation of main pancreatic duct at the papilla and infusion of total amount of contrast (Method 3).  
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Results 
Six pancreata were investigated for this study. Pancreata were randomly assigned a distention 
technique with 2 investigated for each of the methods. Using MRI we were able to detect 
differences in enzyme distribution during distention. In 2 cases where the duodenal lobe was 
separated from the rest of the pancreas, as is done in Methods 1 and 2, we observed reduced or 
no delivery of contrast solution to regions of the duodenal lobe (Figure C.3). Additionally, we 
observed a lack of delivery of contrast solution to a large portion of the connecting lobe in one 
case infused using the traditional Method 1 (Figure C.4A). All other cases demonstrated a 
relatively homogeneous delivery of contrast solution throughout all regions of the pancreas. 
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Figure C.3: Ductal contrast MRI of porcine pancreata lobes. MRI of pancreata before and after infusion 
with contrast solution for each of the 3 methods investigated. Areas of the pancreas that were well 
distended and infused with contrast solution appear as intense white regions in the post-infusion images. 
When the duodenal lobe was separated, occasionally regions with no delivery or reduced delivery (outlined 
in green) were observed in the duodenal lobe. 
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Figure C.4: MRI detects ductal variants. (A) MRI of a porcine pancreas with an uncommon variant 
ductal anatomy infused using Method 1. (B) Illustration of the common types of porcine pancreata ductal 
anatomy observed by Ferrer-Fabrega et al. in 2008 highlighting type ‘A’ that is shown by the MRI image. 
For this pancreas, areas of the connecting lobe outlined in green did not receive any contrast medium 
(white) during infusion because the ductal system in part of the connecting lobe drains through the bridge 
and out through the splenic lobe ductal system. Method 1 will not effectively distend this portion of the 
connecting lobe in these pancreata. 
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Discussion 
Variations in the anatomy of the pancreatic ductal system may be a major factor affecting 
successful islet isolation from porcine pancreata. Presently, these variations are not considered 
prior to distention and this can leave regions within the pancreas with reduced enzyme delivery. 
Inefficient or limited enzyme delivery is regarded as a major cause of incomplete tissue digestion 
in some cases, which contributes to reduced islet yields. As such, new techniques must be 
developed to maximize delivery for all anatomical variants, or the distention should be actively 
monitored with a tool similar to the one discussed here to ensure optimal and efficient enzyme 
delivery and distribution. Pancreatic anatomy varies from donor to donor314 and previous 
studies80,315,317 have demonstrated the importance of pig strain on islet isolation outcome. In our 
study we used Landrace pigs as they are considered to be highly suitable donors for islet isolation 
and xenotransplantation316–318 since isolations with this breed can yield large numbers of islets 
compared to other breeds. A previous study from our laboratory on adult Landrace pig pancreas 
anatomy38 suggested that the current methods of enzyme delivery may limit the uniform delivery 
of enzyme throughout the pancreas when atypical anatomical variations of the ductal network are 
observed. While visual assessment of pancreatic distention can give some idea of gross delivery, 
it is difficult to determine or quantitate the extent of delivery within the pancreas since only the 
superficial aspect can be observed. The MRI method proposed allows for clear visualization of 
the internal ductal system and can be used to appreciate the efficacy and homogeneity of enzyme 
delivery throughout and within the entire pancreas. 
This study aimed to demonstrate that MRI can be utilized as a tool to evaluate the efficacy of 
enzyme delivery throughout the pancreatic ductal system, and that it can be used as a cost-
effective method to screen and evaluate novel strategies for enzyme infusion with the goal of 
optimizing enzyme delivery and improve islet isolation outcomes. Three methods of delivery 
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(Figure C.2) including the presently used method (Method 1) were investigated, and imaged to 
evaluate distention efficacy and enzyme delivery. As demonstrated in Figure C.3, methods of 
enzyme delivery that involved removal of the duodenal lobe from the rest of the pancreas can 
result in reduced or even total lack of delivery to significant portions of the lobe. Additionally, it 
was demonstrated that for pancreata with an atypical ductal anatomy, severing the bridge prior to 
enzyme infusion can prevent delivery to significant regions of either the connecting lobe (Figure 
C.4B, Type ‘A’ ductal anatomy) or the splenic lobe (Type ‘B’ anatomy)69,85,104,309,311,312. The data 
presented in this study further suggests that traditional methods of porcine pancreas distention 
may not facilitate reliable and homogeneous delivery of enzyme throughout the 3 lobes of the 
pancreas. The most likely cause of the incomplete distention of the pancreatic duct is the severing 
and mishandling of key ductal networks required for the delivery of the enzyme. One proposed 
way to avoid disrupting these ductal networks is to avoid segmenting the pancreas prior to 
distention (Method 3). All pancreata investigated with this method exhibited a uniform delivery 
of contrast medium throughout the organ. Therefore, minimizing the manipulation of the ductal 
network prior to distention may facilitate optimal distribution of the enzyme.  
Prior knowledge of the pancreatic ductal system and the variable anatomy could be used to 
determine the most effective distention method for each pancreas, and would allow for 
disqualification of poorly distended pancreata before proceeding with the costly islet isolation 
process. Further development of this technique may enable prospective and real-time 
visualization of ductal network distention by MRI. If this could be developed as a prospective 
tool, it would enable internal visualization to ensure that all regions are adequately infused with 
digestive enzyme, and could improve the use of targeted local parenchymal enzyme injection to 
rescue a portion of inadequately distended tissue. Knowing the variable ductal distribution, and 
avoiding disruption the ductal networks caused by segmenting the pancreas, may make the 
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distention process more efficient and effective, which may intern improve islet isolation 
outcomes.  
The imaging technique described here for internal visualization of the porcine pancreatic ductal 
system may also be useful for human pancreata. One major example where MRI could offer value 
is for cases of pancreas divisum, where there is a lack of a connection between the main and the 
accessory pancreatic ducts. This condition afflicts 10-22% of all pancreata harvested for islet 
isolation368. It is anticipated that this anatomical variation could affect the distention of  
significant parts of the pancreas. This may be especially important in clinical islet auto-
transplantation274 for patients with chronic pancreatitis, as pancreas divisum is reported to be 
associated with chronic pancreatitis368. Kin et al. used the traditional technique for distention, and 
compared isolation outcomes from normal versus visually identified pancreas divisum cases368. 
They observed no visual differences in distention quality, and found no statistical differences in 
islet yields between the 2 ductal variants, although mean islet yield was lower for pancreas 
divisum. Application of this imaging tool would enable the direct visualization of enzyme 
distribution for each of these cases and may offer an explanation for the lower islet yields 
observed for pancreas divisum. Furthermore, MRI could help detect regions with reduced enzyme 
delivery surrounding the accessory pancreatic duct due to narrowing. If these regions are not 
consistently and homogeneously distended, different paths for distention could be tested and 
optimized to potentially improve human islet isolation. This technique can facilitate the 
visualization of possible ductal anomalies or narrowing, the recognition of which could make the 
process of pancreas distention and islet isolation more effective. 
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Conclusions 
Presently utilized methods for enzyme delivery through ductal distension in pig pancreata are 
incapable of delivering the enzyme consistently and homogenously to all pancreatic regions given 
the variability in porcine pancreas anatomy. Visual assessment of pancreatic distention cannot 
accurately assess whether enzyme is effectively delivered throughout the entire pancreas. MRI is 
a valuable tool that can help improve the understanding of the variable pancreatic ductal 
anatomies, and may help overcome the difficulties associated with incomplete distention and 
inhomogeneous enzyme distribution for islet isolation. This imaging method can be used to help 
ensure uniform enzyme distribution in both porcine and human pancreata, and to evaluate and 
optimize new distention methods that might ensure adequate distention of all regions despite 
anatomical variations. The presented MRI based method should be further developed into a 
prospective and quantitative tool for visualization of enzyme distribution during pancreas 
distention for islet isolation. This would enable anatomy specific modifications to distention 
protocols for each individual pancreas, and may increase the consistency and success of certain 
islet isolations. 
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Devices and methods for maintenance of temperature and pressure 
during islet shipment 
Summary 
Exposure to extreme temperatures and pressure ﬂuctuations during shipment by air may have a 
detrimental impact on islet quality. In this study, we sought to assess the ability of methods and 
devices to provide better control of the internal environment of islet shipping containers in terms 
of temperature and pressure. Experimental islet shipping containers were packed with 21 panels 
of commercially available TCP Phase 22 Phase Change Material (TCP). The containers were then 
exposed for at least 15 hours to three constant external temperature conditions, namely, -20°C, 
4°C, and 40°C, and then evaluated for their ability to maintain an internal temperature close to the 
desired value of 22°C. Custom-designed pressure regulated gyroscopic shipping containers 
(PRGSC) placed in a vacuum chamber were exposed to an absolute pressure of 250 mm Hg 
(substantially lower than that experienced during shipment by air) for 25 minutes to assess their 
ability to control internal pressure under vacuum. Electronic data loggers were used to monitor 
internal and external temperatures and pressures under all conditions.  Twenty-one TCP panels 
placed in a single islet shipping container were able to maintain the internal temperature between 
17°C and 24°C for a minimum of 15 hours at all three external temperatures. The PRGSC tested 
were able to maintain a constant internal pressure of 760 mm Hg when exposed to vacuum. Our 
results demonstrated that the use of containers equipped with TCP and PRGSC exert excellent 
environmental control over islet shipments by minimizing temperature and eliminating pressure 
ﬂuctuations.  
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Introduction 
Islet preparations are sensitive to temperature extremes. Although the effects of pressure changes 
on islets have not been studied directly, it has been suggested that pressure ﬂuctuations during 
islet shipment by air may have a negative impact on islet integrity and quality. In addition, some 
shipping vessels may not be able to withstand pressure ﬂuctuations and thus either deform or 
break. Frequently, islets are shipped in a Styrofoam container with cooling packs369. However, 
cooling packs may accelerate freezing when islets are shipped to cold climates or during the 
winter. Overall, cooling temperatures may be detrimental to islet viability and therefore 
undesirable. Additionally, standard Styrofoam containers alone neither insulate well against 
temperature extremes (hot/cold) nor regulate internal pressures during shipment. Hence, there is a 
need to develop methods to control the internal environment of islet shipping containers while 
they are exposed to extreme external temperatures and pressure fluctuations, with the ultimate 
goal to make shipment an extension of islet culture. 
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Materials and Methods 
Temperature Control Investigation  
Experimental container 1 consisted of a corrugated plastic package containing 21 TCP Phase 22 
Phase Change Material panels (TCP, Part# FGEL00052, TCP Reliable, Edison, NJ) weighing 6.3 
kg, Styrofoam walls 4 inches thick, and plastic bubble wrap to keep the culture vessel in place. 
Shipping containers were prepared for three separate temperature conditions, -20°C, 4°C, and 
40°C. A Ken-more upright freezer (Model# 106.8263511, Sears Holdings Corp., Hoffman 
Estates, Ill) was used for all -20°C conditions. The freezer temperature oscillated between -20°C 
and -30°C at an approximate rate of 1 cycle/hour. A Fisher scientiﬁc refrigerator (Isotemp Model, 
Thermo Fisher Scientiﬁc, Inc., Waltham, Mass) was used for all 4°C conditions. A Heraeus 
water-jacketed incubator with 5% CO2 was used for all 40°C conditions (6000 Model, Thermo 
Fisher Scientiﬁc). The TCP panels were appropriately primed for each temperature. Panels 
designated for -20°C and 4°C were fully liquiﬁed by incubation at 37°C for 6 hours before 
packaging. Panels designated for 40°C were fully solidiﬁed by cooling them at 4°C for 6 hours 
before packaging. Culture vessels were loaded with 50 mL of distilled deionized water and 
packed into the shipping containers (one vessel per container). Internal container temperatures 
were recorded using HOBO electronic temperature loggers (Part# H08-007-02, Onset, Pocasset, 
Mass) placed next to the culture vessels. The containers were closed and placed in the -20°C 
freezer, the 4°C refrigerator, or the 40°C incubator. A second set of HOBO electronic temperature 
loggers were placed outside each of the boxes and recorded the external surface temperatures of 
each shipping container. The containers were exposed to the experimental temperatures for 15 
hours, which is the approximate time of an overnight shipment. After exposure, the containers 
were removed and the temperature data analyzed.  
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Experimental container 2 was modeled after a model recently evaluated for standardization of 
shipments of human research islets by the Islet Cell Resource (ICR) Center Consortium. It 
consisted of a ThermoSafe EPS Insulated Shipper (Model# 355, Arlington Heights, Ill), 2 
ThermaSure Temperature Stabilizer gel packs (TS, Model# 1290, Sebra, Tucson, Ariz) weighing 
1.6 kg, and plastic bubble wrap to keep the culture vessel in place. The containers were primed 
according to the manufacturer’s instructions, loaded, and exposed to the above environmental 
temperatures. Data were recorded in the same manner as for the TCP containing packages. A 
modified version of experimental container 2 that included 6 TS units was also tested with 
various pre-shipment preparation techniques. These units were only exposed to -20 °C and 40 °C 
external conditions, but the TS units were prepared prior to the test to be in the solid phase, the 
liquid phase, or a slushy phase. Temperature data was collected from these containers for up to 84 
hours, and the temperature threshold of 20±2 °C was used. Failure of the temperature regulation 
for the container was defined as dropping below freezing (< 0 °C), or rising above 40 °C.  
A ThermoSafe EPS Insulated Shipper (Model# 413) with Styrofoam walls was packed with 
plastic bubble wrap, a culture vessel, and a HOBO electronic temperature logger. It was used as a 
reference container to simulate shipping containers routinely used for distribution of islets in the 
past. This reference container was exposed to the three experimental temperatures for 8 hours. A 
second HOBO electronic temperature logger was placed outside the reference container to record 
external temperatures for each condition. The reference container was also used to record tem-
peratures and pressures during actual islet shipments from the University of Minnesota (UMN) to 
ﬁve investigators around the United States. The data from these shipments are presented in 
Figure D.1A. 
Pressure Control Investigation  
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The pressure regulated gyroscopic shipping container (PRGSC, Part# PR-AY-11-0007, Wilson 
Wolf Manufacturing Corporation, New Brighton, Minn) was designed in a collaboration between 
the UMN and Wilson Wolf Manufacturing Corporation. The PRGSC was loaded with the same 
culture vessel used in the temperature investigation and a HOBO absolute pressure logger (Part# 
HPA0015), sealed, and placed in a custom-designed acrylic vacuum chamber (Donovan 
Specialties, Osseo, Minn). A second HOBO pressure logger was placed on top of the PRGSC to 
measure external pressure. The vacuum chamber was sealed and an attached Cole-Parmer 
vacuum pump (Cat. # K-07061-40, Cole-Parmer Instrument Co., Vernon Hills, Ill) was used to 
reduce the absolute pressure to 250 mmHg (about 150 mmHg lower than the lowest pressure 
observed during shipment, as shown in Figure D.1B) for 25 minutes. After vacuum exposure, the 
PRGSC was removed for analysis of the pressure data.  
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Results  
Internal temperatures and pressures recorded over the course of actual islet shipments with the 
reference container varied substantially (Figure D.1). The variations in temperature depended on 
several factors such as the climate of the shipping and receiving centers, the season, and the 
conditions of air transit, ground transit, and warehouse storage. Pressure ﬂuctuations depended on 
the number of connecting ﬂights used per shipment and the use of pressurized versus 
nonpressurized ﬂight environments.  
When experimental container 1 containing TCP was exposed to temperatures between -20°C and 
-30°C for 15 hours, it maintained an internal temperature between 21°C and 24°C (Figure D.2A). 
In comparison, the internal temperature of experimental container 2 with TS dropped from this 
range within 2 hours, and reached 0 °C after 12 hours of exposure. Experimental container 1 with 
TCP maintained a stable internal temperature of 22 °C for longer than 24 hours when exposed to 
4°C (Figure D.2B). Experimental container 2 with TS exposed to 4°C was unable to maintain an 
internal temperature close to 22°C. The temperature fell as low as 15°C before equilibrating at 
17°C after 6 hours (Figure D.2B). Experimental container 1 containing TCP exposed to 40°C for 
15 hours maintained an internal temperature between 17°C and 22°C (Figure D.2C). In contrast, 
experimental container 2 was able to maintain this temperature range for less than 4 hours and the 
internal temperature was within 3 degrees of the ambient by the end of 15 hours (Figure D.2C).  
Studies using experimental container 2 with a total of 6 TS units exhibited much better thermal 
regulation due to the increased mass of thermal regulating material (Figure D.3). By increasing 
the number of TS devices, the time until failure was dramatically increased, and the best 
performance was achieved when the TS units were prepared allowing for a full phase-transition 
during shipment. When exposed to -20 °C the solid TS units maintained temperatures above 0 °C 
for up to 30 hours, while the recommended slushy preparation lasted for only 22 hours. The 
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internal temperature for all three preparations fell outside of the desired temperature threshold in 
less than 6 hours when exposed to -20 °C, and Experimental container 1 still performed much 
better. When exposed to 40 °C, the solid prepared TS units maintained temperatures < 40°C for 
up to 48 hours, and the recommended slushy preparation failed after only 30 hours. The internal 
temperature of the containers regardless of the TS unit preparation phase fell outside of the 
desired threshold in less than 12 hours when exposed to 40°C while, as presented above, 
experimental container 1 was able to maintain the desired temperature for > 24 hours. 
During the PRGSC trial, the pressure inside the vacuum chamber was reduced from 760 to 250 
mmHg within 1 minute and maintained at that level for over 25 minutes. Despite the large drop in 
external pressure, the PRGSC maintained a constant internal pressure of 760 mmHg (Figure 
D.4). 
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Figure D.1: Temperature and pressure changes during shipment. Shipments using the reference 
container sent to ﬁve research centers from the University of Minnesota, Minneapolis, Minnesota, on 
March 10, 2004. The vertical dashed lines indicate one group of ﬂight departures and arrivals. (A) 
Temperature data recorded every 4 minutes. The horizontal dashed line indicates target islet vessel 
temperature (22 °C). (B) Pressure data recorded every 4 minutes. 
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Figure D.2: Temperature measurements in experimental containers. Comparison of internal 
temperatures for various shipping containers plotted over time under exposure to external temperatures of 
(A) -20°C, (B) 4°C, and (C) 40°C. The horizontal dashed lines indicate the targeted islet vessel temperature 
(22°C). 
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Figure D.3: Temperature measurements in ICR Shipping containers. The ICR shipping container 
contained 6 TS units, and were exposed to -20 °C and 40 °C external environments. The TS units were 
prepared prior to exposure with three different starting-phase conditions (sold, liquid or slushy), the internal 
temperatures were monitored, and failure was defined when the internal temperature exceeded 37 °C or 
dropped below 0 °C. This figure was not included in the original published version of this paper93, but is 
included here as supplemental data in the context of this study. 
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Figure D.4: PRGSC maintains pressure. Internal pressure for pressure regulated gyroscopic shipping 
container (PRGSC) when exposed to 250 mmHg absolute pressure vacuum.  
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Discussion 
Data obtained from actual islet shipments in reference containers during March of 2004 indicated 
that shipped islets were exposed to temperatures that ranged between 0°C and 32°C (Figure 
D.1A). Additionally, the reference containers experienced pressure drops as much as 200 mmHg 
during these shipments (Figure D.1B). The environmental conditions used in this study simulate 
conditions that may occur during overnight islet shipments by air. Ground transit on trucks during 
summer or in warmer climates can result in exposure of shipped islets to external temperatures at 
least as high as 40°C. At the opposite extreme, nonpressurized ﬂights or warehouses without 
temperature control during winter can expose shipped islets to subfreezing temperatures. Islet 
shipments on nonpressurized ﬂights can also experience low pressures (Figure D.1B).  
More recently adopted packaging, such as experimental container 2 with 2 TS units, is better than 
previously used Styrofoam reference containers with or without cooling packs, but it is still 
inadequate for maintaining internal temperature under realistic shipping conditions from various 
islet isolation centers. During extreme heat exposure, the internal temperature of experimental 
container 2 came within 3 degrees of the external temperature after 15 hours. Furthermore, when 
exposed to extreme cold, the internal temperature of experimental container 2 fell below -10°C. It 
is undesirable for investigators to receive tissue exposed to extreme temperatures; freezing can 
lead to reduced viability, whereas overheating can lead to increased metabolic demand, nutrient 
depletion, increased accumulation of toxic metabolic byproducts, and ultimately cell death. 
It should be noted that an exact comparison between the two phase-change materials, TS and 
TCP, was not conducted in this investigation. The number of TS packs used was chosen to 
simulate test containers evaluated by the ICR Center Consortium. Studies using an increased 
number of TS packs (Figure D.3) demonstrated further improvement in the performance of a 
shipping container based on this phase-change material. The density, compactness, and pricing of 
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TS will determine in part the practicality of increasing the number of TS for achieving better 
temperature control.  
The data suggest that the target shipping temperature of 22 ± 2°C can be maintained using 
corrugated plastic shipping containers packed with properly primed TCP. Even when exposed to 
extreme external temperatures, experimental container 1 with TCP maintained moderate internal 
temperatures. These stable temperatures approximated the target culture temperatures for human 
islets 24 hours post-isolation.  
Future temperature control studies should focus on simultaneously protecting against both cold 
and hot temperature extremes. To account for seasonal differences in external temperatures, it has 
been suggested that liquiﬁed packs should be used in the winter and solidiﬁed packs in summer. 
However, this approach of priming the phase-change materials based on season is undesirable 
because of ambiguity during the spring and fall seasons and, more important, because 
temperatures can vary signiﬁcantly across the route of a shipment (e.g., Minneapolis to Miami in 
January). Two approaches for better addressing this problem have been proposed. The ﬁrst 
approach is to prime all packs by bringing them into a slushy (part liquid/part solid) state. 
However, priming may be poorly controlled with this approach as the fraction of the material in 
each phase cannot be accurately quantiﬁed and reproduced in all laboratory environments and 
situations in terms of ambient temperature, heat transfer, and timing. The second approach is to 
liquify a fraction of the packs to protect against cold temperatures and solidify the rest for 
protection against hot temperatures. The shipping container is then loaded with liquiﬁed as well 
as solidiﬁed packs. The fraction of each group could be deﬁned based on the magnitude and 
duration of the possible temperature gradients in each direction.  
The experimental results from the pressure control investigations suggest that the PRGSC can be 
used to maintain a stable internal pressure during islet shipment. When the external pressure was 
  337 
reduced to 250 mmHg, a constant atmospheric pressure of 760 mmHg was maintained internally. 
The PRGSC can reduce the stress upon both the culture vessels and the shipped islets, providing 
one more measure of protection for islet shipments.  
Conclusion 
Based on the results presented in the current manuscript we concluded that, when TCP phase-
change material was used in conjunction with the PRGSC for islet shipments, greater 
environmental control was achieved as pressure variations were eliminated and temperature 
ﬂuctuations were minimized over long periods of time. This level of environmental control is 
expected to result in improvements in the quality of shipped islets received by investigators in the 
United States and worldwide. These improvements are particularly important when shipment of 
islets for clinical transplantation is implemented on a larger scale. 
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Improving purified porcine islet viability by continuous 
quadrupole magnetic sorting (QMS) 
Summary 
Islet transplantation (ITx) is a minimally invasive alternative to whole pancreas transplant for 
patients with uncontrolled type 1 diabetes. The islet isolation and purification process requires 
exposure to extended cold ischemia, warm-enzymatic digestion, mechanical agitation and the use 
of damaging chemicals for density gradient separation (DG), all of which inflict substantial 
damage reducing viable islet yield. Quadrupole magnetic separation (QMS) during digestion has 
been explored as an alternative for islet purification to reduce warm ischemia during isolation, 
minimize enzyme exposure and eliminate the use of density gradients. We explored the use of 
QMS for islet purification and compared the viability of QMS and DG purified islets. Porcine 
pancreata (n=3) were split into 2 parts; the combined connecting/duodenal lobe (CDL) and the 
splenic lobe (SPL). Islets were preferentially labeled using magnetic micro-particles (MMPs) that 
lodge within the islet micro-vasculature when infused into the pancreas. This allowed the 
continuous separation from the exocrine tissue by QMS during the collection phase of the 
digestion process. An optimized dose of MMPs (4.5 µm diameter) were infused into the splenic 
artery to label islets within the SPLs, which were then digested using the Ricordi method and then 
continuously purified by QMS. Unlabeled islets from the paired CDLs were isolated using the 
same method and purified using DG. Oxygen consumption rate (OCR) normalized to DNA 
content (OCR/DNA) was used to compare the fractional viability of islets from both groups. 
Islets purified by QMS exhibited significantly improved viability and better morphology relative 
to control islets. The mean OCR/DNA of islets purified by QMS was higher than those purified 
by DG (209±25 vs. 125±11 nmol/min/mg DNA; p=0.02 via two-tailed paired student’s t test). We 
conclude that continuous islet purification by QMS can reduce the detrimental effects of 
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prolonged exposure to toxic enzymes and density gradient solutions and substantially improve 
islet isolation efficiency and ITx success.  
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Introduction 
Pancreatic islet transplantation is a promising and cost beneficial treatment for select patients 
with type 1 diabetes203,370, but there are many hurdles to overcome before transitioning to a 
standard of care. Using the current islet isolation and purification processes, enormous quantities 
of islets are needed to achieve insulin independence. Because of this large islet dose requirement; 
patients often require multiple islet infusions from two or more donors9,202,205. Islet isolation and 
pancreas allo-transplantation have similar success rates for maintaining insulin independence five 
years following transplant, but shortages of suitable donor pancreata limit the application of this 
encouraging treatment208.  Some centers have demonstrated success with single donor transplants 
, and it is clear that a minimum viable islet dose is required to reverse diabetes208,298. 
Many factors contribute to islet yield and viability including the donor parameters, procurement 
techniques, organ preservation methods, and especially the isolation process itself. Many islets 
are never retrieved during isolation371 or are irreversibly damaged along the way277,372,373. The 
standard isolation processes involves a digestion step to liberate islets from the surrounding 
parenchyma, and a purification step to separate and purify the islets from the digested exocrine 
tissue. Other alternative methods are being explored275,276, but the standard digestion procedure 
uses strong proteolytic enzymes that are infused into the pancreatic ductal system to preferentially 
digest exocrine tissue at 37°C. The digestion process is harmful, and has been shown to damage 
islets374,375, but the purification step also damages islets  most likely synergizing with the stresses 
encountered throughout the islet isolation process. Islets, making up only about 2 % of the total 
pancreas mass, are purified after digestion to decrease the volume of tissue being transplanted and 
to eliminate unnecessary and potentially harmful exocrine tissue. The exocrine tissue itself 
releases endogenous enzymes that may contribute to islet damage and loss in culture376. Co-
culture of islets with contaminating exocrine tissue has been shown to decrease the overall 
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viability of the preparation, and this may have lasting effects decreasing the effectiveness of the 
graft post-transplant. Exocrine contamination may also directly affect graft health post-transplant 
by hindering vascularization377 and eliciting damaging inflammation and immunologic 
responses378.  
Current purification processes rely on a density gradient technique to separate the less dense islets 
from the more dense exocrine tissue. This method confounds the damage islets experience during 
digestion, by prolonging exposure to proteolytic enzymes.  Furthermore, islets continue to 
experience substantial stresses throughout the purification process including extended hypoxia, 
abrupt temperature changes, mechanical shear stresses, as well as prolonged exposure to reactive 
oxygen species, hyperosmolar solutions, and pro-inflammatory cytokines366,379–381. All of these 
factors contribute to the overall viability and potency of the islet preparation. The density 
purification process also involves a collection step where islets are concentrated into pellets 
which create a very hypoxic environment. This is a paramount concern because islets are known 
to be especially sensitive to warm and cold ischemia because they lack the ability to cope with 
hypoxia291. Following the collection step, the islets are exposed to the density gradient chemicals 
(commonly Ficoll® or similar), and then centrifuged as a batch process in a COBE 2991 machine 
to separate the different tissues.  The gradient solutions themselves have also been shown to 
contribute to islet damage and may encourage apoptosis380–382. This process can also be difficult 
to control (especially with human preparations) because of intrinsic inconsistency in exocrine 
tissue density, and variability in the extent of tissue digestion366,383,384. 
Many alternative approaches to gradient purification have been explored, but none have proven to 
be a suitable replacement366 despite the clear need for improvement. This can be partially 
attributed to limitations in scale and a lack of large throughput capability that is required for 
therapeutic islet transplant. Magnetic purification is one suggested method for islet purification, 
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and could offer significant benefits when compared to other methods. Magnetic separation 
techniques have been used to purify islets by selective magnetic labeling of the endocrine383,385, or 
the exocrine tissue386. Islet yields and transplant outcomes in rats were improved when magnetic 
micro particles (MMP) were preferentially entrapped within the tortuous microvasculature and 
purified using magnetic retraction387. Furthermore, developments in quadrupole magnetic 
separation (QMS) technology have shown promise for the large scale batch purification of 
porcine islets, with no observed detrimental effects on islet function due to magnetic forces or 
shear stresses277,388,389. Suszynski et al. also demonstrate that MPs are well tolerated in vivo, with 
no observed increase in islet cytotoxicity or inflammatory responses in mice390.  
To further investigate the potential to improve isolated islet quality and viability, this pilot study 
directly compares density gradient purification and QMS technologies. Three porcine islet 
isolations were conducted to evaluate potential benefits of QMS. There is a growing interest in 
porcine islet xenotransplantation as a promising and cost-efficient approach to alleviate the donor 
shortage33,112. Also, porcine donors are a good surrogate model for these purification comparisons 
due to the similarity in pancreas size to the humans; and the consistency of donor parameters, 
procurement methods, and isolation parameters. For this study, QMS technology was further 
adapted for the continuous purification of porcine islets to reduce exposure to damaging digestion 
components, and eliminate exposure to harmful density gradients. Islet quality was determined by 
morphology score and viability was determined by oxygen consumption rate normalized to DNA 
(OCR/DNA)25–27, a predictor of islet function26. Improving islet quality and viability will improve 
the potency of transplanted islet preparations and may significantly improve the success of single 
donor islet transplantation.  
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Materials and Methods 
Experimental design 
This pilot study compares the quality and viability of isolated porcine islets purified by either 
QMS or continuous density gradients (DG). To control for donor variability, and allow for paired 
comparisons between techniques, QMS and DG were done on islets from separate lobes of the 
same pancreas, that were digested using identical parameters. The pancreata were divided into 
two parts, with the first part composed of the combined connecting and duodenal lobes (CDL), 
and the second part being composed of the splenic lobe (SPL)38. Islets in the SPL were labeled 
with magnetic micro beads as described below, and islets in the CDL were not labeled. Both 
lobes were digested simultaneously but in separate digestion chambers and using identical 
isolation parameters and materials to ensure identical warm and cold ischemia, and similar 
digestion outcomes. Islets from the CDL were purified using standard DG purification, and 
labeled islets from the SPL were purified using an islet QMS system. Islet quality based on 
morphology score, and viability based on oxygen consumption rate normalized to DNA were 
compared between conditions. 
Donors, procurement, and labeling 
All procedures involving animals were approved by the Institutional Animal Care and Use 
Committee (IACUC) and performed at the University of Minnesota. Three adult landrace porcine 
donors were used for this brief study, and all donors had similar mass (257 ± 3 Kg) and age (36 ± 
0 months). Procurements were performed using previously described methods38,50,295, but briefly 
described as follows. Porcine donors were chemically sedated with a 100-500 mg dose of telazol, 
heparinized and then euthanized with a fatal dose of sodium pentobarbital. Following 
confirmation of death, donors were exsanguinated, eviscerated, and pancreata were dissected 
from the viscera en bloc on the back table. During dissection, the aorta was located and the celiac 
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trunk (CT) and superior mesenteric artery (SMA) were simultaneously flushed with 3-5 liters of 
cold organ preservation solution (CPS), and the pancreatic duct was infused with 60 ml of ductal 
preservation solution. The pancreas was also cooled by applying crushed frozen lactated Ringers 
solution and irrigation. All pancreata experienced less than 20 minutes of warm ischemia. After 
complete resection with the vasculature intact, the pancreas was split into the CDL portion, and 
the SPL portion. The native arterial vasculature was preserved with the SPL for infusion of 
MMPs. A previously optimized dose of  4.5 µm diameter MMPs (Dynabead M450, Invitrogen, 
Carlsbad, CA) were suspended in one liter of CPS (16 x108 MP/L) and infused into the splenic 
lobe through the CT and SMA using the hand syringe technique described by Rizzari et al in 
2010295. After bead infusion, a second liter of CPS was flushed into the arteries to rinse out any 
beads that were not securely lodged in the micro-vessels. Then both portions of the pancreas were 
submerged in CPS and transported to the isolation facility in an ice-filled cooler. All pancreata in 
this study experienced less than 250 minutes of cold ischemia before isolation. 
Digestion 
Islets were isolated from each lobe by the isolation team at the Schultze Diabetes Institute at the 
University of Minnesota, in the same manner using the standard enzymatic digestion 
process391,392. The new enzyme mixture described by Balamurugan et al. in 2012 for use with 
human islet isolation274, was used to manually distend the pancreatic lobes from each pancreas. 
Following distension, the pancreas tissue was cut into 1 cm pieces and placed into a digestion 
chamber. Both the CDL and SPL from each pancreas were digested separately, using identical 
isolation parameters. The tissue from the CDLs was collected and purification by density 
gradients, and tissue from the SPL was continuously purified using QMS. 
Density Gradient Purification 
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Following the digestion phase, the digested tissue from the CDL of each pancreas was prepared 
for density gradient purification. The tissue was collected and recombined using the standard 
method in chilled conical tubes primed with heat inactivated porcine serum serum to reduce the 
enzyme activity. The tubes were gently centrifuged and all of the tissue pellets were further 
collected into a single conical. The digested tissue was then separated by continuous density 
gradients (UW/OptiPrep Axis-Shield, Dundee, UK) using a Cobe 2991 cell separator 392,393, to 
attain a pure islet fraction. 
QMS Purification 
After completion of the digestion phase and when periodic sampling indicates that the islets are 
free, tissue from the SPL of each pancreas was separated by QMS. Rather than collection into 
conicals, the digested tissue containing MP labeled islets and unlabeled exocrine tissue was 
directly processed by the QMS system shown in Figure E.1. Before the purification process 
began, the Islet QMS separator (Techshot Inc., Greenville IN)
388
 was primed with Hanks’ 
balanced salt solution (HBSS) containing 10% heat inactivated porcine serum, and an infusion 
bag for flow buffering was prepared containing the same solution. The digested tissue left the 
chamber, and was directly transferred to the buffer bag. The tissue only remained in the buffer 
bag for a few moments as it was quickly passed through the QMS system. The QMS inlet flow 
rate (out of the buffer bag) was matched with the flow rate of tissue leaving the digest chamber to 
maintain a continuous purification process. The mechanism for the QMS process using this 
system is described in detail by Kennedy et al. and others 277,388,394. Briefly, as the tissue flow 
stream entered the QMS separator column, it is met with a parallel fresh stream of HBSS 
solution. Labeled islets are pulled by the magnetic force within the column out of the isolation 
stream and into the fresh solution stream, and then remain within the column. Unlabeled exocrine 
tissue passes freely through the column and into a waste collection vessel. After all of the tissue 
  347 
has been processed, the column is removed from the magnet, and the purified islet tissue is gently 
washed out. 
Isolation Outcomes and Islet Quality Assessment 
After the purified islet fraction is collected from either the COBE bag, or the QMS column, the 
islets are gently washed with fresh culture medium (supplemented ME199, Mediatech Herndon, 
VA). Samples were taken for initial quality assessment, and then cultured using the same medium 
at 37°C with 5% CO2 for up to 7 days in silicon rubber bottom culture vessels (Wilson Wolf 
Manufacturing, New Brighton, MN)91. Islets from both conditions were cultured at a density of 
2000IE/cm2 or less. Initial samples from both conditions were assessed for quality by comparing 
islet morphology score 135,365,392,395 and viability by measuring the OCR/DNA as described in 
literature26. These methods are established, but described briefly as follows. Qualitative 
morphological assessment was made by experienced isolation personnel, where samples of islets 
were viewed under magnification and scored from 0-2 based on the shape, border, integrity, 
diameter, and presence of single cells for a total score from 0-10 for each sample. Islets with 
better gross morphology would have a higher score. Islet viability was determined by measuring 
the OCR/DNA using a titanium stirred micro-chamber system25, and DNA was quantified using 
the Quant-iT PicoGreen dsDNA kit (Molecular Probes, Eugene, OR). 
Statistical Methods 
Small samples sizes are a limitation of this brief study, nonetheless average values are reported as 
the mean ± the standard error of the mean. The two tailed un-paired student t test was used to 
compare OCR/DNA measurements, while the non-parametric Mann-Whitney rank sum test was 
used to compare islet morphology scores between groups. 
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Figure E.1: Schematic diagram of continuous purification QMS system. The QMS replaces the 
collection and purification steps of the islet isolation process with a continuous QMS of labeled islets from 
the collection stream leaving the digestion chamber. This process streamlines islet preparation, avoids the 
harmful centrifugation, recombination, and gradient purification steps, and immediately washes and 
collects the purified islet product. 
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Results 
To explore the potential of using QMS to improve isolated islet quality and viability, this paired 
experiment was designed as a pilot study to directly compare this purification method to the 
traditional method of DG purification. Three porcine pancreata were split into two parts, with the 
first part (CDL) being isolated and purified by DG, and the second part (SPL) being isolated and 
purified by continuous islet QMS. Isolated islets were compared for quality as determined by islet 
morphology score, and viability as determined by OCR/DNA measurements immediately 
following isolation, and after 7 days of culture. 
Porcine islet morphology as reported by the islet score can be a gross indicator of damage that 
occurs during the digestion and purification process. Islets from porcine donors do not have a 
robust islet capsule that is often observed surrounding human islets, and this can make them more 
sensitive to damage associated with the isolation process. Frequently, islets are observed with 
rough and uneven borders indicating damage to the cells around the islet periphery. Figure E.2A 
shows a plot of average islet morphology scores of islets isolated and then purified using the 
QMS and DG systems. Islets purified by QMS had an improved average islet score when 
compared to islets purified using a standard DG system, and Figure E.2B-C shows representative 
micrographs of islets from each condition. Due to the small sample sizes used in this study, the 
difference in average islet scores is not statistically significant (p=0.16), but the differences in 
gross islet morphology observed in the micrographs can be easily appreciated at the higher 
magnification shown. 
Oxygen consumption rate measurements were taken from samples of islets of each condition to 
determine the viability. Samples were collected and assessed immediately following isolation, 
and after 7 days of culture. The OCR/DNA of islets purified by QMS was significantly higher 
than DG purified islets immediately following isolation with mean values of 236 ± 25, and 135 ± 
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11 nmol/min/mg DNA respectively  (p < 0.03) and marginally higher after 7 days in culture with 
mean values of 231 ± 32 and 224 ± 28 nmol/min/mg DNA respectively (p > 0.8). Figure E.2D 
shows a 67% improvement in islet viability immediately following isolation. This improvement is 
not as prominent after the 7-day culture period because the DG average viability increased during 
the culture period. This could be explained by the clearing of dead tissue in the DG condition, 
which improves the average viability with a loss in total tissue recovery. Comparisons of islet 
yield and purity were beyond the scope of this small trial because sort parameters were not 
optimized for these outcomes. 
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Figure E.2: Juvenile porcine islet morphology and OCR/DNA. (A) Islet morphology scores determined 
immediately following isolation and purification. Islets purified by quadrupole magnetic separation (QMS) 
show improved morphology scores compared to traditional density gradient purified islets. Higher scores 
indicate better islet shape, borders, integrity, and diameter along with reduced presence of single cells. The 
sample size is small so the difference is not significant, however QMS purified islets exhibited a better 
score for all three islet isolations. (B-C) Representative magnified images of islets stained with dithizone 
immediately following isolation purified using; (B) density gradients (DG) or; (C) quadrupole magnetic 
separation (QMS). At higher magnification it is easy to appreciate the improved gross morphology of islets 
purified by QMS. Islet purified using QMS noticeably exhibit a more robust appearance, with larger sizes, 
more defined borders and less free single cells. Islets purified using DGs frequently have a more 
fragmented appearance, with smaller size, and rough borders. (D) Bar graph presenting the measured 
viability of islets purified using density gradients (DG), or quadrupole magnetic separation (QMS) 
immediately following isolation-D. QMS purified islets have a significantly higher viability (p = 0.03) than 
DG purified islets immediately after isolation. 
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Discussion 
Islet allo-transplantation is a promising therapy for the treatment of type 1 diabetes, and islet 
xeno-transplantation offers the opportunity to alleviate donor shortages, and expand the 
application of this treatment to a larger patient population. Islet transplantation offers many 
benefits over other therapies such as whole pancreas transplant, or insulin therapy68,396. Despite 
these benefits, one of the primary barriers to expanding the application of islet transplantation is 
the frequent need for multiple islet transplants, from 2-3 donors, to maintain insulin independence 
often in quick succession. This requirement puts further strain on the already stressed organ 
donation programs, and prevents the growth of this promising treatment. Some centers have 
encountered success with single-donor transplants208,298, but most centers still need multiple donor 
pancreata to meet the very large total islet dose required for patients to remain insulin 
independent9,202,205,396. Experience in pancreatic surgery suggests that patients can avoid diabetes 
even when large portions of their pancreas are removed, and research suggests that patients don’t 
become diabetic until a large portion of their islet function fails397–399. These experiences suggest 
that current islet transplant dose requirements have significant room for improvement. There are 
many factors that contribute to this large dose requirement, but the potency of transplanted islets, 
and their function in the body post-transplant are of paramount concern. The potency of an islet 
preparation is affected by a plethora of factors including: donor health, extended exposure to 
brain death, pancreas condition, organ procurement and preservation methods, and islet isolation 
and culture methods. This work focuses on improving islet quality and viability which directly 
affects the therapeutic potency of the islet transplant, and gives islets the best chance of 
engraftment and survival.  
Much attention in the field is given to improving the enzymatic digestion step of the isolation 
process, but there is also significant damage to islets during the purification step366,379–381. Islets 
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experience very harsh conditions that inflict lasting damage during the mechanical and enzymatic 
digestion process374,375, but the current DG purification method significantly prolongs and 
exacerbates this damage. This study proposed the use of QMS technology as an alternative 
method for the purification of liberated islets to significantly improve islet quality and viability. 
The results presented clearly demonstrate that QMS purified islets have improved morphology, 
and significantly improved viability immediately following the isolation process. These 
improvements can be attributed to eliminating the use of harmful DG chemicals380–382 and the 
numerous functional benefits of QMS over the traditional DG purification method. During the 
digestion process, when the tissue within the closed circuit is considered to be adequately 
digested so that most or all of the islets observed in periodic samples appear to be free from the 
exocrine tissue, the digestion phase ends, and the collection phase begins. This is commonly 
called the “switch” point, when closed loop circuit is opened, and the digested tissue is slowly 
collected. Tissue that is not completely digested remains within the chamber to continue the 
digestion process. Purification using DG methods then expose islets to extended periods (up to an 
hour) of warm and cold hypoxia in the digestion solution during the collection, centrifugation 
(recombination), and COBE processes. When using the continuous islet QMS system, these steps 
are completely eliminated, and the digested tissue is transferred directly to the QMS system 
where the islets are almost immediately processed and removed from the harmful digestion 
solution. 
The islet QMS system is a continuous sorting technology previously described in the 
literature277,388 where the stream of digested tissue travels through a uniquely designed separation 
column that is surrounded by a powerful rare-earth magnet. When the tissue stream enters the 
column, it is met by a cool fresh solution stream that will travel through the column along with 
the tissue stream in a laminar flow, so that the two streams have minimal mixing. Islets that are 
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labeled with magnetic beads are quickly but gently “pulled,” by the magnetic forces, out of the 
digestion stream and into the fresh solution stream. The digestion solution contains many of the 
harmful enzymes, cytokines, and reactive oxygen species that can damage islets. Using the 
continuous QMS method within a minute or two after leaving the digestion chamber, the islets are 
removed from the damaging environment, and washed with a fresh solution stream. Using the 
current QMS technical parameters (flow rates etc.) the separated islets were pulled to the side 
wall of the column, and remain within the column for the duration of the purification. During this 
time, the purified islets were continuously washed with a stream of fresh chilled solution. After 
the purification process is complete (shortly after completion of the digestion process), the 
column was sealed, and carefully removed from the QMS system, so that the purified islets could 
be washed out, and collected for culture and quality assessment. 
In this study, QMS purified islet viability as measured by OCR/DNA immediately following 
isolation showed a 67% improvement over DG purified islets. For cases like auto-islet 
transplantation, when islets are almost immediately infused following isolation, these results 
could have profound implications. Auto-islet transplants are routinely done for patients who 
suffer from chronic pain associated with pancreatitis. The pancreatectomy is done to alleviate 
pain, and the patient’s own islets are infused to avoid diabetes. Often, the pancreas in these 
patients is in very poor condition with calcifications and fibrosis, which can significantly reduce 
the islet yield obtained during isolation. This makes the maintenance of islet dose and potency 
primary concerns when total islet mass is very limited. To ensure a maximum amount of 
transplanted islets, sometimes the purification step is avoided, and the total amount of unpurified 
tissue is infused. Literature suggests that this practice may be detrimental to islet engraftment and 
function376–378 due to the large presence of digested exocrine tissue. Some centers will do a 
purification step using density gradients to decrease the amount of exocrine tissue, and total tissue 
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volume for transplant. In these cases, when purification is desired, using QMS instead of DG 
could have a substantial impact on graft function because the purified islets would have increased 
viability and a better chance of survival post-transplant. Figure E.3A illustrates this point by 
projecting more than two-fold improvement in insulin independence rates. The total OCR 
transplanted is a reliable benchmark for predicting insulin independence in auto- and allo-islet 
transplantation26,96(and unpublished work), and this metric encompasses both the total amount of 
tissue transplanted, and the viability of that tissue. More studies focused on the application and 
optimization of QMS as a potential method for purification of islets for auto-transplant cases are 
of critical importance. 
QMS could have an even greater impact on islet allo-transplant outcomes, because islets are 
almost always purified using DG methods, and are frequently cultured for 1-2 days following 
isolation. With significant improvements in viability, the islets will survive better in culture, and 
this will increase the total number of viable islets available at the time of transplant. Figure E.3B 
predicts a 92% insulin independence rate for islet allografts if islet viability was improved by 
67% as observed with QMS purified islets. Future studies comparing the post-culture recovery of 
human islets purified by QMS and DG would be extremely valuable, and would illuminate the 
potential of this method for use in allo-transplant applications and may improve the consistency 
of purification which is problematic at present. QMS purification methods could be a big step 
toward the success of single-donor islet transplantation. 
Furthermore, as the application of porcine islet xeno-transplantation holds much promise for 
alleviating the donor organ shortage, continuous islet QMS could replace DG purification 
methods and increase the consistency and viability of isolated islet products. The field of islet 
xeno-transplantation faces many challenges and islet potency has been determined to be a critical 
metric for approval of this cellular therapy. Xenogeneic islets will be subject to great scrutiny and 
  356 
will require extensive characterization and quality control. QMS can eliminate the use of 
damaging DG chemicals, simplify and streamline the purification process, and improve overall 
preparation quality and potency. 
The results of this pilot study strongly demonstrate that QMS is a promising purification method 
for improving isolated islet quality and viability. Numerous technical parameters (eg. flow rates) 
are associated with the QMS system and critical studies with larger scope are required to optimize 
the process for improving yield and purification efficiency before clinical implementation. 
Further improvements and adjustments in equipment design and implementation for specific 
applications (eg. xeno, allo or auto transplants) may be required and may expand the benefits 
observed in this early study. It should also be noted that the islet labeling methods used for this 
study were established in literature387,295, but in conjunction with QMS equipment and process 
improvements, additional investigation is required to enhance infusion and labeling for  human 
and porcine islets. 
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Conclusion 
To conclude, this study establishes that QMS technology adapted for islet separation can be used 
to significantly improve islet quality and viability immediately post isolation as compared to DG 
purification. Despite the minimal data set, the results presented suggest that with further 
optimization, QMS could be a superior method for islet purification. This technology offers great 
promise for improving the viability of isolated porcine islets, and this application is becoming 
more relevant as xeno-transplantation is approaching clinical application. QMS technology has 
the potential for a more-immediate application to improve clinical outcomes for select islet auto-
transplantation cases, and nearly all islet allo-transplantation cases, by eliminating the use of 
DGs, and improving overall islet preparation viability. There are many challenges to overcome 
for the large-scale implantation of islet transplantation for the treatment of diabetes, but 
improving isolated islet viability is a major step toward single donor success in allo-
transplantation, and implementation of porcine islet products for xeno-transplantation.  
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Figure E.3: Projected transplant outcomes using QMS. QMS improves isolated islet viability which 
projects significantly improved insulin independence rates for clinical islet (A) autografts  and (B) 
allografts. When the observed 67% improvement in viability (OCR/DNA) for QMS separated islets is 
applied to clinical autograft and allograft data, the improvement in viable islet mass (OCRtx/kg BW) 
causes the majority of patients to overcomes the threshold for insulin independents (grey bar, or dashed 
line). This prediction (based on the limited data-set) suggests an increase in insulin independence rates to 
69% and 92% for autografts and allografts respectively.  
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 SUPPLEMENTAL REFERENCE FIGURES Appendix F
Appendix F.1: Organization 
This appendix contains figures and captions providing more details and images on the content 
from the main chapters and appendices of the Thesis. This appendix is organized into sub-
sections to coincide with the chapters or appendices of the Thesis body. If a section does not have 
supplemental figures, the heading will be included followed by “None”. 
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Appendix F.2: Whole Organ Oxygen Consumption 
 
  
Figure F.2.1: Flow type fiber optic oxygen sensor. Specialized fiber optic oxygen sensor designed for 
whole organ oxygen consumption rate measurements were designed to be reusable, stable, and MR 
compatible to allow for oxygen measurements in perfusion solutions following calibration.  
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Appendix F.3: Improving Pancreas Procurement 
None 
Appendix F.4 Hypothermic Machine Perfusion to improve organ 
preservation 
None 
Appendix F.5: Juvenile Porcine Islet Culture 
None 
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Appendix F.6: Nutrient Regulation and SSB Culture 
Figure F.6.1: Prototype outflow tubes v1. Picture of various prototype outflow tubes used to prevent the 
removal of cell-aggregates during perfusion culture in stirred suspension bioreactors. Syringes of various 
materials and diameters were tested with different “baffle” designs to prevent turbulence in the medium of 
the outflow tube. All of the tube designs were intended to maintain a volume of medium within the tube 
that is slowly removed with the linear vertical flow being slower than the settling rate of spheroids in 
culture. Turbulence was observed with all of these outflow tube designs that prevented proper function and 
did not prevent removal of aggregates in the perfusion waste stream. 
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Figure F.6.2: Prototype outflow tubes v2. Second series of outflow tube designs tested with cell 
aggregate cultures in perfusion stirred suspension bioreactors. These designs encoporated more complex 
geometries to reduce turbulence that was observed within the first series of outflow tubes tested. The most 
successful tube was a porous “fritted” glass tube that maximized the surface area for medium removal 
which minimized clogging of the filter. The linear flow velocity through each pore in the filter was much 
lower than the settling rate which prevented clogging at normal cell/aggregate densities in culture. Some 
clogging was observed at very-high cell densities (>>3.0 x 109 cells/ml), and studies were designed to 
avoid this upper limit. 
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Appendix F.7: 
19
F-MRS for Oxygen Measurement 
Figure F.7.1: Surface coil for 
19
F – 1H in vitro studies. This coil was fabricated for use on in vitro studies 
with relatively small samples. It was constructed with 2 cm x 3 cm oblong single loop surface coil made of 
silver plated coper wire with three 16 gauge wire segments. The impedance is divided in the circuit by 
including three ceramic capacitors 4.7, 4.7, 3.6 pf (American technical ceramics) which were equally 
spaced along the loop. A single variable  PTFE capacitor, 0.8 – 20 pF, was used for tuning, and two PTFE 
variable capacitors, 1.5-40 pF, were used for matching the coil (voltronics). The coil was tuned and 
matched under sample load prior to each study using a MR safe RF network analyzer. 
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Figure F.7.2: Surface coil for 
19
F – 1H in vivo studies. A second coil was fabricated for in vivo studies 
(large samples) with 2 cm x 3 cm oblong single loop surface coil made of silver plated coper wire with 
three 16 gauge wire segments. The impedance is divided in the circuit by including three 3.9 pF ceramic 
capacitors (American technical ceramics) which were equally spaced along the loop. A single variable 
PTFE capacitor, 1 – 19 pF, was used for tuning, and two variable PTFE capacitors, 1.5-40 pF, were used 
for matching the coil (voltronics). The coil was tuned and matched under sample load prior to each study 
using a MR safe RF network analyzer. 
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Figure F.7.3: Rat hammock v1 and v2. A custom restraint system was designed for rat studies in the 16.4 
T MR system. The frame of the first version (v1) was composed of wood (top), and the updated version of 
the frame (v2) was made of a polycarbonate semi-cylinder and an ABS plastic end for mounting (bottom). 
The outer diameter of the frame was 11 cm in diameter to coincide with the functional bore diameter of the 
16.4 T MR system. Holes were included on either end to allow for un-obstructed cable travel, and strain 
relief. A notch was also included in the “superior” side of the frame to allow for the anesthesia nose-cone to 
sit in position. 
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Figure F.7.4: Rat hammock v2 mock-up. The updated version of the rat hammock is shown with coil and 
“hammock” in place. The entire apparatus was attached to the end of a guide to provide a means of 
centering the animal in the bore of the 16.4 T MR system. The coil rested in the bottom-center of the 
polycarbonate frame as shown, and coil tuning capacitors were accessed through access slots in the side of 
the frame. The coil could also be positioned in the axial direction by sliding along the bottom of the frame 
to align perfectly with the implanted device in the animal. The hammock itself was made from a stitched 
piece of MR compatible mesh (fiberglass), and was held in-place on the frame with elastic bands. 
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Figure F.7.5: Perfusion bioreactor picture. A perfusion bioreactor was designed and comprised a 
polycarbonate lid with ports for heat-exchanger circulation. The lid was fastened tightly to the main 
chamber using 6 nylon screws to distribute the force needed to adequately seal against the chamber. A thin 
0.5 mm silicon rubber gasket was used at the matting surface to provide a water and air-tight seal. The 
chamber was made of polyoxymethylene (acetal resin, Delrin) plastic, and a central chamber was machined 
to accommodate a TheraCyte device. Three access ports were included on each longitudinal end of the 
chamber to provide access for instrumentation, and for circulating perfusion medium through the central 
chamber. The approximate external dimensions of the assembly were 3.5” x 1.75” x 1” (L x W x H), and 
the internal chamber dimensions were approximately 2.5” x 0.75” x 0.125” (L x W x H). 
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Figure F.7.6: TheraCyte devices with scale. Three different sized TheraCyte devices were used for the 
included studies. The construction of each implant was the same, and only the geometric dimensions were 
scaled to accommodate different cell-doses. 
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Figure F.7.7: TheraCyte devices modified for in vivo cannulation. A subcutaneous MR compatible 
catheter access port (Access Technologies) was attached to the loading port on the TheraCyte devices to 
allow for cannulation or catheterization of the implanted TheraCyte device. These modified devices were 
used for studies that required cannulation with a fiber optic oxygen probe. This provided a means of sterile 
access to the cell compartment of TheraCyte devices, and the fiber optic probe could be inserted using a 
trocar needle and a catheter.  
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Figure F.7.8: TheraCyte with access port. Image of the prototype modified TheraCyte device with 
attached access port. 
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Figure F.7.9: Fiber optic oxygen probe. Image of custom designed MR compatible ultra-thin fiber optic 
oxygen probe (Ocean Optics) built for in vivo validation studies. These probes were designed to be 
extended in length and with MR compatible materials to avoid RF interference and magnetic induced 
mechanical stresses. The ultra-thin single fiber tip was 250 µm in diameter to allow for cannulation through 
the access port of modified TheraCyte devices. 
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Appendix F.8: Oxygenation of implanted TEGs 
 
   
Figure F.8.1: Picture of three-chamber TheraCyte modified for DSO. With the assistance of TheraCyte 
inc. the 40 µL TheraCyte devices was modified to include three chambers with 4 access ports. The lateral 
ports provide access to the top and bottom “cell” chambers, and the two longitudinal ports provide access 
to the central “oxygen” chamber. This initial concept was further adapted for in vivo studies. 
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Figure F.8.2: Illustration of TheraCyte modified for DSO. The TheraCyte devices was further modified 
in the lab to accommodate the surgical convenience of locating the gas inlet and outlet on the same side of 
the device. One lateral port accessing the oxygen chamber was sealed with surgical-grade silicon adhesive. 
The remaining port was adapted to include two 1 fr polyurethane cannulas which were placed inside the 
oxygen chamber to facilitate DSO to the central chamber. The inlet cannula extended to the far side of the 
oxygen chamber, and the outlet cannula only protruded slightly into the chamber. This arrangement 
ensured adequate oxygen gas filling of the internal oxygen chamber. The 1 fr cannulas were adapted to 
larger gauge 3 fr polyurethane cannulas to facilitate connection to the harness, and a short section of silicon 
rubber tubing surrounded the connection points to provide added strain-relief and additional leak 
protection. All of the gaps in the adapter were sealed with silicon medical adhesive to ensure air-tight seals. 
All devices were leak-tested prior to ETO sterilization in preparation for implantation in rats. Prior to 
implantation, the devices were loaded with cells (or islets) in a sterile manner, and the cell chamber access 
ports were sealed with medical grade silicon adhesive. 
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Figure F.8.3: Picture with scale of DSO modified TheraCyte device. 
  376 
  
Figure F.8.4: Dual-channel harness and tether apparatus. Pictures and illustration showing harness 
location on rats, and dual-channel access with swivel showing oxygen flow into and out of the TheraCyte 
device modified for DSO. The device shown was further modified to allow for gas inflow and outflow of 
the same lateral access port. 
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Figure F.8.5: DSO manifold schematic diagram. A DSO manifold was designed in cooperation with 
Giner Inc. to monitor and regulate oxygen delivery pressure and flow to individual channels (up to 8). The 
original electrochemical oxygen concentrator (EOC) was modified to delivery a continuous stream of 
oxygen gas to the manifold, and the manifold was equipped with up to 8 individual channels with needle 
valves for flow control and a pressure gauge to monitor individual delivery pressure. Three-way valves 
(stopcocks) were used to re-direct the flow from a single channel at a time through unique flow path that 
includes a precision ultra-low flow gas flow meter (FM). This approach was employed to avoid individual 
precision FM for each channel which added exorbitant cost to the manifold construction. When an 
individual channel was adjusted, the three way valves were oriented to redirect flow through the FM so that 
the flow and pressure could be controlled and monitored. 
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Figure F.8.6: Pictures of custom assembled DSO manifold. Individual channels shown on the left, and 
close-up view of an individual channel with needle valve, three-way valves, and pressure gauge shown on 
the right. The precision digital mass-air flow meter is also shown on the right (black box). The manifold 
was connected to the EOC with two independent in-line pressure relief valves to prevent an over-pressure 
condition that may damage the manifold, implanted device, or animal. The maximum allowable pressure 
was 3 psi (83 inches of water). 
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Figure F.8.7: Animal cage lid modified for DSO. Each manifold channel was connected to a delivery 
port on modified cage-lids for each animal in the study. Oxygen gas was delivered from the EOC through 
the manifold, and to the cage lid through a sterile .22 µm syringe filter. 
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Figure F.8.8: Pictures of DSO harness and tether apparatus. A port was added to each cage lid for 
animals receiving DSO. The exterior port of the cage lid was connected to the DSO manifold, and the 
interior port of the cage lid was attached to the tether apparatus (Instech Labs.) The entire cage set-up with 
counter-balance, tether, and harness apparatus is picture on top, and view from above shows the tether 
apparatus attached to the dual-channel harness on the animal  (animal is illustrated as a toy cow in photo). 
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Figure F.8.9: Dual-channel harness pictures. The dual-channel harness was attached to the tether 
connector shown on top, and DSO connections from TheraCyte device were attached to nitinol ports on the 
underside of the harness. The inlet and outlet cannulas of the modified TheraCyte device protruded through 
the closed incision and attached to the nitinol ports. The harness was custom manufactured by Instech Labs 
with nitinol ports to reduce RF interference and improve MR compatibility. 
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Figure F.8.10: Dual-channel harness shown in position. The harness was positioned securely on the 
dorsal side of the rat and tightened to provide a snug fit so that the harness covered the incision and the 
protruding cannulas. This arrangement provided protection from the animal and strain-relief for the cannula 
adapters connecting the cannulas to the TheraCyte device. 
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Appendix F.A: Porcine Pancreas Anatomy 
None 
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Appendix F.B: Persufflation Improves Pancreas Preservation 
  
Figure F.B.1: First pig/human organ persufflation preservation system. The persufflator 
(eletrochemical oxygen concentrator) was designed by Giner Inc. and was attached to a pressure and flow 
regulating manifold to deliver humidified gas to the vasculature of a preserved organ. The organ 
temperature was maintained at hypothermic levels (~ 8 °C) using a cooler (electric active cooler pictured), 
or by keeping the entire system inside a “cold room” refrigerator. 
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Figure F.B.2: Illustration of hypothetical ATP levels. Predicted ATP changes for organs 
preserved by (A) static cold storage and periodic oxygenation with persufflation and (B) 
persufflation with constant oxygenation. The ATP levels observed without oxygenation are not 
detectible, and it is hypothesized that when oxygen is delivered via persufflation the ATP levels 
will increase to reflect the organ viability at that time. With continuous oxygenation of tissues via 
persufflation, it is hypothesized that ATP levels will remain at detectible levels, and slowly 
decrease over time as organ viability decreases during the preservation period. 
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Figure F.B.3: Two loop Surface coil for 31P-MRS studies. Surface coil for measuring ATP with 31P-
MRS at 1.5 T in organs during perfusion or persufflation. The coil was designed to accommodate various 
organs sizes (pig organs), for convenient placement within the water jacket, and for manual tuning within 
the MR system. A coil with similar design was used for 1H-MRI during the same studies.  
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Figure F.B.4: Water jacket schematic. Water jacket was used with a circulating water bath for chilling 
organs and tissues when scanned in the 1.5 T MR system. This was used for scanning organs during long 
term cold preservation studies, and maintained temperature of the organ and tissues between 4-8°C. The 
water jacket was designed to accommodate various MR coil designs and an organ container. 
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Figure F.B.5: First-generation PSF organ container schematic. Container designed to accommodate 
perfusion or persufflation of preserved organs, and even multiple organs. 
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Figure F.B.6: First-generation organ container lid. Container lid is equipped with multiple access ports 
to facilitate organ perfusion or persufflation. 
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Figure F.B.7: Picture of 
31
P-MRS study experimental set-up. Experimental set-up showing the water 
jacket with 31P-MRS coil (shown on bottom), 1H-MRI coil (shown on top) and organ container.  
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Figure F.B.8: Integration analysis of 
31
P-MRS spectrum. Representative 13P-MRS spectrum 
from a human pancreas oxygenated by persufflation (PSF) with peak assignment and integration 
analysis. Dimethyl methylphosphonate (DMMP) standard, phosphomonoester, inorganic 
phosphate (Pi), and α, β, and γ ATP peaks are shown with calculated integration areas. These 
areas were compared to report the β-ATP:Pi ratios, and the total ATP:Pi ratios for these studies.
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Appendix F.C: Using MRI to Improve Enzyme Distribution 
None 
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Appendix F.D: Improving Islet Shipment 
 
Figure F.D.1: First generation Wilson Wolf SRM culture devices. These images illustrate the 
importance of temperature regulation during islet shipment, and confirm that the culture vessel contents 
freeze solid when external temperatures are below -20 °C for 24 hours. 
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Figure F.D.2: TheramSure and TCP temperature stabilizing materials. These two materials were 
tested for regulating temperature during islet shipment. The ThermaSure (TS) temperature stabilizing 
material was intended for maintaining temperatures between 16-20 °C and was originally intended for 
transporting blood products. The TCP Phase Change Material (PCM) was intended for maintaining 
temperatures between 20-22 °C, and was investigated as an alternative to TS material due to its improved 
thermal regulatory capacity and because the targeted temperature range coincided well with the standard 
culture temperature used for human islet cultures (22 °C). 
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Figure F.D.3: Preparation of ThermaSure and TCP materials. The recommended preparation and 
loading of temperature stabilizing materials for islet shipment. 
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Figure F.D.4: ThermoSafe and Red Box shipping containers. The ThermoSafe container is the standard 
container recommended for islet shipment, and the Red Box container was investigated as an alternative 
container with improved durability and insulation. 
  397 
   
Figure F.D.5: Beverage container for temperature and pressure regulation. A thermos beverage 
container was proposed for maintaining temperature and pressure of islets during shipment, but was 
abandoned due to difficulty with form-factor. 
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Figure F.D.6: Pressure regulated gyroscopic shipping container (PRGSC). A custom-built pressure 
regulated gyroscopic shipping container was designed and manufactured by Wilson-Wolf Manufacturing 
for studies to investigate the pressure effects on islets during culture and shipment. This container was 
designed to work with silicon rubber membrane flasks that function when they are properly oriented 
(upright), so a gyroscopic mechanism was included in the container to ensure ideal flask orientation during 
shipment. These devices were tested in a vacuum chamber to simulate the pressure changes experienced 
during shipment in the cargo-hold of cargo air-shipments. 
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Figure F.D.7: PRGSC shown with SRM flask. The flask was held in position within the gyroscope using 
a strap and magnetic contacts. The lid created a air-tight seal with the cylinder to maintain normal 
atmospheric pressures (~760 mmHg) during shipment. 
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Appendix F.E: QMS for Improving Islet Purification 
None. 
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 COPYRIGHT PERMISSIONS AND LICENSES Appendix G
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  402 
  403 
  404 
  405 
  406 
  407 
  408 
  409 
  410 
  411 
  412 
  413 
  414 
  415 
  416 
  417 
  418 
  419 
  420 
  421 
  422 
  423 
  424 
  425 
  426 
  427 
  428 
  429 
  430 
  431 
 
  
  432 
  433 
  434 
  435 
  436 
  437 
  438 
 
  
  439 
  440 
  441 
  442 
  443 
  444 
  445 
 
  
  446 
Appendix G.2: Referenced Theses Permissions 
 
  
  447 
Appendix G.3: Figures Reproduced with Permission 
  
  448 
 
  
  449 
  
